JPH03206042A - Hypotensor - Google Patents
HypotensorInfo
- Publication number
- JPH03206042A JPH03206042A JP2000833A JP83390A JPH03206042A JP H03206042 A JPH03206042 A JP H03206042A JP 2000833 A JP2000833 A JP 2000833A JP 83390 A JP83390 A JP 83390A JP H03206042 A JPH03206042 A JP H03206042A
- Authority
- JP
- Japan
- Prior art keywords
- melting point
- amino
- thiazolo
- nmr
- title compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 278
- 125000001424 substituent group Chemical group 0.000 claims abstract description 57
- 125000003118 aryl group Chemical group 0.000 claims abstract description 32
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 20
- 150000003839 salts Chemical class 0.000 claims abstract description 18
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 25
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 16
- 125000003342 alkenyl group Chemical group 0.000 claims description 13
- 125000003277 amino group Chemical group 0.000 claims description 11
- 239000002220 antihypertensive agent Substances 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 229940030600 antihypertensive agent Drugs 0.000 claims description 9
- 125000002252 acyl group Chemical group 0.000 claims description 8
- 125000003282 alkyl amino group Chemical group 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims 3
- 125000000542 sulfonic acid group Chemical group 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 8
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract description 7
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 2
- 102000004257 Potassium Channel Human genes 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 108020001213 potassium channel Proteins 0.000 abstract description 2
- XZBZPCBDCPTAFZ-UHFFFAOYSA-N 2-[2-(4-chlorophenyl)ethenyl]-5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepine Chemical compound C1=CC(Cl)=CC=C1C=CC(S1)=NC2=C1NCCCC2 XZBZPCBDCPTAFZ-UHFFFAOYSA-N 0.000 abstract 1
- WRDQLFOQEXCULO-UHFFFAOYSA-N 2h-[1,3]thiazolo[5,4-b]azepine Chemical class C1=CC=CC2=NCSC2=N1 WRDQLFOQEXCULO-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- 238000002844 melting Methods 0.000 description 238
- 230000008018 melting Effects 0.000 description 238
- 238000000921 elemental analysis Methods 0.000 description 174
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 169
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 133
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 98
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 92
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 72
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 66
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 66
- -1 propyl i-propyl Chemical group 0.000 description 64
- 238000000034 method Methods 0.000 description 58
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 55
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 46
- 238000006243 chemical reaction Methods 0.000 description 46
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 45
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 44
- 239000002904 solvent Substances 0.000 description 41
- 238000000746 purification Methods 0.000 description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 36
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 36
- 150000003951 lactams Chemical class 0.000 description 34
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 32
- 239000000243 solution Substances 0.000 description 32
- 239000000203 mixture Substances 0.000 description 31
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 29
- 125000000217 alkyl group Chemical group 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 239000000047 product Substances 0.000 description 28
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 25
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 21
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 21
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 21
- 238000001816 cooling Methods 0.000 description 20
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 19
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 19
- 238000003756 stirring Methods 0.000 description 19
- PJHKXESPJOFGOA-UHFFFAOYSA-N 1h-azepine;dihydrochloride Chemical compound Cl.Cl.N1C=CC=CC=C1 PJHKXESPJOFGOA-UHFFFAOYSA-N 0.000 description 16
- 239000002253 acid Substances 0.000 description 16
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 16
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 16
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 15
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 14
- 238000010898 silica gel chromatography Methods 0.000 description 14
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 12
- 235000017557 sodium bicarbonate Nutrition 0.000 description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 11
- 239000012264 purified product Substances 0.000 description 11
- 229920006395 saturated elastomer Polymers 0.000 description 11
- AYTCWEGTCFBTLJ-UHFFFAOYSA-N 4h-[1,3]thiazolo[5,4-b]azepine Chemical compound N1C=CC=CC2=C1SC=N2 AYTCWEGTCFBTLJ-UHFFFAOYSA-N 0.000 description 10
- 238000001035 drying Methods 0.000 description 10
- 229910052736 halogen Inorganic materials 0.000 description 10
- 150000002367 halogens Chemical class 0.000 description 10
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 10
- 235000019341 magnesium sulphate Nutrition 0.000 description 10
- 238000006386 neutralization reaction Methods 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- AJUMGSLQADLWKL-UHFFFAOYSA-N 1h-azepine;hydrochloride Chemical compound Cl.N1C=CC=CC=C1 AJUMGSLQADLWKL-UHFFFAOYSA-N 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 230000008602 contraction Effects 0.000 description 9
- 230000003472 neutralizing effect Effects 0.000 description 9
- 150000001412 amines Chemical class 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 238000004440 column chromatography Methods 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 229910000027 potassium carbonate Inorganic materials 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 238000001953 recrystallisation Methods 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 8
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 7
- 239000000460 chlorine Substances 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 239000012046 mixed solvent Substances 0.000 description 7
- 125000004076 pyridyl group Chemical group 0.000 description 7
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 6
- VTQGYRVGBASLDF-UHFFFAOYSA-N 4-aminoazepan-2-one Chemical compound NC1CCCNC(=O)C1 VTQGYRVGBASLDF-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 5
- 125000003545 alkoxy group Chemical group 0.000 description 5
- 125000000304 alkynyl group Chemical group 0.000 description 5
- 230000003276 anti-hypertensive effect Effects 0.000 description 5
- 125000002837 carbocyclic group Chemical group 0.000 description 5
- 125000004093 cyano group Chemical group *C#N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 125000004414 alkyl thio group Chemical group 0.000 description 4
- GFHNAMRJFCEERV-UHFFFAOYSA-L cobalt chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Co+2] GFHNAMRJFCEERV-UHFFFAOYSA-L 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 108010083133 potassium channel protein I(sk) Proteins 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 3
- 241000255925 Diptera Species 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
- 125000005907 alkyl ester group Chemical group 0.000 description 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 3
- 239000002168 alkylating agent Substances 0.000 description 3
- 229940100198 alkylating agent Drugs 0.000 description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 3
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- 125000004043 oxo group Chemical group O=* 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 2
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 2
- SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 2
- ANOUKFYBOAKOIR-UHFFFAOYSA-N 3,4-dimethoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1OC ANOUKFYBOAKOIR-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- VKCLPVFDVVKEKU-UHFFFAOYSA-N S=[P] Chemical compound S=[P] VKCLPVFDVVKEKU-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 2
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 125000001589 carboacyl group Chemical group 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 2
- 229930016911 cinnamic acid Natural products 0.000 description 2
- 235000013985 cinnamic acid Nutrition 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- 125000006627 ethoxycarbonylamino group Chemical group 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- WTBAHSZERDXKKZ-UHFFFAOYSA-N octadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCCCC(Cl)=O WTBAHSZERDXKKZ-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 2
- 239000004036 potassium channel stimulating agent Substances 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- FEIQOMCWGDNMHM-KBXRYBNXSA-N (2e,4e)-5-phenylpenta-2,4-dienoic acid Chemical compound OC(=O)\C=C\C=C\C1=CC=CC=C1 FEIQOMCWGDNMHM-KBXRYBNXSA-N 0.000 description 1
- QVHJQCGUWFKTSE-YFKPBYRVSA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)OC(C)(C)C QVHJQCGUWFKTSE-YFKPBYRVSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- RRLUFPHCTSFKNR-DUXPYHPUSA-N (e)-3-(3,4-dichlorophenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=C(Cl)C(Cl)=C1 RRLUFPHCTSFKNR-DUXPYHPUSA-N 0.000 description 1
- CQNPVMCASGWEHM-VMPITWQZSA-N (e)-3-[4-(dimethylamino)phenyl]prop-2-enoic acid Chemical compound CN(C)C1=CC=C(\C=C\C(O)=O)C=C1 CQNPVMCASGWEHM-VMPITWQZSA-N 0.000 description 1
- WOGITNXCNOTRLK-VOTSOKGWSA-N (e)-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=CC=C1 WOGITNXCNOTRLK-VOTSOKGWSA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- FEGVSPGUHMGGBO-SREVYHEPSA-N (z)-3-(2-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=CC=C1\C=C/C(O)=O FEGVSPGUHMGGBO-SREVYHEPSA-N 0.000 description 1
- YHRUOJUYPBUZOS-UHFFFAOYSA-N 1,3-dichloropropane Chemical compound ClCCCCl YHRUOJUYPBUZOS-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- VZMPWPUYTWKDJG-UHFFFAOYSA-N 1-(2-phenyl-5,6,7,8-tetrahydro-[1,3]thiazolo[5,4-b]azepin-4-yl)octadecan-1-one Chemical compound S1C=2N(C(=O)CCCCCCCCCCCCCCCCC)CCCCC=2N=C1C1=CC=CC=C1 VZMPWPUYTWKDJG-UHFFFAOYSA-N 0.000 description 1
- AVJKDKWRVSSJPK-UHFFFAOYSA-N 1-(4-fluorophenyl)piperazine Chemical compound C1=CC(F)=CC=C1N1CCNCC1 AVJKDKWRVSSJPK-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- YZWKKMVJZFACSU-UHFFFAOYSA-N 1-bromopentane Chemical compound CCCCCBr YZWKKMVJZFACSU-UHFFFAOYSA-N 0.000 description 1
- UZIBPOIXTCIHBH-UHFFFAOYSA-N 1-chlorohex-1-ene Chemical compound CCCCC=CCl UZIBPOIXTCIHBH-UHFFFAOYSA-N 0.000 description 1
- IVVNZDGDKPTYHK-JTQLQIEISA-N 1-cyano-2-[(2s)-3,3-dimethylbutan-2-yl]-3-pyridin-4-ylguanidine Chemical compound CC(C)(C)[C@H](C)N=C(NC#N)NC1=CC=NC=C1 IVVNZDGDKPTYHK-JTQLQIEISA-N 0.000 description 1
- BFWYTORDSFIVKP-VAEKSGALSA-N 15(S)-HPETE Chemical compound CCCCC[C@H](OO)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O BFWYTORDSFIVKP-VAEKSGALSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- BIAIZATYCMOMBP-UHFFFAOYSA-N 1h-azepine;oxalic acid Chemical compound OC(=O)C(O)=O.N1C=CC=CC=C1 BIAIZATYCMOMBP-UHFFFAOYSA-N 0.000 description 1
- VFYFMNCKPJDAPV-UHFFFAOYSA-N 2,2'-(5-oxo-1,3-dioxolan-4,4-diyl)diessigs Chemical compound C1N(C2)CN3CN1CN2C3.OC(=O)CC1(CC(O)=O)OCOC1=O VFYFMNCKPJDAPV-UHFFFAOYSA-N 0.000 description 1
- NJYBIFYEWYWYAN-UHFFFAOYSA-N 2,4-difluorobenzoic acid Chemical compound OC(=O)C1=CC=C(F)C=C1F NJYBIFYEWYWYAN-UHFFFAOYSA-N 0.000 description 1
- ONOTYLMNTZNAQZ-UHFFFAOYSA-N 2,6-difluorobenzoic acid Chemical compound OC(=O)C1=C(F)C=CC=C1F ONOTYLMNTZNAQZ-UHFFFAOYSA-N 0.000 description 1
- GGYQIZQYVRYNBU-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepine Chemical compound FC1=CC(F)=CC=C1C(S1)=NC2=C1NCCCC2 GGYQIZQYVRYNBU-UHFFFAOYSA-N 0.000 description 1
- ZQLHMKCXFAAADK-UHFFFAOYSA-N 2-(4-methoxyphenyl)-5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepine;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1C(S1)=NC2=C1NCCCC2 ZQLHMKCXFAAADK-UHFFFAOYSA-N 0.000 description 1
- KBDLTYNZHQRMQC-UHFFFAOYSA-N 2-(4-methoxyphenyl)propanoic acid Chemical compound COC1=CC=C(C(C)C(O)=O)C=C1 KBDLTYNZHQRMQC-UHFFFAOYSA-N 0.000 description 1
- DACBICUQFYZQEW-UHFFFAOYSA-N 2-(4-phenylbuta-1,3-dienyl)-5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepine Chemical compound S1C=2NCCCCC=2N=C1C=CC=CC1=CC=CC=C1 DACBICUQFYZQEW-UHFFFAOYSA-N 0.000 description 1
- PGCSZPCDIDIMAM-UHFFFAOYSA-N 2-(5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepin-2-yl)ethanamine;dihydrochloride Chemical compound Cl.Cl.C1CCCNC2=C1N=C(CCN)S2 PGCSZPCDIDIMAM-UHFFFAOYSA-N 0.000 description 1
- DVVXXHVHGGWWPE-UHFFFAOYSA-N 2-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=CC=C1C(O)=O DVVXXHVHGGWWPE-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- BXKKANHRUUQUGA-UHFFFAOYSA-N 2-[2-(1h-imidazol-5-yl)ethenyl]-5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepine;dihydrochloride Chemical compound Cl.Cl.S1C=2NCCCCC=2N=C1C=CC1=CNC=N1 BXKKANHRUUQUGA-UHFFFAOYSA-N 0.000 description 1
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 1
- NBUUUJWWOARGNW-UHFFFAOYSA-N 2-amino-5-methylbenzoic acid Chemical compound CC1=CC=C(N)C(C(O)=O)=C1 NBUUUJWWOARGNW-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- BOWUOGIPSRVRSJ-UHFFFAOYSA-N 2-aminohexano-6-lactam Chemical compound NC1CCCCNC1=O BOWUOGIPSRVRSJ-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- RAAGZOYMEQDCTD-UHFFFAOYSA-N 2-fluorobenzoyl chloride Chemical compound FC1=CC=CC=C1C(Cl)=O RAAGZOYMEQDCTD-UHFFFAOYSA-N 0.000 description 1
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
- QDZGJAJEMFIUCF-UHFFFAOYSA-N 2-methyl-n-(2-oxoazepan-4-yl)-3-phenylprop-2-enamide Chemical compound C1CCNC(=O)CC1NC(=O)C(C)=CC1=CC=CC=C1 QDZGJAJEMFIUCF-UHFFFAOYSA-N 0.000 description 1
- COPSJQVPEUUOKY-UHFFFAOYSA-N 2-methylsulfanylpyridine-3-carboxylic acid Chemical compound CSC1=NC=CC=C1C(O)=O COPSJQVPEUUOKY-UHFFFAOYSA-N 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- DAUAQNGYDSHRET-UHFFFAOYSA-N 3,4-dimethoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1OC DAUAQNGYDSHRET-UHFFFAOYSA-N 0.000 description 1
- WBKTZOKHVUJKIP-UHFFFAOYSA-N 3-(1-methylimidazol-4-yl)prop-2-enoic acid Chemical compound CN1C=NC(C=CC(O)=O)=C1 WBKTZOKHVUJKIP-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- LXSQYTCOTVWNMS-UHFFFAOYSA-N 3-(3-amino-4-methylphenyl)prop-2-enoic acid Chemical compound CC1=CC=C(C=CC(O)=O)C=C1N LXSQYTCOTVWNMS-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- BLGNHBRAQBHMAB-UHFFFAOYSA-N 3-[3-methoxy-4-(methylsulfanylmethoxy)phenyl]prop-2-enoic acid Chemical compound COC1=CC(C=CC(O)=O)=CC=C1OCSC BLGNHBRAQBHMAB-UHFFFAOYSA-N 0.000 description 1
- DOERLUCWEUSMIF-UHFFFAOYSA-N 3-[4-(diethylazaniumyl)phenyl]prop-2-enoate Chemical compound CCN(CC)C1=CC=C(C=CC(O)=O)C=C1 DOERLUCWEUSMIF-UHFFFAOYSA-N 0.000 description 1
- XKFIFYROMAAUDL-UHFFFAOYSA-N 3-amino-4-methylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C=C1N XKFIFYROMAAUDL-UHFFFAOYSA-N 0.000 description 1
- INUNLMUAPJVRME-UHFFFAOYSA-N 3-chloropropanoyl chloride Chemical compound ClCCC(Cl)=O INUNLMUAPJVRME-UHFFFAOYSA-N 0.000 description 1
- YDIYEOMDOWUDTJ-UHFFFAOYSA-N 4-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=C(C(O)=O)C=C1 YDIYEOMDOWUDTJ-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- XRHGYUZYPHTUJZ-UHFFFAOYSA-N 4-chlorobenzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C=C1 XRHGYUZYPHTUJZ-UHFFFAOYSA-N 0.000 description 1
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 1
- GXLIFJYFGMHYDY-ZZXKWVIFSA-N 4-chlorocinnamic acid Chemical compound OC(=O)\C=C\C1=CC=C(Cl)C=C1 GXLIFJYFGMHYDY-ZZXKWVIFSA-N 0.000 description 1
- UYBTXTORMJOMJC-UHFFFAOYSA-N 4-cyano-3-ethylbenzoic acid Chemical compound CCC1=CC(C(O)=O)=CC=C1C#N UYBTXTORMJOMJC-UHFFFAOYSA-N 0.000 description 1
- LTRYUAZFLOGRLJ-UHFFFAOYSA-N 4-cyano-3-methylbenzoic acid Chemical compound CC1=CC(C(O)=O)=CC=C1C#N LTRYUAZFLOGRLJ-UHFFFAOYSA-N 0.000 description 1
- RQZAOZFUPDCSMU-UHFFFAOYSA-N 4-methoxy-n-(2-oxoazepan-4-yl)benzamide Chemical compound C1=CC(OC)=CC=C1C(=O)NC1CC(=O)NCCC1 RQZAOZFUPDCSMU-UHFFFAOYSA-N 0.000 description 1
- NNJMFJSKMRYHSR-UHFFFAOYSA-N 4-phenylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=CC=C1 NNJMFJSKMRYHSR-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- VNHBYKHXBCYPBJ-UHFFFAOYSA-N 5-ethynylimidazo[1,2-a]pyridine Chemical compound C#CC1=CC=CC2=NC=CN12 VNHBYKHXBCYPBJ-UHFFFAOYSA-N 0.000 description 1
- ZKAQPVQEYCFRTK-UHFFFAOYSA-N 5-methyl-1,2-oxazole-4-carbonyl chloride Chemical compound CC=1ON=CC=1C(Cl)=O ZKAQPVQEYCFRTK-UHFFFAOYSA-N 0.000 description 1
- IFLKEBSJTZGCJG-UHFFFAOYSA-N 5-methyl-2-thiophenecarboxylic acid Natural products CC=1C=CSC=1C(O)=O IFLKEBSJTZGCJG-UHFFFAOYSA-N 0.000 description 1
- VCNGNQLPFHVODE-UHFFFAOYSA-N 5-methylthiophene-2-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)S1 VCNGNQLPFHVODE-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- DFXQXFGFOLXAPO-UHFFFAOYSA-N 96-99-1 Chemical compound OC(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 DFXQXFGFOLXAPO-UHFFFAOYSA-N 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 125000006538 C11 alkyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000017399 Caesalpinia tinctoria Nutrition 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N Caprolactam Natural products O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102100034744 Cell division cycle 7-related protein kinase Human genes 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241001573186 Citrus keraji Species 0.000 description 1
- TVZCRIROJQEVOT-UHFFFAOYSA-N Cromakalim Chemical compound OC1C(C)(C)OC2=CC=C(C#N)C=C2C1N1CCCC1=O TVZCRIROJQEVOT-UHFFFAOYSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 102100028138 F-box/WD repeat-containing protein 7 Human genes 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000945740 Homo sapiens Cell division cycle 7-related protein kinase Proteins 0.000 description 1
- 101001060231 Homo sapiens F-box/WD repeat-containing protein 7 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OWIKHYCFFJSOEH-UHFFFAOYSA-N Isocyanic acid Chemical compound N=C=O OWIKHYCFFJSOEH-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 101100241859 Mus musculus Oacyl gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- ZVIDMSBTYRSMAR-UHFFFAOYSA-N N-Methyl-4-aminobenzoate Chemical compound CNC1=CC=C(C(O)=O)C=C1 ZVIDMSBTYRSMAR-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 102100026123 Pirin Human genes 0.000 description 1
- 101710176373 Pirin Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229940127315 Potassium Channel Openers Drugs 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229910018105 SCl2 Inorganic materials 0.000 description 1
- 101000650578 Salmonella phage P22 Regulatory protein C3 Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000388430 Tara Species 0.000 description 1
- 101001040920 Triticum aestivum Alpha-amylase inhibitor 0.28 Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 101001135436 Urodacus yaschenkoi Antimicrobial peptide scorpine-like-2 Proteins 0.000 description 1
- GPVDHNVGGIAOQT-UHFFFAOYSA-N Veratric acid Natural products COC1=CC=C(C(O)=O)C(OC)=C1 GPVDHNVGGIAOQT-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 239000004004 anti-anginal agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 125000004659 aryl alkyl thio group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000004653 carbonic acids Chemical class 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- FEIQOMCWGDNMHM-UHFFFAOYSA-N cinnamylideneacetic acid Natural products OC(=O)C=CC=CC1=CC=CC=C1 FEIQOMCWGDNMHM-UHFFFAOYSA-N 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000003184 effect on constriction Effects 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- SRCUUTCUWBEXIW-UHFFFAOYSA-N ethyl 3-(5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepin-2-yl)benzenecarboximidate Chemical compound CCOC(=N)C1=CC=CC(C=2SC=3NCCCCC=3N=2)=C1 SRCUUTCUWBEXIW-UHFFFAOYSA-N 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical group Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 150000007928 imidazolide derivatives Chemical class 0.000 description 1
- 125000005945 imidazopyridyl group Chemical group 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000006626 methoxycarbonylamino group Chemical group 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- ZXUQEPZWVQIOJE-UHFFFAOYSA-N methyl 2-chloro-2-oxoacetate Chemical compound COC(=O)C(Cl)=O ZXUQEPZWVQIOJE-UHFFFAOYSA-N 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- WFGHQKYXGHELTJ-UHFFFAOYSA-N n,n-dimethyl-3-(5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepin-2-yl)aniline Chemical compound CN(C)C1=CC=CC(C=2SC=3NCCCCC=3N=2)=C1 WFGHQKYXGHELTJ-UHFFFAOYSA-N 0.000 description 1
- AOKZDSCBFYEQOY-UHFFFAOYSA-N n-(2-oxoazepan-4-yl)-2,3-diphenylprop-2-enamide Chemical compound C=1C=CC=CC=1C=C(C=1C=CC=CC=1)C(=O)NC1CCCNC(=O)C1 AOKZDSCBFYEQOY-UHFFFAOYSA-N 0.000 description 1
- NSNPSJGHTQIXDO-UHFFFAOYSA-N naphthalene-1-carbonyl chloride Chemical compound C1=CC=C2C(C(=O)Cl)=CC=CC2=C1 NSNPSJGHTQIXDO-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- LBHIOVVIQHSOQN-UHFFFAOYSA-N nicorandil Chemical compound [O-][N+](=O)OCCNC(=O)C1=CC=CN=C1 LBHIOVVIQHSOQN-UHFFFAOYSA-N 0.000 description 1
- 229960002497 nicorandil Drugs 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001301 oxygen Chemical group 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- RLZZZVKAURTHCP-UHFFFAOYSA-N phenanthrene-3,4-diol Chemical compound C1=CC=C2C3=C(O)C(O)=CC=C3C=CC2=C1 RLZZZVKAURTHCP-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000007699 photoisomerization reaction Methods 0.000 description 1
- 229960002310 pinacidil Drugs 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- NPSSWQJHYLDCNV-UHFFFAOYSA-N prop-2-enoic acid;hydrochloride Chemical compound Cl.OC(=O)C=C NPSSWQJHYLDCNV-UHFFFAOYSA-N 0.000 description 1
- RIBFXMJCUYXJDZ-UHFFFAOYSA-N propanoyl bromide Chemical compound CCC(Br)=O RIBFXMJCUYXJDZ-UHFFFAOYSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 description 1
- GSUAURPIYWEOII-UHFFFAOYSA-N pyridine-3-carboxamide;dihydrochloride Chemical compound Cl.Cl.NC(=O)C1=CC=CN=C1 GSUAURPIYWEOII-UHFFFAOYSA-N 0.000 description 1
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005017 substituted alkenyl group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003461 sulfonyl halides Chemical class 0.000 description 1
- 230000006103 sulfonylation Effects 0.000 description 1
- 238000005694 sulfonylation reaction Methods 0.000 description 1
- 229910052717 sulfur Chemical group 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- FWMUJAIKEJWSSY-UHFFFAOYSA-N sulfur dichloride Chemical compound ClSCl FWMUJAIKEJWSSY-UHFFFAOYSA-N 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000003396 thiol group Chemical class [H]S* 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- QIQITDHWZYEEPA-UHFFFAOYSA-N thiophene-2-carbonyl chloride Chemical compound ClC(=O)C1=CC=CS1 QIQITDHWZYEEPA-UHFFFAOYSA-N 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
Landscapes
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、降圧剤として有用な化合物及び降圧剤に関す
る。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to compounds useful as antihypertensive agents and antihypertensive agents.
従来の技術と発明が解決しようとする課題近年カリウム
チャンネルオープナー(カリウムチャンネル活性化薬)
と言われる化合物(例、BRL34915,ピナシジル
,ニコランジルなど)が新しい作用機作に基づく降圧剤
や抗狭心症薬として注目を集めている。Problems to be solved by conventional technology and inventions Potassium channel openers (potassium channel activators) in recent years
Compounds said to be antihypertensive (eg, BRL34915, pinacidil, nicorandil, etc.) are attracting attention as antihypertensive and antianginal drugs based on a new mechanism of action.
本発明の目的は、上記した従来知られているカリウムチ
ャンネルオープナー化合物とは全く異る新規構造を有し
、かつすぐれたカリウムチャンネル活性化作用を有する
降圧剤を提供することである。An object of the present invention is to provide an antihypertensive agent that has a novel structure completely different from the previously known potassium channel opener compounds described above and has an excellent potassium channel activating effect.
課題を解決するための手段
本発明者らは、新しい降圧剤の探索を鋭意続けた結果、
特願平1−187790に過酸化脂質生成抑制作用、リ
ポ牛シゲナーゼ阻害作用等を有する化合物として開示さ
れている下記式CIEで表わされるチアゾロ[5.4−
b]アセピン誘導体あるいはその塩がカリウムチャンネ
ル活性化作用に基づくと考えられる強力な降圧作用を有
する事を見出し、さらに検討を重ねて本発明を完成した
。Means for Solving the Problems As a result of our diligent search for new antihypertensive agents, the present inventors discovered that
Thiazolo [5.4-
b] It was discovered that acepine derivatives or salts thereof have a strong antihypertensive effect, which is thought to be based on potassium channel activating effect, and after further studies, the present invention was completed.
すなわち本発明は、式[11
R1
[式中、Rlは水素原子又は、それぞれ置換基を有して
いてもよい脂肪族基、カルボン酸アシル基若しくはスル
ホン酸アシル基を、R2は水素原子又は、それぞれ置換
基を有していてもよい芳香環基若しくは脂肪族基を示す
。]で表わされる化合物またはその塩を含有することを
特徴とする降圧剤に関する。That is, the present invention provides a hydrogen atom or an aliphatic group, a carboxylic acid acyl group, or a sulfonic acid acyl group, each of which may have a substituent, and R2 is a hydrogen atom or Each represents an aromatic ring group or an aliphatic group which may have a substituent. ] or a salt thereof.
さらに式[1]で表わされる化合物のうち、とりわけR
2か式
R7
『
[式中、R 5, R e及びR7はそれぞれ同一又は
異なって水素原子、低級アルキル基又は置換基を有して
いてもよい芳香環基を示し、R5とR7は互に結合し環
を形成していてもよい。たたし、R ’, R ’の少
なくとも一方は置換基を有していてもよい芳香環基であ
る。]で表わされる基である化合物(以下化合物[ド]
と称することがある)は、強い降圧作用を示すことが判
明した。Furthermore, among the compounds represented by formula [1], especially R
2 or Formula R7 "[In the formula, R5, Re and R7 are the same or different and each represents a hydrogen atom, a lower alkyl group, or an aromatic ring group which may have a substituent, and R5 and R7 each represent They may be combined to form a ring. However, at least one of R' and R' is an aromatic ring group which may have a substituent. ] (hereinafter referred to as compound [do]
) was found to have a strong antihypertensive effect.
又、就中、式[11においてR2が式
CH=CH−R”
[式中、R”は、アミノ基又は置換アミ7基で置換され
た芳香環基で、チアゾロアゼピン環に対しシス配位であ
る]で表わされる基である化合物(以下化合物[I”]
と称することがある)が好ましい。In addition, in particular, in formula [11, R2 is of the formula CH=CH-R" [wherein R" is an aromatic ring group substituted with an amino group or a substituted amino group, and is in cis coordination with respect to the thiazoloazepine ring. A compound which is a group represented by [I”]
) is preferred.
一般式[I]においで、R1で表わされる脂肪族基とし
ては、飽和の基であっても、又不飽和の基であってもよ
く、例えば、アルキル基、アルケニル基、アルキニル恭
が挙げられる。該アルキル基は直鎖状、分枝状あるいは
環状でもよい。これらアルキル基のうち、炭素数1〜6
程度の低級アルキル基が好適で例えば、メチル,エチル
,プロピルi−プロビル,ブチル,i−ブチル,t−ブ
チル,ペンチル,ヘキシル,シクロプロビル.シクロブ
チル,シクロペンチル等が挙げられる。又、R1で表わ
さ?るアルケニル基としては、一般に炭素¥1.2〜6
のものが好ましく、例えば、ビニル,アリル,ブロペニ
ル,i−プロベニル,2−ブテニル,2.4−ブタジエ
ニル,1,:3−ブタジェニル,2−ペンテニル,2,
4−ペンタジエニル等が挙げられる。又R1で表わされ
るアルキニル基としては一般に炭素数2〜6の基が好ま
しく例えばエチニル,2フロピニル等が挙げられる。こ
れらの脂肪族基が有していてもよい置換基としてはどの
ようなものでもよいが、通常医薬に用いられる基であれ
ばとのようなものでもよく具体的には例えばヒドロキシ
ル+CI−3アルコキ7、例えばメトキシ、エトキン、
n−プロボキ/又はiso−ブロポキシなど(例えばメ
トキシメチル又はl一エトキンエチルなどにおける如く
):アリールオキシ、例えばフェノキシなど;C7■。In the general formula [I], the aliphatic group represented by R1 may be a saturated group or an unsaturated group, and examples thereof include an alkyl group, an alkenyl group, and an alkynyl group. . The alkyl group may be linear, branched or cyclic. Among these alkyl groups, carbon number 1 to 6
Preferred are lower alkyl groups such as methyl, ethyl, propyl i-propyl, butyl, i-butyl, t-butyl, pentyl, hexyl, cyclopropyl. Examples include cyclobutyl and cyclopentyl. Also, is it represented by R1? The alkenyl group generally has 1.2 to 6 carbon atoms.
are preferred, such as vinyl, allyl, propenyl, i-probenyl, 2-butenyl, 2,4-butadienyl, 1,:3-butadienyl, 2-pentenyl, 2,
Examples include 4-pentadienyl. The alkynyl group represented by R1 is generally preferably a group having 2 to 6 carbon atoms, such as ethynyl, 2-furopynyl, and the like. The substituent that these aliphatic groups may have may be any substituent, but any substituent that is commonly used in medicine may be used. Specifically, for example, hydroxyl + CI-3 alkoxy 7. For example, methoxy, etquin,
n-proboxy/or iso-propoxy, etc. (as in methoxymethyl or l-ethynethyl, etc.); aryloxy, such as phenoxy; C7■.
アルアルコキシ、例えばベンンルオ牛シなと:メルカプ
ト;Cl−3アルキルチオ、例えばメチルチオ又はエチ
ルチオなど アリールチオ.C7,。アルアルキルチオ
,アミノ(例エハ2−アミノエチルにおける如<);C
+−:+アルキル?置換されたモノ又はジ置換アミノ、
例えばメチルアミノ、エチルアミノ又はジメチルアミノ
など;ハロゲン、例えばクロロ又はブロモ(例えば2ブ
ロモエチルなどにおける如<);エステル化力ルボ牛シ
、例えばC t−Sアルコキシカルボニル(メトキシカ
ルポニル又はエトキシカルボニルなど)、又はペンジル
オキシカルボニルなど; C 2−4アルコキン力ルポ
ニルオキシ;ホルミル: C t−+ Oアシル例えば
アセチル、プロビオニル又はペンゾイルなど;C2■。Aralkoxy, such as mercapto; Cl-3 alkylthio, such as methylthio or ethylthio; arylthio. C7. Aralkylthio, amino (e.g. < in 2-aminoethyl); C
+-: +alkyl? substituted mono- or di-substituted amino,
such as methylamino, ethylamino or dimethylamino; halogens, such as chloro or bromo (such as in dibromoethyl); esterification compounds, such as C t-S alkoxycarbonyl (such as methoxycarbonyl or ethoxycarbonyl); or penzyloxycarbonyl; C2-4alcoquinyloxy; formyl: Ct-+Oacyl such as acetyl, probionyl or penzoyl; C2■.
アシルオキシ、例えばアセトキシ、プロピオニルオキ/
又はピバロイルオキシなど;シアノ;フタルイミド:
C t−1。アシ.ルアミド、例えばアセトアミド又は
ペンズアミドなど;Cz−sアルコキシカルボニルアミ
ノ、例えばメトキシヵルボニルアミノ又はエトキシ力ル
ポニルアミ7など:又はC7−10アルアルコキシカル
ボニルアミノ例えばペンジルオ牛シカルボニルアミノ,
環状アミ7基(例えばピロリジノ,モルホリ7など)、
カルボキ/ル基,カルバモイル基(これらの基から成る
群を以下A群と称する。)などがあげられる。Acyloxy, e.g. acetoxy, propionyloxy/
or pivaloyloxy; cyano; phthalimide:
C t-1. Ashi. Cz-s alkoxycarbonylamino, such as methoxycarbonylamino or ethoxycarbonylamino; or C7-10 aralkoxycarbonylamino, such as penzyloxycarbonylamino,
Cyclic amine 7 group (e.g. pyrrolidino, morphol 7, etc.),
Examples thereof include a carboxyl group, a carbamoyl group (the group consisting of these groups is hereinafter referred to as group A), and the like.
これらA群の中で、とりわけカルボキシル基,エステル
化されたカルボキシル基,カルバモイル基,モノー又は
ジー(C +−3アルキル)アミ7基等が好ましい。R
lで表わされるスルホン酸アシル基としては、メタンス
ルホニル,エタンスルホニル,プロパンスルホニルなど
の好ましくは炭素数1〜3のアルキルスルホニル基やフ
エニルスルホニル基があげられる。これらのうちアルキ
ルスルホニル基は、例えば上記A群から遺ばれる置換基
を有していてもよい。とりわけこれら置換基のうちジメ
チルアミノ,ジエチルアミノのようなC1−3アルキル
で置換されたモノ又はジ置換アミノが好ましい。Among these group A, carboxyl groups, esterified carboxyl groups, carbamoyl groups, mono- or di(C + -3 alkyl) amine 7 groups, etc. are particularly preferred. R
Examples of the sulfonic acid acyl group represented by l include alkylsulfonyl groups preferably having 1 to 3 carbon atoms, such as methanesulfonyl, ethanesulfonyl, and propanesulfonyl, and phenylsulfonyl groups. Among these, the alkylsulfonyl group may have a substituent remaining from Group A above, for example. Among these substituents, mono- or di-substituted amino substituted with C1-3 alkyl such as dimethylamino and diethylamino is particularly preferred.
R1で表わされるフェニルスルホニル基がフェニル環上
に置換基を有する場合、その置換基としては、たとえば
ハロゲン,ニトロ,アミノ(1〜2個のC,一.アル牛
ル, C ,,アルケニル+C3−IIシクロ7ル4−
ル,フェニルを置換基として有していてもよい。).ス
ルホ,メルカブト,ヒドロキシ,スルホオキン,スルフ
ァモイル,C11アルキル(アミノ,ジC,−37ルキ
ルアミ/.モノC I−ffアルキルアミノ,ハロゲン
,ヒドロキシ,シアノ,カルボキシを1〜3個置換基と
して有していてもよい),C,一。アルコキシ(C ,
−37ルキルチオを1〜3個置換基として有していても
よい),ペンジルオキシ+ C I−3アルキルチオ+
CI−37ルキルスルホンアミド,アミジノ(CI−3
アルヰル,ベンジルで置換されていてもよい), C
+−sアルコキシホルムイミドイル,メチレンジオキシ
,C,−,アルキルスルホニルr C I−3アルキル
スルホニルアミノ,エステル化カルボキシ、例えばC,
−47ルコキシカルボニル(メトキシ力ルポニル又はエ
トキシカルボニルなど)、又はペンジルオ牛シカルボニ
ルなど;C,−4アルコキシヵルボニルオキシ;ホルミ
ル:Cl−I。アシル例えばアセチル、ロピオニル又は
ベンゾイルなど;C,一,。アシルオキシ、例えばアセ
トキシ、プロピオニルオキシ又はビバロイルオ牛シなど
;シアノ;フタルイミド: C ffi−10アシルア
ミド、例えばアセトアミド又はペンズアミドなど;C.
,アルコキシカルボニルアミノ、例えばメトキン力ルポ
ニルアミノ又はエトキシ力ルポニルアミノなど1又はC
?−+oアルアルコ牛シ力ルポニルアミノ、例えばペン
シルオキシカルポニルアミノ;環状アミ7基(例えばピ
ロリジノ,モルホリノなど):及びカルポキシル基,カ
ルバモイル基,ハロゲン,メトキン及びC,−3アルキ
ル基等で置換されていてもよいフエニル(これらの置換
基の群を以下P群と称する。)などか挙げられる。これ
らのうち、とりわi+水酸基.c,sアルコキシ,c,
−eアルキル,ハロゲン,ニトロ,アミノ1モノ〜又は
ジー(C,−.アルキル)アミン+ C I−6アルキ
ルチオ,アミジノ,アミ/CI−6アルキル,シアノ,
C11アルコキンカルボニル+CI−6アルコキンカル
ボニルオキシ,フエニル,フェニルアミジノ,アルコキ
ンホルムイミドイルが好ましい。さらにメチル,メトキ
シ,塩素.弗素などが特に好ましい。When the phenylsulfonyl group represented by R1 has a substituent on the phenyl ring, examples of the substituent include halogen, nitro, amino (1 to 2 C, 1.alkyl, C,, alkenyl+C3- IIcyclo7ru4-
or phenyl as a substituent. ). Sulfo, mercabuto, hydroxy, sulfoquine, sulfamoyl, C11 alkyl (amino, diC, -37lkylami/.monoC I-ff having 1 to 3 substituents of alkylamino, halogen, hydroxy, cyano, carboxy) (also good), C, one. Alkoxy (C,
-37 alkylthio may have 1 to 3 substituents), penzyloxy+ C I-3 alkylthio+
CI-37 Rukylsulfonamide, amidino (CI-3
(optionally substituted with alwyl, benzyl), C
+-s alkoxyformimidoyl, methylenedioxy, C, -, alkylsulfonyl r C I-3 alkylsulfonylamino, esterified carboxy, e.g.
-47 alkoxycarbonyl (such as methoxycarbonyl or ethoxycarbonyl), or pendyloxycarbonyl; C, -4 alkoxycarbonyloxy; formyl: Cl-I. Acyl such as acetyl, ropionyl or benzoyl; C, 1,. Acyloxy, such as acetoxy, propionyloxy or bivaloyloxy; cyano; phthalimide: C ffi-10 acylamide, such as acetamide or penzamide; C.
, alkoxycarbonylamino, such as metquinylamino or ethoxycarbonylamino, or C
? -+o Alalco-calponylamino, such as pencyloxycarponylamino; cyclic amino group (e.g., pyrrolidino, morpholino, etc.); Examples include good phenyl (the group of these substituents is hereinafter referred to as the P group). Among these, especially i + hydroxyl group. c, s alkoxy, c,
-e alkyl, halogen, nitro, amino 1 mono- or di(C,-.alkyl)amine + CI-6 alkylthio, amidino, ami/CI-6 alkyl, cyano,
C11 alkoxycarbonyl+CI-6 alkoxycarbonyloxy, phenyl, phenylamidino, and alkoxyformimidoyl are preferred. Furthermore, methyl, methoxy, and chlorine. Particularly preferred is fluorine.
又、R1で表わされるカルポン酸アシル基としては、一
般に式R3CO−(式中、R3は、置換基を有していて
もよい飽和又は不飽和の脂肪族基又は置換基を有してい
てもよい芳香環基を示す。)で表わされる基かあげられ
る。In addition, the carboxyl acyl group represented by R1 generally has the formula R3CO- (wherein R3 is a saturated or unsaturated aliphatic group which may have a substituent or a saturated or unsaturated aliphatic group which may have a substituent). This indicates a good aromatic ring group.).
R3で表わされる芳香環基としては、芳香炭素環基及び
芳香複素環基が含まれる。前者の例としては例えば、フ
エニル.ナフチルが挙げられる。The aromatic ring group represented by R3 includes an aromatic carbocyclic group and an aromatic heterocyclic group. An example of the former is phenyl. Examples include naphthyl.
芳香複素環基としては、例えば窒素、酸素,硫黄等のへ
テロ原子1〜4個好ましくは1〜2個含有する5〜6員
芳香腹素環が好ましい。芳香複素環の具体例としては、
例えばピリジル,フリル,チェニル,ビラジニル,ビロ
リル,イミダゾリル,イソ手サゾリル等が例示される。The aromatic heterocyclic group is preferably a 5- to 6-membered aromatic abdominal ring containing 1 to 4, preferably 1 to 2, heteroatoms such as nitrogen, oxygen, and sulfur. Specific examples of aromatic heterocycles include:
Examples include pyridyl, furyl, chenyl, birazinyl, virolyl, imidazolyl, isohandsazolyl, and the like.
さらに、このような芳香環基に、同一又は別の芳香環(
上記したような芳香複素環や芳香炭素環)が縮合した基
も好ましい。これら縮合環の例としては、例えば、イン
ドリル,ペンズイミダゾリル,牛ノリル,イミダゾピリ
ジル及びチアゾロピリンル等があげられる。Furthermore, such an aromatic ring group may include the same or another aromatic ring (
A group in which aromatic heterocycles and aromatic carbocycles as described above are condensed is also preferable. Examples of these condensed rings include indolyl, penzimidazolyl, oxnoryl, imidazopyridyl, and thiazolopyrinyl.
芳香炭素環基が有していてもよい置換基としては、例え
ば、上記P群から遺ばれる基が好ましい。As the substituent that the aromatic carbocyclic group may have, for example, groups remaining from the above-mentioned P group are preferable.
又芳香複素環基が有していてもよい置換基としては、た
とえばアミノ(C,−18アシル,ハロゲン置換C,−
,アシル,フェニル,C,〜3アルキルを置換基と?て
有していてもよい。),ハロゲン,ニトロ,スルホ,シ
アノ,ヒドロキン,カルボキシ,オキソ,C ,,.ア
,ルキル(フエニル,ハロゲン,アミノ,ヒドロキ/,
カルボキシ+ C +−3アルコキシ+ C I−3ア
ルキルスルホニル,C1〜3ジアルキルアミ7等を置換
基として有していてもよい。),C3.シクロアルキル
+CI−3アルコキシ+ C t− 1。アシル,フエ
ニル(ハロゲン,ニトロ.アルキル,アルコキシ,アミ
/.スルホ,ヒドロキン,シアノを置換基として有して
いてもよい。),オキソ,C1■0アルキルーチオ(フ
エニル,ハロゲン,アミノ,ヒドロ牛シ,カルボキシ,
C,−3アルフキシ+CI−3アルキルスルホニル,ジ
C1−37ル牛ルアミノ等を置換基として有していても
よい。)(以上の置換基の群を以下H群と称する。)か
ら遭ばれる置換基が挙げられる。これらHWの中で、と
りわけCI−10アルキル,アミノ,モノー又はシー(
C1−3アルキル)アミノ,ハロゲン,アミ/ C ,
−3アルキル等が好ましい。Examples of substituents that the aromatic heterocyclic group may have include amino (C, -18 acyl, halogen-substituted C, -
, acyl, phenyl, C, ~3 alkyl as a substituent? You may also have one. ), halogen, nitro, sulfo, cyano, hydroquine, carboxy, oxo, C , . a, alkyl (phenyl, halogen, amino, hydroxy/,
It may have carboxy + C + -3 alkoxy + C I-3 alkylsulfonyl, C1-3 dialkylami7, etc. as a substituent. ), C3. Cycloalkyl+CI-3alkoxy+Ct-1. Acyl, phenyl (may have halogen, nitro, alkyl, alkoxy, ami/sulfo, hydroquine, cyano as a substituent), oxo, C1■0 alkylthio (phenyl, halogen, amino, hydrocyan, carboxy,
It may have C,-3alfoxy+CI-3alkylsulfonyl, di-C1-37-alkylamino, etc. as a substituent. ) (the above group of substituents is hereinafter referred to as group H). Among these HWs, especially CI-10 alkyl, amino, mono or
C1-3 alkyl)amino, halogen, amino/C,
-3 alkyl and the like are preferred.
R3で表わされる脂肪族基としては、飽和の基であって
も、又不飽和の基であってもよく、例えば、アルキル基
、アルケニル基、アルキニル基が挙げられる。ここでア
ルキル基としては、Rlで表わされるアルキル基として
上記したような低級アルキル基に加え、ヘブチル、オク
チル、ノニル、デシル、ウンデシル、ドデシル、ヘプタ
デシル、オクタデシル等炭素数7以上の高級アルキル基
も含まれる。R3で表わされるアルキル基としては、炭
素数1〜18のアル牛ル基が好ましい。The aliphatic group represented by R3 may be a saturated group or an unsaturated group, and includes, for example, an alkyl group, an alkenyl group, and an alkynyl group. In addition to the lower alkyl groups mentioned above as the alkyl group represented by Rl, the alkyl group also includes higher alkyl groups having 7 or more carbon atoms such as hebutyl, octyl, nonyl, decyl, undecyl, dodecyl, heptadecyl, and octadecyl. It will be done. The alkyl group represented by R3 is preferably an alkyl group having 1 to 18 carbon atoms.
R3で表わされるアルケニル基及びアルキニル基として
は、Rlに関してそれぞれ上記したような基が好ましい
。アルケニル基、アルキニル基としてはとりわけ炭素数
1〜4のものか好ましい。The alkenyl group and alkynyl group represented by R3 are preferably the groups described above with respect to Rl. The alkenyl group and alkynyl group are particularly preferably those having 1 to 4 carbon atoms.
これらのR3で表わされる飽和又は不飽和の脂肪族基が
有していてもよい置換基としては、上記A群の基,上記
したようなP群から遺ばれる置換基で置換されていても
よいフエニル基,環上に上記P群から遭ばれる置換基を
有していてもよいフエ不チルアミノ基又はペンシルアミ
ノ基及び上記H群から選ばれる置換基で置換されていて
もよい複素環基等か挙げられる。ここで複素環基として
は、R3で表わされる芳香環基に関して上記したような
芳香複素環基に加え、それらか一部又は全部飽和した複
素環基(例、モルホリノ、ピペリジニル、ピペリジノ、
ピペラジニル、ピロリジニル等)が含まれる。As the substituent that the saturated or unsaturated aliphatic group represented by R3 may have, it may be substituted with a substituent from the group A or the group P as described above. A phenyl group, a phenyl amino group or pensylamino group which may have a substituent from the above group P on the ring, a heterocyclic group which may be substituted with a substituent selected from the above group H, etc. Can be mentioned. Here, the heterocyclic group includes, in addition to the aromatic heterocyclic group mentioned above regarding the aromatic ring group represented by R3, a partially or fully saturated heterocyclic group (e.g., morpholino, piperidinyl, piperidino,
piperazinyl, pyrrolidinyl, etc.).
R2で表わされる脂肪族基としては、例えばRに関して
上に述へたような飽和又は不飽和の脂肪族基かあげられ
る。ざらにR2で表わされる不飽和脂肪族基のアルケニ
ル基としては、R1の例として述へたような低級のもの
に加え、炭素数7〜10のアルケニル基も好ましい。こ
れらのR2て表わされる脂肪族基か有していてもよい置
換基としては、上記R3て表わされる脂肪族基の置換基
と同様な基があげられ、さらにオ牛ソ基等で置換されて
いてもよい。Examples of the aliphatic group represented by R2 include saturated or unsaturated aliphatic groups as described above for R. As the alkenyl group of the unsaturated aliphatic group roughly represented by R2, in addition to the lower alkenyl groups mentioned as examples of R1, alkenyl groups having 7 to 10 carbon atoms are also preferable. Examples of substituents that the aliphatic group represented by R2 may have include the same substituents as the aliphatic group represented by R3 above, and further substituted with an oxo group, etc. You can.
又、R2で表わされる芳香環基としては、R3に関して
前記したような芳香炭素環基及び芳香複素環基及ひそれ
らの縮合環基があげられる。さ占に芳香炭素環基か有し
ていてもよい置換基としては上記P群から選ばれる基か
、又芳香複素環基か有していてもよい置換基としては上
記H群から選ばれる基がそれぞれあげられる。Further, examples of the aromatic ring group represented by R2 include aromatic carbocyclic groups, aromatic heterocyclic groups, and condensed ring groups thereof as described above for R3. The substituent that may be present on an aromatic carbocyclic group is a group selected from the above group P, and the substituent that may be present on an aromatic heterocyclic group is a group selected from the above group H. can be given respectively.
R ’, R ”で示される置換基を有していてもよい
基が有する置換基の数は1〜5好ましくは1〜3である
。The number of substituents in the optionally substituted group represented by R', R'' is 1 to 5, preferably 1 to 3.
式[1]においで、Rlが水素原子又はカルボン酸アシ
ル基(該アンル基としては、アセチル基,フロビオニル
基等が好ましく、これらの基中のメチル基、エチル基は
、上記したような置換基をさらに有していてもよい。)
である化合物が好ましい。In formula [1], Rl is a hydrogen atom or a carboxylic acid acyl group (the anru group is preferably an acetyl group, a flobionyl group, etc., and the methyl group or ethyl group in these groups is a substituent as described above) ).
Compounds are preferred.
特にR’が水素原子である化合物が好ましい。R2とし
ては置換基を有していてもよいフェニル又は置換基を有
していてもよい芳香環で置換されていてもよいアルケニ
ル基である化合物が好ましい。Particularly preferred are compounds in which R' is a hydrogen atom. R2 is preferably a compound which is a phenyl group which may have a substituent or an alkenyl group which may be substituted with an aromatic ring which may have a substituent.
特に式[目においてR2の置換基を有していてもよい脂
肪族基か、式 R’X(式中、R4は置換基を有してい
てもよい芳香環基、Xはチア/ロアゼビン環のチアゾー
ル環と共役結合を形成しうる不飽和脂肪族基)で表わさ
れる基である化合物が好ましい。ここでR4て表わされ
る゛゜置換基を有していでもよい芳香環基゜゜の゛′芳
香環゜゜及ひ″゛置換基゜′としては、R3についてそ
れぞれ上記したものかそのままあてはまる。Xとしては
、例えばCH=CH−,−CH=CH−CH=CH一等
があげられる。更には、R’が水素原子で、R2が置換
基を有していてもよいフェニル基又はフェニル,チェニ
ル.フリル ピリジル,ピラジニル又はイミダゾリル基
で置換されていてもよい炭素数2〜4のチアゾール環と
共役しているアルケニル基である化合物が、その作用面
から見た好ましい態様である。R2で表わされる置換さ
れていてもよいアルケニル基の特に好ましい例としては
置換されていてもよいフェニルで置換されたビニル及び
ブタンエニルが挙げられる。In particular, an aliphatic group optionally having a substituent of R2 in the formula R'X (wherein R4 is an aromatic ring group optionally having a substituent, A compound represented by an unsaturated aliphatic group capable of forming a conjugate bond with the thiazole ring is preferred. Here, as for the ``aromatic ring'' and the ``substituent'' of the aromatic ring group ゛゜ that may have a substituent represented by R4, the same applies as described above for R3.For X, For example, CH=CH-, -CH=CH-CH=CH, etc. Furthermore, R' is a hydrogen atom, and R2 is a phenyl group which may have a substituent, or phenyl, chenyl, furyl, pyridyl. , pyrazinyl or imidazolyl group, which is an alkenyl group conjugated with a thiazole ring having 2 to 4 carbon atoms is a preferred embodiment from the viewpoint of its function. Particularly preferred examples of optionally substituted alkenyl groups include vinyl substituted with optionally substituted phenyl and butaneyl.
上記のとりわけ降圧効果の点ですぐれる化合物[ドコに
関しで、R S, R @. R ?で表わされる低級
アル牛ル基としては、メチル基,エチル基,プロビル基
,イソブロビル基等炭素数1〜3のアルキル基が挙げら
れる。The above-mentioned compounds particularly excellent in terms of hypotensive effect [Doco-related, R S, R @. R? Examples of the lower alkyl group represented by include alkyl groups having 1 to 3 carbon atoms such as methyl group, ethyl group, probyl group, and isobrobyl group.
R 5, R 6, R ’で表わされる芳香環基とし
てはフェニル基,ピリジル基,チェニル基.ビロリル基
,ピラジニル基などが好ましい。とりわけフェニル基が
好適である。Aromatic ring groups represented by R 5 , R 6 and R' include phenyl group, pyridyl group, and chenyl group. Preferred are virolyl group, pyrazinyl group, and the like. A phenyl group is particularly preferred.
このような芳香環基の有する置換基としては上記P群か
ら遭ばれる置換基があげられる。このような芳香環基の
置換基としては特にアミ7基,モノ低級アルキルアミ7
基,ジ低級アルキルアミノ基が好ましい。ここでアミノ
基の置換基としての低級アルキル基としては、Rlに関
し、P群の置換基の例示として上述したような炭素数1
〜6のアルキル基が挙げられる。とりわけ、芳香環基の
有する置換基としてはジエチルアミノ基が、好ましい。Examples of the substituents possessed by such an aromatic ring group include the substituents found in the above-mentioned P group. Examples of substituents for such aromatic ring groups include amide 7 groups and mono-lower alkyl amine 7 groups.
and di-lower alkylamino groups are preferred. Here, as a lower alkyl group as a substituent for an amino group, a carbon number 1 as mentioned above as an example of a substituent of the P group with respect to Rl is used.
-6 alkyl groups are mentioned. In particular, a diethylamino group is preferred as the substituent for the aromatic ring group.
R5とR7が環を形成する場合、その環としては炭素環
であっても、又N,S,O等のへテロ原子を環構戊原子
として含んだヘテロ環であってもよい。When R5 and R7 form a ring, the ring may be a carbocyclic ring or a heterocyclic ring containing a heteroatom such as N, S, O, etc. as a ring atom.
このような環としては、ンクロペンタン,シクロベンテ
ン,シクロヘ牛サン1/クロヘキセン,フラン,チオフ
エン,ピロール.ベンゼン,ビIJ 9ン等が挙げられ
る。Such rings include cyclopentane, cyclobentene, cyclohexane/chlorohexene, furan, thiophene, pyrrole. Examples include benzene, vinyl chloride, and the like.
化合物[V′]においで、Rll/で表わされる「アミ
7基または置換アミノ基で置換された芳香環基」の芳香
環基としては、R6について上記した芳香環基が挙げら
れ、とりわけフェニル基が好ましい。In compound [V'], examples of the aromatic ring group of "the aromatic ring group substituted with an amino group or a substituted amino group" represented by Rll/ include the aromatic ring groups described above for R6, especially phenyl groups. is preferred.
これらR8′における置換アミ7基としては、R6で表
わされる芳香環基の置換基として上記したようなモノー
又はンー低級アルキルアミ7基が好ましい。The substituted amine 7 group in R8' is preferably a mono- or lower alkyl amine 7 group as described above as a substituent for the aromatic ring group represented by R6.
尚、一般式[1]で示される化合物は、R ’, R
”の置換基の種類如何によっては立体異性体が生じる可
能性があるが、これら異性体単独のみならず、それらの
混合物も本発明に含まれる。In addition, the compound represented by the general formula [1] has R', R
Although stereoisomers may occur depending on the type of substituent, not only these isomers alone but also mixtures thereof are included in the present invention.
一般式[1]で表わされる化合物の塩としては、好まし
くは医薬上許容される塩であり、医薬上許容される塩の
例としては、ハロゲン化水素(例、塩化水素,臭化水素
)、リン酸,硫酸などの無機酸や有機カルホン酸(例、
シュウ酸,フタル酸,フマル酸,マレイン酸)、スルホ
ン酸(L メタンスルホン酸,ベンゼンスルホン酸)な
どの有機酸があげられる。又化合物[+]がR’やR2
上の置換基としてカルボキシル基等の酸性基を有する場
合、アルカリ金属(例、ナトリウム、カリウム)又はア
ルカリ土類金属(例、マグネシウム)等との無機塩基塩
及び有機塩基(例、ジシクロヘキシルアミン、トリエチ
ルアミン、2,6−ルチジン等のアミン類)との塩があ
げられる。The salt of the compound represented by the general formula [1] is preferably a pharmaceutically acceptable salt, and examples of pharmaceutically acceptable salts include hydrogen halides (e.g., hydrogen chloride, hydrogen bromide), Inorganic acids such as phosphoric acid and sulfuric acid and organic carbonic acids (e.g.
Examples include organic acids such as oxalic acid, phthalic acid, fumaric acid, maleic acid) and sulfonic acid (L methanesulfonic acid, benzenesulfonic acid). Also, compound [+] is R' or R2
When the above substituent has an acidic group such as a carboxyl group, inorganic base salts with alkali metals (e.g., sodium, potassium) or alkaline earth metals (e.g., magnesium) and organic bases (e.g., dicyclohexylamine, triethylamine) , amines such as 2,6-lutidine).
以下、一般式[1]で表わされる化合物及びその塩を化
合物[r]と総称する。Hereinafter, the compound represented by general formula [1] and its salt will be collectively referred to as compound [r].
本発明の化合物[1]は、たとえば、図式−■の方法に
より製造し得る。Compound [1] of the present invention can be produced, for example, by the method shown in Scheme -■.
図式−■
またはその塩
[1]
またはその塩
[II]
Rl
またはその塩
[+]
[図式−I中、RlおよびR2は前記と同意義、R′C
oXはカルボン酸の反応性誘導体を示す。]すなわち、
化合物[1]又はその塩(塩としては、化合物[I]の
塩として前記した塩があげられる。)を式R ”C O
Xで表わされるカルボン酸の反応性誘導体でアシル化
し化合物[Ir]を得、続いて[I[’1を硫化剤で処
理する事により化合物[1]を得る事が出来る。さらに
詳しく述べれば、R’COXで表わされる反応性誘導体
としては酸塩化物、酸臭化物,イミダゾリド,酸無水物
,酸アジド,N−フタルイミドエステル,N−オキシコ
ハク酸イミドエステルなどがあげられる。また活性エス
テルを用いる代りに、R’COOHで表わされるカルポ
ン酸を、N,N’−ジシクロへキ7ルカルポジイミド(
以下DCCと略称することがある。)などのカノブリン
グ試薬の存在下で、直接化合物[I[1]と反応させて
もよい。Scheme-■ or a salt thereof [1] or a salt thereof [II] Rl or a salt thereof [+] [In scheme-I, Rl and R2 have the same meanings as above, R'C
oX represents a reactive derivative of carboxylic acid. ] That is,
Compound [1] or a salt thereof (salts include the salts listed above as the salt of compound [I]) with the formula R "C O
Compound [1] can be obtained by acylating with a reactive derivative of carboxylic acid represented by X to obtain compound [Ir], and then treating [I['1] with a sulfurizing agent. More specifically, the reactive derivatives represented by R'COX include acid chlorides, acid bromides, imidazolides, acid anhydrides, acid azides, N-phthalimide esters, N-oxysuccinimide esters, and the like. Moreover, instead of using an active ester, the carboxylic acid represented by R'COOH can be replaced with N,N'-dicyclohexylcarpodiimide (
Hereinafter, it may be abbreviated as DCC. ) may be directly reacted with the compound [I[1] in the presence of a canobling reagent such as ).
化合物[■11モルに対し、R ’C O Xで表わさ
れる反応性誘導体を約1〜3モル好ましくは約i〜1.
2モル用いる。R’COOHで表わされるカルポン酸と
反応させる場合は、通常化合物[11I]1モルに対し
、カルボン酸約1〜3モル好ましくは約1〜1.2モル
を同じ化合物[II1]に対し約1〜1.2モルのカノ
ブリング試薬の存在下で反応させる。About 1 to 3 moles of the reactive derivative represented by R'C O
Use 2 moles. When reacting with a carboxylic acid represented by R'COOH, usually about 1 to 3 moles of carboxylic acid, preferably about 1 to 1.2 moles, is added to 1 mole of compound [11I], and about 1 to 1.2 moles is added to the same compound [II1]. React in the presence of ~1.2 moles of Canobling reagent.
反応は通常水冷下〜室a(以下の製法説明における室温
とは、具体的には5〜35°Cを意味する。)でスムー
ズに進行する。この時用いる溶媒は、反応に不活性なも
のであれば何でもよく、特に制限はないが、クロロホル
ム,メチレンクロリド,テトラヒドロフラン,ジオキサ
ン,ジメチルホルムアミドなどがよく用いられる。アシ
ル化剤として酸塩化物または酸臭化物を用いる場合には
、反応系内にトリエチルアミン、ビリジンなどのアミン
を加えておく事か望ましい。反応時間は、用いる試薬や
溶媒、温度にもよるが通常30分〜12時間程度である
。The reaction usually proceeds smoothly under water cooling or in room a (room temperature in the following description of the manufacturing method specifically means 5 to 35°C). The solvent used at this time may be any solvent as long as it is inert to the reaction, and is not particularly limited, but chloroform, methylene chloride, tetrahydrofuran, dioxane, dimethylformamide, etc. are often used. When using an acid chloride or an acid bromide as an acylating agent, it is desirable to add an amine such as triethylamine or pyridine to the reaction system. The reaction time is usually about 30 minutes to 12 hours, although it depends on the reagent, solvent, and temperature used.
化合物[I1]を化合物[I]に導く反応は、五硫化燐
やローソン試薬などの硫化剤の存在下で行なわれる。こ
の時用いる硫化剤の量は、一般的には化合物[I1]1
モルに対し約1〜3モル、通常は化合物[I[]と等モ
ル程度が望ましい。反応溶媒としてはピリジンが望まし
いが、特に制限はない。反応は50°〜120℃程度の
範囲で行なわれるが、約80’〜120゜Cが望ましい
。反応に要する時間は、反応温度によって異なるが、通
常3〜12時間程度で、例えば約lOO〜120℃で反
応させれば、大体5時間内に反応は終る。The reaction for converting compound [I1] into compound [I] is carried out in the presence of a sulfurizing agent such as phosphorus pentasulfide or Lawesson's reagent. The amount of sulfurizing agent used at this time is generally compound [I1]1
It is preferably about 1 to 3 moles per mole, usually about the same mole as that of compound [I[]. Pyridine is preferable as the reaction solvent, but there is no particular restriction. The reaction is carried out at a temperature of about 50° to 120°C, preferably about 80° to 120°C. Although the time required for the reaction varies depending on the reaction temperature, it usually takes about 3 to 12 hours. For example, if the reaction is carried out at about 100° C. to 120° C., the reaction will be completed within about 5 hours.
図式−■中、R1で示される置換基は、任意の段階でR
1で示される他の置換基に変換してもよいか、通常は化
合物[1]を得た後、R1の部分を変換するのが有利で
ある。このようなRlの変換反応としては、R1が水素
原子の化合物を常法によりアルキル化、スルホニル化又
はアシル化等の反応に付し、それぞれR’が置換されて
いてもよいアルキル基、スルホン酸アシル基又はカルボ
ン酸アンル基である目的の化合物を得る反応が挙げられ
る。In the scheme -■, the substituent represented by R1 is R1 at any stage.
Alternatively, it is usually advantageous to convert the R1 portion after obtaining the compound [1]. In such a conversion reaction of Rl, a compound in which R1 is a hydrogen atom is subjected to a reaction such as alkylation, sulfonylation, or acylation by a conventional method, and R' is converted to an optionally substituted alkyl group, sulfonic acid, etc. Examples include reactions to obtain the target compound which is an acyl group or a carboxylic acid amyl group.
これらの反応は自体公知の方法に従い行なうことができ
るが、例えば次のような方法で行なうこともできる。These reactions can be carried out according to methods known per se, but can also be carried out, for example, by the following methods.
化合物[I]のRlが水素原子である化合物[以下化合
物[1](R’=H)と示すことがある。]から、R1
がアシル基である化合物を得るには、化合物[1](R
’=H)をアシル化すればよい。Rlがカルボン酸アシ
ル基の化合物を得るには、該カルボン酸アシルの反応性
誘導体と化合物[I](R’=H)を反応させればよい
。カルボン酸アシルの反応性誘導体の種類、反応条件等
は化合物[I11r]から化合物[n]を得る反応につ
いて前記したものが通常そのまま適用される。これらの
条件等で、反応はスムーズに進行する。化合物[1](
R’=H)をRlがスルホン酸ア/ルである化合物に導
くには、化合物[I ](R ’= H)をハロゲン化
スルホニルと反応させる方法が好都合である。反応は通
常、トリエチルアミンやピリジンなどのアミンの存在下
で行なわれる。この時用いられる溶媒は反応に不活性な
ものであれば何でもよいが、アセトン,ジオキサン,ジ
メチルホルムアミド1テトラヒド口フランクロロホルム
,メチレンクロリドなどが好んて用いられる。場合によ
ってはピリジンを溶媒として用いてもよい。反応はO0
C〜室温でスムーズに進行し、30分〜5時間で終了す
る。この時用いるアミンの量は化合物[1]1モルに対
し約1〜3モル,アシル化剤の量は約1〜2モルである
。A compound in which Rl of compound [I] is a hydrogen atom [hereinafter sometimes referred to as compound [1] (R'=H). ], R1
is an acyl group, compound [1] (R
'=H) may be acylated. In order to obtain a compound in which Rl is a carboxylic acyl group, a reactive derivative of the carboxylic acyl group may be reacted with compound [I] (R'=H). Regarding the type of reactive derivative of acyl carboxylate, reaction conditions, etc., those described above for the reaction to obtain compound [n] from compound [I11r] are generally applied as they are. Under these conditions, the reaction proceeds smoothly. Compound [1] (
In order to lead to a compound in which Rl is ar/al sulfonate (R'=H), it is convenient to react the compound [I] (R'=H) with a sulfonyl halide. The reaction is usually carried out in the presence of an amine such as triethylamine or pyridine. The solvent used at this time may be any solvent as long as it is inert to the reaction, but acetone, dioxane, dimethylformamide, tetrahydrofuran, chloroform, methylene chloride and the like are preferably used. Pyridine may be used as a solvent in some cases. The reaction is O0
C~Proceeds smoothly at room temperature and completes in 30 minutes to 5 hours. The amount of amine used at this time is about 1 to 3 moles per 1 mole of compound [1], and the amount of the acylating agent is about 1 to 2 moles.
化合物[1]のRlが水素原子である化合物からR1が
アルキル基の化合物を得るには、化合物[I](R’=
H)をアルキル化反応に付すとよい。この時用いるアル
キル化剤としては、ハロゲン化アルキル(ハロゲンとし
ては塩素,臭素,ヨウ素),スルホン酸のアルキルエス
テル(Lp−トルエンスルホン酸のアルキルエステル,
メタンスルホン酸のアルキルエステル等)などがあげら
れる。用いるアルキル化剤の量は化合物[I]1モル当
たり約1〜2モルである。反応は通常、炭酸カリウムや
炭酸ナトリウム等の無機塩基、又は、トリエチルアミン
,ピリジン等の有機塩基の存在下に行なわれる。塩基は
アルキル化剤と等モル程度用いるのがよい。使用する溶
媒に特に限定はないが、例えばテトラヒド口フラン,ジ
オキサン,ジメチルホルムアミド,ジメチルアセトアミ
ド等が好適に用いられる。反応は通常、加熱下に行なわ
れ、約30°〜1 0 0 ’Cの範囲が適している。To obtain a compound in which R1 is an alkyl group from a compound in which R1 is a hydrogen atom, compound [I] (R'=
H) may be subjected to an alkylation reaction. The alkylating agents used at this time include alkyl halides (halogens include chlorine, bromine, and iodine), alkyl esters of sulfonic acid (alkyl esters of Lp-toluenesulfonic acid,
alkyl esters of methanesulfonic acid, etc.). The amount of alkylating agent used is about 1 to 2 mol per 1 mol of compound [I]. The reaction is usually carried out in the presence of an inorganic base such as potassium carbonate or sodium carbonate, or an organic base such as triethylamine or pyridine. The base is preferably used in an equimolar amount with the alkylating agent. The solvent used is not particularly limited, but for example, tetrahydrofuran, dioxane, dimethylformamide, dimethylacetamide, etc. are preferably used. The reaction is usually carried out under heating, suitably in the range of about 30° to 100°C.
R’がアルキル基の化合物[1]は、Rlがカルボン酸
アシル基の化合物[Nを還元しても得られる。A compound [1] in which R' is an alkyl group can also be obtained by reducing a compound [N] in which Rl is a carboxylic acid acyl group.
還元は常法に従って行なえるが、例えば水素化アルミニ
ウムリチウムやジボランのような還元剤による還元が適
している。この時溶媒としては、エーテル,テトラヒド
口フラン,ジオキサンが用いられ、通常還流下に反応は
進行する。Although the reduction can be carried out according to conventional methods, reduction using a reducing agent such as lithium aluminum hydride or diborane is suitable. At this time, ether, tetrahydrofuran, or dioxane is used as the solvent, and the reaction usually proceeds under reflux.
化合物[1]は、その他公知方法又はそれらに準じる方
注によって製造することもできる。Compound [1] can also be produced by other known methods or methods similar thereto.
尚、本発明の製造法の原料化合物である化合物CIII
]のうちR1が水素原子である化合物は、公知化合物で
あり、Rlが水素原子以外の化合物は例えば、J. P
. Snyderらの方法[J, P. Snyder
etal.,ジャーナル オブ メディシナル ケミ
ストリー(J. Med. Chem.),2 9
, 2 5 1,(1 9 8 6)]に従い図式−H
の方法で合成出来る。In addition, compound CIII, which is a raw material compound for the production method of the present invention,
], compounds in which R1 is a hydrogen atom are known compounds, and compounds in which R1 is other than a hydrogen atom are described, for example, in J. P
.. The method of Snyder et al. [J, P. Snyder
etal. , Journal of Medicinal Chemistry (J. Med. Chem.), 29
, 2 5 1, (1 9 8 6)] according to the scheme -H
It can be synthesized using the following method.
図式
■
[式中R1は前記と同意義で、Xはノ\ロゲン原子をB
OCはtert−ブトキシカルボニル基を示す]又、上
記した化合物[+]のR1部分を変換する反応に従っで
、Rlか水素原子である化合物から化合物[IEが製造
できる場合もある。Diagram ■ [In the formula, R1 has the same meaning as above, and X represents a norogen atom as B
OC represents a tert-butoxycarbonyl group] In some cases, the compound [IE] can also be produced from a compound where R1 is a hydrogen atom, according to the reaction for converting the R1 moiety of the compound [+] described above.
R2がアルケニル基の場合、光異性化等の通常の異性化
反応によりンス体をトランス体に、トランス体を/ス体
に適宜異性化させてもよい。When R2 is an alkenyl group, the trans isomer may be appropriately isomerized to the trans isomer, and the trans isomer may be isomerized to the /s isomer, as appropriate, by a normal isomerization reaction such as photoisomerization.
以上の方広によって得られる化合物[1]は、たとえば
再結晶、蒸留,クロマトグラフイーなどの通常の分離手
段により単離、精製する事ができる。Compound [1] obtained by the above method can be isolated and purified by conventional separation means such as recrystallization, distillation, and chromatography.
かくして得られる化合物[+]が遊離の形て得られた場
合には、自体公知の方法により中和等によって塩に変え
る事ができ、逆に塩で得られた場合には常法により、遊
離のものに変えることができる。If the compound [+] obtained in this way is obtained in a free form, it can be converted into a salt by neutralization etc. by a method known per se.On the other hand, if it is obtained in a salt form, it can be converted into a free form by a conventional method. can be changed to
本発明の化合物[I]は、特願平1−187790に記
載されているような多価不飽和脂肪酸(リノール酸,γ
−リノレン酸.α−リノレン酸,アラキドン酸,ジホモ
ーγ−リノレン酸,エイコサペンタエン酸)の代謝改善
、特に過酸化脂質生成反応を抑制する作用(抗酸化作用
),5−リボキシゲナーゼ系代謝産物E例、ロイコトリ
エン類,5−ヒドロベルオキシエイコサテトラエン酸(
HPETE),5−ヒドロキンエイコサテトラエン酸(
HETE),リボキシン類,ロイコトキシン類など]の
生成抑制作用、トロンボキサンA,合戊酵素の阻害作用
、プロスタグランジンI,合或酵素保持促進作用、LT
D.受容体拮抗作用、活性酸素種の消去作用などの循環
系改善作用や抗アレルギー作用に加え、カリウムチャン
ネルの活性化作用も有する。The compound [I] of the present invention is a polyunsaturated fatty acid (linoleic acid, γ
-Linolenic acid. α-linolenic acid, arachidonic acid, dihomo-γ-linolenic acid, eicosapentaenoic acid) metabolic improvement, especially the effect of suppressing lipid peroxide production reaction (antioxidant effect), 5-riboxygenase metabolite E example, leukotrienes, 5-hydroberoxyeicosatetraenoic acid (
HPETE), 5-hydroquineicosatetraenoic acid (
HETE), riboxins, leukotoxins, etc.], thromboxane A, synthetic enzyme inhibitory effect, prostaglandin I, synthetic enzyme retention promoting effect, LT
D. In addition to circulatory system-improving effects such as receptor antagonism and scavenging of reactive oxygen species, and antiallergic effects, it also has potassium channel activating effects.
化合物[1]の毒性,副作用は低い。Compound [1] has low toxicity and side effects.
従っで、本発明の化合物[+]は噛乳動物(マウス,ラ
ノト,ウサギ,イヌ,サル,ヒトなど)における高血圧
や狭心症などの循環器系疾患の治療薬として有用である
。Therefore, the compound [+] of the present invention is useful as a therapeutic agent for cardiovascular diseases such as hypertension and angina pectoris in mammalian animals (mice, rats, rabbits, dogs, monkeys, humans, etc.).
化合物[1]は、そのままもしくは自体公知の薬学的に
許容される担体,賦形剤などと混合した医薬組戊物(例
、錠剤,カプセル剤,液剤,注射剤,坐剤)として経口
的もしくは非経口的に安全に投与することかできる。投
与量は投与対象、投与ルート、症状などによっても異な
るが、例えば、成人の患者に対して通常1回量として経
口投与するときは、約0.1〜l O O mg/戊人
程度、好ましくは約0.3〜50mg/成人、さらに好
ましくは05〜20mg/成人程度を、又静脈注射投与
の場合は、約0 1〜20mg/戊人、好ましくは0.
3〜]Omg/成人程度を1日2〜3回程度投与するの
か好都合てある。Compound [1] can be administered orally as it is or as a pharmaceutical composition (e.g., tablet, capsule, liquid, injection, suppository) mixed with known pharmaceutically acceptable carriers, excipients, etc. It can be safely administered parenterally. The dosage varies depending on the subject, administration route, symptoms, etc., but for example, when orally administered as a single dose to an adult patient, it is preferably about 0.1 to 1 O O mg/person. is about 0.3 to 50 mg/adult, more preferably about 0.5 to 20 mg/adult, and in the case of intravenous administration, about 0.1 to 20 mg/adult, preferably about 0.
3~] It is convenient to administer about 0mg/adult about 2 to 3 times a day.
発明の効果
本発明化合物[ドは、下記試験例でも示されるようにカ
リウムチャンネル活性化作用等を有し、循環2g系疾患
、高血圧症等の治療や予防のための医薬として有用であ
る。Effects of the Invention The compound of the present invention has potassium channel activating effects, etc., as shown in the following test examples, and is useful as a medicine for the treatment and prevention of circulatory 2g-related diseases, hypertension, etc.
以下に試験例,実施例および参考例を記載するが、本発
明はこれらに限定されるものではない。Test Examples, Examples, and Reference Examples are described below, but the present invention is not limited thereto.
坦一里
試験例1 ラソト大動脈標本における作用1) テト
ラエチルアンモニウムクロリド(TEA)及びバリウム
クロリド(B a)で惹起した収縮の抑制率
20dの液槽中(Krebs − Henseleit
液37゜C,95%0.−5%COl気流下)にラ・ノ
ト大動脈リング標本を懸垂し用いた。TEAおよびBa
がそれぞれ4 5mM,0.3mMの濃度になるように
添加し収縮を惹起した。収縮が定常状態に達した後、試
験化合物を10−5Mの濃度になる様添加し、その弛緩
作用を調べた。TEA+Baによる収縮張力を100と
し、弛緩作用の大きさを%で表わし、TEA+Ba収縮
抑制率とした。Tanichiri test example 1 Effect on Rasotho aorta specimen 1) Inhibition rate of contraction induced by tetraethylammonium chloride (TEA) and barium chloride (Ba) in a liquid bath of 20 d (Krebs-Henseleit)
Liquid 37°C, 95% 0. A La Noto aortic ring specimen was suspended in a -5% CO1 airflow). TEA and Ba
were added to a concentration of 45mM and 0.3mM, respectively, to induce contraction. After the contraction reached a steady state, the test compound was added to a concentration of 10-5M and its relaxing effect was examined. The contraction tension due to TEA+Ba was set as 100, and the magnitude of the relaxing effect was expressed in %, which was defined as the TEA+Ba contraction inhibition rate.
2) 80mMカリウムクロリド(K C f!)収
縮に対する作用
収縮惹起剤としで、TEA+Baの代りに、KCQを8
0mMの濃度になる様に添加した以外は1)の方法に準
じで、弛緩作用を調べ、収縮抑制率を求めた。2) 80mM potassium chloride (K C f!) Effect on contraction KCQ was used as a contraction inducing agent instead of TEA + Ba.
The relaxation effect was examined and the contraction inhibition rate was determined in the same manner as in 1) except that the concentration was 0 mM.
上に示した様に、本出願の化合物はTEA+Ba収縮を
8−100%抑制したが、80mMKC(2収縮には全
く影響を与えなかった。これらの結果から本出願の化合
物は血管平屑筋のカリウムチャンネルを開口する事によ
り弛緩作用を示すと考えられる。As shown above, the compound of the present application suppressed TEA+Ba contraction by 8-100%, but had no effect on the contraction of 80mMKC (2). It is thought that it exhibits a relaxing effect by opening potassium channels.
試験例2 麻酔ラノトにおける降圧作用雄性W i s
t a rラ,トを用いベントバルビタール麻酔下に
実験を行った。右頚動脈に挿入したカニュ−レを介して
血圧を測定した。被験薬物は右大腿静脈に留置したカニ
ューレを介して投与した。Test Example 2 Antihypertensive effect of male Wis under anesthesia
Experiments were carried out using tara under anesthesia with bentobarbital. Blood pressure was measured via a cannula inserted into the right carotid artery. The test drug was administered via a cannula placed in the right femoral vein.
結果
lmg/kgの薬物を投与すると1〜2分後には投与上
記結果は本出願の化合物が血圧降下作用を有する事を示
している。Results: When 1 mg/kg of drug was administered, it was administered 1 to 2 minutes later.The above results show that the compound of the present application has a hypotensive effect.
実施例
以下、参考例,実施例をあげで、本発明をさらに詳しく
説明するか、本発明は、これらの実施例等に限定される
ものではない。EXAMPLES Hereinafter, the present invention will be explained in more detail by reference examples and examples, but the present invention is not limited to these examples.
以下の実施例のカラムクロマトグラフィにおける溶出は
T L C (Thin Layer Chrom
atography薄層クロマトグラフィ)による観察
下に行なわれた。TLC観察においては、TLCプレー
トとして(Merck)社製のキーセルケル6 0 F
250(7 0 〜230メノ7ユ)を、展開溶媒と
してはカラムクロマトグラフィで溶出溶媒として用いら
れた溶媒を、検出広としてUV検出器を採用した。カラ
ム用シリカケルは同じくメルク社製のキーゼルゲル6
0 (7 0〜230メノシュ)を用いた。NMRスペ
クトルはプロトンNMRを示し、内部基準としてテトラ
メチルシランを用いてVARIANE M 3 9 0
(90MHz型スベクト口メーター)で測定し、δ値を
ppmで示した。The elution in column chromatography in the following examples was performed using TLC (Thin Layer Chromatography).
The analysis was carried out under observation using thin layer chromatography (atography). For TLC observation, Kiesselkel 60F manufactured by Merck was used as a TLC plate.
250 (70 to 230 mm) was used as the developing solvent, the solvent used as the elution solvent in column chromatography was used as the developing solvent, and a UV detector was used as the detection range. The silica gel for the column is Kieselgel 6, also manufactured by Merck.
0 (70-230 menosh) was used. The NMR spectra show proton NMR and are VARIANE M390 using tetramethylsilane as internal reference.
(90 MHz type Subect Meter), and the δ value was expressed in ppm.
尚、実施例で用いる略号は、次のような意義を有する。The abbreviations used in the examples have the following meanings.
s,ノングレノト, br:ブロード(幅広い),d:
ダブレット,t:トリプレノト,q.クワルテット,m
マルチブレット,dd:ダブレソト オブダプレソツ,
j:カノブリング定数,Hz:ヘルツ,CDCQ.:重
クロロホルム,ds−DMSO:重ジメチルスルホキソ
ド,%・重量%
また室温とあるのは約15〜25゜Cを意味する。s, nongrenote, br: broad, d:
doublet, t: triplet, q. quartet, m
Multi-bullet, dd: double bullet, double bullet,
j: Canobling constant, Hz: Hertz, CDCQ. : Deuterated chloroform, ds-DMSO: Deuterated dimethyl sulfoxide, %/wt% Also, room temperature means about 15 to 25°C.
融点及びt島度はすへて七ノ氏で示した。The melting point and temperature are given in Mr. Nanano.
参考例1
3−(4−クロロンンナモイル)アミノーε一カプロラ
クタム
p−クロロけい皮酸13.ogのTHF溶液500dに
、N,N’一カルボニルジイミダゾール13.9gを加
え、室温にて20分間撹拌した。次に3−アミノーε一
カブ口ラクタム9. 1 2gを加え、5時間撹拌後析
出結晶をろ取、洗浄し,減圧下で乾燥して表題化合物を
得た(llg)。この化合物は精製することなく次反応
に用いた。Reference Example 1 3-(4-chloronnamoyl)amino-ε-caprolactam p-chlorocinnamic acid 13. 13.9 g of N,N'-carbonyldiimidazole was added to 500 d of THF solution of 0.0 g, and the mixture was stirred at room temperature for 20 minutes. Next, 3-amino-epsilon lactam 9. After stirring for 5 hours, the precipitated crystals were collected by filtration, washed, and dried under reduced pressure to obtain the title compound (llg). This compound was used in the next reaction without purification.
融点256−257°
I R(K Br)am ’: 319g, 16g6
. 1644, 1614,1563, L{48,
814
NMR (C D CR.) δ : 1.30 −
2.20(6H,m), 3.203.42(2H,
m), 4.55−4.78(IH.m), 6.43
(LH,d,J1BHz), 7.10(2H,ml
7J9(2H,m), 7.56(18,d,J=l6
}1z)
以下同様にして次の化合物を得た。Melting point 256-257° IR(KBr)am': 319g, 16g6
.. 1644, 1614, 1563, L{48,
814 NMR (CDCR.) δ: 1.30 −
2.20 (6H, m), 3.203.42 (2H,
m), 4.55-4.78 (IH.m), 6.43
(LH, d, J1BHz), 7.10 (2H, ml
7J9 (2H, m), 7.56 (18, d, J=l6
}1z) The following compounds were obtained in the same manner.
参考例2
3−(4−メトキシシンナモイル)アミノーεカプ口ラ
クタム
融点238−239°
I R (K Br)cn+−’: 1672,
1650, 1604, 1532,1511,
1257. 11?2.N M R (do D
M S O )δ: 1. 1g − 1. 85
(6H, m), 3.07−3. 25(28,
m), 3. 76(3H, s), 4. 52
(LH, dd, J7Hz,10Hz), 6.7
7(IH,d,J=16Hz), 6.95(2H,
d, J一8Hz), 7.34(IH,d,J=
16Hz), 7.51(2H,d,J=8Hz),
7.84(IH,t,J=5Hz), 7.97
(18,d,J=7Hz).参考例3
3−ンンナモイルアミノーε一カブ口ラクタム融点19
4−196°
I R(K Br)cm−’: 3294, 2924
, 1656, 1619,1536. 14g0,
1433. 1226NMR(CDCQ.3)δ:
1. 28 − 2. 23(6H, m), 3.
093. 40(2H, m). 4. 56 −
4. 79(1}1, m), 6. 49(IH,
d, J= 15Hz), 6. 90 − 7. 6
0(5H, m), 7. 61(In, d, J=
15Hz)
参考例4
1(2−フエニルブチリル)アミノーε一カブロラクタ
ム
融点152−153°
I R(KBr)cm−’+ 3280. 293
4, 1641, 1531,1479. 14
36.
NMR(CDCff3): 0.8g(38,t,J
=7Hz), 1.33 2.32(8H,n+)
, 3.13−3.37(2H,+n). 4.0
0(1}1,t,J=7Hz), 4.36−4.6
1(IH,m), 7.30(5H.s).参考例5
:3−(4−メトキシベンゾイル)アミノーε一カブ口
ラクタム
融点214−215°
I R(K Br)cm−’: 2926, 1641
, 1548, 1505,1246. 1187.
NMR(d.−DMSO)δ: l. 17 − 2.
02(6H, m), 3.11−3.30(2H,
m), 3.82(3H,s), 4.56−4.64
(IHm), 7. 00(2H, d, J= 9H
z), 7. 83(2H, d, J= 9Hz),
8、09(li{, d, J = 6Hz)参考例6
3−(4−メチルンンナモイル)アミノーε一カブ口ラ
クタム
融点229−230’
I R(K Br)am−’: 3196. 2932
, 1685, 1610,1347 807
NMR(CDCf23)δ: 1.22−2.28(6
H,m), 2、37(3H, s). 3. 2
3 − 3. 50(2H. m). 4. 59
− 4.81(IL m),6.46(IH.d,J=
16Hz). 7.20(2H,d,J=9Hz).
7.43(2H, d, J = 9Hz),
7.63(IH,d, J= 16Hz).参考例7
1(4−エトキシシンナモイル)アミノーε一カブ口ラ
クタム
融点236−237°
I R(K Br)cm”−’: 16g6, 164
4, 1605, 1562,1513. 1{04,
1233. 1173.NMR(d.−DMSO)δ
: 1,32(3}1,t,J=7Hz), 1.20
−2.00(6H,m), 3.09−3..33(
2H,m), 4.06(2H,q,J=7Hz),
4.44−4.63(IH,m), 6.72(IH
,d.J=16}1z). 6. 93(2H, d,
J= 9Hz), 7. 32(IH, d, J=
16Hz). 7.50(2H,d,J=9Hz).
参考例8
1(4−イソブロビルシンナモイル)アミノーε一カブ
口ラクタム
融点199−200°
I R(K Br)cm−’: 3320, 16
70, 1651. 16151528, 14
30.
NMR(d.−DMSO)δ: 1.18(6H,d.
J=6Hz), I.33−2.00(6H,m),
2.81−2.98(IH,m), 3.04−
325(2H,m), 4.43−4.63(1B,
m), 6.83(IH,d,J一16Hz),
7、24(2H,d,J=7Hz), 7.38(I
H,d,J=16Hz), 7.50(2H,d,J
=7Hz).参考例9
3−[5−(4−メトキシフエニル)ペンタジエノイル
]アミノ−ε一カブ口ラクタム
融点204−206°
I R(KBr)cttr−’: 1645, 159
8, 1510, 1480,1435, 1255.
1176, 1029.NMR(d,−DMSO)
δ: 1.15−1.93(68,m), 3.00
− 3. 20(2H, m), 3. 77(3H,
s), 4. 38 − 4. 61(1B,m),
6. 26(IH, d, J= 14Hz), 6
. 83 − 7. 05(3H, m),6. 91
(2H, d, J= 8Hz), 7. 50(2H
, d, J= 8Hz)参考例10
3−(4−インプaボキシシンナモイル)アミノーε一
カブ口ラクタム
融点2’2 5 − 2 2 6°
I R(K Br)cm ’: 1671, 1
651, 1606, 1535,1510,
1254.
NMR(CDCl23)δ: l. 16−2. 3
0(6H, m), 1. 32(6H, d, J
= 6Hz), 3. 12 − 3. 40(2H
, m), 4. 56(IH,septet,J=
6Hz), 6.33(1}1,d,J=16Hz)
, 6.83(211d,J=9Hz), 7.4
1(2H,d,J=9Hz), 7.55(18,d
,J=16Hz).
参考例11
3−(3.5−ジーt−ブチルー4−ヒドロキシシンナ
モイル)アミノーε一カブロラクタム融点112−11
3°
I R(K Br)clTl−’: 2956, 16
57, 1615. 14791435. 120g
.
NMR(d..−DMSO)δ: 1.10−2.00
(6H,m), 1.39(18H.s), 3.0
4−3.32(2H.m), 4.4:{−4.65(
ltl,m). 6.76(IH,d,J=16Hz)
, 7.29(LH,d,J=16Hz),7. 31
(2H, s)
参考例12
3−(2−メトキシ/ンナモイル)アミノーεカブ口ラ
クタム
融点213−214°
I R(K Br)cm−’: 3216, 1685
, 1643, 1613,1557. 144g,
1245.
NMR(d.−DMSO)δ: 1.18−1.96(
6H.m), 3.03−3. 27(2}1, 0
+), 3. 83(3}1. s), 4. 43
− 4. 65(1}1,m), 6.76−7.56
(6H,m).参考例13
1(3.4一メチレンジオキシシンナモイル)アミノー
ε一カブ口ラクタム
融点275−276°
I R(K Br)am−’: 1669, 1652
, 1616, 1532,1500, 1488,
1250.NMR(d.−DMSO)δ: 1.17
−1.95(6H,m), 3.05−3.32(2H
,m), 4.40 − 4. 60(IH, m),
6. 03(2H,s), 6.73(1B,d,J
=16Hz), 6.80−7.17(3}1,+n)
7. 30(IH, d, J= 16Hz).参考例
14
3−(α−フエニルシンナモイル)アミノーεカプロラ
クタム
融点159−160°
I R(K Br)cm−’: 3354, 32
54, 1656. 1617,1501, 1
445, 709.NMR(d.−DMSO)δ:
1.22−1.98(6H,m), 3.00−
3. 19(2}!, m), 4. 40(IH,
dd, J= 4Hz, 7Hz), 6.95
− 7. 56(IIH, m).参考例15
3−(2,3.4− }リメトキシシンナモイル)アミ
ノーε一カブロラクタム
融点208−209°
I R(KBr>cm−’: 1673. 1646,
1614, 1495,1464. 1297. 1
097.
NMR(d.−DMSO)δ:l、18 − 1. 9
7(6H, m), 3.(18−3.22(2H,m
), 3.75(3H,s), ’3.80(3H,s
), 3.82(31,s). 4.43−4.63(
IH,n), 6.79(LH,d,J16Hz).
6.89(IH,d.J=9Hz). 7.32(lH
.d,J=9Hz). 7.53(1B,d.J=16
Hz).参考例l6
3−(3.4−ジメト牛シシンナモイル)アミノーε一
カプロラクタム
融点185−186°
I R(K Br)cn+−’: 3302, 1
650, 1611, 1514,1468,
1260, 1137.NMR(d.−DMS O)
δ: 1. 18−1. 96(6H, m),
3.08−3.29(21{,n+), 3.79(
3H,s), 3.81(3H,s), 449
− 5. 08(LH, m), 6. 86(18
, d, J= 16Hz), 6. 98(LH,
d, J= 8Hz), 7. 13(IH, d
d, J= 2Hz, 8Hz), 7、23(it
{,d,J=2Hz), 7.34(IH,d,J=
16Hz).参考例l7
3−(3.4−ジメトキシベンゾイル)アミノε一カブ
ロラクタム
3,4−ジメト牛シ安息香酸10.Ogのテトラヒドロ
フラン溶iffl300jI12に、N,N’一カノレ
ボニルジイミダゾール9.79gを加え、室温にて30
分間撹拌した。次に3−アミノーε一カブロラクタム7
.04gを加え、5時間撹拌後析出結晶をろ取、洗浄し
、減圧下で乾燥して表題化合物を得た(8.5g)。こ
の化合物は精製することなく次反応に用いた。Reference example 2 3-(4-methoxycinnamoyl)amino-ε capulactam melting point 238-239° I R (K Br) cn+-': 1672,
1650, 1604, 1532, 1511,
1257. 11?2. N M R (do D
M SO ) δ: 1. 1g - 1. 85
(6H, m), 3.07-3. 25 (28,
m), 3. 76 (3H, s), 4. 52
(LH, dd, J7Hz, 10Hz), 6.7
7 (IH, d, J=16Hz), 6.95 (2H,
d, J-8Hz), 7.34 (IH, d, J=
16Hz), 7.51 (2H, d, J=8Hz),
7.84 (IH, t, J=5Hz), 7.97
(18, d, J=7Hz). Reference example 3 3-nnnamoylamino-ε monolactam melting point 19
4-196°IR(KBr)cm-': 3294, 2924
, 1656, 1619, 1536. 14g0,
1433. 1226NMR (CDCQ.3) δ:
1. 28-2. 23 (6H, m), 3.
093. 40 (2H, m). 4. 56-
4. 79(1}1, m), 6. 49 (IH,
d, J= 15Hz), 6. 90-7. 6
0 (5H, m), 7. 61(In, d, J=
15Hz) Reference Example 4 1(2-phenylbutyryl)amino-ε-cabrolactam Melting point 152-153° I R(KBr) cm-'+ 3280. 293
4, 1641, 1531, 1479. 14
36. NMR (CDCff3): 0.8g (38,t,J
=7Hz), 1.33 2.32 (8H, n+)
, 3.13-3.37 (2H, +n). 4.0
0(1}1,t,J=7Hz), 4.36-4.6
1 (IH, m), 7.30 (5H.s). Reference example 5: 3-(4-methoxybenzoyl)amino-ε-1 turnip lactam Melting point 214-215° I R(K Br) cm-': 2926, 1641
, 1548, 1505, 1246. 1187. NMR (d.-DMSO) δ: l. 17-2.
02 (6H, m), 3.11-3.30 (2H,
m), 3.82 (3H, s), 4.56-4.64
(IHm), 7. 00(2H, d, J= 9H
z), 7. 83 (2H, d, J=9Hz),
8,09 (li{, d, J = 6Hz) Reference Example 6 3-(4-methylnnnamoyl)amino-ε-1-cubic lactam melting point 229-230' I R(K Br) am-': 3196. 2932
, 1685, 1610, 1347 807 NMR (CDCf23) δ: 1.22-2.28 (6
H, m), 2, 37 (3H, s). 3. 2
3-3. 50 (2H.m). 4. 59
- 4.81 (IL m), 6.46 (IH.d, J=
16Hz). 7.20 (2H, d, J=9Hz).
7.43 (2H, d, J = 9Hz),
7.63 (IH, d, J= 16Hz). Reference Example 7 1(4-Ethoxycinnamoyl)amino-ε monolactam Melting point 236-237° I R(K Br) cm"-': 16g6, 164
4, 1605, 1562, 1513. 1{04,
1233. 1173. NMR(d.-DMSO)δ
: 1,32(3}1,t,J=7Hz), 1.20
-2.00 (6H, m), 3.09-3. .. 33(
2H, m), 4.06 (2H, q, J=7Hz),
4.44-4.63 (IH, m), 6.72 (IH
, d. J=16}1z). 6. 93 (2H, d,
J=9Hz), 7. 32 (IH, d, J=
16Hz). 7.50 (2H, d, J=9Hz).
Reference Example 8 1(4-isobrobylcinnamoyl)amino-ε monolactam Melting point 199-200° I R(K Br) cm-': 3320, 16
70, 1651. 16151528, 14
30. NMR (d.-DMSO) δ: 1.18 (6H, d.
J=6Hz), I. 33-2.00 (6H, m),
2.81-2.98 (IH, m), 3.04-
325 (2H, m), 4.43-4.63 (1B,
m), 6.83 (IH, d, J-16Hz),
7, 24 (2H, d, J = 7Hz), 7.38 (I
H, d, J = 16Hz), 7.50 (2H, d, J
=7Hz). Reference Example 9 3-[5-(4-methoxyphenyl)pentadienoyl]amino-ε monolactam Melting point 204-206° I R(KBr)cttr-': 1645, 159
8, 1510, 1480, 1435, 1255.
1176, 1029. NMR (d,-DMSO)
δ: 1.15-1.93 (68, m), 3.00
-3. 20 (2H, m), 3. 77 (3H,
s), 4. 38-4. 61 (1B, m),
6. 26 (IH, d, J= 14Hz), 6
.. 83-7. 05 (3H, m), 6. 91
(2H, d, J= 8Hz), 7. 50 (2H
, d, J = 8 Hz) Reference Example 10 3-(4-impaboxycinnamoyl)amino-ε-1-cubic lactam melting point 2'2 5 - 2 2 6° I R (K Br) cm': 1671, 1
651, 1606, 1535, 1510,
1254. NMR (CDCl23) δ: l. 16-2. 3
0 (6H, m), 1. 32 (6H, d, J
= 6Hz), 3. 12-3. 40 (2H
, m), 4. 56 (IH, septet, J=
6Hz), 6.33 (1}1, d, J=16Hz)
, 6.83 (211d, J=9Hz), 7.4
1 (2H, d, J=9Hz), 7.55 (18, d
, J=16Hz). Reference Example 11 3-(3.5-di-t-butyl-4-hydroxycinnamoyl)amino-ε-cabrolactam Melting point 112-11
3° IR(KBr)clTl-': 2956, 16
57, 1615. 14791435. 120g
.. NMR (d..-DMSO) δ: 1.10-2.00
(6H, m), 1.39 (18H.s), 3.0
4-3.32 (2H.m), 4.4:{-4.65(
ltl, m). 6.76 (IH, d, J=16Hz)
, 7.29 (LH, d, J=16Hz), 7. 31
(2H, s) Reference Example 12 3-(2-methoxy/annamoyl)amino-ε Kabuchi lactam Melting point 213-214° I R(K Br) cm-': 3216, 1685
, 1643, 1613, 1557. 144g,
1245. NMR (d.-DMSO) δ: 1.18-1.96 (
6H. m), 3.03-3. 27(2}1, 0
+), 3. 83(3}1.s), 4. 43
-4. 65(1}1,m), 6.76-7.56
(6H, m). Reference Example 13 1(3.4-methylenedioxycinnamoyl)amino-ε-1-cubic lactam Melting point 275-276° I R(K Br) am-': 1669, 1652
, 1616, 1532, 1500, 1488,
1250. NMR (d.-DMSO) δ: 1.17
-1.95 (6H, m), 3.05-3.32 (2H
, m), 4.40 - 4. 60 (IH, m),
6. 03 (2H, s), 6.73 (1B, d, J
=16Hz), 6.80-7.17(3}1,+n)
7. 30 (IH, d, J= 16Hz). Reference Example 14 3-(α-Phenylcinnamoyl)amino-ε-caprolactam Melting point 159-160° I R(K Br) cm-': 3354, 32
54, 1656. 1617, 1501, 1
445, 709. NMR (d.-DMSO) δ:
1.22-1.98 (6H, m), 3.00-
3. 19(2}!, m), 4. 40 (IH,
dd, J=4Hz, 7Hz), 6.95
-7. 56 (IIH, m). Reference Example 15 3-(2,3.4-}rimethoxycinnamoyl)amino-ε-cabrolactam Melting point 208-209° I R (KBr>cm-': 1673. 1646,
1614, 1495, 1464. 1297. 1
097. NMR (d.-DMSO) δ:l, 18-1. 9
7 (6H, m), 3. (18-3.22(2H, m
), 3.75(3H,s), '3.80(3H,s
), 3.82 (31, s). 4.43-4.63(
IH, n), 6.79 (LH, d, J16Hz).
6.89 (IH, d.J=9Hz). 7.32 (lH
.. d, J=9Hz). 7.53 (1B, d.J=16
Hz). Reference example 16 3-(3.4-dimethocycinnamoyl)amino-ε-caprolactam melting point 185-186° IR(KBr)cn+-': 3302, 1
650, 1611, 1514, 1468,
1260, 1137. NMR (d.-DMSO)
δ: 1. 18-1. 96 (6H, m),
3.08-3.29(21{,n+), 3.79(
3H,s), 3.81(3H,s), 449
-5. 08 (LH, m), 6. 86 (18
, d, J= 16Hz), 6. 98(LH,
d, J=8Hz), 7. 13(IH, d
d, J= 2Hz, 8Hz), 7, 23(it
{,d,J=2Hz), 7.34(IH,d,J=
16Hz). Reference Example 17 3-(3,4-dimethoxybenzoyl)amino ε-cabrolactam 3,4-dimethoxybenzoic acid 10. 9.79 g of N,N'-canolebonyldiimidazole was added to IFFL300JI12 in which Og was dissolved in tetrahydrofuran, and the mixture was heated for 30 minutes at room temperature.
Stir for a minute. Next, 3-amino-ε-cabrolactam 7
.. After stirring for 5 hours, the precipitated crystals were collected by filtration, washed, and dried under reduced pressure to obtain the title compound (8.5 g). This compound was used in the next reaction without purification.
融点 190−191°
l R (K B r)cm−’ : 1657,
1617, 1574, 1510, 1476.12
63
NMR (ds− DMS O)δ: l. 16−
2. 00(6H, m),3. 03−3. 25(
21{, m), 3. lli+(6H, s),
4. 57−4. 65(IH, m),7. 02(
11{, d, J = 8Hz), 7. 43−7
. 50(2H, m), 7、83−7. 89(I
H, m), 8. 15(If{, d, J= 7
Hz).以下同様にして次の化合物を得た。Melting point 190-191° l R (K B r) cm-': 1657,
1617, 1574, 1510, 1476.12
63 NMR (ds-DMSO) δ: l. 16-
2. 00 (6H, m), 3. 03-3. 25(
21{, m), 3. lli+(6H, s),
4. 57-4. 65 (IH, m), 7. 02(
11{, d, J = 8Hz), 7. 43-7
.. 50(2H, m), 7, 83-7. 89 (I
H, m), 8. 15(If{, d, J= 7
Hz). The following compounds were obtained in the same manner.
参考例l8
3〜(3−メトヰシシンナモイル)アミ7ーεカフロラ
クタム
融点 +73−174°
l R (K B r)am ’ : 3312, 1
671, 1653, 1621. 15781540
, 1434. 1289
NMR(dll−DMS○)δ: I. +5−2.
00(6H, m)3. 12−3. 28(2B.
m). 3. 79(38, s), 4. 54(
Ift, dd, J= 3Hz, 7Hz), 6.
92−7. 4 1(6H, m),7. 88(I
H, t, J = 4Hz),8. 05(IH,
d, J = 71tz).参4例19
3−(3.5−ジメトキ/ンンナモイル)アミノε一カ
フロラクタム
融点 174−175°
I R (K B r)cm−’ : 1654,
1619, 1535, 1426. 1208116
0、
NMR(d,DMS○)δ: 1. 20−1. 9
7(6H, ml3. 09−3. 32(2H, m
), 3. 77(6H, s), 4. 53(IH
, dd, J= 4Hz, 7Hz), 6.50(
IH, t, J = 2Hz), 6. 77(2H
, d, J = 2Hz), 6. 98(IH,
d, J −= 16Hz), 7. 32(IH,
d, J = 16Hz), 7. 88(IH, t
, J = 6Hz), 8. 01(IH, d,
J = 787.).参考例20
3−(2.3−ジメト牛シシンナモイル)アミンε〜カ
ブロラクタム
融点 187−188°
I R (K B r)cm”−’ : 3208.
1686, 1613, 1577. 14g0,12
70.
NMR(da−DMS○)δ: 1. 18−1.
89(6H, ml3. 09−3. 28(2■,
m), 3. 75(3H, s), 3. 82(3
H, s), 4. 54(IH, dd, J −
3Hz, 7Hz), 6. 93(IH, d, J
= 16Hz), 7, 037. 22(3}1,
m), 7. 64(IH, d, J = ] 6
}1z), 7. 85(III, t, J一6Hz
), 8. 13(IH, d, J= 7Hz)参考
例21
3−(2.5一ンメト牛ンンノナモイル)アミノε一カ
ブ口ラクタム
融点 19Cl191°
I R (K B r)cm ’ : 1655, 1
600, 1524, 1494. 1431.122
3
NMR(d.−DMSO)δ: 1.20−1.93
(6H,m)+3. 00−3. 26(28, m)
, 3. 75(3H, s), 3. 80(3H,
s), 4. 54(IH, dd, J = 2H
z, 6Hz), 6. 92−7.01(3H, m
), 7. 14(IH,d. J = 31{z),
7. 64(IH. d, J= 16Hz), 7
. 88(IH, t, J=7Hz), 8. 02
(18, d, J− 8Hz).堅考例22
3−(4−メトキシー3−メチルシンナモイノレ)アミ
ノーε一カブ口ラクタム
融点 2+8−219°
I R (K B r)am−’゜3280. 292
0. +660. 1640, 1600.1500
1248.1122
NMR(d.−DMSO)δ: 1.20−1.92
(6H,m),2. I 6(3H, s), 3.
06−3. 25(2H, m), 3. 82(3L
s), 4. 484. 57(18. m). 6
. 78(IH, d. J = 16Hz), 6.
97(ltl, d, J911z). 7. 31
(I}I, d, J = 16Hz), 7. 39
−7.42(2}1, m)7. 86(1}1, t
, J= 5Hz), 7. 95(IH, d, J
= 7Hz)参考例23
3−[4−メトキシー3〜(2−メチルチオエトキン)
ンンナモイル]アミノーε一カブ口ラクタム融点 19
2−193°
I R (K B r)am−’ : 1673, 1
650, 1610, 1511. 1428.126
2 1143.
NMR(d@−DMSO)δ: 1.19−1.97
(6H,m),2. 18(3B, s). 2. 8
7(2H, t, J = 7Hz), 3. 024
. 2g(21m), 3. 79(38. s),
4. 17(2H, t, J = 7Hz), 4.
52(IH, dd,J= 3Hz, 5Hz),
6. 84(IH. d, J = 16Hz). 6
、98(18, d, J一8Hz), 7. 13(
IH, dd, J = 3. 8Hz), 7. 2
4(IH, d, J = 3Hz), 7. 32(
1B, d. J = 16Hz), 7. 85−7
. 91(2H, m)参考例24
3−(3,4.5− 1−リメトキ/ンンナモイル)ア
ミノーε一カブ口ラクタム
融点 197−198°
I R (K B r)cm−’ : 1667, 1
645, 1600. 157g, 1502.141
1 1122
NMR(d.−DMso)δ: 1. 18−1.
97(6H, m),3. 03−3. 24(2H,
m), 3. 69(3H, s), 3. 82(
6H, s), 4. 53(18, dd, J =
3Hz, 7Hz), 6. 95(2H, s),
6. 96(IH, d, J16Hz), 7.
34(IH, d, J−16Hz), 7. 89−
1. 93(2H, m).参考例25
3−(2.4−ジメトキンシンナモイル)アミノε一カ
プ口ラクタム
融点 207−208°
I R (K B r)am−’ : 3294. 1
678, 1644, 1599, 1519.121
2 1159.
NMR(d.−DMS○)δ: 1. 21−1.
89(6H, m),3. 07−3. 20(2H,
m), 3. 81(3H, s), 3. 86(
3H, s), 4. 53(IH. dd. J =
3Hz, 7Hz), 6. 56−6. 61(2
H, m), 6. 78(IHd, J = 161
{z), 7. 49(IH, d, J= 9Hz)
, 7. 58(LH, d, J16Hz), 7.
84(IH, t, J = 6Hz), 7. 9
5(LH, d, J = 7Hz)参考例26
3−(3−ブロモー4−メトキシシンナモイル)アミノ
ーε一カプ口ラクタム
融点 226−227°
I R (K B r)cm”−’ : 1671,
1649, 1619. 1598. 1496,+
260.
NMR(d.−DMSO)δ: 1.19−1.96
(6H,m),3. 08−3. 25(2H, m)
, 3. 89(31{, s), 4. 48−4.
57(IH, m),6. 89(IH, d, J
= 16Hz), 7. 16(IH, d, J=
9Hz), 7. 33(IH, d, J = 16
Hz), 7. 59(LH, dd, J= 2Hz
, 9Hz), 7. 85(IH, d, J= 2
Hz).
参考例27
1(3.5−ジーtert−ブチルー4−ヒドロキンベ
ンゾイル)アミノ−ε一カブ口ラクタム融点 131−
132°
I R (K B r)am−’ : 2954, 1
710, 1675, 1644. 14791427
, 1231.
N M R (do D M S O )δ: 1
.23−1.98(6H.m),1. 41(18H,
s), 3. 09−3. 28(2H, m),
4. 53−4. 62(IH, m), 7. 59
(2H, s).
参考例28
3−(2.4−ジメトキシベンゾイル)アミノε一カプ
ロラクタム
融点 196−197°
I R (K B r)cm−’ : 3310, 1
669, 1494. 132g, 1261,121
0 1013.
NMR(d.−DMSO)δ: 1.18−2.09
(6H,m),3. 04−3. 24(2H, m)
, 3. 83(3H, s), 3. 95(3H,
s), 4. 504. 58(IH, m), 6
. 63−6. 68’(2H. m), 7. 93
(IH, d, J= 9Hz).
参考例29
3−(3.4−ジメチルシンナモイル)アミノε一カブ
口ラクタム
融点 226−227°
I R (K B r)cm”−’ : 2934,
1685, 1643, 1613, 1562,14
79. 1242.
NMR(d.−DMSO)δ: 1. 16−1.
98(6H, m),2. 24(6H, s), 3
. 03−3. 21(2H, m), 4. 49−
4. 58(IH, m),6. 88([1, d,
J= 16Hz), 7. 17(IH, d, J
= 8Hz), 7. 297. 37(3H, m)
参考例30
3−(2−メトキシー3−メチルンンナモイル)アミノ
ーε一カブロラクタム
融点 186−187°
I R (K B r)cm−’ : 3270, 3
222. 16g4, 1638, 1621,156
9. 1467.
NMR(d.−DMS○)δ: 1. 19−1.
98(6H, m),2. 26(3H, s), 3
. 06−3. 24(2H, m), 3. 68(
38, s), 4. 51−4. 60(IH, m
), 6. 94(IH, d, J = 16Hz)
, 7. 09(IH, t, J6Hz). 7.
24(IH, d, J= 6Hz), 7. 47(
IH, d, J= 6}fz)7. 63(IH,
d, J= 16Hz). 7. 87(IH, t,
J = 5Hz), 8. 15(IH, d, J
= 7Hz)、
参考例31
3−(3−メトキシベンゾイル)アミノーε−カブロラ
クタム
融点 118−149°
I R (K B r)cm−’ : 1680. 1
648. 15g7, 1542, 1487,130
0.
NMR(d.−DMso)δ: 1.19−2.00
(6H,m),3. 03−3. 27(2}1, m
). 3. 81(38, s), 4. 57−4.
68(IH, m)7. 07−7. 14(IH,
m), 7. 35−7. 42(3H, m).参
考例32
3−(α−メチルシンナモイル)アミノーε一カプロラ
クタム
融点 1 6 0 − 1 6 ’1°I R (K
B r)cm−’ : 3384, 1672. 16
60, 1593. 1511l475
N M R (d.−DMSO)δ: 1. 18−
1. 96(6H, m),2. 03(3}1, s
), 3. 02−3. 27(2H, m), 4.
46−4. 54(IH, m)7. 29−7.
43(6H, m).参考例33
3−(4−トリフルオロメチルベンゾイル)アミノーε
一カブロラクタム
融点 283〜284°
I R (K B r)cm ’ : l687, 1
636, 1324, 1295, 1174.111
6
NMR(de−DMSO)δ: 1. 14−2.
00(6H, m),3. 04−3. 24(2H,
m>. 4. 60−4. 71 (IH, m),
7. 86(28, d,J= 811z), 8.
07(2H, d. J= 8Hz).参考例34
3−(3.4−メチレンジオキシベンゾイル)アミノー
ε一カブ口ラクタム
融点 196−197°
J R (K B r)Cm”−’ : 1660.
1635, 1602, 1475, 1253.10
33
NMR(d.−DMSO)δ: 1. 12−1.
99(6H, n),3. 08−3、27(2H,
II1). 4. 55−4. 62(IH, II1
), 6. 11(2H, s),6. 99(1B.
d, J = 8Hz), 7. 39(IH, d
, J−2Hz), 7. 45(LH, dd, J
= 2Hz. 8Hz).参考例35
3−(p−}ルオイル)アミノーε一カプロラクタム
融点 202−203°
I R (K B r)am−’ : 3262, 3
200, 1654, 1539, 1295,128
2.
NMR(d.−DMSO)δ: 1. 22−1.
98C6H, m’).2. 36(3H, s),
3. 03−3. 24(28, m). 4. 56
−4、64(18, m)7. 28(2H, d,
J = 11!Hz), 7. 76(2H, d,
J = 8[]z).参考例36
3−(2,3.4−トリメトキシベンゾイル)アミノー
ε一カブロラクタム
融点 240−24 1°
I R (K B r)cm−’ : 3262, 1
678. 1656, 1634. 15191482
, 1093、
NMR(d.−DMSO)δ: 1. 15−2.
08(6H, m),3. 08−3. 21(2B,
m), 3. 78(3H, s), 3. 85(
3H, s), 3. 90(3H, s), 4.
52−4. 61(IH, m), 6. 95(18
, d, J= 9Hz).7. 70(IH, d,
J= 9Hz).参考例37
3−(3−トリフルオロメチルシンナモイル)アミノー
ε一カブ口ラクタム
融点 201204°
I R (K B r)cm−’ : 1673. 1
651, 1624, 1347, 1162.112
1
NMR(d.−DMSO)δ: 1. 17−1.
98(6H, m),3. 09−3. 36(2H,
m), 4. 50−4. 59(IH, m),
7. 15(IH, d,J = 16Hz). 7.
50(IH, d, J = 16Hz), 7.
61−7. 98(4}1,m)
参考例38
3 − (N − tert−ブトキンカルボニルーβ
−アラニル)アミノーε一カブ口ラクタム
融点 11CIIII°
I R (K B r)cm−’ : 3346, 1
677, 1632, 1526, 1285.117
3
NMR(d,−DMSO)δ: 1.25−2.1g
(6B,m)+1. 42(9B, s), 2. 4
1(2H. t, J= 6Hz), 3. 14−
3. 47(41{,m), 4. 41−4. 60
(1B, m).参考例39
3−(4−メトキシカルポニルベンゾイル)アミノーε
一カブロラクタム
融点 226−227°
I R (K B r)am−’ : 3306, 1
714, 1672, 1632. 1428.128
4.
NMR(d.−DMSO)δ: l. 20−2.
02(68, m),3. 10−3. 22(2H,
m), 3. 89(:{H, s), 4. 60
−4. 68(1B, m),7. 98(2H, d
, J= 9Hz), 8. 06(2B, d, J
= 9Hz).参考例40
3−(4−エトキシカルボニルシンナモイル)アミノー
ε一カブ口ラクタム
融点 208−209°
I R (K B r)cm”−’ : 1715,
1670, 1655, 1619, 1282,12
72.
NMR(d.−DMSO)δ: 1. 21−1.
98(6H, m)1. 33(3H, t, J =
7Hz), 3. 07−3. 22(2H. m)
. 4. 33(2B,ci, J= 7Hz). 4
. 50−4. 59(1H, m), 7. 09(
IL d, J= 16Hz), 7. 46(1B,
d, J = 16Hz), 7. 72(2B,
d, J = 8}1z),7. 98(2H, d,
J = 8Hz).参考例4l
3 [4−(tert−ブトキシカルボニルアミノメ
チル)ペンゾイル]アミノーε一カブ口ラクタム融点
174−175°
I R (K B r)am ’ : 3364, 1
683, 1637, 1527. 1288.117
0
NMR(d8−DMSO)δ: 1.21−2.00
(6H,m),1. 40(9H, s), 3. 0
2−3. 28(2H, m), 4. 17(2H,
d, J = 8Hz), 4. 56−4. 65
(IH, m), 7. 32(2H, d, J=
8Hz), 7. 80(2H, d, J = 8H
z)
参考例42
3−[1−(エトキシカルボニルオキシ)シンナモイル
]アミノーε一カブ口ラクタム
3−ヒドロキ/−4−メトキシけい皮酸22.5gおよ
びトリエチルアミン32.Mを400dのテトラヒド口
フランに加え、水冷撹拌下、22.2dのクロロぎ酸エ
チルを滴下した。滴下終了後、さらに15分間撹拌し、
続いて3−アミノーε一カブ口ラクタム14.9gのテ
トラヒドロフラン溶液200mを滴下し、滴下終了後室
温にて1時間撹拌した。反応液を減圧下濃縮し、残留物
をクロロホルムに溶解した。この溶液を水洗乾燥後、減
圧下溶媒を留去した。残留物を酢酸エチルで洗浄後、減
圧下乾燥し、表題化合物を得た(28g)。この化合物
は精製することなく次反応に用いた。Reference example 18 3-(3-methoxycinnamoyl)amy7-εcafrolactam Melting point +73-174° l R (K B r) am': 3312, 1
671, 1653, 1621. 15781540
, 1434. 1289 NMR (dll-DMS○) δ: I. +5-2.
00(6H, m)3. 12-3. 28 (2B.
m). 3. 79 (38, s), 4. 54(
Ift, dd, J= 3Hz, 7Hz), 6.
92-7. 4 1 (6H, m), 7. 88 (I
H, t, J = 4Hz), 8. 05(IH,
d, J = 71tz). Reference 4 Example 19 3-(3.5-dimethoxy/nnnnamoyl)amino ε-cafrolactam Melting point 174-175° I R (K B r) cm-': 1654,
1619, 1535, 1426. 1208116
0, NMR (d, DMS○) δ: 1. 20-1. 9
7 (6H, ml3.09-3.32(2H, m
), 3. 77 (6H, s), 4. 53 (IH
, dd, J= 4Hz, 7Hz), 6.50(
IH, t, J = 2Hz), 6. 77 (2H
, d, J = 2Hz), 6. 98 (IH,
d, J −= 16Hz), 7. 32 (IH,
d, J = 16Hz), 7. 88 (IH, t
, J = 6Hz), 8. 01(IH, d,
J = 787. ). Reference Example 20 3-(2.3-dimethocycinnamoyl)amine ε~cabrolactam melting point 187-188° I R (K B r) cm"-': 3208.
1686, 1613, 1577. 14g0,12
70. NMR (da-DMS○) δ: 1. 18-1.
89(6H, ml3.09-3.28(2■,
m), 3. 75 (3H, s), 3. 82(3
H, s), 4. 54 (IH, dd, J-
3Hz, 7Hz), 6. 93 (IH, d, J
= 16Hz), 7, 037. 22(3}1,
m), 7. 64 (IH, d, J = ] 6
}1z), 7. 85 (III, t, J-6Hz
), 8. 13 (IH, d, J = 7 Hz) Reference example 21 3-(2.51-methoxynnnonamoyl)amino ε-1-cubic lactam Melting point 19Cl191° I R (K B r) cm': 1655, 1
600, 1524, 1494. 1431.122
3 NMR (d.-DMSO) δ: 1.20-1.93
(6H, m)+3. 00-3. 26 (28, m)
, 3. 75 (3H, s), 3. 80 (3H,
s), 4. 54 (IH, dd, J = 2H
z, 6Hz), 6. 92-7.01 (3H, m
), 7. 14 (IH, d. J = 31{z),
7. 64 (IH. d, J= 16Hz), 7
.. 88 (IH, t, J=7Hz), 8. 02
(18, d, J-8Hz). Consideration Example 22 3-(4-Methoxy3-methylcinnamoinole)amino-ε-1-cubic lactam Melting point 2+8-219° I R (K B r) am-'° 3280. 292
0. +660. 1640, 1600.1500
1248.1122 NMR (d.-DMSO) δ: 1.20-1.92
(6H, m), 2. I 6 (3H, s), 3.
06-3. 25 (2H, m), 3. 82 (3L
s), 4. 484. 57 (18. m). 6
.. 78 (IH, d. J = 16Hz), 6.
97 (ltl, d, J911z). 7. 31
(I}I, d, J = 16Hz), 7. 39
-7.42(2}1, m)7. 86(1}1, t
, J=5Hz), 7. 95 (IH, d, J
= 7Hz) Reference Example 23 3-[4-methoxy3-(2-methylthioethquine)
Nannamoyl] amino-ε monolactam melting point 19
2-193° I R (K B r) am-': 1673, 1
650, 1610, 1511. 1428.126
2 1143. NMR (d@-DMSO) δ: 1.19-1.97
(6H, m), 2. 18 (3B, s). 2. 8
7 (2H, t, J = 7Hz), 3. 024
.. 2g (21m), 3. 79 (38.s),
4. 17 (2H, t, J = 7Hz), 4.
52 (IH, dd, J= 3Hz, 5Hz),
6. 84 (IH. d, J = 16Hz). 6
, 98 (18, d, J-8Hz), 7. 13(
IH, dd, J = 3. 8Hz), 7. 2
4 (IH, d, J = 3Hz), 7. 32(
1B, d. J = 16Hz), 7. 85-7
.. 91 (2H, m) Reference Example 24 3-(3,4.5-1-rimethoxy/nnnnamoyl)amino-ε-1-cubic lactam Melting point 197-198° I R (K B r) cm-': 1667, 1
645, 1600. 157g, 1502.141
1 1122 NMR (d.-DMso) δ: 1. 18-1.
97 (6H, m), 3. 03-3. 24 (2H,
m), 3. 69 (3H, s), 3. 82(
6H, s), 4. 53 (18, dd, J =
3Hz, 7Hz), 6. 95 (2H, s),
6. 96 (IH, d, J16Hz), 7.
34 (IH, d, J-16Hz), 7. 89-
1. 93 (2H, m). Reference Example 25 3-(2.4-dimethquine cinnamoyl)amino ε-capsulactam Melting point 207-208° I R (K B r) am-': 3294. 1
678, 1644, 1599, 1519.121
2 1159. NMR (d.-DMS○) δ: 1. 21-1.
89 (6H, m), 3. 07-3. 20 (2H,
m), 3. 81 (3H, s), 3. 86(
3H, s), 4. 53 (IH. dd. J =
3Hz, 7Hz), 6. 56-6. 61(2
H, m), 6. 78 (IHd, J = 161
{z), 7. 49 (IH, d, J = 9Hz)
, 7. 58 (LH, d, J16Hz), 7.
84 (IH, t, J = 6Hz), 7. 9
5 (LH, d, J = 7Hz) Reference Example 26 3-(3-bromo-4-methoxycinnamoyl)amino-ε-monocaplactam Melting point 226-227° I R (K B r) cm"-': 1671,
1649, 1619. 1598. 1496,+
260. NMR (d.-DMSO) δ: 1.19-1.96
(6H, m), 3. 08-3. 25 (2H, m)
, 3. 89(31{, s), 4. 48-4.
57 (IH, m), 6. 89 (IH, d, J
= 16Hz), 7. 16(IH, d, J=
9Hz), 7. 33 (IH, d, J = 16
Hz), 7. 59 (LH, dd, J= 2Hz
, 9Hz), 7. 85 (IH, d, J= 2
Hz). Reference Example 27 1(3.5-di-tert-butyl-4-hydroquinbenzoyl)amino-ε-monolactam melting point 131-
132° I R (K B r) am-': 2954, 1
710, 1675, 1644. 14791427
, 1231. N M R (do D M SO ) δ: 1
.. 23-1.98 (6H.m), 1. 41 (18H,
s), 3. 09-3. 28 (2H, m),
4. 53-4. 62 (IH, m), 7. 59
(2H, s). Reference Example 28 3-(2.4-dimethoxybenzoyl)amino ε-caprolactam Melting point 196-197° I R (K B r) cm-': 3310, 1
669, 1494. 132g, 1261,121
0 1013. NMR (d.-DMSO) δ: 1.18-2.09
(6H, m), 3. 04-3. 24 (2H, m)
, 3. 83 (3H, s), 3. 95 (3H,
s), 4. 504. 58 (IH, m), 6
.. 63-6. 68' (2H.m), 7. 93
(IH, d, J= 9Hz). Reference example 29 3-(3.4-dimethylcinnamoyl)amino epsilon lactam melting point 226-227° I R (K B r) cm"-': 2934,
1685, 1643, 1613, 1562, 14
79. 1242. NMR (d.-DMSO) δ: 1. 16-1.
98 (6H, m), 2. 24 (6H, s), 3
.. 03-3. 21 (2H, m), 4. 49-
4. 58 (IH, m), 6. 88 ([1, d,
J=16Hz), 7. 17 (IH, d, J
= 8Hz), 7. 297. 37 (3H, m) Reference Example 30 3-(2-methoxy3-methylnnnamoyl)amino-ε-cabrolactam Melting point 186-187° I R (K B r) cm-' : 3270, 3
222. 16g4, 1638, 1621,156
9. 1467. NMR (d.-DMS○) δ: 1. 19-1.
98 (6H, m), 2. 26 (3H, s), 3
.. 06-3. 24 (2H, m), 3. 68(
38, s), 4. 51-4. 60 (IH, m
), 6. 94 (IH, d, J = 16Hz)
, 7. 09 (IH, t, J6Hz). 7.
24 (IH, d, J = 6Hz), 7. 47(
IH, d, J= 6}fz)7. 63 (IH,
d, J = 16Hz). 7. 87 (IH, t,
J = 5Hz), 8. 15 (IH, d, J
= 7 Hz), Reference Example 31 3-(3-methoxybenzoyl)amino-ε-cabrolactam Melting point 118-149° I R (K B r) cm-': 1680. 1
648. 15g7, 1542, 1487,130
0. NMR (d.-DMso) δ: 1.19-2.00
(6H, m), 3. 03-3. 27(2}1, m
). 3. 81 (38, s), 4. 57-4.
68 (IH, m)7. 07-7. 14 (IH,
m), 7. 35-7. 42 (3H, m). Reference Example 32 3-(α-Methylcinnamoyl)amino-ε-caprolactam Melting point 1 6 0 − 1 6 '1°I R (K
B r) cm-': 3384, 1672. 16
60, 1593. 1511l475 NMR (d.-DMSO) δ: 1. 18-
1. 96 (6H, m), 2. 03(3}1, s
), 3. 02-3. 27 (2H, m), 4.
46-4. 54 (IH, m)7. 29-7.
43 (6H, m). Reference Example 33 3-(4-trifluoromethylbenzoyl)amino-ε
-Cabrolactam melting point 283-284° IR (KBr) cm': 1687, 1
636, 1324, 1295, 1174.111
6 NMR (de-DMSO) δ: 1. 14-2.
00 (6H, m), 3. 04-3. 24 (2H,
m>. 4. 60-4. 71 (IH, m),
7. 86 (28, d, J= 811z), 8.
07 (2H, d.J=8Hz). Reference Example 34 3-(3.4-methylenedioxybenzoyl)amino-ε-1-cubic lactam Melting point 196-197° J R (K B r) Cm''-': 1660.
1635, 1602, 1475, 1253.10
33 NMR (d.-DMSO) δ: 1. 12-1.
99 (6H, n), 3. 08-3, 27 (2H,
II1). 4. 55-4. 62 (IH, II1
), 6. 11 (2H, s), 6. 99 (1B.
d, J = 8Hz), 7. 39 (IH, d
, J-2Hz), 7. 45 (LH, dd, J
= 2Hz. 8Hz). Reference Example 35 3-(p-}luoyl)amino-ε-caprolactam Melting point 202-203° I R (K B r) am-': 3262, 3
200, 1654, 1539, 1295, 128
2. NMR (d.-DMSO) δ: 1. 22-1.
98C6H, m'). 2. 36 (3H, s),
3. 03-3. 24 (28, m). 4. 56
-4, 64 (18, m) 7. 28 (2H, d,
J = 11! Hz), 7. 76 (2H, d,
J = 8[]z). Reference Example 36 3-(2,3.4-trimethoxybenzoyl)amino-ε-cabrolactam Melting point 240-24 1° I R (K B r) cm-': 3262, 1
678. 1656, 1634. 15191482
, 1093, NMR (d.-DMSO) δ: 1. 15-2.
08 (6H, m), 3. 08-3. 21 (2B,
m), 3. 78 (3H, s), 3. 85(
3H, s), 3. 90 (3H, s), 4.
52-4. 61 (IH, m), 6. 95 (18
, d, J = 9Hz). 7. 70 (IH, d,
J=9Hz). Reference Example 37 3-(3-trifluoromethylcinnamoyl)amino-[epsilon]-cubic lactam Melting point 201204° I R (K B r) cm-': 1673. 1
651, 1624, 1347, 1162.112
1 NMR (d.-DMSO) δ: 1. 17-1.
98 (6H, m), 3. 09-3. 36 (2H,
m), 4. 50-4. 59 (IH, m),
7. 15 (IH, d, J = 16Hz). 7.
50 (IH, d, J = 16Hz), 7.
61-7. 98(4}1,m) Reference Example 38 3-(N-tert-butquine carbonyl-β
-alanyl)amino-ε monolactam Melting point 11CIII° I R (K B r) cm-': 3346, 1
677, 1632, 1526, 1285.117
3 NMR(d,-DMSO) δ: 1.25-2.1g
(6B, m)+1. 42 (9B, s), 2. 4
1 (2H.t, J=6Hz), 3. 14-
3. 47(41{,m), 4. 41-4. 60
(1B, m). Reference Example 39 3-(4-methoxycarponylbenzoyl)amino-ε
Monocabrolactam melting point 226-227° I R (K B r) am-': 3306, 1
714, 1672, 1632. 1428.128
4. NMR (d.-DMSO) δ: l. 20-2.
02 (68, m), 3. 10-3. 22 (2H,
m), 3. 89(:{H, s), 4. 60
-4. 68 (1B, m), 7. 98 (2H, d
, J=9Hz), 8. 06 (2B, d, J
= 9Hz). Reference example 40 3-(4-ethoxycarbonylcinnamoyl)amino-ε monolactam Melting point 208-209° I R (K B r) cm"-': 1715,
1670, 1655, 1619, 1282, 12
72. NMR (d.-DMSO) δ: 1. 21-1.
98 (6H, m) 1. 33 (3H, t, J =
7Hz), 3. 07-3. 22 (2H.m)
.. 4. 33 (2B, ci, J=7Hz). 4
.. 50-4. 59 (1H, m), 7. 09(
IL d, J= 16Hz), 7. 46 (1B,
d, J = 16Hz), 7. 72 (2B,
d, J = 8}1z), 7. 98 (2H, d,
J = 8Hz). Reference example 4l 3 [4-(tert-butoxycarbonylaminomethyl)penzoyl]amino-ε-1-cubic lactam melting point
174-175° I R (K B r) am': 3364, 1
683, 1637, 1527. 1288.117
0 NMR (d8-DMSO) δ: 1.21-2.00
(6H, m), 1. 40 (9H, s), 3. 0
2-3. 28 (2H, m), 4. 17 (2H,
d, J = 8Hz), 4. 56-4. 65
(IH, m), 7. 32 (2H, d, J=
8Hz), 7. 80 (2H, d, J = 8H
z) Reference Example 42 22.5 g of 3-[1-(ethoxycarbonyloxy)cinnamoyl]amino-ε-monocarbolactam 3-hydroxy/-4-methoxycinnamic acid and 32.5 g of triethylamine. M was added to 400 d of tetrahydrofuran, and 22.2 d of ethyl chloroformate was added dropwise while stirring under water cooling. After the addition was completed, stir for another 15 minutes,
Subsequently, 200 ml of a solution of 14.9 g of 3-amino-[epsilon]-lactam in tetrahydrofuran was added dropwise, and after the dropwise addition was completed, the mixture was stirred at room temperature for 1 hour. The reaction solution was concentrated under reduced pressure, and the residue was dissolved in chloroform. After washing this solution with water and drying, the solvent was distilled off under reduced pressure. The residue was washed with ethyl acetate and dried under reduced pressure to obtain the title compound (28 g). This compound was used in the next reaction without purification.
融点 209−210’
I R (K B r)c+n−’ : 1770,
1650, 1613, 1515, 1249,12
17.
NMR(CDCi23)δ: 1.23−1.95(
6H,m),1.37(3}1,t, J = 7Hz
), 3. 20−3. 40(2H, m), 3.
86(3H, s), 4. 41 (2H, q,
J = 7Hz), 4. 55−4. 78(IH
. m), 6. 35(IH, d, J=16Hz
), 6. 92(IH, d, J = 9Hz),
7. 30−7. 40(2H, m),7. 51
(IH, d, J = 16Hz)以下同様にして次
の化合物を得た。Melting point 209-210' I R (K B r)c+n-' : 1770,
1650, 1613, 1515, 1249, 12
17. NMR (CDCi23) δ: 1.23-1.95 (
6H, m), 1.37 (3}1, t, J = 7Hz
), 3. 20-3. 40 (2H, m), 3.
86 (3H, s), 4. 41 (2H, q,
J = 7Hz), 4. 55-4. 78 (IH
.. m), 6. 35 (IH, d, J=16Hz
), 6. 92 (IH, d, J = 9Hz),
7. 30-7. 40 (2H, m), 7. 51
(IH, d, J = 16Hz) The following compound was obtained in the same manner.
参考例43
3−(4−エトキシカルボニルオキシベンゾイル)アミ
ノーε一カブ口ラクタム
融点 195−196°
T R (K B r)cm−’ : 3312,
3266, 1766, 1683, 1634,12
90,1252.1212
NMR(d.−DMSO)δ: 1. 40(3H,
t , J= 9Hz).1. 53−2. 36(
6H, lTl). 3. 20−3. 41(2H,
m), 4、31(2H,Q,J = 9Hzl 4
. 58−4. 80(IH, m), 7. 26(
2H, d, J = 8Hz),7. 90(2H,
d, J = 8Hz>.参考例44
3−(4−シアノベンゾイル)アミノーε一カブロラク
タム
参考例17と同様の方法により表題化合物を得た。Reference Example 43 3-(4-Ethoxycarbonyloxybenzoyl)amino-ε monolactam Melting point 195-196° T R (K B r) cm-': 3312,
3266, 1766, 1683, 1634, 12
90,1252.1212 NMR (d.-DMSO) δ: 1. 40 (3H,
t, J=9Hz). 1. 53-2. 36(
6H, lTl). 3. 20-3. 41 (2H,
m), 4, 31 (2H, Q, J = 9Hzl 4
.. 58-4. 80 (IH, m), 7. 26(
2H, d, J = 8Hz), 7. 90 (2H,
d, J = 8Hz>. Reference Example 44 3-(4-cyanobenzoyl)amino-ε-cabrolactam The title compound was obtained in the same manner as in Reference Example 17.
融点 189−190°
I R (K B r)cm−’ : 2224, 1
643, 1549, 1300, 937, 758
.NMR(d.−DMSO)δ: 1. 17−2.
01(6H, Rl),3. 10−3. 26(2
H. m), 4. 59−4. 60(IH. m)
, 7、96(2H, d,J = 8Hz), 8.
03(2H, d, J = 8Hz).参考例45
3−(3−シアノベンゾイル)アミノーε一カブ口ラク
タム
参考例17と同様の方広により、表題化合物を得た。Melting point 189-190° I R (K B r) cm-': 2224, 1
643, 1549, 1300, 937, 758
.. NMR (d.-DMSO) δ: 1. 17-2.
01 (6H, Rl), 3. 10-3. 26 (2
H. m), 4. 59-4. 60 (IH. m)
, 7, 96 (2H, d, J = 8Hz), 8.
03 (2H, d, J = 8Hz). Reference Example 45 3-(3-cyanobenzoyl)amino-epsilon-kabuchi lactam The title compound was obtained by the same method as in Reference Example 17.
融点 221−222°
I R (K B r)cm−’ : 2932, 1
6g2, 1669, 1647, 1551,130
1.
NMR(d.−D’MSO)δ: 1. 20−2.
00(6H, m),3. 09−3. 28(2H
. m), 4. 60−4. 71(IH, m),
7. 70(IH, t,J = 8Hz), 7.
84(1B, t, J = 6Hz). 7. 9
9−1!I、04(IH, +n),8. 15−1
20(IH, m), 8. 31−8. 32(IH
. m), 8. 58(LH, d,J=7Hz).
参考例46
3−(5−ペンズイミダゾリルカルボニル)アミノーε
一カブロラクタム
参考例17と同様の方法により、表題化合物を得た。Melting point 221-222° I R (K B r) cm-': 2932, 1
6g2, 1669, 1647, 1551,130
1. NMR (d.-D'MSO) δ: 1. 20-2.
00 (6H, m), 3. 09-3. 28 (2H
.. m), 4. 60-4. 71 (IH, m),
7. 70 (IH, t, J = 8Hz), 7.
84 (1B, t, J = 6Hz). 7. 9
9-1! I, 04 (IH, +n), 8. 15-1
20 (IH, m), 8. 31-8. 32 (IH
.. m), 8. 58 (LH, d, J=7Hz). Reference Example 46 3-(5-penzimidazolylcarbonyl)amino-ε
Monocabrolactam The title compound was obtained in the same manner as in Reference Example 17.
融点 297−299°.
l R (K B r)c+n−’ : 3256,
1672, 1623, 1540. 1305128
9.
NMR(d.−DMSO)δ: 1. 15−2. 0
2(6L m), 3. 09−3. 26(2H,
m), 4. 64(IH. dd, J= 7Hz,
10Hz), 7. 64−8. 34(6H, m
).
参考例47
3−ニコチノイルアミノーε一カブロラクタム参考例l
7と同様の方法により、表題化合物を得た。Melting point 297-299°. l R (K B r)c+n-': 3256,
1672, 1623, 1540. 1305128
9. NMR (d.-DMSO) δ: 1. 15-2. 0
2 (6L m), 3. 09-3. 26 (2H,
m), 4. 64 (IH. dd, J= 7Hz,
10Hz), 7. 64-8. 34 (6H, m
). Reference example 47 3-nicotinoylamino-ε-cabrolactam reference example l
The title compound was obtained in the same manner as in Example 7.
融点 220−221’
I R (K B r)cm ’ : 333g, 1
677, 1646. 152g, 1418,133
4
NMR(do DMSO)δ: 1. 15−2.
01(6H, m), 3. 023. 2B(2H,
m), 4. 60−4. 70(IH, m),
7. 46−7. 55(IH, m), 7. 83
( IH, t, J = 7Hz), 8. 20(
IH, dt, J = 2Hz, llHz),8.
54(IH, d, J= 7Hz), 8. 70
(IH, dd, J= 2Hz, 5Hz)9. 0
2(IH, dd, J = IHz, 2Hz).参
考例48
3−ビクリノイルアミノーε一カプロラクタム参考例l
7と同様の方法により表題化合物を得た。Melting point 220-221' I R (K B r) cm': 333 g, 1
677, 1646. 152g, 1418,133
4 NMR (do DMSO) δ: 1. 15-2.
01 (6H, m), 3. 023. 2B (2H,
m), 4. 60-4. 70 (IH, m),
7. 46-7. 55 (IH, m), 7. 83
(IH, t, J = 7Hz), 8. 20(
IH, dt, J = 2Hz, llHz), 8.
54 (IH, d, J = 7Hz), 8. 70
(IH, dd, J= 2Hz, 5Hz)9. 0
2 (IH, dd, J = IHz, 2Hz). Reference example 48 3-vicrinoylamino-ε-caprolactam reference example l
The title compound was obtained in the same manner as in Example 7.
融点 177−178°,
I R (K B r)cm−’ : 16g5, 1
653, 1509, 1487. 14691424
.
NMR(d.−DMSO)δ: 1. 22−2. 1
1(6H, m), 3. 033. 19(2}1,
m), 4. 52−4. 62(1H, m>,
7. 60−7. 68(IL m), 7. 98−
8. 16(3H, m), 13. 66−8. 7
2(IH, m), 9. 04(18, d,J =
6Hz)
参考例49
3−[4−(4−メチルピペラジニル)ペンソイル]ア
ミノーε一カブ口ラクタム
参考例17と同様の方法により表題化合物を得た。Melting point 177-178°, I R (K B r) cm-': 16g5, 1
653, 1509, 1487. 14691424
.. NMR (d.-DMSO) δ: 1. 22-2. 1
1 (6H, m), 3. 033. 19(2}1,
m), 4. 52-4. 62 (1H, m>,
7. 60-7. 68 (IL m), 7. 98-
8. 16 (3H, m), 13. 66-8. 7
2 (IH, m), 9. 04(18, d, J =
6 Hz) Reference Example 49 3-[4-(4-Methylpiperazinyl)pensoyl]amino-epsilon-kabuchi lactam The title compound was obtained in the same manner as in Reference Example 17.
融点 232−234°
I R (K B r)cm”” : 3282, 1
679, 1544, 1513, 1451, 12
93 1244.
N M R (da D M S O )δ 1、1
6−1. 98(6H, m), 2. 22(3t{
, s), 2. 44(4H, t, J = 5H
z), 3. 12−3. 21(2H. m),3.
25(4H, t, J= 5Hz), 4. 53
−4. 63(IH, m), 6. 96(28d,
J= 9Hz), 7. 73(2FI, d, J
= 9FIz)参考例50
3−(1−メチルーIH−1.2.3−}リアゾール−
4−イルーカルホニル)アミノーε一カプ口ラクタム
参考例l7と同様の方広により表題化合物を得た。Melting point 232-234° I R (K B r) cm"": 3282, 1
679, 1544, 1513, 1451, 12
93 1244. N M R (da D M SO ) δ 1, 1
6-1. 98 (6H, m), 2. 22(3t{
, s), 2. 44 (4H, t, J = 5H
z), 3. 12-3. 21 (2H.m), 3.
25 (4H, t, J=5Hz), 4. 53
-4. 63 (IH, m), 6. 96 (28d,
J=9Hz), 7. 73 (2FI, d, J
= 9FIz) Reference Example 50 3-(1-methyl-IH-1.2.3-}riazole-
4-yl-carbonyl)amino-epsilon-capsulactam The title compound was obtained by the same method as in Reference Example 17.
融点 259−260°.
I R (K B r)cm”−’ : 3388,
3108, 1677, 1640, 1571,15
02.
NMR(d.−DMSO)δ:1、13−2. 07C
6H, m). 3. 033、28(2H, m),
4. 09(3H, s). 4. 55(LH,
dd, J = 6Hz,10Hz), 8. 05(
IH, t, J = 6Hz), 8. 26(18
, d, J= 6Hz),8.54(18 s).
参考例5l
3−(インドール−3−カルボニル)アミノーεカブ口
ラクタム
参考例17と同様の方法により表題化合物を得た。Melting point 259-260°. I R (K B r) cm"-': 3388,
3108, 1677, 1640, 1571, 15
02. NMR (d.-DMSO) δ: 1, 13-2. 07C
6H, m). 3. 033, 28 (2H, m),
4. 09 (3H, s). 4. 55 (LH,
dd, J = 6Hz, 10Hz), 8. 05(
IH, t, J = 6Hz), 8. 26 (18
, d, J = 6Hz), 8.54 (18 s). Reference Example 5l 3-(indole-3-carbonyl)amino-ε Kabukuchi lactam The title compound was obtained in the same manner as in Reference Example 17.
融点 243−244°
I R (K B r)cn+−’ : 3272,
1675, 1620. 154g, 1439,13
10. 1209.
NMR(d,DMSO)δ: 1. 17−2. 01
(6}1, m), 3. 05−3. 26(2H,
m), 4. 66(18, dd, J = 7H
z, 10Hz), 7. 117. 20(2B,
m), 7. 42−7、47(IH, m), 7.
71(IH, d, J=7Hz), 7. 88−
7. 93(IH, m), 8. 04−8. 09
(2H, m), 11. 63(IH, br),
参考例52
3−(1−メチルイミダゾール−5−イルカルボニル)
アミノーε一カブロラクタム
参考例17と同様の方法により表題化合物を得た。Melting point 243-244° I R (K B r)cn+-': 3272,
1675, 1620. 154g, 1439,13
10. 1209. NMR (d, DMSO) δ: 1. 17-2. 01
(6}1, m), 3. 05-3. 26 (2H,
m), 4. 66 (18, dd, J = 7H
z, 10Hz), 7. 117. 20 (2B,
m), 7. 42-7, 47 (IH, m), 7.
71 (IH, d, J=7Hz), 7. 88-
7. 93 (IH, m), 8. 04-8. 09
(2H, m), 11. 63 (IH, br), Reference Example 52 3-(1-methylimidazol-5-ylcarbonyl)
The title compound was obtained in the same manner as in Amino-ε-Cabrolactam Reference Example 17.
融点 221−223°
I R (K B r)cm−’ + 3214. 1
670. 155g, 1532, 1477,124
0.
NMR(d.−DMSO)δ: 1. 16−1. 9
9(60, m), 3. 033. 24(2H,
m). 3. 80(3H, s), 4. 53−4
. 63(IH, m),7. 02(IH, s),
7. 64(IH. s>, 7. 83(IH.
t, J= 6}1z),8. 05(IH, d,
J= 7Hz)参考例53
3−(1−メチルイミダゾール−4−イルカルボニル)
アミノーε一カブ口ラクタム
参考例l7と同様の方法により表題化合物を得た。Melting point 221-223° I R (K B r) cm-' + 3214. 1
670. 155g, 1532, 1477,124
0. NMR (d.-DMSO) δ: 1. 16-1. 9
9 (60, m), 3. 033. 24 (2H,
m). 3. 80 (3H, s), 4. 53-4
.. 63 (IH, m), 7. 02(IH, s),
7. 64 (IH. s>, 7. 83 (IH.
t, J= 6}1z), 8. 05(IH, d,
J=7Hz) Reference Example 53 3-(1-methylimidazol-4-ylcarbonyl)
The title compound was obtained in the same manner as in Amino-ε-Cab-Lactam Reference Example 17.
融点 223−234°
T R (K B r)cm−’ : 3262, 1
663, 1641, 1567, 1484,133
4.
N M R (ds D M S O )δ: 1.
16−2. 04(6H, m). 3. 043.
2g(2H, m), 3. 69(3H, s).
4. 42−4. 52(IH, m),7. 63
(IH, s), 7. 65(IH, s), 8.
00(IH, t, J= 6Hz),8. 09(I
H, d. J= 6Hz).参考例54
3−{β〜(1−メチルイミダゾール−4−イル)アク
リロイル}アミノーε一カブロラクタムβ−(1−メチ
ルイミダゾールー4−イル)アクリル酸(7 0g,
0.3 7モル)のジメチルホルムアミト溶岐(500
d)に、トリエチルアミン(75.1g,0.74モル
)、l−ヒドロキ7ヘンゾトリアゾールー水和物(6
2.5g,0.4 1モル)を加えて水冷し、ジシクロ
へキシルカルボジイミド(842g,0.41モル)の
ジメチルホルムアミド溶岐(50d)を滴下した。室温
で1時間、更に70’Cで30分間加熱撹拌した後、反
応l夜に3−アミノε一カプ口ラクタム(52.3g,
0.4 1モル)を加えて70’Cで14時間加熱撹拌
した。室温まで冷却後重背水を加えてクロロホルム、メ
タノール混合溶媒で抽出し、硫酸マグネシウムで乾燥後
減圧下溶媒を留去した。残留物をシリカゲルのカラムク
ロマト上で精製し、エタノールから再結晶することによ
り表題化合物が82.6g(84.8%)得られた。Melting point 223-234° T R (K B r) cm-': 3262, 1
663, 1641, 1567, 1484, 133
4. N M R (ds D M SO ) δ: 1.
16-2. 04 (6H, m). 3. 043.
2g (2H, m), 3. 69 (3H, s).
4. 42-4. 52 (IH, m), 7. 63
(IH, s), 7. 65 (IH, s), 8.
00 (IH, t, J=6Hz), 8. 09(I
H, d. J=6Hz). Reference Example 54 3-{β~(1-methylimidazol-4-yl)acryloyl}amino-ε-cabrolactam β-(1-methylimidazol-4-yl)acrylic acid (70 g,
0.3 7 mol) of dimethylformamide (500
d), triethylamine (75.1 g, 0.74 mol), l-hydroxy-7henzotriazole-hydrate (6
2.5 g, 0.4 1 mol) was added thereto, the mixture was cooled with water, and a dimethylformamide solution (50d) of dicyclohexylcarbodiimide (842 g, 0.41 mol) was added dropwise. After heating and stirring at room temperature for 1 hour and then at 70'C for 30 minutes, 3-amino epsilon-capsulactam (52.3 g,
0.41 mol) was added thereto, and the mixture was heated and stirred at 70'C for 14 hours. After cooling to room temperature, heavy backwater was added and extracted with a mixed solvent of chloroform and methanol. After drying over magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was purified on silica gel column chromatography and recrystallized from ethanol to obtain 82.6 g (84.8%) of the title compound.
融点 244〜246°(エタノールから再結晶),I
R (K B r)am−’ : 3312. 32
30, 1678. 1655, 1625,1512
, 1482, 1374. 1360.NMR(d.
−DMSO)6 1.10〜2. 00(6H, m)
. 3. 13(2H, m), 3. 65(3H,
s), 4. 52(IH, m), 6. 65(
IH, d, J15、39Hz), 7. 25(I
H, d, J= 15. 39Hz), 7. 39
(IH, s), 7. 62(18, s), 7.
77(IH, br. t, J = 5. 90H
z), 7. 99(IH, d, J= 7. 32
Hz)、元素分析値: C,3H,,N,02として
計算値: C,59.53; H,6.92;
N,21.36.実測値: C,59.30; H
,7.13: N,21.13.参考例55
3−(β一(l一エチルイミダゾール−4−イル)アク
リロイル}アミノーε一カブロラクタム参考例54と同
様の方注により、β−(1−エチルイミタプール−4−
イル)アクリル酸、トリエチルアミン、1−ヒド口キシ
ベンゾトリアゾールー水和物、ジシクロへキシルカルボ
ジイミド及び3−アミノーε一カブ口ラクタムから表題
化合物が得られた(収率94.8%)。Melting point 244-246° (recrystallized from ethanol), I
R(KBr)am-': 3312. 32
30, 1678. 1655, 1625, 1512
, 1482, 1374. 1360. NMR (d.
-DMSO)6 1.10-2. 00 (6H, m)
.. 3. 13 (2H, m), 3. 65 (3H,
s), 4. 52 (IH, m), 6. 65(
IH, d, J15, 39Hz), 7. 25(I
H, d, J= 15. 39Hz), 7. 39
(IH, s), 7. 62 (18, s), 7.
77 (IH, br. t, J = 5. 90H
z), 7. 99 (IH, d, J= 7.32
Hz), elemental analysis value: Calculated value as C,3H,,N,02: C, 59.53; H, 6.92;
N, 21.36. Actual value: C, 59.30; H
, 7.13: N, 21.13. Reference Example 55 3-(β-(l-ethylimidazol-4-yl)acryloyl}amino-ε-cabrolactam By the same method as Reference Example 54, β-(1-ethylimidazol-4-yl)
The title compound was obtained from (yield: 94.8%) acrylic acid, triethylamine, 1-hydroxybenzotriazole-hydrate, dicyclohexylcarbodiimide, and 3-amino-ε-monolactam.
融点 254〜255°(エタ/−ルから再.結晶),
I R (K B r)Cm ’ : 3322, 1
681, 1657, 1631, 15061469
,1370,826.
NMR(d.−DMSO)δ: 1. 15〜1. 9
7(6H, m), 1. 35(3H, t, J=
7. 29Hz), 3. 13(2H, m).
3. 99(2H, q. J7. 29Hz), 4
. 53(IH, m), 6. 66(IH, d,
J = 15. 4Hz). 725(IH, d,
J= 15. 4Hz), 7. 47(II. s
), 7. 69(IH, s), 7.76(lH,
t,J = 5.86Hz),7.99(1}1,d,
J一了.24Hz>.元素分析値: C,.H,。N
. O−とじて計算値: C,60.85; H
,7.29: N,20.27.実測値: C,6
0.60; H,7.49. N,19.88参考
例56
3−(2−キノリル)カルホニルアミノーε一カブロラ
クタム
参考例17と同様の方法により、キナルジン酸、l,1
′一カルボニルイミダゾール及び3−アミノε一カブ口
ラクタムから表題化合物が得られた(収率95.1%)
。Melting point: 254-255° (recrystallized from ethanol),
I R (K B r) Cm': 3322, 1
681, 1657, 1631, 15061469
, 1370, 826. NMR (d.-DMSO) δ: 1. 15-1. 9
7 (6H, m), 1. 35 (3H, t, J=
7. 29Hz), 3. 13 (2H, m).
3. 99 (2H, q. J7. 29Hz), 4
.. 53 (IH, m), 6. 66 (IH, d,
J = 15. 4Hz). 725 (IH, d,
J=15. 4Hz), 7. 47 (II. s.
), 7. 69 (IH, s), 7.76 (lH,
t, J = 5.86Hz), 7.99(1}1, d,
J Ichigo. 24Hz>. Elemental analysis value: C,. H. N
.. Calculated value including O-: C, 60.85; H
, 7.29: N, 20.27. Actual value: C, 6
0.60; H, 7.49. N, 19.88 Reference Example 56 3-(2-quinolyl)carbonylamino-ε-cabrolactam Quinaldic acid, l, 1
The title compound was obtained from '-carbonylimidazole and 3-amino ε-monolactam (yield 95.1%).
.
融点 248〜250°(エタノールから再結晶)r
R (K B r)cm−’ : 3360, 321
6, 1655, 1564, 1515,1498.
14g7, 1443, 1274.NMR(da−
DMSO)δ: 1. 15 〜2. 20(6H,
m), 3. 23(2H, m). 4. 67(I
H, m), 7. 73(LH, dt, J= 1
. 43Hz. 7.55Hz), 7. 89(In
, dt, J = 1. 43Hz, 7. 55H
z), 8. 05〜8、13(4H, m). 8.
60(IH, d, J = 8. 44Hz).
9. 18(IH, d, J= 6. 23Hz).
元素分析値: C 18H INN 30 2として
計算値: C,67.83; H,6.Q5;
N,14.83.実測値: C,67.77. H
,6.12; N.l4.74.参考例57
3−(1.3−ジメチルビラゾールー4−イルカルホニ
ル)アミノーε一カブロラクタム参考例l7と同様の方
注により、表題化合物を得た。Melting point: 248-250° (recrystallized from ethanol)
R(KBr)cm-': 3360, 321
6, 1655, 1564, 1515, 1498.
14g7, 1443, 1274. NMR (da-
DMSO) δ: 1. 15 ~2. 20 (6H,
m), 3. 23 (2H, m). 4. 67 (I
H, m), 7. 73 (LH, dt, J= 1
.. 43Hz. 7.55Hz), 7. 89 (In
, dt, J = 1. 43Hz, 7. 55H
z), 8. 05-8, 13 (4H, m). 8.
60 (IH, d, J = 8.44Hz).
9. 18 (IH, d, J = 6.23Hz). Elemental analysis value: Calculated value as C 18H INN 30 2: C, 67.83; H, 6. Q5;
N, 14.83. Actual value: C, 67.77. H
, 6.12; N. l4.74. Reference Example 57 3-(1.3-dimethylvirazol-4-ylcarbonyl)amino-ε-cabrolactam The title compound was obtained by pouring in the same manner as in Reference Example 17.
融点 236.0〜237.0°
I R (K B r)am ’ : 3324.
327(1. 1878, 1626, 1549.1
272
NMR(d.−DMSO)δ: 1. 15−1.
98(6H, m), 2. 31(aH, s),
3. 03−3. 24(2H, m), 3. 76
(3H, s)、4. 53(IHdd, J = 7
Hz, 10Hz), 7. 53(IH, d, J
= 7Hz), 7. 1116(IH,t+ J
= 7Hz), 8. 17(IH, s)参考例58
3−(1.3−ジメチルビラゾール−5−イルカルボニ
ル)アミノーε一カプロラクタム参考例17と同様の方
法により、表題化合物を得た。Melting point 236.0-237.0° I R (K B r) am': 3324.
327 (1. 1878, 1626, 1549.1
272 NMR (d.-DMSO) δ: 1. 15-1.
98 (6H, m), 2. 31 (aH, s),
3. 03-3. 24 (2H, m), 3. 76
(3H, s), 4. 53 (IHdd, J = 7
Hz, 10Hz), 7. 53 (IH, d, J
= 7Hz), 7. 1116(IH,t+J
= 7Hz), 8. 17 (IH, s) Reference Example 58 3-(1.3-dimethylvirazol-5-ylcarbonyl)amino-ε-caprolactam The title compound was obtained in the same manner as in Reference Example 17.
融点 183.0〜184.0°
I R (K B r)am ’ : 3356, 3
224, 1667, 1639. 1542+515
1441.
NMR(d.−DMSO)δ: l. 16{. 99
(6H, m), 2. 16(3H, s), 3.
07−3. 26(2H, m). 3. 95(3
}1, s), 4. 51−4. 60(18, m
). 6. 60(IH, s), 7. 82−7.
88(IH, m), 8. 10(IHd, J
= 7Hz).
参考例59
:3−(3−インドリルアクリロイル)アミノーεカブ
口ラクタム
参考例17と同様の方法により、表題化合物を得た。Melting point 183.0-184.0° IR(KBr)am': 3356, 3
224, 1667, 1639. 1542+515
1441. NMR (d.-DMSO) δ: l. 16{. 99
(6H, m), 2. 16 (3H, s), 3.
07-3. 26 (2H, m). 3. 95 (3
}1, s), 4. 51-4. 60 (18, m
). 6. 60 (IH, s), 7. 82-7.
88 (IH, m), 8. 10(IHd, J
= 7Hz). Reference Example 59: 3-(3-indolylacryloyl)amino-ε Kabukuchi lactam The title compound was obtained in the same manner as in Reference Example 17.
融点 198.0〜199.0’
I R (K B r)cm ’ : 1670, 1
644, 1576, 1432, 1270,738
、
NMR(d.−DMSO)δ: 1. 20−2. 0
0(6tl, m), 3. 043. 25(2H,
m), 4. 57(IH, dd, J= 5Hz
, IOHz), 6. 88(IH, d, J =
16Hz), 7. 10−7. 24(3H, m
), 7. 41−7. 48(IH,m). 7.
60(IH, d, J = 16Hz), 7. 9
7−8. 07(IH, m).参考例60
3−(1.5−シメチルピラゾール−3−イルカルボニ
ル)アミノーε一カブロラクタム参考例17と同様の方
法により、表題化合物を得た。Melting point 198.0-199.0' IR (KBr) cm': 1670, 1
644, 1576, 1432, 1270,738
, NMR (d.-DMSO) δ: 1. 20-2. 0
0 (6tl, m), 3. 043. 25 (2H,
m), 4. 57 (IH, dd, J= 5Hz
, IOHz), 6. 88 (IH, d, J =
16Hz), 7. 10-7. 24 (3H, m
), 7. 41-7. 48 (IH, m). 7.
60 (IH, d, J = 16Hz), 7. 9
7-8. 07 (IH, m). Reference Example 60 3-(1.5-dimethylpyrazol-3-ylcarbonyl)amino-ε-cabrolactam The title compound was obtained in the same manner as in Reference Example 17.
融点 199.(1200.0’
I R (K B r)am−’ : 3390, 1
640, 1519, 1475, 1407,137
2. 132g.
NMR(d6−DMSO)δ: l. 17−2. 0
3(6H, m), 2. 27(3H, s), 3
. 00−3. 28(21L m), 3. 77(
3H, s), 4. 43−4. 52(1[1,
m), 6. 40(LH, s), 7. 92(I
H, d, J = 6Hz), 8. 01(LH,
L, J= 6Hz).
参考例61
3−(5.7−ジメチルピラゾロ[1,5一aコピリミ
ジン−3−イルカルポニル)アミノーε一カブ口ラクタ
ム
参考例17と同様の方法により、表題化合物を得た。Melting point 199. (1200.0' I R (K B r) am-' : 3390, 1
640, 1519, 1475, 1407, 137
2. 132g. NMR (d6-DMSO) δ: l. 17-2. 0
3 (6H, m), 2. 27 (3H, s), 3
.. 00-3. 28 (21L m), 3. 77 (
3H, s), 4. 43-4. 52(1[1,
m), 6. 40 (LH, s), 7. 92(I
H, d, J = 6Hz), 8. 01(LH,
L, J = 6Hz). Reference Example 61 3-(5,7-dimethylpyrazolo[1,51a-copyrimidin-3-ylcarponyl)amino-ε-monocarbolactam In the same manner as in Reference Example 17, the title compound was obtained.
融点 264.0−265.0’
I R (K B r)cm−’ : 16g3, 1
645, 1562, 1514, 1436,119
0.
NMR(d6−DMso)δ:1、3g−2. 34(
6H, m), 2. 71(3H, s), 2.
78(3H, s), 3.26−3. 42(2H,
m), 4. 81−4. 91(IH, m),
6. 71(18, s), 8. 60(IH, s
).参考例62
3−(2−ビフエニルカルボニル)アミノーεカブ口ラ
クタム
参考例17と同様の方法により、表題化合物を得た。Melting point 264.0-265.0' I R (K B r) cm-': 16g3, 1
645, 1562, 1514, 1436, 119
0. NMR (d6-DMso) δ: 1, 3g-2. 34(
6H, m), 2. 71 (3H, s), 2.
78 (3H, s), 3.26-3. 42 (2H,
m), 4. 81-4. 91 (IH, m),
6. 71 (18, s), 8. 60 (IH, s
). Reference Example 62 3-(2-biphenylcarbonyl)amino-ε Kabukuchi lactam The title compound was obtained in the same manner as in Reference Example 17.
融点 183.0−184.0°
I R (K B r)cm−’ : 3250,
1678, 1645, 1541, 1476,13
02,745.
N M R ( C D C Q.)δ: 1. 07
−1. 40(21!, +n). 1. 63−2.
01(4H, m)’, 3. 15−3. 28(
2H, m). 4. 46−4. 55(IH, m
), 5.98(LH, br. s), 6. 75
(LH, br. s), 7. 30−7. 68(
9H. m)参考例63
3−(1−メチルイミダゾール−5−イルアクリロイル
)アミノーε一カブ口ラクタム参考例54と同様の方法
により、表題化合物を得た。Melting point 183.0-184.0° I R (K B r) cm-': 3250,
1678, 1645, 1541, 1476, 13
02,745. N M R ( C D C Q.) δ: 1. 07
-1. 40 (21!, +n). 1. 63-2.
01(4H, m)', 3. 15-3. 28(
2H, m). 4. 46-4. 55 (IH, m
), 5.98 (LH, br. s), 6. 75
(LH, br. s), 7. 30-7. 68(
9H. m) Reference Example 63 3-(1-Methylimidazol-5-yl acryloyl)amino-ε-monolactam The title compound was obtained in the same manner as in Reference Example 54.
融点 1 4 8.0− 1 5 0.0°r R (
K B r)am−’ : 1659, 1620,
1500, 1479, 1335,1122.
NMR(d,−DM’SO)δ:1、14−1. 96
(68, m), 3. 07−3. 22(2H,
m). 3. 71(3H, s), 4. 48−4
. 59(LH, i), 6. 72(IH, d,
J = 15. 8Hz), 7. 28(LH,
d, J= 15. 8Hz), 7. 31(IH,
s), 7.’ 70(IL s), 7. 84(
1}!, t, J = 6.0}Iz), 8. 0
4(IH, d, J= 7, OHz).実施例l
2−(4−クロロスチリル)−5.6,7.8−テトラ
ヒド口−4H−チアゾロ[5.4−b]アゼビン3−(
4−クロロシンナモイル)アミノーε一カブロラクタム
(11.0g),五硫化燐(8.37g)を500dの
ピリジンに加え、1.5時間還流した。Melting point 1 4 8.0- 1 5 0.0°r R (
KBr)am-': 1659, 1620,
1500, 1479, 1335, 1122. NMR (d, -DM'SO) δ: 1, 14-1. 96
(68, m), 3. 07-3. 22 (2H,
m). 3. 71 (3H, s), 4. 48-4
.. 59 (LH, i), 6. 72 (IH, d,
J = 15. 8Hz), 7. 28(LH,
d, J=15. 8Hz), 7. 31 (IH,
s), 7. '70 (ILs), 7. 84(
1}! , t, J = 6.0}Iz), 8. 0
4 (IH, d, J= 7, OHz). Example l 2-(4-chlorostyryl)-5.6,7.8-tetrahydride-4H-thiazolo[5.4-b]azebin 3-(
4-Chlorocinnamoyl)amino-ε-cabrolactam (11.0 g) and phosphorus pentasulfide (8.37 g) were added to 500 d of pyridine, and the mixture was refluxed for 1.5 hours.
冷却後、反応物を重曹水に加え、クロロホルムで抽出し
た。抽出層は水洗、乾燥後,wt圧下溶媒を留去した。After cooling, the reaction product was added to aqueous sodium bicarbonate and extracted with chloroform. The extracted layer was washed with water, dried, and the solvent was distilled off under wt pressure.
残留物を7リカゲルのカラムクロマトて精”Aし、シク
ロヘキサンから再結晶すると、融点188−189°の
結晶として表題化合物が得られた(収量6.28g,収
率57%)。The residue was purified by 7 silica gel column chromatography and recrystallized from cyclohexane to give the title compound as crystals with a melting point of 188-189° (6.28 g, 57% yield).
I R (K Br)cm ’: 3274, 292
6, 1543. 14321355, 1090.
807
NMR(CDCQ3)δ: 1.50−1.98(4}
1,m), 2.832.97(2H,m), 3.0
7−3.16(2H,m), 3.96(IH,br.
s)6. 98(2H, d, J−= IHz).
7. :{2(4H, d, J= IHz).元素分
析値 C .,H ,5N,S CQとして計算値:
C,61.95. H,5.20; N,9.63.
実測値: C,62.08; H,5.08; N,
9.90.実施例2
2−(4−メトキンスチリル)−5.6,7.8テトラ
ヒドロー4H−チアゾロ[5.4−b]アゼピン
実施例1と同様の方法により、3−(4−メトキシシン
ナモイル)アミノーε一カブロラクタムと五硫化燐から
表題化合物が得られた(収率34,8%)。融点13c
l−131’(シクロヘキサンから再結晶)
I R(K Br)cm−’: 2914, 1601
, 1547, 1510,1251, 117
5, 949.N M R (C D C l2s’
)δ: 1.67−1.84(4H,m), 2.89
(2H, t, J= 6Hz), 3. 11(2B
, t, J= 5Hz), 3. 82(3H,s)
, 6.88(2H,d,J=9Hz). 6.98(
2H,s), 7.41(2H,d, J = 9Hz
)
元素分析値: Cl8H,8N,OSとして計算値:
c,a’y.io; H,6J3; N,9.7g.
実測値: C,67.29; H,6.23; N,
9.70.実施例3
2−スチリル−5.6,7.8−テトラヒドロ4H−チ
アゾロ[5.4−b]アゼピン実施例1と同様の方法に
より、3−シンナモイルアミノーε一カブ口ラクタムと
五硫化燐から表題化合物が得られた(収率40.3%)
。融点169−170°(シクロヘキサンから再結晶)
.I R(K Br)am−’: 3220, 291
8, 1523, 1439,1362. 1269.
93+11.N M R (C D C 123)
δ: 1.50−1.93(4H,m), 2.802
.92(2H,m), 3.01−3.12(2H,m
), 7.05(2H.s),7、23−7. 59(
5H, m).元素分析値: C,.H,.N,Sと
して計算値: C,?0.27; H,6.29;
N,10.93.実劃値: C,70.53; H,
6.30; N,10.94.実施例4
2−(1−フェニルプ口ピル)”5,6,7.8テトラ
ヒド口−4H−チアゾロ[5.4−b]アゼピン
実施例1と同様の方法により、3−(2−フエニルブチ
リル)アミノーε一カブロラクタムと五硫化燐から表題
化合物が得られた(収率31.9%)。I R (K Br) cm': 3274, 292
6, 1543. 14321355, 1090.
807 NMR (CDCQ3) δ: 1.50-1.98 (4}
1, m), 2.832.97 (2H, m), 3.0
7-3.16 (2H, m), 3.96 (IH, br.
s)6. 98 (2H, d, J-=IHz).
7. :{2(4H, d, J=IHz). Elemental analysis value C. , H , 5N, S Calculated value as CQ:
C, 61.95. H, 5.20; N, 9.63.
Actual value: C, 62.08; H, 5.08; N,
9.90. Example 2 2-(4-methkinstyryl)-5.6,7.8tetrahydro 4H-thiazolo[5.4-b]azepine 3-(4-methoxycinnamoyl)amino-ε The title compound was obtained from monocabrolactam and phosphorus pentasulfide (yield 34.8%). Melting point 13c
l-131' (recrystallized from cyclohexane) I R (K Br) cm-': 2914, 1601
, 1547, 1510, 1251, 117
5, 949. N M R (C D C l2s'
) δ: 1.67-1.84 (4H, m), 2.89
(2H, t, J= 6Hz), 3. 11 (2B
, t, J=5Hz), 3. 82 (3H, s)
, 6.88 (2H, d, J=9Hz). 6.98 (
2H, s), 7.41 (2H, d, J = 9Hz
) Elemental analysis value: Calculated value as Cl8H, 8N, OS:
c, a'y. io; H, 6J3; N, 9.7g.
Actual value: C, 67.29; H, 6.23; N,
9.70. Example 3 2-Styryl-5.6,7.8-tetrahydro 4H-thiazolo[5.4-b]azepine By the same method as in Example 1, 3-cinnamoylamino-epsilon lactam and pentasulfide were prepared. The title compound was obtained from phosphorus (yield 40.3%)
. Melting point 169-170° (recrystallized from cyclohexane)
.. IR(KBr)am-': 3220, 291
8, 1523, 1439, 1362. 1269.
93+11. NMR (CDC 123)
δ: 1.50-1.93 (4H, m), 2.802
.. 92 (2H, m), 3.01-3.12 (2H, m
), 7.05 (2H.s), 7, 23-7. 59(
5H, m). Elemental analysis value: C,. H,. Calculated value as N, S: C,? 0.27; H, 6.29;
N, 10.93. Actual value: C, 70.53; H,
6.30; N, 10.94. Example 4 2-(1-phenylbutyryl)"5,6,7.8tetrahydride-4H-thiazolo[5.4-b]azepine By the same method as in Example 1, 3-(2-phenylbutyryl) The title compound was obtained from amino-ε-cabrolactam and phosphorus pentasulfide (yield 31.9%).
融点106−107°(ヘキサンより再結晶).r R
(K Br)am−’: 3244, 2924. 1
474, 1261. 701NMR (C D cI
2s)δ: 0.89(3H,t,J=7Hz),
1.38−2. 38(6H, m), 2. 7
7−3. 05(4H, n+3. 3. 32(I
H, br. s), 4. 93(18, t,
J= 8Hz), 7. 28(5H, s).元素
分析値: C 1sH ,oN t Sとして計算値
: C,?0.55; H,7,40; N,10.
28.実測値: C,70.45; H,7.27.
N,10.15実施例5
2−(4−メトキシフェニル)−5.6,7.8−テト
ラヒドロ−4H−チアゾロ[5.4−b]アゼピン・塩
酸塩
実施例lと同様の方法により、3−(4−メトキシベン
ゾイル)アミノーε一カプロラクタムと五硫化燐を反応
させ、精製後塩酸塩に導き表題化合物が得られた(収率
9.6%)。融点177178°(メタノール・エーテ
ルより再結晶) .I R(K Br)cm−’: 1
605, 1533, 1292, 1281,126
3, 1190, 832.
NMR (C D Cl23)δ: 1.50−1.9
0(4H,m), 3.033. 30(4H, o+
), 3、80(3H,s). 6.89(2H.d,
J=9Hz),7. 98(2}1, d, J= 9
Hz).元素分析値: .C,4H,.N,S−HC
Cとして計算値: C,56.65. H,5.77
. N,9.44;C Q, 11. 94.
実厠値: C,56.48; H,5、87; N,
9.40;CCI2.17
?施例6
2−(4−メチルスチリル)−5.6,7.8−テトラ
ヒド口−4 8−チアゾロ[5.4−blアゼビン実施
例lと同様の方広により、3−(4−メチルシンナモイ
ル)アミノーε一カブロラクタムと五硫化燐から表題化
合物が得られた(収率49.5%)。融点166−16
7°(シクロへ牛サンから再結晶)
] R(KBr)cm””: 2920. 1546.
143g, 1355,1270, 955■ 8
02.
NM R (C D C&3)δ: 1.51−1.9
5(4H,m), 2J5(3}1,s), 2.80
−2.93(2H,m), 3.01−3.15(2H
,m),7.05(2H,s), 7.15(2H,d
,J=8}1z), 7.38(2H,d,J=8Hz
)
元素分析値・ C ..H ..N 2Sとして計算値
: C,71.07; H,6、71; N,10.
36.実測値: C,71.02; H,6.57;
N,10.23.実施例7
2−(4−エトキシスチリル)−5.6,7.8テトラ
ヒドロー4H−チアゾロ[5.4−b]アゼピン
実施例1と同様の方法により、3−(4−エトキシソン
ナモイル)アミノーε一カブロラクタムと五硫化燐より
表題化合物か得られた(収率426%)。融点159i
60°(シクロヘキサンから再結晶)
I R(KBr)Cm−’: 2924, 1601,
1550, 1510,1268 1244, 1
176.
NMR(CDCff.)δ: 1.40(3H,t,J
=7Hz), 1.60L.93(41m), 2.
89(2R,dd,J==4Hz,6Hz), 3.1
1(2H,t,J=5Hz), 4.03(2H,q,
J=7Hz), 6.84(2Hd,J=9Hz),
6.96(2H,s), 7.36(2H,d,J=
9tlz).元素分析値: C I78 20N t
o Sとして計算値: C,67.97; H,6.
71: N,9.32.実測値: C,68.06.
H,6.63. N,9.45実施例8
2−(4−イソプロビルスチリル)−5.6,7.8−
テトラヒド口−4H−チアゾロ[5.4−b]アゼビン
実施例lと同様にしで、3−(4−イソプロピル/ンナ
モイル)アミノーε一カブ口ラクタムと五硫化燐から表
題化合物が得られた(収率47.8%)。融点148−
149°
T R(K Br)c+n−’: 3258. 295
0, 2922, 1547,143g,l357,
1266.
N M R (C D C Q3)δ: 1.23(6
H,d,J=7Hz), 1.611. 93(4L
m), 2. 72−1 18(5H, n+), 7
. 19(2H. d, J=9Hz), 7.20(
2H,s), 7.38(2H,d,J=9Hz).元
素分析値: C,.H,,N2Sとして計算値 C,
72.44; H,7.43. N,9.39.実測値
二 C,72.11. H,7.34. N,9.35
.実権例9
2−E4−(4−メトキシフェニル)ブタジエニル]
一5.6,7.8−テトラヒドロ−4H−チアゾロI5
.4−bjアセピン
実施例lと同様にしで、lc5−(4−メトキシフエニ
ル)ペンタジエノイル]アミノーε一カプロラクタムと
五硫化燐から表題化合物が得られたく収率19,4%)
。融点140−142°(シクロヘ牛サンより再結晶)
.
r R(KBr)am−’: 1542, 1509,
1441. 136g,1251, 1172,
986.
NMR(CDCQ3)δ: 1.52−1.93(4}
1,m), 2.802. 92(2H. m), 3
. 03−3. 14(2H, m), 3. 80(
3H, s),6.43−6.76(4H,m), 6
.83(2H,d,J=9Hz), 7.35(2H,
d, J−9Hz)
元素分析値: C ,.H ,.N ,O Sとして
計算値: C,69、20; H,6.45; N,
8.97実測値: C,6g.90; H,6.62
; N,8.80.実施例10
2−(4−イ゛/ブロポキシスチリル)−5.6,7.
8−テトラヒド口−4H−チアゾロ[5.4−blアゼ
ビン
実施例1と同様にしで、3−(4−イソプロポキシシン
ナモイル)アミノーε一カブロラクタムと五硫化燐から
、表題化合物が得られた(収率35.5%)。融点16
1−162°(シクロヘキサンから再結晶)
I R(KBr)cm−’: 3266, 1547,
1509, 1442,1359, 1239.
943
NMR(CDC(3)δ: 1.30(6H,d,J=
6Hz), 1.58−1.92(4H,m), 2.
80−2.95(2}1,m), 3。03−3. 1
3(2H,m), 4. 53(18, septet
, J= 6Hz), 6. 82(2H, J= 9
Hz)6.92(2H,s), 734(2H,d,J
=9){z).元素分析値: C 18H 22N
to Sとして計算値: C,6g.75; H,7
.05; N,8.91.実測値: C,69.10
; H,7.12; N,9.01.実施例11
2−(3.5一ンーt−ブチルー4−ヒドロキシスチリ
ル)−5.6,7.8−テトラヒドロ−4Hチアゾロ[
5.1−b]アセピン・オギザレート実施例lと同様に
しで、i(3.5−ジーt一ブチルー4−ヒドロキシシ
ンナモイル)アミノε一カブ口ラクタムと五硫化燐を反
応、精製後,7ユウ酸で中和する事により表題化合物を
得た(収率37.4%)。融点205−206°I R
(KBr)cm ’: 29511!, 1729,
1592, 1437,1374, 1237
. 120g、NMR(CDCIδ: 1. 40
(18H, s), 1. 53−1. 83(4H
,+n), 2.60−2.76(2[{,m),
2.86−3.03(2H,m)6. 94(2H,
s), 7. 28(2H, s).元素分析値:
C,3H3,N2OS−C.H20,・H,Oとし
て
計算値: C,60.95; H.7.37; N,
5.69.実測値: C,60,97. H,7.3
0: N,5.72実施例12
2−(2−メトキシスチリル)−5.6,7.8=テト
ラヒド口−4H−チアゾロ[5.4−b]アゼビン・オ
キザレート
実施例lと同様にしで、3−(2−メトキシンンナモイ
ル)アミノーε一カブ口ラクタムと五硫化燐を反応、精
製後,ンユウ酸て中和する事により表題化合物を得た(
収率36 7%)。Melting point: 106-107° (recrystallized from hexane). r R
(KBr)am-': 3244, 2924. 1
474, 1261. 701NMR (CD cI
2s) δ: 0.89 (3H, t, J=7Hz),
1.38-2. 38 (6H, m), 2. 7
7-3. 05 (4H, n+3. 3. 32 (I
H, br. s), 4. 93 (18, t,
J=8Hz), 7. 28 (5H, s). Elemental analysis value: C 1sH , oN t Calculated value as S: C,? 0.55; H, 7,40; N, 10.
28. Actual value: C, 70.45; H, 7.27.
N, 10.15 Example 5 2-(4-methoxyphenyl)-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b]azepine hydrochloride By the same method as Example 1, 3-(4-Methoxybenzoyl)amino-ε-caprolactam was reacted with phosphorus pentasulfide, and after purification, the title compound was converted into a hydrochloride salt (yield: 9.6%). Melting point: 177,178° (recrystallized from methanol/ether). IR(KBr)cm-': 1
605, 1533, 1292, 1281, 126
3, 1190, 832. NMR (CDCl23)δ: 1.50-1.9
0 (4H, m), 3.033. 30 (4H, o+
), 3, 80 (3H, s). 6.89 (2H.d,
J=9Hz), 7. 98(2}1, d, J= 9
Hz). Elemental analysis value: . C,4H,. N,S-HC
Calculated value as C: C, 56.65. H, 5.77
.. N, 9.44; C Q, 11. 94. Actual value: C, 56.48; H, 5, 87; N,
9.40; CCI2.17? Example 6 2-(4-methylstyryl)-5.6,7.8-tetrahydride-48-thiazolo[5.4-bl azebin By the same method as in Example 1, 3-(4-methylstyryl)-5.6,7.8-tetrahydride The title compound was obtained from cinnamoyl)amino-ε-cabrolactam and phosphorus pentasulfide (yield 49.5%). Melting point 166-16
7° (recrystallized from cyclohexane)] R (KBr) cm"": 2920. 1546.
143g, 1355, 1270, 955■ 8
02. NMR(CDC&3)δ: 1.51-1.9
5 (4H, m), 2J5 (3}1, s), 2.80
-2.93 (2H, m), 3.01-3.15 (2H
, m), 7.05 (2H, s), 7.15 (2H, d
, J=8}1z), 7.38(2H,d,J=8Hz
) Elemental analysis value・C. .. H. .. Calculated as N2S: C, 71.07; H, 6,71; N, 10.
36. Actual value: C, 71.02; H, 6.57;
N, 10.23. Example 7 2-(4-ethoxystyryl)-5.6,7.8tetrahydro 4H-thiazolo[5.4-b]azepine 3-(4-ethoxysonnamoyl)amino The title compound was obtained from ε-cabrolactam and phosphorus pentasulfide (yield 426%). Melting point 159i
60° (recrystallized from cyclohexane) IR(KBr)Cm-': 2924, 1601,
1550, 1510, 1268 1244, 1
176. NMR (CDCff.) δ: 1.40 (3H, t, J
=7Hz), 1.60L. 93 (41m), 2.
89 (2R, dd, J==4Hz, 6Hz), 3.1
1 (2H, t, J=5Hz), 4.03 (2H, q,
J=7Hz), 6.84(2Hd, J=9Hz),
6.96 (2H, s), 7.36 (2H, d, J=
9tlz). Elemental analysis value: CI78 20Nt
o Calculated as S: C, 67.97; H, 6.
71: N, 9.32. Actual value: C, 68.06.
H, 6.63. N, 9.45 Example 8 2-(4-isoprobylstyryl)-5.6,7.8-
Tetrahydro-4H-thiazolo[5.4-b]azebinSimilarly to Example 1, the title compound was obtained from 3-(4-isopropyl/annamoyl)amino-e-monocablactam and phosphorus pentasulfide (harvested rate 47.8%). Melting point 148-
149° T R (K Br) c+n-': 3258. 295
0, 2922, 1547, 143g, l357,
1266. N M R (C D C Q3) δ: 1.23 (6
H, d, J=7Hz), 1.611. 93 (4L
m), 2. 72-1 18 (5H, n+), 7
.. 19 (2H. d, J=9Hz), 7.20 (
2H, s), 7.38 (2H, d, J=9Hz). Elemental analysis value: C,. Calculated value as H,,N2S C,
72.44; H, 7.43. N, 9.39. Actual measurement value 2 C, 72.11. H, 7.34. N, 9.35
.. Practical example 9 2-E4-(4-methoxyphenyl)butadienyl]
-5,6,7,8-tetrahydro-4H-thiazolo I5
.. 4-bj acepine In the same manner as in Example 1, the title compound was obtained from lc5-(4-methoxyphenyl)pentadienoyl]amino-ε-caprolactam and phosphorus pentasulfide (yield 19.4%).
. Melting point 140-142° (recrystallized from cyclohexane)
.. r R(KBr)am-': 1542, 1509,
1441. 136g, 1251, 1172,
986. NMR (CDCQ3) δ: 1.52-1.93(4}
1, m), 2.802. 92 (2H.m), 3
.. 03-3. 14 (2H, m), 3. 80(
3H, s), 6.43-6.76 (4H, m), 6
.. 83 (2H, d, J=9Hz), 7.35 (2H,
d, J-9Hz) Elemental analysis value: C,. H. Calculated values as N, O S: C, 69, 20; H, 6.45; N,
8.97 Actual value: C, 6g. 90; H, 6.62
; N, 8.80. Example 10 2-(4-I/bropoxystyryl)-5.6,7.
8-tetrahydride-4H-thiazolo[5.4-bl azebin] In the same manner as in Example 1, the title compound was obtained from 3-(4-isopropoxycinnamoyl)amino-ε-cabrolactam and phosphorus pentasulfide ( yield 35.5%). melting point 16
1-162° (recrystallized from cyclohexane) IR(KBr)cm-': 3266, 1547,
1509, 1442, 1359, 1239.
943 NMR (CDC(3)δ: 1.30 (6H, d, J=
6Hz), 1.58-1.92 (4H, m), 2.
80-2.95 (2}1, m), 3.03-3. 1
3 (2H, m), 4. 53(18, septet
, J=6Hz), 6. 82 (2H, J=9
Hz) 6.92 (2H, s), 734 (2H, d, J
=9) {z). Elemental analysis value: C 18H 22N
Calculated value as to S: C, 6g. 75; H, 7
.. 05; N, 8.91. Actual value: C, 69.10
; H, 7.12; N, 9.01. Example 11 2-(3.5-t-butyl-4-hydroxystyryl)-5.6,7.8-tetrahydro-4Hthiazolo[
5.1-b] Acepine oxalate In the same manner as in Example 1, i(3,5-di-t-butyl-4-hydroxycinnamoyl)amino epsilon-kabuguchi lactam and phosphorus pentasulfide were reacted, and after purification, 7 The title compound was obtained by neutralizing with uric acid (yield 37.4%). Melting point 205-206°IR
(KBr)cm': 29511! , 1729,
1592, 1437, 1374, 1237
.. 120g, NMR (CDCIδ: 1.40
(18H, s), 1. 53-1. 83 (4H
, +n), 2.60-2.76(2[{,m),
2.86-3.03 (2H, m)6. 94 (2H,
s), 7. 28 (2H, s). Elemental analysis value:
C, 3H3, N2OS-C. Calculated value as H20, .H,O: C, 60.95; H. 7.37; N,
5.69. Actual value: C, 60, 97. H, 7.3
0: N, 5.72 Example 12 2-(2-methoxystyryl)-5.6,7.8=tetrahydride-4H-thiazolo[5.4-b]azevin oxalate Same as Example 1. , 3-(2-methoxynnnamoyl)amino-ε-monocarboxylic lactam was reacted with phosphorus pentasulfide, and after purification, the title compound was obtained by neutralizing with phosphoric acid (
Yield: 36.7%).
融点171−172°
I R(KBr)cm−’: 1592, 1519.
1378, 1352,1253. 1207.
NMR(d.−DMSO)δ: l. 33−1.
82(48, m).2. 68−2. 80(2H,
m), 2. 90−3. 02(2H, m),
3. 84(3H,s), 6. 83−7.6
3(4H, m), 7. 15(2H, s).元
素分析値: C,.H,.N,OS−C,H.O.・
0 . 3 H t○として
計算値: C,56.62; H,5.44; N,
7.34.実測値: C,56.67; H,5.1
3; N,7.14.実施例l3
2’−(3.4−メチレンジオキシスチリル)−5.6
,7.8−テトラヒド口−4H−チアゾロ[5,4b]
アゼビン・塩酸塩
実施例1と同様にしで、3−(3.4−メチレンシオキ
シシンナモイル)アミノーε一カプ口ラクタムと五硫化
燐を反応、精製後生成物を塩酸で中和する事により表題
化合物を得た(収率42,3%)。Melting point 171-172° IR(KBr) cm-': 1592, 1519.
1378, 1352, 1253. 1207. NMR (d.-DMSO) δ: l. 33-1.
82 (48, m). 2. 68-2. 80 (2H,
m), 2. 90-3. 02 (2H, m),
3. 84 (3H, s), 6. 83-7.6
3 (4H, m), 7. 15 (2H, s). Elemental analysis value: C,. H,. N, OS-C, H. O.・
0. Calculated value as 3 H t○: C, 56.62; H, 5.44; N,
7.34. Actual value: C, 56.67; H, 5.1
3; N, 7.14. Example 13 2'-(3.4-methylenedioxystyryl)-5.6
,7.8-tetrahydro-4H-thiazolo[5,4b]
Azevin/hydrochloride In the same manner as in Example 1, 3-(3,4-methylenecyoxycinnamoyl)amino-epsilon-capsulactam and phosphorus pentasulfide were reacted, and after purification, the product was neutralized with hydrochloric acid. The title compound was obtained (yield 42.3%).
融点196−197°(クロロホルムーエーテルから再
結晶).
I R(KBr)am”−’: 1597. 1505
. 1487, 1449,1356, 1256。Melting point 196-197° (recrystallized from chloroform-ether). IR(KBr)am"-': 1597. 1505
.. 1487, 1449, 1356, 1256.
NMR(d.−DMSO)δ: 1.50−1、91
(4H, m),2. 75−2. 93(2H, m
), 2. 99−3. 15(2H, m),
6. 06(2H,s), 6. 90−7. 55
(5}1, m).元素分析値: C,,H,.N,
O,S−HCf2−0.3H!Oとして
計算値: C,56.15; H,5.18; N,
8.19.実測値: C,56.3g. H,4.8
9; N,8.22.実施例l4
2−(α−フェニルスチリル)−5.6,7.8テトラ
ヒドロー4H−チアゾロ[5.4−b]アゼビン・塩酸
塩
実施例1と同様にしで、3−(α−フエニルシンナモイ
ル)アミノーε一カブロラクタムと五硫化燐を反応、精
製後生成物を塩化水素で中和する事により、表題化合物
を得た(収率13.5%)。NMR (d.-DMSO) δ: 1.50-1, 91
(4H, m), 2. 75-2. 93 (2H, m
), 2. 99-3. 15 (2H, m),
6. 06 (2H, s), 6. 90-7. 55
(5}1, m). Elemental analysis values: C,,H,. N,
O,S-HCf2-0.3H! Calculated value as O: C, 56.15; H, 5.18; N,
8.19. Actual value: C, 56.3g. H, 4.8
9; N, 8.22. Example 14 2-(α-phenylstyryl)-5.6,7.8tetrahydro 4H-thiazolo[5.4-b]azevin hydrochloride In the same manner as in Example 1, 3-(α-phenylcinnamate) The title compound was obtained by reacting amino-ε-cabrolactam with phosphorus pentasulfide and neutralizing the purified product with hydrogen chloride (yield: 13.5%).
融点188−189°
I R(K Br)cm−’: 3180, 1595
, 1506, 1490,1352, 693.
N M R (ds D M S O )δ: 1.
47−1. 90(4H, m),2.83−3.1
1(4H.m). 6.90−7.56(IIH,m)
元素分析値’ Ct+HtoNtS @ HC(1・
0.2H,○として
計算値: C,67.71; H,5.79; N,
7.52.実測値: C,67,79. H,5.6
8. N,7.53.実施例15
2−(2,3.4 − トリメトキシスチリル)−5,
6.7.8−テトラヒドロー4H−チアゾロ[5,4b
]アゼピン・オギザレート
実施例1と同様にしで、3−(2,3.4−}リメトキ
シシンナモイル)アミノーε一カブ口ラクタムと五硫化
燐を反応、精製後,生成物をシュウ酸で中和すると表題
化合物が得られる(収率42.7%)。融点145−1
46°(酢酸エチルから再結晶)
I R(K Br)cm−’: 1742, 1588
, 1495, 1283,1203. 1108.
1098
NMR(d.−DMSO)δ: 1.56−1.69(
4H,m),2. 73(2H, t, J= 5Hz
), 2. 94−2. 99(2H, m), 3、
76(3H, s), 3. 80(3H, s),
3. 82(3H, s). 6.83(IH, d,
J一9Hz), 7. 06(2H, s), 7.
39(IH, d, J= 9Hz).元素分析値:
C +sH ttN to 3S−C ,Hto−
・0.5H20として
計算値: C,53、92: H,5.66; N,
6.29.実測値: C,53.66; H,5.4
1; N,6.14.実施例l6
2−(3.4−ジメトキシスチリル)−5.6.7.8
−テトラヒドロー4H−チアゾロ[5.4−b]アゼ・
ピン・塩酸塩
実施例1と同様にしで、3−(3.4−ジメトキシシン
ナモイル)アミノーε一カブ口ラクタムと五硫化燐を反
応、精製後,生成物を塩化水素で中和し、表題化合物を
得た(収率23.7%)。融点159−160°(クロ
ロホルムーエーテルから再結晶).
I R(K Br)cm−’: 343g, 3220
, 1609, 1593,1516. 126g.
NMR(de−DMSO)δ: 1. 62−1. 7
3(4H, m),2. 80−2. 85(2H,
m), 3. 04−3. 09(2H, m), 3
、80(3Hs), 3.82(3H,s), 7.0
1(LH,d,J=8Hz), 7.17(1B,dd
,J=8Hz,2Hz). 7.26(IH,d,J=
2Hz), 7.24(IH,d,J=16Hz),
7.43(IH,d,J=16Hz)、元素分析値:
C 17H 2oN 20 zs ” H C(l
’1.3Htoとして
計算値: C,54、26; H,6J2. N,7
.44.実測値: C,54.48: H,6.31
; N,7.46.実施例17
2−(9−デセニル)−5.6,7.8−テトラヒドロ
ー4H−チアゾロ[5.4−b]アゼピンウンデシレン
酸(15g)のテトラヒド口フラン溶演に15.8gの
1,1′一カルボニルジイミダゾールを加え、15分間
室温で撹拌後、10.4gの3−アミノーε一カブロラ
クタムを加え、室温で5時間撹拌した。次に減圧下溶媒
を留去し、得られた粗1−(10−ウンデセメイル)ア
ミノーε一カブロラクタムと18.1gの五硫化燐を5
00dのピリジンに加え、1時間還流下で撹拌した。冷
却後、反応物を飽和重曹水に加え、クロロホルムで抽出
した。抽出層は水洗、乾燥後,減圧下溶媒を留去した。Melting point 188-189° IR(KBr)cm-': 3180, 1595
, 1506, 1490, 1352, 693. N M R (ds D M SO ) δ: 1.
47-1. 90 (4H, m), 2.83-3.1
1 (4H.m). 6.90-7.56 (IIH, m)
Elemental analysis value' Ct+HtoNtS @HC(1・
Calculated value as 0.2H, ○: C, 67.71; H, 5.79; N,
7.52. Actual value: C, 67, 79. H, 5.6
8. N, 7.53. Example 15 2-(2,3.4-trimethoxystyryl)-5,
6.7.8-Tetrahydro 4H-thiazolo[5,4b
]Azepine oxalate In the same manner as in Example 1, 3-(2,3.4-}rimethoxycinnamoyl)amino-ε-monolactam and phosphorus pentasulfide were reacted, and after purification, the product was dissolved in oxalic acid. The title compound is obtained (yield 42.7%). Melting point 145-1
46° (recrystallized from ethyl acetate) I R(K Br) cm-': 1742, 1588
, 1495, 1283, 1203. 1108.
1098 NMR (d.-DMSO) δ: 1.56-1.69 (
4H, m), 2. 73 (2H, t, J= 5Hz
), 2. 94-2. 99 (2H, m), 3,
76 (3H, s), 3. 80 (3H, s),
3. 82 (3H, s). 6.83 (IH, d,
J-9Hz), 7. 06 (2H, s), 7.
39 (IH, d, J = 9Hz). Elemental analysis value:
C +sH ttN to 3S-C, Hto-
・Calculated value as 0.5H20: C, 53, 92: H, 5.66; N,
6.29. Actual value: C, 53.66; H, 5.4
1; N, 6.14. Example 16 2-(3.4-dimethoxystyryl)-5.6.7.8
-tetrahydro4H-thiazolo[5.4-b]aze・
Pin hydrochloride In the same manner as in Example 1, 3-(3,4-dimethoxycinnamoyl)amino-ε-monocabactam and phosphorus pentasulfide were reacted, and after purification, the product was neutralized with hydrogen chloride, and the title A compound was obtained (yield 23.7%). Melting point 159-160° (recrystallized from chloroform-ether). IR(KBr)cm-': 343g, 3220
, 1609, 1593, 1516. 126g. NMR (de-DMSO) δ: 1. 62-1. 7
3 (4H, m), 2. 80-2. 85 (2H,
m), 3. 04-3. 09 (2H, m), 3
, 80 (3Hs), 3.82 (3H,s), 7.0
1 (LH, d, J=8Hz), 7.17 (1B, dd
, J=8Hz, 2Hz). 7.26 (IH, d, J=
2Hz), 7.24 (IH, d, J=16Hz),
7.43 (IH, d, J=16Hz), elemental analysis value:
C 17H 2oN 20 zs ” H C(l
'Calculated value as 1.3Hto: C, 54, 26; H, 6J2. N,7
.. 44. Actual value: C, 54.48: H, 6.31
; N, 7.46. Example 17 2-(9-decenyl)-5.6,7.8-tetrahydro 4H-thiazolo[5.4-b]azepine undecylenic acid (15 g) was dissolved in tetrahydrofuran with 15.8 g of 1,1 After adding '-carbonyldiimidazole and stirring at room temperature for 15 minutes, 10.4 g of 3-amino-ε-cabrolactam was added and the mixture was stirred at room temperature for 5 hours. Next, the solvent was distilled off under reduced pressure, and the obtained crude 1-(10-undecemyl)amino-ε-cabrolactam and 18.1 g of phosphorus pentasulfide were
00d of pyridine and stirred under reflux for 1 hour. After cooling, the reaction product was added to saturated aqueous sodium bicarbonate solution and extracted with chloroform. The extracted layer was washed with water, dried, and the solvent was distilled off under reduced pressure.
残留物をシリカゲルカラムクロマトで精製し、続いてシ
ュウ酸塩とした。イソブロビルエーテルから再結晶し7
.7g(24.7%)の表題化合物を得た。融点94−
95゜C,I R(KBr)cm−’: 2928,
2854, 1607, 1528,1404, 12
79, 720.
NMR(CD(d!s)δ: 1.30(12H,br
.s). 1.50−2. 16(6H, m). 2
. 78−3. 17(6H, m), 4. 89−
5. 07(2H,m), 5. 58−6. 03(
IH, m).元素分析値: C,,H,.N.S
− C.H.O.として計算値: C,59.66;
H,7.90: N,7J2.実測値: C,59
.78; H,8.13; N,7.28.実施例l8
2−(2.6−ジフルオ口フェニル)−5.6.,7.
8−テトラヒドロー4H−チアゾロ[5.4−bコアゼ
ピン
2,6−ジフルオロ安息香酸(12g)のテトラヒドロ
(200m)溶液に1 4.8gの1.1′一カルボニ
ルジイミダゾールを加え、室温で15分間撹拌後、9.
73gの3−アミノーε一カブ口ラクタムを加え5時間
室温で撹拌した。減圧下溶媒を留去し、残留物をメチレ
ンクロリドで洗浄すると、粗結晶として13.5gの3
−(2.6−ジフルオ口ベンゾイル)アミノーε一カブ
ロラクタムが得られた。この粗結晶を8.96gの五硫
化燐と共に200−のピリジンに加え、24時間還流撹
拌した。冷却後ピリジンを留去し、残留物に飽和重曹水
を加え、クロロホルムで抽出した。抽出層は、水洗,乾
燥後,減圧下で濃縮した。残留物をシリカゲルのカラム
クロマトで精製し、続いてメチレンクロリドーイソブ口
ビルエーテルから再結晶すると、表題化合物が3.1
9g(23.8%)得られた。The residue was purified by silica gel column chromatography and subsequently converted to oxalate. Recrystallized from isobrobyl ether7
.. 7g (24.7%) of the title compound was obtained. Melting point 94-
95°C, IR(KBr)cm-': 2928,
2854, 1607, 1528, 1404, 12
79, 720. NMR (CD (d!s) δ: 1.30 (12H, br
.. s). 1.50-2. 16 (6H, m). 2
.. 78-3. 17 (6H, m), 4. 89-
5. 07 (2H, m), 5. 58-6. 03(
IH, m). Elemental analysis values: C,,H,. N. S
-C. H. O. Calculated value: C, 59.66;
H, 7.90: N, 7J2. Actual value: C, 59
.. 78; H, 8.13; N, 7.28. Example 18 2-(2.6-difluorophenyl)-5.6. ,7.
8-Tetrahydro 4H-thiazolo[5.4-b coazepine To a solution of 2,6-difluorobenzoic acid (12 g) in tetrahydro (200 m) was added 14.8 g of 1.1'-carbonyldiimidazole and the mixture was stirred at room temperature for 15 minutes. After stirring, 9.
73 g of 3-amino-ε-monolactam was added and stirred at room temperature for 5 hours. The solvent was distilled off under reduced pressure and the residue was washed with methylene chloride to give 13.5 g of 3 as crude crystals.
-(2,6-difluorobenzoyl)amino-ε-cabrolactam was obtained. The crude crystals were added to 200-g of pyridine together with 8.96 g of phosphorus pentasulfide, and the mixture was stirred under reflux for 24 hours. After cooling, pyridine was distilled off, saturated aqueous sodium bicarbonate was added to the residue, and the mixture was extracted with chloroform. The extracted layer was washed with water, dried, and then concentrated under reduced pressure. Purification of the residue by column chromatography on silica gel followed by recrystallization from methylene chloride isobutyl ether afforded the title compound in 3.1
9g (23.8%) was obtained.
融点141144°
I R(K Br)cm ’: 3230, 2912
, 1467, 1355,1013 990,
783.
N M R (C D C c,i)δ: 1.50−
2.00(4H,m), 2.913. 25(4H,
m), 6. 78−7. 45(3H, m).元
素分析値: C,3H,,N,SF2として計算値:
C,5g.63; H,4.54; N,10.5
2.実測値: C,5g.72; H,4.52.
N,10.32.実施例19
2−(2.4−ジフルオロフエニル)−5.6,7,8
−テトラヒド口−4H−チアゾロ[5.4−b]アゼピ
ン
実施例18と同様の方法で、2,4−ジフルオ口安息香
酸、3−アミノーε一カブ口ラクタムおよび五硫化燐か
ら表題化合物が得られた(収率43.7%)。融点10
5.5−107.0°(シクロヘキサンから再結晶).
I R(KBr)cn+−’: 1545, 150
4, 1479, 1436,1351, 1095.
NMR (C D cc3)δ: 1.50−1.98
(4H,m), 2、903. 16(4H, m),
3. 76(IH, br. s), 6. 73−
7. 03(28, m),8、03−8. 30(I
H, m).元素分析値: C,3H,2N,SF,
として計算値: C,58.63; H,4.54;
N,10.52.実測値: C,58.68; H
,4.47; N,10.59,実施例20
2−(3,4−ジクロロスチリル)−5.6,7.8テ
トラヒドロ−4H−チアゾロC5,4 −b]アゼビン
実施例18と同様の方広で、3,4−ジクロロけい皮酸
、3−アミノーε一カブ口ラクタムおよび五硫化燐から
表題化合物が得られた。Melting point 141144° I R (K Br) cm': 3230, 2912
, 1467, 1355, 1013 990,
783. N M R (C D C c, i) δ: 1.50-
2.00 (4H, m), 2.913. 25 (4H,
m), 6. 78-7. 45 (3H, m). Elemental analysis value: Calculated value as C, 3H,, N, SF2:
C, 5g. 63; H, 4.54; N, 10.5
2. Actual value: C, 5g. 72; H, 4.52.
N, 10.32. Example 19 2-(2,4-difluorophenyl)-5.6,7,8
-Tetrahydro-4H-thiazolo[5.4-b]azepine In a similar manner to Example 18, the title compound was obtained from 2,4-difluorobenzoic acid, 3-amino-epsilon-cabulactam and phosphorus pentasulfide. (yield 43.7%). melting point 10
5.5-107.0° (recrystallized from cyclohexane). IR(KBr)cn+-': 1545, 150
4, 1479, 1436, 1351, 1095. NMR (CD cc3) δ: 1.50-1.98
(4H, m), 2, 903. 16 (4H, m),
3. 76 (IH, br. s), 6. 73-
7. 03(28, m), 8, 03-8. 30 (I
H, m). Elemental analysis values: C, 3H, 2N, SF,
Calculated values as: C, 58.63; H, 4.54;
N, 10.52. Actual value: C, 58.68; H
, 4.47; N, 10.59, Example 20 2-(3,4-dichlorostyryl)-5.6,7.8tetrahydro-4H-thiazoloC5,4-b]azebin Same as Example 18 In general, the title compound was obtained from 3,4-dichlorocinnamic acid, 3-amino-epsilon lactam and phosphorus pentasulfide.
融点191−192°(インプロバノールより再結晶)
.
I R(K Br)cm−’: 3276, 2922
, 1539. 142g,1355. 940
NMR(CDCC.)δ: 1. 65−1. 72(
2H, m), 1. 801.88(28,m),
2.92(2H,t,J=6Hz), 3.13(2H
,t,J一5Hz), 6.93(IH,d,J=16
Hz), 7.10(IH,d,J=16Hz), 7
.28(IH,dd,J=8Hz,2Hz), 7、4
0(IH, d, J8Hz), 7、52(IH,
d, J = 2}1z).元素分析値: C,,H
,,N.SCl2,として計算値: C,55.39
. H,4.34: N,8.61.実測値: C,
55.22; H,4.26; N,8.91.実施例
2l
2−(4−フェニルブタジエニル)−5.6,7.8−
テトラヒド口−4H−チアゾロ[5.4−b]アゼピン
実施例18と同様の方広で、5−フエニル−2,4−ペ
ンタジエン酸、3−アミノーε一カブロラクタムおよび
五硫化燐から表題化合物が得られた(収率31.9%)
。融点156−157°(シクロへ牛サンから再結晶)
.
I R(KBr)cm−’: 3278, 2914,
1547, 1509,1495, 1369.
980.
NMR(CDCC.)δ: 1.53−1.92(4H
,m), 2、802.92(2H,n+), 3.0
3−3.16(2H,m), 6.70−6.87(4
H,m), 7. 18−7. 46(5H, m).
元素分析値: C ,,H ,,N ,Sとして計算
値: C,72.30; H,6.42; N,9.
92実測値: C,72.12; H,6.35.
N,9.66.実施例22
2−(4−ニトロスチリル)−5.6,7.8−テトラ
ヒドロ−4H−チアゾロ[5.4−b]アゼピン実施例
l8と同様の方法で、4−ニトロけい皮酸、3−アミノ
ーε一カブロラクタムおよび五硫化燐から表題化合物が
得られた(収率20,2%)。Melting point 191-192° (recrystallized from Improbanol)
.. IR(KBr)cm-': 3276, 2922
, 1539. 142g, 1355. 940 NMR (CDCC.) δ: 1. 65-1. 72(
2H, m), 1. 801.88 (28, m),
2.92 (2H, t, J=6Hz), 3.13 (2H
, t, J-5Hz), 6.93 (IH, d, J=16
Hz), 7.10 (IH, d, J=16Hz), 7
.. 28 (IH, dd, J=8Hz, 2Hz), 7, 4
0 (IH, d, J8Hz), 7, 52 (IH,
d, J = 2}1z). Elemental analysis value: C,,H
,,N. Calculated value as SCl2: C, 55.39
.. H, 4.34: N, 8.61. Actual value: C,
55.22; H, 4.26; N, 8.91. Example 2l 2-(4-phenylbutadienyl)-5.6,7.8-
Tetrahydro-4H-thiazolo[5.4-b]azepine The title compound is obtained from 5-phenyl-2,4-pentadienoic acid, 3-amino-epsilon-cabrolactam and phosphorous pentasulfide in the same manner as in Example 18. (yield 31.9%)
. Melting point 156-157° (recrystallized from cyclohegyusan)
.. IR(KBr)cm-': 3278, 2914,
1547, 1509, 1495, 1369.
980. NMR (CDC.) δ: 1.53-1.92 (4H
, m), 2, 802.92 (2H, n+), 3.0
3-3.16 (2H, m), 6.70-6.87 (4
H, m), 7. 18-7. 46 (5H, m).
Elemental analysis values: Calculated values as C,,H,,N,S: C, 72.30; H, 6.42; N, 9.
92 actual value: C, 72.12; H, 6.35.
N, 9.66. Example 22 2-(4-nitrostyryl)-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b]azepine 4-nitrocinnamic acid, 3 The title compound was obtained from -amino-epsilon-cabrolactam and phosphorus pentasulfide (yield 20.2%).
融点219−220°(インプロバノールより再結晶)
.
I R(KBr)cn+−’: 327g, 1595
, 1531, 1514,1435, 1356.
133g, 1270, 936.NMR(d
.−DMS○)δ: 1.65(4B,br.s),
2.702. 83(2H, m), 2. 9
3−3. 04(2}1, m), 7. 10(I
H, d,J=16Hz), 7.46(IH,d,
J二16Hz). 7.87(2H,d,J9Hz)
, 8.21(2H,d,J=9Hz)元素分析値:
C,5H,5N30,Sとして計算値 C,59.
78; H,5.02; N,13.94.実測値:
C,59.49; H,4.88; N,13.61
実施例23
2−(2−フルオロフェニル)−5.6,7.8テトラ
ヒトロー4 H−チアゾロ[5.4−b]アセビン
200Mのメチレンクロリドに3−アミノーεカプ口ラ
クタム(11.0g)とトリエチルアミン(15.7d
)を加え、水冷撹拌下、2−フルオロベンソイルクロリ
ト(15.0g)のメチレンクロリド(30d)溶t夜
を滴下した、滴下終了後、室温で1.5時間撹拌し、析
出結晶をろ取し、3−(2フルオロヘンゾイル)アミノ
ーε一カブ口ラクタムの粗結晶を得た。このものと、五
硫化燐(165 .g)を200dのピリジンに加え、
12時間還流撹拌した。冷却後、ピリシンを留去し、残
留物に飽和重曹水を加えクロロホルムで抽出した。抽出
層は、水洗乾燥後、減圧下溶媒を留去した。残留物をシ
リカゲルのカラムクロマトで精製し、続いてエーテルか
ら再結晶すると4.55g(24.7%)の表題化合物
が得られた。融点115−116°I R(K Br)
cm−’: 3236, 2944, 2916, 1
496,1453, 1371, 1357, 110
2, 757.NMR(CDC(23)δ: 1.36
−2.03(4H,m), 2.923、20(48,
m), 3.66(IH, br. s), 6。93
−7. 32(3H, m)8. 08−8. 27(
LH, m).元素分析値 C ,.H ,.N,S
Fとして計算値: C,62.88. H,5.28
; N,11.28実測値: C,62.87; H
,5.14; N,11.36実施例24
2−(4−ニトロフエニル)−5.6,7.8−テトラ
ヒドロ−4H−チアゾロC5,4−b]アゼピン実施例
23と同様の方法により、4−ニトロペンゾイルクロリ
ド、3−アミノーε一カブロラクタムおよび五硫化燐か
ら表題化合物が得られた(収率44 8%)。融点15
9−160°(シクロヘキサンから再結晶).
I R(KBr)cm””: 2920, 1592,
1534, 1510,1490, 1430, 1
355. 13031103.
NMR(CDC(3)δ l. 49−1. 96(4
H, m). 2, 903.00(2H,m). 3
.10−3.20(2H,m), 4.14(IH,b
r.s), 7.86(2}1,d,J=9Hz).
8.21(2H,d,J=9Hz).元素分析値・ C
,3H ,3N 30,Sとして計算値: C,5
6.71; H,4.76; N,15.26.実測値
: C,56.90; H,4.69; N,15.
39.実施例25
2−(3−ニトロフエニル)−5.6.7.8−テトラ
ヒド口−4H−チアゾロE5.4−b]アゼピン実施例
23と同様の方広により、3−ニトロペンゾイルクロリ
ド、3−アミノーε一カブロラクタムおよび五硫化燐か
ら表題化合物が得られた(収率45 7%)。融点16
8−169(クロロホルムーイソブロビルエーテルから
再結晶) .I R(K Br)cm ’: 29
20. 1520, 1450, 1370,1
345, 1300, 1270. 735N
M R ( C D C Q3)δ: 1.49−
1.99(4H,m), 2.93(2H, dd,
J= 4Hz, 6Hz), 3.06−3.16
(2H,m). 3.834. 19(IH, br
. s), 7. 50(IH, t, J= 8H
z), 8. 008. 16(2H, m),
8. 57(IH, t, J= 2Hz)元素分析値
: C 131”1 13N 3o tsとして計算
値: C,56,71; H,4.76; N,15
、26.実測値: C,56.66; H,4.71
; N,15.10.実施例26
2−フエニル−5.6,7.8−テトラヒドロ4H−チ
アゾロ[5.4−b]アセビン実施例23と同様の方広
により、ペンゾイルクロリド、3−アミノーε一カブロ
ラクタムおよひ五硫化燐から表題化含物が得られた(収
率44.5%)。融点1 2 2.0 − 1 2 3
.5°(エタノール水から再結晶).
I R(K Br)cm ’: 3228, 3004
. 2926, 1564,1524 1502
1462. 13701270. 757
NMR (C D Cl!3)δ: 1.50−1.
96(4H,m), 2.893. 15<4H,
m), 3. 56([1, br. s), 7
. 26−7. 48(3H, m), 7.69−
7.80(2H,m).元素分析値: C ,3H
I4N tSとして計算値: C,67.79; H
’,6、13; N,12.16実測値: C,67
.55. H,6.04; N,12.17.実施例2
7
2−エチル−5.6,7.8〜テトラヒドo−48−チ
アゾロ[5,4.−b]アゼピン・オギザレート実施例
23と同様の方注・により、臭化プロピオニル、3−ア
ミノ−ε一カプ口ラクタムおよび五硫化燐を反応させ、
精製後ンユウ酸で中和する事により表題化合物を得た(
収率34.O%)。Melting point 219-220° (recrystallized from Improbanol)
.. IR(KBr)cn+-': 327g, 1595
, 1531, 1514, 1435, 1356.
133g, 1270, 936. NMR(d
.. -DMS○) δ: 1.65 (4B, br.s),
2.702. 83 (2H, m), 2. 9
3-3. 04(2}1, m), 7. 10(I
H, d, J=16Hz), 7.46(IH, d,
J2 16Hz). 7.87 (2H, d, J9Hz)
, 8.21 (2H, d, J=9Hz) elemental analysis value:
Calculated value as C, 5H, 5N30, S C, 59.
78; H, 5.02; N, 13.94. Actual value:
C, 59.49; H, 4.88; N, 13.61
Example 23 2-(2-fluorophenyl)-5.6,7.8tetrahydro4H-thiazolo[5.4-b]acevin 200M methylene chloride with 3-amino-epsilon capulactam (11.0 g) Triethylamine (15.7d
) was added thereto, and a solution of 2-fluorobenzoyl chloride (15.0 g) in methylene chloride (30d) was added dropwise under stirring with water cooling. After the dropwise addition was completed, the mixture was stirred at room temperature for 1.5 hours, and the precipitated crystals were filtered. The crude crystals of 3-(2-fluorohenzoyl)amino-ε monolactam were obtained. Add this and phosphorus pentasulfide (165.g) to 200d of pyridine,
The mixture was stirred under reflux for 12 hours. After cooling, pyricin was distilled off, saturated aqueous sodium bicarbonate was added to the residue, and the mixture was extracted with chloroform. The extracted layer was washed with water and dried, and then the solvent was distilled off under reduced pressure. The residue was purified by column chromatography on silica gel, followed by recrystallization from ether to yield 4.55 g (24.7%) of the title compound. Melting point 115-116°IR(KBr)
cm-': 3236, 2944, 2916, 1
496, 1453, 1371, 1357, 110
2, 757. NMR (CDC(23)δ: 1.36
-2.03 (4H, m), 2.923, 20 (48,
m), 3.66 (IH, br. s), 6.93
-7. 32 (3H, m)8. 08-8. 27(
LH, m). Elemental analysis value C,. H. N,S
Calculated value as F: C, 62.88. H, 5.28
; N, 11.28 Actual value: C, 62.87; H
, 5.14; N, 11.36 Example 24 2-(4-nitrophenyl)-5.6,7.8-tetrahydro-4H-thiazoloC5,4-b]azepine By the same method as Example 23, The title compound was obtained from 4-nitropenzoyl chloride, 3-amino-ε-cabrolactam and phosphorous pentasulfide (yield 448%). Melting point 15
9-160° (recrystallized from cyclohexane). IR(KBr)cm"": 2920, 1592,
1534, 1510, 1490, 1430, 1
355. 13031103. NMR (CDC(3)δ l. 49-1. 96(4
H, m). 2,903.00 (2H, m). 3
.. 10-3.20 (2H, m), 4.14 (IH, b
r. s), 7.86 (2}1, d, J=9Hz).
8.21 (2H, d, J=9Hz). Elemental analysis value・C
,3H ,3N Calculated value as 30,S: C,5
6.71; H, 4.76; N, 15.26. Actual measurements: C, 56.90; H, 4.69; N, 15.
39. Example 25 2-(3-nitrophenyl)-5.6.7.8-tetrahydride-4H-thiazoloE5.4-b]azepine By the same method as in Example 23, 3-nitropenzoyl chloride, 3- The title compound was obtained from amino-ε-cabrolactam and phosphorus pentasulfide (yield 457%). melting point 16
8-169 (recrystallized from chloroform-isobrobyl ether). IR(KBr)cm': 29
20. 1520, 1450, 1370,1
345, 1300, 1270. 735N
M R (C D C Q3) δ: 1.49-
1.99 (4H, m), 2.93 (2H, dd,
J=4Hz, 6Hz), 3.06-3.16
(2H, m). 3.834. 19 (IH, br
.. s), 7. 50 (IH, t, J= 8H
z), 8. 008. 16 (2H, m),
8. 57 (IH, t, J = 2Hz) Elemental analysis value: Calculated value as C 131"1 13N 3o ts: C, 56,71; H, 4.76; N, 15
, 26. Actual value: C, 56.66; H, 4.71
; N, 15.10. Example 26 2-phenyl-5.6,7.8-tetrahydro 4H-thiazolo[5.4-b]acevin By the same method as in Example 23, penzoyl chloride, 3-amino-ε-cabrolactam and The title compound was obtained from phosphorus sulfide (yield 44.5%). Melting point 1 2 2.0 - 1 2 3
.. 5° (recrystallized from ethanol water). IR(KBr)cm': 3228, 3004
.. 2926, 1564, 1524 1502
1462. 13701270. 757 NMR (C D Cl!3) δ: 1.50-1.
96 (4H, m), 2.893. 15<4H,
m), 3. 56 ([1, br. s), 7
.. 26-7. 48 (3H, m), 7.69-
7.80 (2H, m). Elemental analysis value: C, 3H
Calculated value as I4N tS: C, 67.79; H
', 6, 13; N, 12.16 Actual value: C, 67
.. 55. H, 6.04; N, 12.17. Example 2
7 2-ethyl-5.6,7.8-tetrahydro-48-thiazolo[5,4. -b] Azepine oxalate In the same manner as in Example 23, propionyl bromide, 3-amino-ε-monocapsulactam and phosphorus pentasulfide are reacted,
After purification, the title compound was obtained by neutralizing with sulfuric acid (
Yield 34. 0%).
融点145−146°(イソブロバノールより再結晶)
I R(K Br)cm ’: 2930, 1720
, 1600, 1520,1370, 1275,
1200. 720NMR(d.−DMS O)6i
: 1.16(3H,t,J=7Hz)1.32−1
.81(48,m), 2,464.73(4H,m)
, 2.812. 92(2H, II1)
元素分析値: C,H,,N,S−C,H204とし
て計算値: C,4g.52. H.5.92; N
,10.29実測値: C,48.52: H,5.
98; N,10.18実施例28
2−スチリル−5.6,7.8−テトラヒドロー4H−
チアゾロ[5.4−bコアゼビン・オギザレート
実施例23と同様の方法により、塩化シンナモイル、3
−アミノーε一カプ口ラクタムおよび五硫化燐を反応さ
せ、精製後シュウ酸で中和する事により、表題化合物を
得た(収率53%)。Melting point 145-146° (recrystallized from isobrobanol) IR(KBr)cm': 2930, 1720
, 1600, 1520, 1370, 1275,
1200. 720NMR(d.-DMSO)6i
: 1.16 (3H, t, J=7Hz) 1.32-1
.. 81 (48, m), 2,464.73 (4H, m)
, 2.812. 92 (2H, II1) Elemental analysis value: C, H,, N, S-C, calculated value as H204: C, 4g. 52. H. 5.92; N
, 10.29 Actual value: C, 48.52: H, 5.
98; N, 10.18 Example 28 2-styryl-5.6,7.8-tetrahydro 4H-
Thiazolo [5.4-b Coazevin oxalate By a method similar to Example 23, cinnamoyl chloride, 3
-Amino-ε monocapsulactam and phosphorus pentasulfide were reacted, purified and neutralized with oxalic acid to obtain the title compound (yield 53%).
融点18f3−189°(エーテルから再結晶)I R
(KBr)cm−’: 3280. 2920, 16
10, 1590,1520. 13g0, 1350
. 1190NMR(CDCC3)δ: 1.46−
1.96(4H,ml 2.773.17(4H,m)
, 6.93(IH,d,J=16Hz), 7.15
(IH,dJ= 16Hz), 7. 19−7. 6
0(5H, m).元素分析値二CI5HllIN,S
−C2I4,o4・0.5H,Oとして
計算値: C,57,45. H,5.39; N,
7.88.実測値・ C,57.46; H,5、13
; N,7.91実施例2つ
2−へブタデンル−5.6,7.8−テトラヒド口−4
8−チアゾロ[5.4−b]アゼビン実施例23と同
様の方法により、塩化ステアロイル、3−アミノーε一
カプロラクタムおよび五硫化燐から表題化合物を得た(
収率26.1%)。Melting point 18f3-189° (recrystallized from ether) I R
(KBr)cm-': 3280. 2920, 16
10, 1590, 1520. 13g0, 1350
.. 1190NMR (CDCC3) δ: 1.46-
1.96 (4H, ml) 2.773.17 (4H, m)
, 6.93 (IH, d, J=16Hz), 7.15
(IH, dJ=16Hz), 7. 19-7. 6
0 (5H, m). Elemental analysis value 2 CI5HllIN,S
Calculated value as -C2I4,o4・0.5H,O: C,57,45. H, 5.39; N,
7.88. Actual value: C, 57.46; H, 5, 13
; N, 7.91 Examples 2-2-hebutadene-5.6,7.8-tetrahydride-4
8-thiazolo[5.4-b]azebin The title compound was obtained from stearoyl chloride, 3-amino-epsilon-caprolactam and phosphorus pentasulfide by a method similar to Example 23 (
yield 26.1%).
融点7 5−7 6°(メタノールから再結晶).I
R(K Br)cm’−’: 3230, 2930.
2g50, 1465,1265.
NMR(CDC(3)δ: 0.88(3H,t,J=
5Hz), 1.26(301{,br.s), 1.
47−1.90(4H.m), 2.67−2.90(
4H,m), 2.98−3.10(2H,m)元素分
析値二 C 24H 44N 2Sとして計算値:
C,73.41; H,+1.29; N,7.13.
実測値: C,73.46; H,11.00. N
,7Jl実施例30
2−(2−ナフチル)−5.6,7.8−テトラヒト口
−4H−チアゾロ[5.4 −b]アゼピン実施例23
と同様の方法により、塩化ナフトイル、3−アミノーε
一カブロラクタムおよび五硫化燐から、表題化合物が得
られた(収率42.9%)。Melting point 7 5-7 6° (recrystallized from methanol). I
R(KBr)cm'-': 3230, 2930.
2g50, 1465, 1265. NMR (CDC(3)δ: 0.88 (3H, t, J=
5Hz), 1.26 (301{,br.s), 1.
47-1.90 (4H.m), 2.67-2.90 (
4H, m), 2.98-3.10 (2H, m) Elemental analysis value 2 Calculated value as C 24H 44N 2S:
C, 73.41; H, +1.29; N, 7.13.
Actual value: C, 73.46; H, 11.00. N
,7Jl Example 30 2-(2-naphthyl)-5.6,7.8-tetrahydrogen-4H-thiazolo[5.4-b]azepine Example 23
Naphthoyl chloride, 3-amino-ε
The title compound was obtained from monocabrolactam and phosphorus pentasulfide (42.9% yield).
融点171−172°
I R(K Br)cm−”: 3442, 3240
, 2920, 1529,1508. 1371.
NMR(CDCl23)δ: 1.56−2.00(4
H,ml 2、923.18(4H,m), 7.{5
−8.18(7}1,m)元素分析値: C ,7H
1gN 2Sとして計算値: C,72.82;
H,5.75; N,9.99.実測値: C,72
.78; H,5.87; N,9.79実施例3l
2−(2−チェニル)−5.6,7.8−テトラヒドロ
ー4H−チアゾロ[5.4−blアゼピン実施例23と
同様の方法により、塩化2−テノイル、3−アミノーε
一カフロラクタムおよび五硫化燐から、表題化合物が得
られたく収率59%)。Melting point 171-172°IR(KBr)cm-”: 3442, 3240
, 2920, 1529, 1508. 1371. NMR (CDCl23) δ: 1.56-2.00 (4
H, ml 2, 923.18 (4H, m), 7. {5
-8.18 (7}1,m) Elemental analysis value: C,7H
Calculated value as 1gN 2S: C, 72.82;
H, 5.75; N, 9.99. Actual value: C, 72
.. 78; H, 5.87; N, 9.79 Example 3l 2-(2-chenyl)-5.6,7.8-tetrahydro 4H-thiazolo[5.4-bl azepine Same method as Example 23 2-Thenoyl chloride, 3-aminoε
The title compound was obtained from monocafrolactam and phosphorous pentasulfide (yield 59%).
融点123−124°
I R(KBr)cm−’: 3240, 2916,
1554. 15191415. 1370
NMR(CDC(!3)δ: 1.47−1.95(4
H,m), 2.83−2. 95(2H, m),
3. 00−3. 11(2H, m), 3.
65(IH. br. s)6. 90−7. 00(
IH, m), 7. 19−7. 23(2H,
m).元素分析値: C + + H ,t N t
S 2として計算値: C,55.90. H,5
.12; N,11.85.実測値: C,55.8
0; }1,5.13; N,11.83.実施例32
1−(4−メチル−1−ピペラシニル)アセチル2−フ
エニルー5,6,7.8−テトラヒドロ4H−チアゾロ
[5.4−b]アゼピン2−フエニル−5.6,7.8
−テトラヒドロ4H−チアゾロ[5.4−b]アゼビン
(3.0g)およびトリエチルアミン(3.6ml2)
をioo蚊のメチレンクロリトに加え、水冷撹拌下、2
.2gの塩化クロロアセチルを滴下した。室温で30分
撹拌後、減圧下で溶媒を留去し、残留物をクロロホルム
で抽出した。抽出層は飽和重曹水、水で洗浄後、無水硫
酸ナトリウムで乾燥した。減圧下溶媒を留去して得た粗
生或物(4 . 0 g)の1.9gを、2.6dのト
リエチルアミンと共に2iのテトラヒド口フランに加え
、次にN−メチルピペラジン(1.4d)を加え、室温
で5時間撹拌した。反応液を濃縮し、エーテルで抽出し
た。抽出層は水洗、乾燥後減圧下で濃縮した。残留物を
シリカゲルのカラムクロマトで精製後、塩酸塩としイン
ブロパノールーエーテルから再結晶すると1.66g(
56%)の表題化合物が得られた。融点195−197
°I R(KBr)cm−’: 3340, 2560
, 1660, 1460,1370.
NMR(CDCf2ff)δ: 1.50−2.15(
4H,m), 2.26(3Hs), 2. 33−2
. 76(8H, m), 2. 83−3. 12(
2H, m), 3. 21(2H, s), 3.
62−3. 86(2H, m), 7. 30−7.
54(3H, m),7. 80−8. 00(2H.
m).元素分析値: C 2oH teN−O S
・2HCI2・2H,Oとして
計算値: C,50.10; H,6.73; N,
11.69.実測値: C,49.f!13; H,
6.71; N,11.67実施例33
4−モルホリノアセチル−2−フエニルー5,6,7.
8−テトラヒド口−4H−チアゾロ[5.4b]アセピ
ン・塩酸塩
実施例32と同様にしで、2−フェニル−5,6.7.
8−テトラヒド口−4H−チアゾロ[5,4−b]アゼ
ピン、塩化クロロアセチルおよびモルホリンから表題化
合物が得られた(収率34.4%)。Melting point 123-124° IR (KBr) cm-': 3240, 2916,
1554. 15191415. 1370 NMR (CDC(!3)δ: 1.47-1.95(4
H, m), 2.83-2. 95 (2H, m),
3. 00-3. 11 (2H, m), 3.
65 (IH.br.s)6. 90-7. 00(
IH, m), 7. 19-7. 23 (2H,
m). Elemental analysis value: C + + H, t N t
Calculated value as S2: C, 55.90. H, 5
.. 12; N, 11.85. Actual value: C, 55.8
0; }1,5.13; N,11.83. Example 32 1-(4-Methyl-1-piperacinyl)acetyl 2-phenyl-5,6,7.8-tetrahydro 4H-thiazolo[5.4-b]azepine 2-phenyl-5.6,7.8
-Tetrahydro 4H-thiazolo[5.4-b]azevin (3.0g) and triethylamine (3.6ml2)
was added to the methylene chloride of the ioo mosquito, and stirred under water cooling for 2 hours.
.. 2 g of chloroacetyl chloride was added dropwise. After stirring at room temperature for 30 minutes, the solvent was distilled off under reduced pressure, and the residue was extracted with chloroform. The extracted layer was washed with saturated sodium bicarbonate solution and water, and then dried over anhydrous sodium sulfate. 1.9 g of the crude material (4.0 g) obtained by distilling off the solvent under reduced pressure was added to 2i tetrahydrofuran together with 2.6 d of triethylamine, and then N-methylpiperazine (1.4 d ) and stirred at room temperature for 5 hours. The reaction solution was concentrated and extracted with ether. The extracted layer was washed with water, dried, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography, converted to hydrochloride, and recrystallized from imbropanol-ether to give 1.66 g (
56%) of the title compound was obtained. Melting point 195-197
°IR(KBr)cm-': 3340, 2560
, 1660, 1460, 1370. NMR (CDCf2ff) δ: 1.50-2.15 (
4H, m), 2.26 (3Hs), 2. 33-2
.. 76 (8H, m), 2. 83-3. 12(
2H, m), 3. 21 (2H, s), 3.
62-3. 86 (2H, m), 7. 30-7.
54 (3H, m), 7. 80-8. 00 (2H.
m). Elemental analysis value: C2oHteN-OS
・Calculated value as 2HCI2・2H,O: C, 50.10; H, 6.73; N,
11.69. Actual value: C, 49. f! 13;H,
6.71; N, 11.67 Example 33 4-morpholinoacetyl-2-phenyl-5,6,7.
8-Tetrahydro-4H-thiazolo[5.4b]acepine hydrochloride In the same manner as in Example 32, 2-phenyl-5,6.7.
The title compound was obtained from 8-tetrahydro-4H-thiazolo[5,4-b]azepine, chloroacetyl chloride and morpholine (yield 34.4%).
融点208−211(インブロバノールーエーテルか与
再結晶)
I R(K Br)cm−’: 2490, 16g0
, 1460. 1450,1365. 1120.
NMR(CDCC3)δ: 1.53−2.20(4H
,m), 2.40−2. 70(4H, m), 2
. 83−3. 12(2H, m). 3. 20(
2B, s),3. 53−3. 94(6H, m)
, 7. 30−7. 53(3H, m), 7.
807、911t(2H, m).
元素分析値: C+sH,3N.O.S−HCg−0
.5HtOとして
計算値: C,56.64; H,6.25; N,
10.43.実測値: C,56.40; H,6.
{2; N.10.49.実施例34
4 −E3−(4−メチル−1−ビベラジニル)プロピ
オニル二一2−フエニルー5,6,7.8−テ−トラヒ
ド口−4H−チアゾロE5.4−bjアゼビン゜フマレ
イト
実施例32と同様にしで、2−フエニル−5,6,7.
8−テトラヒド口−4H−チアゾロ[5.4−b]アゼ
ビン、塩化3−クロロプロビオニル,Nメチルビベラジ
ンおよびフマル酸より表題化合物が得られた(収率35
%)。融点201202°(イソブロパノールから再結
晶).I R(KBr)cn+−’: 2930, 1
660, 1540, 1450,1380 117
0.
N M R (C D C (!3)δ: 1.54−
2.20(4H,m1 2.23(3Hs). 2.
41(8H. m), 2. 59−2. 76(48
, m), 2. 88−3. 13(2B, m),
3. 60−3. 94(2H. m), 7. 3
3−7. 55(3H, m),7. 80−7. 9
6(2H, m).元素分析値: C tlH zs
N −O S ’ C 4H 40.とじて
計算値: C,59.98: H,6.44; N,
11.19.実測値: C,59.82; H,6.
58; N,11.16,実施例35
1−(3−モルホリノプロピオニル)−2−フエニルー
5, 6, 7. 8−テトラヒド口−4H−チアゾロ
[5.4−b]アゼピン・塩酸塩
実施例32と同様にしで、2−フェニル−5,6,7.
8−テトラヒドロー4H−チアゾロ[5,4b]アゼビ
ン、塩酸塩3−クロロプ口ビオニル,モルホリンおよび
塩化水素より、表題化合物が得られた(収率43%)。Melting point 208-211 (recrystallized from inbrobanol ether) IR(KBr)cm-': 2490, 16g0
, 1460. 1450, 1365. 1120. NMR (CDCC3) δ: 1.53-2.20 (4H
, m), 2.40-2. 70 (4H, m), 2
.. 83-3. 12 (2H, m). 3. 20(
2B, s), 3. 53-3. 94 (6H, m)
, 7. 30-7. 53 (3H, m), 7.
807, 911t (2H, m). Elemental analysis value: C+sH, 3N. O. S-HCg-0
.. Calculated value as 5HtO: C, 56.64; H, 6.25; N,
10.43. Actual value: C, 56.40; H, 6.
{2; N. 10.49. Example 34 4-E3-(4-Methyl-1-biverazinyl)propionyl 2-2-phenyl-5,6,7.8-tetrahydride-4H-thiazolo E5.4-bj azevin゜fumarate Example 32 Similarly, 2-phenyl-5,6,7.
The title compound was obtained from 8-tetrahydro-4H-thiazolo[5.4-b]azevin, 3-chloroprobionyl chloride, N-methylbiverazine and fumaric acid (yield: 35
%). Melting point 201202° (recrystallized from isopropanol). IR(KBr)cn+-': 2930, 1
660, 1540, 1450, 1380 117
0. N M R (C D C (!3) δ: 1.54-
2.20 (4H, m1 2.23 (3Hs). 2.
41 (8H.m), 2. 59-2. 76 (48
, m), 2. 88-3. 13 (2B, m),
3. 60-3. 94 (2H.m), 7. 3
3-7. 55 (3H, m), 7. 80-7. 9
6 (2H, m). Elemental analysis value: C tlH zs
N -O S' C 4H 40. Calculated value: C, 59.98: H, 6.44; N,
11.19. Actual value: C, 59.82; H, 6.
58; N, 11.16, Example 35 1-(3-morpholinopropionyl)-2-phenyl 5, 6, 7. 8-Tetrahydro-4H-thiazolo[5.4-b]azepine hydrochloride In the same manner as in Example 32, 2-phenyl-5,6,7.
The title compound was obtained from 8-tetrahydro-4H-thiazolo[5,4b]azevin, 3-chloropropyl hydrochloride, morpholine, and hydrogen chloride (yield: 43%).
融点184−186°(イソプロバノールより再結晶)
I R(K Br)cm ’: 3450, 2920
, 2370, 1640,1455. 1430.
NMR(CDC&3)δ: 1.52−2.19(4H
,m), 2.292.51(4H,m). 2.60
−2.73(4H,m), 2.86−3.10(2H
,m), 3.50−3.88(6H m), 7.3
2−7.53(38,m), 7.81−7. 97(
2H, m)
元素分析値: C 208 25N 30 2S ’
H C Q ’0 5H20として
計算値: C,57.61・H.6.53; N,1
0.0g.実測値: C,57.77. H,6.4
9. N, 9.98実施例36
.l[3−(3.4−ジメトキシフェ不チノレ)アミノ
プロピオニル〕−2−フェニルー5,6.7.8テトラ
ヒド口−4H−チアゾロ[5.4−b]アゼピン・フマ
レイト
実施例32と同様にしで、2−フエニル−5,6,7.
8−テト−ラヒド口−4H−チアゾロ[5,4b]アゼ
ピン、塩化クロロプロピオニル,β−(3,4−ジメト
キシフェニル)エチルアミンおよびフマル酸から表題化
合物が得られた(収率42%)。Melting point 184-186° (recrystallized from isoprobanol) IR(KBr)cm': 3450, 2920
, 2370, 1640, 1455. 1430. NMR (CDC & 3) δ: 1.52-2.19 (4H
, m), 2.292.51 (4H, m). 2.60
-2.73 (4H, m), 2.86-3.10 (2H
, m), 3.50-3.88 (6H m), 7.3
2-7.53 (38, m), 7.81-7. 97(
2H, m) Elemental analysis value: C 208 25N 30 2S'
Calculated value as H C Q '0 5H20: C, 57.61・H. 6.53; N, 1
0.0g. Actual value: C, 57.77. H, 6.4
9. N, 9.98 Example 36. 1[3-(3.4-dimethoxyphetinole)aminopropionyl]-2-phenyl-5,6.7.8tetrahydro-4H-thiazolo[5.4-b]azepine fumarate Same as Example 32. and 2-phenyl-5,6,7.
The title compound was obtained from 8-tetorahydride-4H-thiazolo[5,4b]azepine, chloropropionyl chloride, β-(3,4-dimethoxyphenyl)ethylamine and fumaric acid (yield 42%).
融点143−144°(エーテルから再結晶)I R
(K B r)cm”−’ : 1710, 1660
, 1342, 1320,1405, 1255.
NM R (C D C (13’)δ: 1.50−
2.13(5H,m), 2.463.20(IOH,
m), 3.55−4.00(2H,m), 4.81
(3H,s),4、83(38, s), 6. 75
(3H, br. s), 7. 33−7. 98(
3H, m), 7.80−7.98(2H,m).元
素分析値: C 211H 3+N Go 3S ’
C 4H 40 4・0.5H,0として
計算値: C.61.00; H,6.14; N,
7.11.実測値: C.61.l7; H,5.9
4; N,6.84実施例37
4−(4−メチル−1−ピベラシニル)アセチル2−ス
チリル−5.6,7.8−テトラヒドロ4H−チアゾロ
[5.4−b]アゼピン・塩酸塩実施例32と同様にし
で、2−スチリル−5,6,7.8−テトラヒドロ−4
H−チアゾロ[5,4−b]アゼピン、塩化クロロアセ
チル,N−メチルビベラジンおよび塩化水素より表題化
合物が得られた(収率23%)。融点182−184°
(メタノール・エーテルより再結晶).
I R(K Br)cm−’: 3400, 1670
, 1610, 1440,1410.
NMR(d,−DMSO)δ l. 36−2. 13
(4H. m),2. 72−3. 02(5H, m
), 3. 27(2H, s), 3. 36−4.
00(IOH,m), 7. 27−7. 75(7
H, m).元素分析値: C 2,H 2.N ,
O S・3HCQ・t.3Htoとして
計算値: C,49.92; H,6.40; N,
10.58.実測値: C,49.97; H,6.
57: N,10.59.実施例38
4−I(3.4−ジメトキンフェ不チノレ)アミ/アセ
チノレニ−2−スチリノレ−5.6,7.8−テトラヒ
ドロー4H−チアゾロ[5.4−b]アゼビン・塩酸塩
実施例32と同様にしで、2−スチリル−56.7.8
−テトラヒド口−4H−チアゾロ[5.4b]アゼビン
、塩化クロロアセチル,β−(3.4ジメトキシフェニ
ル)エチルアミンおよび塩化水素から表題化合物が得ら
れた(収率29%)。Melting point 143-144° (recrystallized from ether) I R
(KBr)cm"-': 1710, 1660
, 1342, 1320, 1405, 1255. NMR(CDC(13')δ: 1.50-
2.13 (5H, m), 2.463.20 (IOH,
m), 3.55-4.00 (2H, m), 4.81
(3H, s), 4, 83 (38, s), 6. 75
(3H, br.s), 7. 33-7. 98(
3H, m), 7.80-7.98 (2H, m). Elemental analysis value: C 211H 3+N Go 3S'
Calculated value as C 4H 40 4・0.5H,0: C. 61.00; H, 6.14; N,
7.11. Actual value: C. 61. l7; H, 5.9
4; N, 6.84 Example 37 4-(4-Methyl-1-piveracinyl)acetyl 2-styryl-5.6,7.8-tetrahydro 4H-thiazolo[5.4-b]azepine hydrochloride implementation Similarly to Example 32, 2-styryl-5,6,7.8-tetrahydro-4
The title compound was obtained from H-thiazolo[5,4-b]azepine, chloroacetyl chloride, N-methylbiverazine and hydrogen chloride (yield 23%). Melting point 182-184°
(Recrystallized from methanol/ether). IR(KBr)cm-': 3400, 1670
, 1610, 1440, 1410. NMR(d,-DMSO)δ l. 36-2. 13
(4H.m), 2. 72-3. 02 (5H, m
), 3. 27 (2H, s), 3. 36-4.
00 (IOH, m), 7. 27-7. 75 (7
H, m). Elemental analysis value: C2, H2. N,
OS・3HCQ・t. Calculated value as 3Hto: C, 49.92; H, 6.40; N,
10.58. Actual value: C, 49.97; H, 6.
57: N, 10.59. Example 38 4-I(3.4-dimethoquinfetinole)ami/acetinoleni-2-styrinole-5.6,7.8-tetrahydro 4H-thiazolo[5.4-b]azevin hydrochloride Example 32 Similarly, 2-styryl-56.7.8
The title compound was obtained from -tetrahydride-4H-thiazolo[5.4b]azevin, chloroacetyl chloride, β-(3.4 dimethoxyphenyl)ethylamine and hydrogen chloride (yield 29%).
融点170−172°
I R(KBr)cm−’: 1660, 1600,
1520, 1410,1255. 1235.
NMR(CDCff3)δ: 1.49−2.11(5
1{,m), 2.603.06(6H,m), 3.
12(2H,s), 3.56−3.80(2H,n+
).3、82(3H, s), 3. 84(3B,
s), 6. 74(3H, br. s),7. 2
6−7. 41(7H, m).元素分析値: C,
7H3,N30,s・3HCC・0 4H20として
計算値: C,58.14; H,6.11; N,
7.53;S, 5.75.
実測値: C , 58. 23; H , 6、0
2; N,7.47S, 6.01.
実施例39
2−(2−フロロフエニル)−4−[3−(N−(4フ
ロロフェニル)ピペラジノ)フロピオニル]5,6.7
.8−テトラヒド口−4H−チアゾロ[5,4−b]ア
ゼビン・塩酸塩
実施例32と同様にしで、2−(2−フロロフエニル)
−5.6,7.8−テトラヒド口−4H−チアゾロ[5
,4−b]アゼピン、塩化3−クロロプ口ピオニル,N
一(4−フロロフエニル)ピペラジンおよび塩化水素か
ら表題化合物が得られた(収率5l%).融点131−
132°
I R(K Br)cm ’: 33,50, 164
5, 1509,1443,1410 1229.
NMR(d,−DMSO)δ: 1.50−2.10(
4H,m),2. 89−3. 10(2H, m).
3. 30−4. 00(14H, m), 6.
957. 63(7H, m), 8. 05−8.
30(IH, m)元素分析値’ C 28H 2B
N40SF2・3HCi2・0.9H20として
計算値 C,51.35; H,5.44; N,9.
21:S, 5.27. CC,17.49
実副値: C,51.39; H,5.44; N,
9.16;S, 5.27. C(,17.14実
施例40
2−フエニル−4−ステアロイルー5,6,7.8−テ
トラヒド口−4H−チアゾロ[5.4−b]アゼピン
2−フエニル−5.6,7.8−テトラヒドロ4H−チ
アゾロ[5.4−b]アゼビン(2.65g)トリエチ
ルアミン(2.21)を30Hのテトラヒドロフランに
加え、水冷撹拌下,4.65dの塩化ステアロイルを滴
下した。滴下終了後、室温で1.5時間し、戚圧下溶媒
を留去した。残留物をクロロホルムで抽出し、抽出層は
水洗,乾燥後盾媒を留去した。残留物をンリカゲルのカ
ラムクロマトで精製し、表題化合物(4.31g,76
%)を得た。融点38−40°
I R(K Br)cm−’: 2900, 2850
, 1670, 1640,1450. 1410
NMR(CDC7!3)δ 0.87(3H,t,J=
6Hz), 1.24(30H.br.s), 1.5
2−2.10(4H,s). 2.41(2H,t,J
一5Hz), 2. 97(2H, t, J= 5
Hz), 3. 61−3. 92(2H, m)了
.32−7.53(3}!,m), 7.81−8
.03(2H,m)元素分析値: C3,H,,N2
0Sとして計算値: C,74.95; H,9.7
4; N,5.64.実測値 C,74.64: H,
9。67; N,5.77.実施例41
4−メタンスルホニル−2−(4−ピリジル)5,6,
7.8−テトラヒド口−4H〜チアゾロ[5,4−b]
アゼピン
イソニコチン酸(10g)のシメチルホルムアミト(3
0 0 が111%,i液にカルホニルイミタゾール
(15.8g)を除々に加え、30分間室思で撹拌後、
10.4gの3−アミノーε一カブ口ラクタムを加えた
。室温で3時間撹拌後、減圧下で溶媒を留去した。残留
物に200dのピリジンと12.4gの五硫化燐を加え
、1.5時間加熱還流した。冷却i麦戚圧下て溶媒を留
去し、残留物をクロロホルムで抽出した。抽出層は重曹
水、水で洗浄,乾燥後,減圧下溶媒を留去し1 4.3
gの粉末を得た。この粉末2.5gに30−のテトラヒ
ド口フランと2,28Mのトリエチルアミンを加え、水
冷撹拌下l,08dの塩化メタンスルホニルを滴下した
。1時間室温で撹拌後、溶媒を留去し、クロロホルムで
抽出した。抽出層は洗浄後乾燥し、減圧下で溶媒を留去
した。残留物をシリカゲルのカラムで精製後、メチレン
ク口リドーイソブロビルエーテルから再結晶し、表題化
合物を105g(24%)得た。Melting point 170-172° IR (KBr) cm-': 1660, 1600,
1520, 1410, 1255. 1235. NMR (CDCff3) δ: 1.49-2.11 (5
1{, m), 2.603.06 (6H, m), 3.
12 (2H, s), 3.56-3.80 (2H, n+
). 3, 82 (3H, s), 3. 84 (3B,
s), 6. 74 (3H, br. s), 7. 2
6-7. 41 (7H, m). Elemental analysis value: C,
7H3,N30,s・3HCC・0 Calculated value as 4H20: C, 58.14; H, 6.11; N,
7.53;S, 5.75. Actual value: C, 58. 23; H, 6, 0
2; N, 7.47S, 6.01. Example 39 2-(2-fluorophenyl)-4-[3-(N-(4fluorophenyl)piperazino)flopionyl]5,6.7
.. 8-Tetrahydro-4H-thiazolo[5,4-b]azebin hydrochloride In the same manner as in Example 32, 2-(2-fluorophenyl)
-5.6,7.8-tetrahydride-4H-thiazolo[5
, 4-b] azepine, 3-chloropionyl chloride, N
The title compound was obtained from mono(4-fluorophenyl)piperazine and hydrogen chloride (yield 51%). Melting point 131-
132° I R (K Br) cm': 33, 50, 164
5, 1509, 1443, 1410 1229. NMR(d,-DMSO) δ: 1.50-2.10(
4H, m), 2. 89-3. 10 (2H, m).
3. 30-4. 00 (14H, m), 6.
957. 63 (7H, m), 8. 05-8.
30 (IH, m) Elemental analysis value' C 28H 2B
Calculated value as N40SF2・3HCi2・0.9H20 C, 51.35; H, 5.44; N, 9.
21:S, 5.27. CC, 17.49 Actual subvalue: C, 51.39; H, 5.44; N,
9.16;S, 5.27. C(,17.14 Example 40 2-phenyl-4-stearoyl-5,6,7.8-tetrahydro-4H-thiazolo[5.4-b]azepine 2-phenyl-5.6,7.8- Tetrahydro 4H-thiazolo[5.4-b]azevin (2.65 g) and triethylamine (2.21) were added to 30H tetrahydrofuran, and 4.65 d of stearoyl chloride was added dropwise with stirring while cooling with water. After completion of the dropwise addition, at room temperature. After 1.5 hours, the solvent was distilled off under reduced pressure.The residue was extracted with chloroform, and the extracted layer was washed with water, dried, and the shielding medium was distilled off.The residue was purified by column chromatography on linica gel to obtain the title compound (4). .31g, 76
%) was obtained. Melting point 38-40°IR(KBr)cm-': 2900, 2850
, 1670, 1640, 1450. 1410 NMR (CDC7!3) δ 0.87 (3H, t, J=
6Hz), 1.24 (30H.br.s), 1.5
2-2.10 (4H, s). 2.41 (2H, t, J
-5Hz), 2. 97 (2H, t, J= 5
Hz), 3. 61-3. 92 (2H, m) completed. 32-7.53 (3}!, m), 7.81-8
.. 03 (2H, m) Elemental analysis value: C3, H,, N2
Calculated value as 0S: C, 74.95; H, 9.7
4; N, 5.64. Actual value C, 74.64: H,
9.67; N, 5.77. Example 41 4-methanesulfonyl-2-(4-pyridyl)5,6,
7.8-Tetrahydro-4H~thiazolo[5,4-b]
azepine isonicotinic acid (10 g) in dimethylformamide (3
0 0 was 111%, carbonylimitazole (15.8 g) was gradually added to liquid i, and after stirring in a room for 30 minutes,
10.4 g of 3-amino-ε monolactam was added. After stirring at room temperature for 3 hours, the solvent was distilled off under reduced pressure. 200 d of pyridine and 12.4 g of phosphorus pentasulfide were added to the residue, and the mixture was heated under reflux for 1.5 hours. The solvent was distilled off under cooled pressure, and the residue was extracted with chloroform. The extracted layer was washed with aqueous sodium bicarbonate and water, dried, and the solvent was distilled off under reduced pressure.1 4.3
g of powder was obtained. 30-tetrahydrofuran and 2.28 M triethylamine were added to 2.5 g of this powder, and 1.08 d of methanesulfonyl chloride was added dropwise with stirring while cooling with water. After stirring at room temperature for 1 hour, the solvent was distilled off and the mixture was extracted with chloroform. The extracted layer was washed and dried, and the solvent was distilled off under reduced pressure. The residue was purified with a silica gel column and then recrystallized from methylene chloride isobrobyl ether to obtain 105 g (24%) of the title compound.
融点193−194°
I R(K Br)cm−’: 1595, 1530
, 1430, 1370,1340, 1150.
NMR(CDC(.)δ・t. 56−2. 16(4
Fl,耐,3.QQ3.20(2H,m), 3.04
(3H,s), 3.79(2H,t,J=5Hz)7
.66−7.80(2H,m), 8.61−8.78
(2Lm)元素分析値: C13}1.5N302S
.とじて計算値: C,50.46; H,4.89
; N,13.58実測値・ C,50.33; H,
4.91; N,13.61実施例42
4−(5−メチル−4−イソオキサゾリル)カルポニル
ー2−メチル−5.6,7.8−テトラヒト口−4H−
チアゾロ[5.4−b]アセピン2.55gの3−アセ
チルアミノーε一カブロラクタムと五硫化燐(6.08
)を41のビリジンに加え80゜Cの油浴中て20時間
撹拌した。冷却後、反応物にクロロホルムを加え、重曹
水,水で洗浄した。乾燥後、減圧下で溶媒を留去すると
259gの油秋物か得られた。この油状物を40dのピ
リジンに溶かし、水冷下で4gの(5−メチル4−イソ
オキサゾリル)カルボニルクロリトを滴下した。廊下終
了後、室温で一夜撹拌しクロロナルムで抽出した。抽出
層は水洗後乾燥し、減圧下で溶媒を留去した。残留物を
/リカケルのカラムクロマトで精製し、続いてヘキサン
から再結晶すると0.9g(19%)の表題化合物か得
られた。Melting point 193-194° IR(KBr)cm-': 1595, 1530
, 1430, 1370, 1340, 1150. NMR (CDC(.) δ・t. 56-2. 16(4
Fl, resistance, 3. QQ3.20 (2H, m), 3.04
(3H, s), 3.79 (2H, t, J=5Hz)7
.. 66-7.80 (2H, m), 8.61-8.78
(2Lm) Elemental analysis value: C13}1.5N302S
.. Calculated value: C, 50.46; H, 4.89
; N, 13.58 actual value・C, 50.33; H,
4.91; N, 13.61 Example 42 4-(5-methyl-4-isoxazolyl)carbonyl-2-methyl-5.6,7.8-tetrahuman-4H-
Thiazolo[5.4-b]acepine 2.55 g of 3-acetylamino-ε-cabrolactam and phosphorus pentasulfide (6.08
) was added to pyridine No. 41 and stirred in an oil bath at 80°C for 20 hours. After cooling, chloroform was added to the reaction mixture, and the mixture was washed with aqueous sodium bicarbonate and water. After drying, the solvent was distilled off under reduced pressure, yielding 259 g of oily fruit. This oil was dissolved in 40 d of pyridine, and 4 g of (5-methyl 4-isoxazolyl) carbonyl chloride was added dropwise under water cooling. After completion of the passage, the mixture was stirred at room temperature overnight and extracted with chloronarum. The extracted layer was washed with water, dried, and the solvent was distilled off under reduced pressure. The residue was purified by Rikakel column chromatography, followed by recrystallization from hexane to yield 0.9 g (19%) of the title compound.
融点] 1 7.0−] 1 85°
I R(Nujol)cm ’: 1650, 160
5, 1560. 14501400 1240
1180
NMR(CDCI6 1.5−2.2(4H,m),
2.9−3.2(211, m), 3. 7−4.
0(2H, m), 2. 60(6H, s), 7
. 60(IH,S)
元素分析値: C,,H,5N302Sとして計算値
: C,56.30; H,5.45; N,15、
15実測値: C,56.33: H,5J3; N
,14.94.実施例43
4−(4−フロロベンゾイル)−2−メチル−5.6,
7.8−テトラヒド口−4H−チアゾロ[5.4b]ア
ゼピン
実施例42と同様にしで、3−アセチルアミノε一カブ
口ラクタム、五硫化燐および塩化4クロロベンゾイルか
ら表題化合物が得られた(収率37%)。融点9 3.
5 0−9 5.0 0°(ヘキサンから再結晶)、
I R(Nujol)cm−’: 1640, 160
0, 1440. 14051315, 1295,
1225. 1180,845, 760
NMR (C D Cf23)δ: 1. 6−2.
2(411, m), 2. 48(311, s),
2.90−3.17(2H.m), 3.77−4.
00(2H.m), 6.837. 53(4H, m
).
元素分析値: C,,H15N20SFとして計算値
: C,62.05; H,5.21. N,9.6
5実測値: C,62.24; H,5.28: N
,9.60.実施例44
4−(α−テノイル)−2−メチル−5.6,7.8−
テトラヒド口−4H−チアゾロ[5.1−b]アセピン
実施例42と同様にしで、3−アセチルアミノε一カブ
ロラクタム、五硫化燐およびα一塩化テノイルから表題
化合物が得られた(収率45%)。Melting point] 1 7.0-] 1 85° I R (Nujol) cm': 1650, 160
5, 1560. 14501400 1240
1180 NMR (CDCI6 1.5-2.2 (4H, m),
2.9-3.2 (211, m), 3. 7-4.
0(2H, m), 2. 60 (6H, s), 7
.. 60 (IH, S) Elemental analysis value: C,, H, Calculated value as 5N302S: C, 56.30; H, 5.45; N, 15,
15 Actual value: C, 56.33: H, 5J3; N
, 14.94. Example 43 4-(4-fluorobenzoyl)-2-methyl-5.6,
7.8-Tetrahydro-4H-thiazolo[5.4b]azepine Similarly to Example 42, the title compound was obtained from 3-acetylamino epsilon-lactam, phosphorus pentasulfide and 4-chlorobenzoyl chloride ( yield 37%). Melting point 9 3.
5 0-9 5.0 0° (recrystallized from hexane), IR (Nujol) cm-': 1640, 160
0, 1440. 14051315, 1295,
1225. 1180,845,760 NMR (CD Cf23) δ: 1. 6-2.
2 (411, m), 2. 48 (311, s),
2.90-3.17 (2H.m), 3.77-4.
00 (2H.m), 6.837. 53 (4H, m
). Elemental analysis value: C,, calculated value as H15N20SF: C, 62.05; H, 5.21. N, 9.6
5 Actual value: C, 62.24; H, 5.28: N
, 9.60. Example 44 4-(α-Thenoyl)-2-methyl-5.6,7.8-
Tetrahydro-4H-thiazolo[5.1-b]acepine Similarly to Example 42, the title compound was obtained from 3-acetylamino ε-cabrolactam, phosphorus pentasulfide and α-thenoyl monochloride (yield 45%). ).
融点108.OllO.O’ (ヘキサンから再結晶)
I R(Nujol)am−’: 1630, 144
0, 1420, 1302,1290. 1180,
735.
NMR(CDCj3)δ: 1. 6−2. 3(4H
, m), 2. 57(3H, s)2.88−3.
15(2H,m) 3.73−4.03(2H,m)
. 6,857. 50(3H, m).
元素分析値: C +3Hl4N to s tとし
て計算値 C,56.09; H,5.07; N,1
0.06実測値: C,56.12; }{,5.0
4; N,10.02.実施例45
4−ニコチノイル−2−メチル−5.6,7.8テトラ
ヒド口−4H−チアゾロE5,4 −b]アセピン
実施例42と同様にしで、3−アセチルアミ/ε一カブ
口ラクタム、五硫化燐およびニコチン酸クロリドから表
題化合物が得られた(収率34%)。融点107.0−
109.0’ (ヘキサンから再結晶).
I R(Nujol)am−’: 1650. 158
5, 1550, 1465,1420 1310,
1290. 1180,740
N M R (C D C f23)δ: l. 8−
2. 3(4H, m), 2. 45(3H, s)
2.92−3.20(28,m). 3.77−4.0
3(2H,m), 7.138. 6(4H, m)
元素分析値: C +4H +sN 30 Sとして
計算値: C,61.52; H,5.53; N,
15J7、実測値: C,61.84; H,5.5
5; N.15.20実施例46
2−(3−メトキシスチリル)−5.6,7.8テトラ
ヒドロー4H−チアゾロC5,4−b]アセビン・塩酸
塩
実施例1と同様にしで、3−(3−メトキ/ンンナモイ
ル)アミノーε一カブ口ラクタムと五硫化燐を反応、精
製後生戊物を塩化水素で中和し、表題化合物を得た(収
率3o,3%)。融点177178°(クロロホルムー
エタノールかラ再結晶).
I R (K B r)cm−’ : 3366, 3
216, 2930, 1604, 1525.148
9.1269.
NMR(d8−DMSO)δ: l. 63−1.
74(4H, m),2. 80−2. 86(2H,
m), 3. 01−3. 07(2H, rn),
3. 80(3H, s),6. 94 (IH,
dd, J = 3Hz. 7Hz), 7. 18−
7. 20(2B, m), 7. 32(IN, d
, J = 8Hz), 7. 38(2H, s).
元素分析値: CI.H..N,OSC(lとして計算
値: C,59.52: H,5.93; N,8
.5g.実測値・C,59.19; H,5.85;
N,8.69.実施例47
2−(3.5−ジメトキシスチリル)−5.6,7.8
−テトラヒトロー4H−チアゾロ[5.4−b]アゼビ
ン
実施例1と同様の方広により、3−(3.5−ンメトキ
シシンナモイル)アミノーε一カプロラクタムと五硫化
燐から表題化合物が得られたく収率2i.4%)。融点
104−105°(エーテルから再結晶).
I R (K B r)am”” : 1594, 1
546. 1431, 1419, 1355,120
7, 1156.
NMR(CDCl23)δ: 1.62−1.90(
4H,m),2.90(2}1,t, J = 6Hz
), 3. 12(2H, t, J= 5Hz),
3. 81(6H, s),3. 93(IH, br
), 6. 40(IH, t, J= 2Hz),
6. 62(2H, d, J= 2Hz), 6.
92(IH, d, J= 16Hz), 7. 10
(IH. d, J= 16Hz).
元素分析値; C 17H ,oN so tsとして
計算値:C,64.53: H,6.37; N,
8.85.実測値: C,64.59; H,6.5
2; N,8.80.実施例48
2 − (2 .3−ンメト牛/スチワル’)−5.6
.78−テトラヒドl−48−チアゾc7[5.1−b
]アゼピン
実施例1と同様の方注により、3−(2.3−ジメトキ
シシンナモイル)アミノーε一カブ口ラクタムと五硫化
燐から表題化合物か得られた(収率35.0%)。融点
125−126°(シクロへ牛サンから再結晶),
I R (K B r)cm−’ : 3214, 1
527, 1476,4447, 1422,1270
, 1072.
NMR(CDCt2.)δ: 1. 501. 89
(4H, m), 2. 90C2H.t, J −
6Hz), 3. 12(2H, t, J = 5H
z), 3. 85(3H. s), 3. 88(3
H, s), 6. 84 (IH, dd, J=
2Hz, 8Hz>, 7. 05(IH, t, J
= 8Hz), 7. 15(IH. d, J =
16Hz), 7. 16(II, dd, J= 2
Hz, 8Hz), 7. 31(IH, d. J=
16Hz).元素分析値: C ,7H ,.N ,
O ,Sとして計算値: C,64.53. H,6
.37; N,8.85.実測値: C,64.44
; H,6JO’ N,8.91,実施例49
2−(2.5−ジメト牛シスチリル)−5.6,7.8
−テトラヒド口−4H−チアゾロ[5.4−b]アセピ
ン
実施例lと同様の方法により、3−(2.5−ジメトキ
シシンナモイル)アミ7〜ε一カブロラクタムと五硫化
燐から表題化合物が得られた(収率32 3%)。融点
155−156°(シクロヘキサンから再結晶),
I R (K B r)cm−’ : 1527, 1
498, 1436, 1362, 1226,121
3.
N M R (C D C (23)δ: 1. 5
0−1. 18C4H, m), 2. 74(2}!
,t, J = 6Hz), 2. 92−3. (1
2(2H, m), 3. 75(3H, s), 3
. 80(3■, s). 6. 83(IH, dd
, J− 3}iz, 9Hz), 6. 96(IN
, d, J = 9Hz). 7. 18−7. 2
1(3H, m)元素分析値: C ,,H ,.N
,O .Sとして計算値: C,64.53; H,
6.37; N,8.85実測値: C,64.39
; H,6,31: N,8.71実施例50
2−(3.4−ジメトキシフェニル)−5.6,7.8
〜テトラヒドロ−4H−チアゾロ[5.4−b]アゼピ
ン・塩酸塩
実施例1と同様の方法により、3−(3.4−ジメトキ
シベンゾイル)アミノーε一カブ口ラクタムと五硫化燐
を反応、精製後生成物を塩化水素で中和し、表題化合物
を得た(収率45.4%)。融点186−187°(メ
タノールーエーテルから再桔晶)
I R (K B r)cm ’ : 1609,
1535, 1509, 1342. 126g,1
152.
NMR(d.−DMSO)δ: 1. 56−1.
82(4H, m),2. 88−2. 94(2H,
m), 3. 02−3. 08(2H, m),
3. 82(3H, s),3. 85(3H, s)
, 7. 05(IH, d, J = 9Hz),
7. 35(IH. dd, J2Hz, 9Hz),
7. 58(IH, d, J= 2Hz).元素分
析値二C +sH 1sN to tc (l・0.
5H ,Oとして
計算値:C,53、64; H,6.00; N,
8.34.実測値: C,53J9; H,5.86
; N,8.05実施例51
2−(4−メトキシー3−メチルスチリル)−5,6,
7.8−テトラヒド口−4H−チアゾロ[5,4b]ア
ゼピン
実施例1と同様の方法により、3−(4−メトキン−3
−メチルシンナモイル)アミノーε一カブ口ラクタムと
五硫化燐から表題化合物が得られた(収率33.6%)
。融点139−140°(シクロヘキサンから再結晶)
.
I R (K B r)cm ’ : 2922, 1
542, 1506, 1365, 1255,112
9.
NMR(CDCQ3)δ: l. 59−1. 88
(4H, m), 2. 22(3H,s), 2.
89(28, t, J= 6Hz), 3. 11(
2H, t, J= 5Hz), 3. 84(3H,
s), 6. 80(LH, d, J= 9Hz)
, fi. 96(2H, s), 7. 26−7.
30(2H, m).
元素分析値:C,,H,。N.OSとして計算値: C
,67.97; H,6.71; N,9.32.
実測値: C,6g.19; H,6.80: N
,9J9.実施例52
2−[4−メトキシー3−(2−メチルチオエトキシ)
スチリル]−5.6.7.8−テトラヒドロ4H−チア
ゾロ[5.4−b]アゼピン実施例lと同様の方法によ
り、3−[4−メトキシー3−(2−メチルチオエトキ
シ)シンナモイル]アミノーε一カブ口ラクタムと五硫
化燐から表題化合物が得られた(収率15.O%)。融
点l17−118°(シクロへ牛サンから再結晶).I
R (K B r)cm ’ : 1553, 15
14, 1442. 135g, 1263,1141
.
NMR (C D Cl2 3) δ 二 1.
48−1. 97(4H, m), 2. 20(3H
s), 2. 81−2. 95(2H, m), 2
. 90(2H, t, J= 7Hz), 3. 0
43. 17(2H, m). 3. 85(3H.
s), 4. 20(2H, t, J= 7Hz),
6. 81(IH, d, J = 9Hz), 6、
92(2H, s), 6. 97−7. 06(2H
,m)
元素分析値: C ..H ,.N ,○tStとして
計算値: C,60.61; H,6.42; N
,?.44.実測値: C,60.62; H,6.
47; N,7.40,実施例53
2−(3.4.5−}リメトキシスチリル)−5,6,
7.8−テトラヒドロー4H−チアゾロ[5,4b]ア
ゼピン・塩酸塩
実施例lと同様にしで、3−(31415− トリメト
キシシンナモイル)アミノーε一力プ口ラクタムと五硫
化燐を反応、精製後生成物を塩化水素で中和し、表題化
合物を得た(収率22.8%)。Melting point 108. OllO. O' (recrystallized from hexane) I R (Nujol) am-': 1630, 144
0, 1420, 1302, 1290. 1180,
735. NMR (CDCj3) δ: 1. 6-2. 3 (4H
, m), 2. 57 (3H, s) 2.88-3.
15 (2H, m) 3.73-4.03 (2H, m)
.. 6,857. 50 (3H, m). Elemental analysis value: Calculated value as C + 3Hl4N to s t C, 56.09; H, 5.07; N, 1
0.06 Actual value: C, 56.12; }{, 5.0
4; N, 10.02. Example 45 4-Nicotinoyl-2-methyl-5.6,7.8tetrahydro-4H-thiazoloE5,4-b]acepine In the same manner as in Example 42, 3-acetylamide/ε-1-cubic lactam, The title compound was obtained from phosphorus sulfide and nicotinic acid chloride (yield 34%). Melting point 107.0-
109.0' (recrystallized from hexane). IR(Nujol)am-': 1650. 158
5, 1550, 1465, 1420 1310,
1290. 1180,740 N M R (C D C f23) δ: l. 8-
2. 3 (4H, m), 2. 45 (3H, s)
2.92-3.20 (28, m). 3.77-4.0
3 (2H, m), 7.138. 6 (4H, m) Elemental analysis value: C + 4H + sN 30 Calculated value as S: C, 61.52; H, 5.53; N,
15J7, actual value: C, 61.84; H, 5.5
5;N. 15.20 Example 46 2-(3-methoxystyryl)-5.6,7.8tetrahydro4H-thiazoloC5,4-b]acevin hydrochloride In the same manner as in Example 1, 3-(3-methoxystyryl)-5.6,7.8 /nnnamoyl)amino-ε monocabulactam and phosphorus pentasulfide were reacted, and the purified product was neutralized with hydrogen chloride to obtain the title compound (yield 3o, 3%). Melting point: 177,178° (chloroform-ethanol recrystallization). I R (K B r) cm-': 3366, 3
216, 2930, 1604, 1525.148
9.1269. NMR (d8-DMSO) δ: l. 63-1.
74 (4H, m), 2. 80-2. 86 (2H,
m), 3. 01-3. 07 (2H, rn),
3. 80 (3H, s), 6. 94 (IH,
dd, J = 3Hz. 7Hz), 7. 18-
7. 20 (2B, m), 7. 32(IN, d
, J = 8Hz), 7. 38 (2H, s).
Elemental analysis value: CI. H. .. N, OSC (calculated value as l: C, 59.52: H, 5.93; N, 8
.. 5g. Actual value: C, 59.19; H, 5.85;
N, 8.69. Example 47 2-(3.5-dimethoxystyryl)-5.6,7.8
-Tetrahydro4H-thiazolo[5.4-b]azebin By the same method as in Example 1, the title compound was obtained from 3-(3.5-methoxycinnamoyl)amino-ε-caprolactam and phosphorus pentasulfide. Yield 2i. 4%). Melting point 104-105° (recrystallized from ether). I R (K B r) am””: 1594, 1
546. 1431, 1419, 1355, 120
7, 1156. NMR (CDCl23) δ: 1.62-1.90 (
4H, m), 2.90 (2}1, t, J = 6Hz
), 3. 12 (2H, t, J=5Hz),
3. 81 (6H, s), 3. 93 (IH, br
), 6. 40 (IH, t, J= 2Hz),
6. 62 (2H, d, J= 2Hz), 6.
92 (IH, d, J= 16Hz), 7. 10
(IH. d, J= 16Hz). Elemental analysis value; Calculated value as C 17H , oN so ts: C, 64.53: H, 6.37; N,
8.85. Actual value: C, 64.59; H, 6.5
2; N, 8.80. Example 48 2-(2.3-Nmet Beef/Stiwal')-5.6
.. 78-Tetrahydro l-48-thiazoc7[5.1-b
] The title compound was obtained from 3-(2,3-dimethoxycinnamoyl)amino-ε-monolactam and phosphorus pentasulfide by pouring in the same manner as in Example 1 of Azepine (yield: 35.0%). Melting point 125-126° (recrystallized from cyclohexane), I R (K B r) cm-': 3214, 1
527, 1476, 4447, 1422, 1270
, 1072. NMR (CDCt2.) δ: 1. 501. 89
(4H, m), 2. 90C2H. t, J-
6Hz), 3. 12 (2H, t, J = 5H
z), 3. 85 (3H.s), 3. 88 (3
H, s), 6. 84 (IH, dd, J=
2Hz, 8Hz>, 7. 05(IH, t, J
= 8Hz), 7. 15 (IH. d, J =
16Hz), 7. 16(II, dd, J= 2
Hz, 8Hz), 7. 31 (IH, d. J=
16Hz). Elemental analysis values: C, 7H, . N,
Calculated value as O, S: C, 64.53. H, 6
.. 37; N, 8.85. Actual value: C, 64.44
; H, 6JO' N, 8.91, Example 49 2-(2.5-dimethobovcystyryl)-5.6, 7.8
-Tetrahydride-4H-thiazolo[5.4-b]acepine The title compound was obtained from 3-(2,5-dimethoxycinnamoyl)ami7-ε-cabrolactam and phosphorus pentasulfide in the same manner as in Example 1. (yield 32.3%). Melting point 155-156° (recrystallized from cyclohexane), I R (K B r) cm-': 1527, 1
498, 1436, 1362, 1226, 121
3. N M R (C D C (23) δ: 1.5
0-1. 18C4H, m), 2. 74(2}!
, t, J = 6Hz), 2. 92-3. (1
2 (2H, m), 3. 75 (3H, s), 3
.. 80 (3■, s). 6. 83 (IH, dd
, J-3}iz, 9Hz), 6. 96 (IN
, d, J = 9Hz). 7. 18-7. 2
1 (3H, m) Elemental analysis value: C,,H,. N
,O. Calculated value as S: C, 64.53; H,
6.37; N, 8.85 Actual value: C, 64.39
; H,6,31: N,8.71 Example 50 2-(3.4-dimethoxyphenyl)-5.6,7.8
~Tetrahydro-4H-thiazolo[5.4-b]azepine hydrochloride By the same method as in Example 1, 3-(3,4-dimethoxybenzoyl)amino-ε monocubic lactam and phosphorus pentasulfide were reacted and purified. The post-product was neutralized with hydrogen chloride to obtain the title compound (yield 45.4%). Melting point 186-187° (recrystallized from methanol-ether) I R (K B r) cm': 1609,
1535, 1509, 1342. 126g, 1
152. NMR (d.-DMSO) δ: 1. 56-1.
82 (4H, m), 2. 88-2. 94 (2H,
m), 3. 02-3. 08 (2H, m),
3. 82 (3H, s), 3. 85 (3H, s)
, 7. 05 (IH, d, J = 9Hz),
7. 35 (IH. dd, J2Hz, 9Hz),
7. 58 (IH, d, J= 2Hz). Elemental analysis value 2C +sH 1sN to tc (l・0.
Calculated values as 5H, O: C, 53, 64; H, 6.00; N,
8.34. Actual value: C, 53J9; H, 5.86
; N, 8.05 Example 51 2-(4-methoxy3-methylstyryl)-5,6,
7.8-Tetrahydro-4H-thiazolo[5,4b]azepine 3-(4-methquine-3
The title compound was obtained from -methylcinnamoyl)amino-ε-monocablactam and phosphorus pentasulfide (yield 33.6%).
. Melting point 139-140° (recrystallized from cyclohexane)
.. I R (K B r) cm': 2922, 1
542, 1506, 1365, 1255, 112
9. NMR (CDCQ3) δ: l. 59-1. 88
(4H, m), 2. 22 (3H, s), 2.
89 (28, t, J= 6Hz), 3. 11(
2H, t, J=5Hz), 3. 84 (3H,
s), 6. 80 (LH, d, J = 9Hz)
, fi. 96 (2H, s), 7. 26-7.
30 (2H, m). Elemental analysis values: C,,H,. N. Calculated value as OS: C
, 67.97; H, 6.71; N, 9.32.
Actual value: C, 6g. 19; H, 6.80: N
,9J9. Example 52 2-[4-methoxy3-(2-methylthioethoxy)
3-[4-methoxy3-(2-methylthioethoxy)cinnamoyl]amino-ε The title compound was obtained from one cabbage lactam and phosphorus pentasulfide (yield 15.0%). Melting point 117-118° (recrystallized from cyclohexane). I
R (K B r) cm': 1553, 15
14, 1442. 135g, 1263,1141
.. NMR (CD Cl2 3) δ 2 1.
48-1. 97 (4H, m), 2. 20 (3H
s), 2. 81-2. 95 (2H, m), 2
.. 90 (2H, t, J=7Hz), 3. 0
43. 17 (2H, m). 3. 85 (3H.
s), 4. 20 (2H, t, J=7Hz),
6. 81 (IH, d, J = 9Hz), 6,
92 (2H, s), 6. 97-7. 06 (2H
, m) Elemental analysis value: C. .. H. Calculated value as N, ○tSt: C, 60.61; H, 6.42; N
,? .. 44. Actual value: C, 60.62; H, 6.
47; N, 7.40, Example 53 2-(3.4.5-}rimethoxystyryl)-5,6,
7.8-Tetrahydro 4H-thiazolo[5,4b]azepine hydrochloride In the same manner as in Example 1, 3-(31415-trimethoxycinnamoyl)amino-ε monolactam and phosphorus pentasulfide were reacted and purified. The post-product was neutralized with hydrogen chloride to obtain the title compound (yield 22.8%).
融点204−205°(メタノールーエーテルから再結
晶).
I R (K B r)cn+−’ : 2910,
1572, 1500, 1432, 1410,12
3i!l, +120.
NMR(d.−DMSO)δ: l, 55−1.
80(4H, m),2. 77−2. 85(2H,
m), 3. 02−3. 09(2H, m),
3. 69(3H, s),3. 82(6H, s)
, 6、95(2■, s). 7. 28(2H,
s)元素分析値: C,.H,3N,033C9として
計算値: C,56.46; H,6.05; N
,7J2.実測値: C,56.14; H,6.0
1; N,7.28.実施例54
2−(3−エトキシカルボニルオキン−4−メトキシス
チリル)−5.6,7.8−テトラヒドロ4H−チアゾ
ロ[5.4−bコアゼビン実施例1と同様の方法により
、3−(3−エトキンカルボニルオキシ−4−メトキシ
シンナモイル)アミノーε一カプロラクタムと五硫化燐
から表題化合物が得られた(収率65.4%)。Melting point 204-205° (recrystallized from methanol-ether). I R (K B r)cn+-': 2910,
1572, 1500, 1432, 1410, 12
3i! l, +120. NMR (d.-DMSO) δ: l, 55-1.
80 (4H, m), 2. 77-2. 85 (2H,
m), 3. 02-3. 09 (2H, m),
3. 69 (3H, s), 3. 82 (6H, s)
, 6, 95 (2■, s). 7. 28 (2H,
s) Elemental analysis value: C,. Calculated value as H, 3N, 033C9: C, 56.46; H, 6.05; N
, 7J2. Actual value: C, 56.14; H, 6.0
1; N, 7.28. Example 54 2-(3-ethoxycarbonyloquine-4-methoxystyryl)-5.6,7.8-tetrahydro 4H-thiazolo[5.4-b coazebin 3-( The title compound was obtained from 3-ethquincarbonyloxy-4-methoxycinnamoyl)amino-epsilon-caprolactam and phosphorus pentasulfide (yield 65.4%).
融点132−133°(イソプロビルエーテルから再結
晶).
r R (K B r)cm−’ : 1761, 1
514, 1439, 1368, 1276,113
7, 1059.
N M R (C D C I23)δ: 1.3g
(3H,t,J=7Hz),1.501. 95(4H
, m). 2. H−2. 92(2H, m),
3. 02−3. 13(2H, m),3. 86(
3B, s), 4. 30(2H. q. J =
7Hz), 6. 1110−7. 00.(IH,m
), 6. 94(2H, s), 7. 25−7.
37(2H, m).元素分析値: C .9H ,
,N .0 .Sとして計算値 C,60.94;
H,5.92; N,7.4111.実測値 C,6
0.86; H,5133; N,7、52実施例
55
2(2.4−7メトキシスチリル)−5.6,7.8−
テトラヒドロー4H−チアゾロ[5.4−b]アゼピン
・塩酸塩
実施例lと同様にしで、3−(2.4−ンメトキンンン
ナモイル)アミンーε一カプ口ラクタムと五硫化燐を反
応、精製後生成物を塩化水素で中和し、表題化合物を得
た(収率8.5%)。融点l65−167°(メタノー
ルーエーテルから再結晶).I R (K B r)c
m ’ : 1603, 1542, 1505, 1
433. 12g9,1265, 1209. 115
8
NMR <c D cc3)δ: 1.5g−1.8
9(4B, m), 2. 862. 91(2H,
m), 3. 08−3. 13(2H, m), 3
. 83(3H, s), 3. 86(3tl, s
), 6. 47(Ill, dd, J = 2Hz
, 8Hz), 6. 52(IH, d, J2Hz
), 7. 09(IH, d, J= 16Hz).
7. 25(18, d, J= 16Hz), 7
. 42(IH, d, J = 8Hz).元素分析
値:C17H,IN202SCQ・t.5H20として
計算値: C,53.75; H,6.37; N
,7.37実測値: C,54.02. H.6.1
0; N,7.44.実施例56
1−(4−エトキシ力ルポニルオキシフェニル)5,6
,7.8−テトラヒド口−4H−チアゾロ[54−b]
アゼピン
実施例1と同様の方法により、3−(4−エトキ/カル
ポニルオキシベンゾイル)アミノーεカプ口ラクタムと
五硫化燐から表題化合物が得られた(収率21,3%)
。Melting point 132-133° (recrystallized from isopropyl ether). r R (K B r) cm-': 1761, 1
514, 1439, 1368, 1276, 113
7, 1059. NMR (CDC I23)δ: 1.3g
(3H, t, J=7Hz), 1.501. 95 (4H
, m). 2. H-2. 92 (2H, m),
3. 02-3. 13 (2H, m), 3. 86(
3B, s), 4. 30 (2H. q. J =
7Hz), 6. 1110-7. 00. (IH,m
), 6. 94 (2H, s), 7. 25-7.
37 (2H, m). Elemental analysis value: C. 9H,
,N. 0. Calculated value as S: C, 60.94;
H, 5.92; N, 7.4111. Actual value C, 6
0.86; H, 5133; N, 7, 52 Example 55 2(2.4-7methoxystyryl)-5.6,7.8-
Tetrahydro 4H-thiazolo[5.4-b]azepine hydrochloride In the same manner as in Example 1, 3-(2.4-methquinnannamoyl)amine-ε-capsulactam and phosphorus pentasulfide were reacted and purified. The post-product was neutralized with hydrogen chloride to obtain the title compound (8.5% yield). Melting point 165-167° (recrystallized from methanol-ether). I R (K B r)c
m': 1603, 1542, 1505, 1
433. 12g9, 1265, 1209. 115
8 NMR <c D cc3) δ: 1.5g-1.8
9 (4B, m), 2. 862. 91 (2H,
m), 3. 08-3. 13 (2H, m), 3
.. 83 (3H, s), 3. 86 (3tl, s
), 6. 47(Ill, dd, J = 2Hz
, 8Hz), 6. 52 (IH, d, J2Hz
), 7. 09 (IH, d, J= 16Hz).
7. 25 (18, d, J= 16Hz), 7
.. 42 (IH, d, J = 8Hz). Elemental analysis value: C17H, IN202SCQ・t. Calculated value as 5H20: C, 53.75; H, 6.37; N
, 7.37 Actual value: C, 54.02. H. 6.1
0; N, 7.44. Example 56 1-(4-ethoxylponyloxyphenyl)5,6
,7.8-tetrahydro-4H-thiazolo[54-b]
The title compound was obtained from 3-(4-ethoxy/carponyloxybenzoyl)amino-e-capsulactam and phosphorus pentasulfide in the same manner as in Azepine Example 1 (yield 21.3%).
.
融点93−94°(エーテルーヘキサンから再結晶)
T R (K B r)cm−’ : 1753, 1
50g, 1370, 1302, 1258,120
7.
NMR(CDCh)δ: 1.36(3H,t,J=
7Hz),1.50−1. 95(48, m), 2
. 85−2. 97(2H, m), 3. 02−
3. 12(2H, m)3. 85(IH, br)
, 4. 30(2}1, q, J = 7Hz).
7. 16(2H, d, J一9Hz), 7.
75(2H, d, J = 9Hz)元素分析値・C
,.H ,.N 20 3Sとして計算値: C,6
0.36; H,5.70, N,8.80;S
10.07
実測値: C,60Jl; H,5.60; N,
8.74;S 10.12.
実施例57
2−(3−プロモー4−メトキンスチリル)−5,6,
7.8−テトラヒド口−4H−チアゾロ[5,4b]ア
ゼピン
実施例lと同様の方広により、3−(3−ブロモー4−
メトキンシンナモイル)アミノーε一カプロラクタムと
五硫化燐から表題化合物が得られた(収率25.O%)
。融点158−159°(酢酸エチルか与再結晶).
I R (K B r)cm ’ : 1546, 1
499, 1440, 1352, 1291.125
8
NMR(CDC(!+)δ: 1.61−1.87(
4H, m), 2. 89(2H,t, J= 6H
z), 3. 09−3. 14(2H, m), 3
. 91(3H, s), 6. 88(IH, d,
J= 9tlz), 6. 93−6. 94(2t
{, m), 7. 37(IH, dd, J一2H
z, 9Hz), 7. 66(IH, d, J =
2Hz).元素分析値: C ,6H ,7N 20
SBrとして計算値: C.52.61; H,4.
69; N,7.67.S , 8. 7g.
実測値: C,52.37; H,4.64; N
,7.60;S 8.92.
実施例58
?−(3.5−ジーtert−ブチルー4−ヒドロキシ
フエニル)−5.6,7.8−テトラヒドロ−4H一チ
アゾロ[5.4−b]アセピン・塩酸塩実施例1と同様
にしで、3−(3.5−ジーtertブチルー4−ヒド
ロキシベンゾイル)アミノε一カブ口ラクタムと五硫化
燐を反応、精製後生成物を塩化水素で中和し、表題化合
物を得た(収率11.8%)。融点19=l196°(
エタノールーエーテルから再結晶)
I R (K B r)am−’ : 34g6, 3
220, 2924. 1608. 1394+307
1226 1119
NMR(CDCQ3)δ: 1.49(18H,s)
,1.61−1.87(4H, m), 3. 11−
3. 16(2}1, m), 3. 24−3. 3
0(2H, m), 5. 82(IH s), 7.
83(2H, s).元素分析値: C 21H 3
,N t○SCQとして計算値: C,63.85.
H.7.91. N,?.09.S, 8.12;
C色8. 98.実測値・C,64.03; H
,7.99. N,6.90S,8.02; ’C
(,8.86.実施例59
2−(2.4−7メトキシフエニル)−5.6.78−
テトラヒド口−4H−チアゾロ[5.4−b]アゼピン
・塩酸塩
実施例1と同様にしで、3−(2.4−ジメトキ/ベン
ゾイル)アミノーε−カブロラクタムと五硫化燐を反応
、精製後生成物を塩化水素で中和し、表題化合物を得た
(収率56.2%)。融点214−215°(エタノー
ルーエーテルから再結晶),I R (K B r’)
cm ’ : 3198, 1610, 1572,
1527. 1321,1300. 12]2.
NMR(d.−DMSO)δ: 1.55−1.81
(4H,m)2. 90−2. 97(2H, m),
3. 02−3. 10(2H, m), 3. 8
6(3H, s),3. 99(3H, s), 6.
71−6. 79(2H, m), 8. 31(I
H, d, J = 911z)
元素分析値: C 15H IEN t○,SCQとし
て計算値: C,55.12; H,5.86;
N,8.57;S, 9.81; Cf2, 10.
85.実測値: C,54.97; H,5.84;
N,8.64;S, 9.79; Cff, 1
0.80.実施例60
1−(3.4−ジメチルスチリル)−5.6,7.8テ
トラヒド口−4H−チアゾロ[5.4−b]アセピン
実施例lと同様の方法により、l(3.4−ジメチルノ
ンナモイル)アミノーε一カプロラクタムと五硫化燐か
ら表題化合物が得られた(収率50 4%)。融点16
5−166°(酢酸エチルから再結晶).
I R (K B r)cm ’ : 3258, 2
944, 2920, 1544. 14311,35
5.
N M R (C, D C +23)δ: 1.
52−1. 96(4H, m), 2. 26(6H
,s), 2. 80−2. 92(2H, m),
3. 03−3. 14(2H, m), 3. 86
(IHbr), 7. 00(28, s), 7.
11−7. 25(3H, m).元素分析値 C ,
,H ,。N,Sとして計算値: C,71.79.
H,7.09; N,9.85S , 11. 2
7.
実測値: C,71.92; H,7.03; N
,9.83;S , 11. 43
実施例61
2−(2−メトキシー3−メチルスチリル)−5,6,
7.8−テトラヒド口−4H−チアゾロ〔5,4b]ア
ゼピン
実施例lと同様の方法により、3−(2−メトキシー3
−メチルシンナモイル)アミノーε一カブ口ラクタムと
五硫化燐から表題化合物が得られた(収率45,3%)
。融点114−115°(工一テルから再結晶).
r R (K B r)cm−’ : 3216, 2
920. 152g, 1436. 136g,135
3. 1005
NMR(d.−DMSO)δ: I. 62−1.
89(4H, m),2. 31(3H, s), 2
. 90(2H, t, J = 6Hz), 3.
12(2H. t, J一5Hz). 3. 75(3
H, s), 7. 02(18, t, J= 8H
z), 7. 12(IHdd J = 2Hz, 8
Hz), 7. 14(IH, d, J= 16Hz
), 7. 28(IH,d, J = 16Hz),
7. 39(IH, dd, J = 2Hz, 8
t(z).元素分析値: C l?H 20N 20S
として計算値: C,67.97; H,6.71;
N,9.32;S , 10. 67.
実測値: C,67.91; H,6.69; N
,9J4;S , 10. 85.
実施例62
2−(3−メトキシフエニル)−5.6,7.8テトラ
ヒド口−4H−チアゾロ[5.4−b]アゼピン
実施例1と同様の方法により、3−(3−メトキシベン
ゾイル)アミノーε一カブ口ラクタムと五硫化燐から表
題化合物が得られた(収率40.0%)。融点82−8
3°(シクロヘキサンから再結晶).
I R (K B r)cn+−’ : 3206,
1597, 1495, 1370, 1272.78
5
NMR (C D CQ3)δ: 1. 61−1.
90(4H, m), 2、95(2H,t, J
= 6Hz), 3. 12(2H, t, J =
5Hz), 3. 86(3H, s), 6. 84
−6. 90(IH, m), 7. 22−7. 3
6(3H, m)元素分析値 C ,.}I ,,N
,O Sとして計算値: C,64.59; H,6
.19; N,10、76;S , 12. 32.
実測値: C,64.52; H,6、03; N
,10、49;S , 12. 44.
実施例63
2−(α−メチルスチリル)−5.6.7.8−テトラ
ヒドロー4H−チアゾロ[5.4−b]アゼビン
実施例1と同様の方注により、3−(α−メチルンンナ
モイル)アミノーε一カブ口ラクタムと五硫化燐から表
題化合物が得られた(収率16、6%)。融点122−
123°(イソプロビルエーテルから再結晶)
! R (K B r)cm−’ : 3226, 2
922, 1552, 1512, 1432,136
2, H55, 696
NMR (C D CC3)δ: 1. 61−1.
89(48, m), 2. 32(3Hs), 2
. 92(2H, t, J = 6Hz), 3.
11(2H, t, J= 5Hz), 3. 91(
11 br. s), 7. 13−7. 39(6H
. m).元素分析値: C ,.H ,.N ,Sと
して計算値: C,?1.07; H,6.71.
N,10.36;s , 11. 86.
実測値: C,71.01; H,6.55; N
,10.28;S , 11. 6:{,
実施例64
2−(4−}リフルオロメチルフエニル)−5.6,7
.8−テトラヒドロ−4H−チアゾロ[5,4b]アゼ
ピン
実施例lと同様の方法により、3−(4−トリフルオ口
メチルベンゾイル)アミノーε一カブ口ラクタムと五硫
化燐から表題化合物が得られた(収率50.4%)。融
点158159°(シクロヘキサンから再結晶).
T R (K B r)am−’ : 1518. 1
330, 1159, 1121, 1069,837
.
NMR(CDC(3)δ: 1.65−1.91(4
H.m),2.942. 99(2H, m), 3.
14(2H, t, J= 5Hz), 4. 00
(IH. br. s)7、61(2H, d, J−
8Hz), 7. 1116(2H, d, J=
8Hz)元素分析値: C 14H 13N ts F
3として計算値 C,56、aa; H,4J9;
N,9J9;S 10.75・ F , 19.
10.実測値: C,56.39; H,4J3;
N,9.40;S,10.78. F,1g、9
2.実施例65
2−(3.4−メチレンジオキシフェニル)−5.6,
7.8−テトラヒド口−4H−チアゾロ[5,4b]ア
ゼピン・塩酸塩
実施例1と同様にしで、3−(3.4−メチレンジオキ
シベンゾイル)アミノーε一カブロラクタムと五硫化燐
を反応、精製後生戊物を塩化水素で中和し、表題化合物
を得た(収率27.2%)。融点190192°(メタ
ノールーエーテルから再結晶)9
I R (K B r)cm ’ : 3196, 1
619, 1602, 1506, 1348.126
6
NMR(CDC4)3)δ: 1、68−1. 90(
4H, m), 3. 173. 28(4H, m)
. 6. 04(2H, s), 6. 85(IH,
d, J= 8Hz, )7. 56(IH, s)
, 7. 65(LH, d, J= 8Hz)元素分
析値 CI4H 15N t0 2S C Qとして計
算値: C,54.10; H,4.1116;
N,9.0L;S,+0.32; (J!,11.4
1.実測値: C,53.72; H,4.99;
N,8.85;S , 10. 26; C ff
, 11. 13.実施例66
2−(p−}リル)−5.6,7.8−テトラヒドロ4
H−チアゾロ[5.4−b]アゼピン実施例lと同様の
方注により、3 − (p − トルオイル)アミノー
ε一カブ口ラクタムと五硫化燐から表題化合物が得られ
た(収率43.4%)。融点128−129°(シクロ
へ牛サンから再結晶).I R (K B r)cm−
’ : 3236, 3018, 2918, 151
6, 1460,!372,816.
NMR(CDCl23)δ: 1. 61−1. 8
9(4H, m), 2. 35(3Hs), 2.
91−2. 97(28, Wl), 3. 11(2
H, t, J= 5Hz), 7. 11(2H.
d, J= 8Hz), 7. 65(2H, d,
J = 8Hz).元素分析値: C ,,H ,,N
2Sとして計算値: C,6181; H,6.6
0: N,11.46;S , 13. 12.
実測値: C,68.57; H,6.60: N
,11.62;S , 13. 28.
実施例67
2 [4 (tert−ブトキシカルポニルアミノ
メチル)フエニル]−5.6,7.8−テトラヒドロ4
H−チアゾロ[5.4−bコアゼビン実施例1と同様
の方法により、3 [4 (tertブトキンカル
ホニルアミノメチル)ペンゾイル]アミ/一ε一カブロ
ラクタムと五硫化燐から表題化合物が得られた(収率1
9.6%)。融点170171°(酢酸エチルから再結
晶),
I R (K B r)am ’ : 3312, 1
673, 1524. 136g, 1269,116
7.
N M R (C D C f23)δ: 1. 4
6(9H, s), 1. 64−1. 90(4Hm
), 2. 94(2H, t, J= 6Hz),
3. 11(2H, t, J = 5Hz), 4.
31(2H, d, J= 6Hz), 7. 27
(2H, d, J = 8Hz), 7. 72(2
+{, d,J=8Hz’)
元素分析値・C I9H 25N 30,Sとして計算
値: C,63.48; H,7.01; N,1
1.69;S,8.92.
実測値: C,63.47; H,7.07; N
,11.7g.S,8.86
実施例68
2−(2,3.4−トリメトキシフエニル)一5,6,
7.8−テトラヒド口−4H−チアゾロ[5,4b]ア
ゼビン
実施例lと同様の方法により、3−(2.3.4トリメ
トキシベンゾイル)アミノーε一カブ口ラクタムと五硫
化燐から表題化合物が得られた(収率l8.9%)。融
点133−134°(エタノールから再結晶),
I R (K B r)am−’ : 2934, 1
553. 149g, 1437, 1290,109
2.
NMR(CDCff3)δ: 1. 60−1. 9
0(4H, m), 2. 95(2H,t, J =
6Hz), 3. 11(2H, t, J= 5H
z), 3. 89(6H, s),3. 96(3)
{, s), 6. 74(IH, d, J= 9H
z), 7。89(IH, d, J =9Hz).
元素分析値: C 16H toN 20 3Sとして
計算値: C,59.98; H,6.29; N
,8.74;3 10.01
実測値: C,59.94; H,6.:{6;
N.8、63;S, 9.95.
実施例69
2−(3−トリフルオ口メチルスチリル)−5.6,7
.8−テトラヒド口−4H−チアゾロ[5,4b]アゼ
ピン
実施例1と同様の方法により、3−(3−トリフルオ口
メチルシンナモイル)アミノーε一カブ口ラクタムと五
硫化燐から表題化合物が得られた(収率51.0%)。Melting point 93-94° (recrystallized from ether-hexane) T R (K B r) cm-': 1753, 1
50g, 1370, 1302, 1258, 120
7. NMR (CDCh) δ: 1.36 (3H, t, J=
7Hz), 1.50-1. 95 (48, m), 2
.. 85-2. 97 (2H, m), 3. 02-
3. 12 (2H, m)3. 85 (IH, br)
, 4. 30 (2}1, q, J = 7Hz).
7. 16 (2H, d, J-9Hz), 7.
75 (2H, d, J = 9Hz) elemental analysis value・C
、. H. Calculated value as N 20 3S: C, 6
0.36; H, 5.70, N, 8.80; S
10.07 Actual value: C, 60 Jl; H, 5.60; N,
8.74;S 10.12. Example 57 2-(3-promo 4-methkinstyryl)-5,6,
7.8-Tetrahydro-4H-thiazolo[5,4b]azepine By the same method as in Example 1, 3-(3-bromo4-
The title compound was obtained from metquincinnamoyl)amino-ε-caprolactam and phosphorus pentasulfide (yield 25.0%)
. Melting point: 158-159° (recrystallized from ethyl acetate). I R (K B r) cm': 1546, 1
499, 1440, 1352, 1291.125
8 NMR (CDC(!+)δ: 1.61-1.87(
4H, m), 2. 89 (2H, t, J= 6H
z), 3. 09-3. 14 (2H, m), 3
.. 91 (3H, s), 6. 88 (IH, d,
J=9tlz), 6. 93-6. 94 (2t
{, m), 7. 37 (IH, dd, J-2H
z, 9Hz), 7. 66 (IH, d, J =
2Hz). Elemental analysis value: C, 6H, 7N 20
Calculated value as SBr: C. 52.61; H, 4.
69; N, 7.67. S, 8. 7g. Actual value: C, 52.37; H, 4.64; N
, 7.60; S 8.92. Example 58? -(3.5-di-tert-butyl-4-hydroxyphenyl)-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b]acepine hydrochloride In the same manner as in Example 1, 3 -(3.5-Di-tertbutyl-4-hydroxybenzoyl)amino epsilon-cabulactam was reacted with phosphorus pentasulfide. After purification, the product was neutralized with hydrogen chloride to obtain the title compound (yield: 11.8 %). Melting point 19=l196°(
Recrystallized from ethanol-ether) IR (KBr)am-': 34g6, 3
220, 2924. 1608. 1394+307
1226 1119 NMR (CDCQ3) δ: 1.49 (18H, s)
, 1.61-1.87 (4H, m), 3. 11-
3. 16(2}1, m), 3. 24-3. 3
0(2H, m), 5. 82 (IH s), 7.
83 (2H, s). Elemental analysis value: C21H3
, N t○SCQ: C, 63.85.
H. 7.91. N,? .. 09. S, 8.12;
C color 8. 98. Actual value C, 64.03; H
, 7.99. N, 6.90S, 8.02; 'C
(,8.86.Example 59 2-(2.4-7methoxyphenyl)-5.6.78-
Tetrahydro-4H-thiazolo[5.4-b]azepine hydrochloride In the same manner as in Example 1, 3-(2,4-dimethoxy/benzoyl)amino-ε-cabrolactam and phosphorus pentasulfide are reacted and produced after purification. The product was neutralized with hydrogen chloride to obtain the title compound (yield 56.2%). Melting point 214-215° (recrystallized from ethanol-ether), I R (K B r')
cm': 3198, 1610, 1572,
1527. 1321, 1300. 12]2. NMR (d.-DMSO) δ: 1.55-1.81
(4H, m)2. 90-2. 97 (2H, m),
3. 02-3. 10 (2H, m), 3. 8
6 (3H, s), 3. 99 (3H, s), 6.
71-6. 79 (2H, m), 8. 31 (I
H, d, J = 911z) Elemental analysis value: C 15H IEN t○, calculated value as SCQ: C, 55.12; H, 5.86;
N, 8.57; S, 9.81; Cf2, 10.
85. Actual value: C, 54.97; H, 5.84;
N, 8.64; S, 9.79; Cff, 1
0.80. Example 60 1-(3.4-dimethylstyryl)-5.6,7.8tetrahydro-4H-thiazolo[5.4-b]acepine By a method similar to Example 1, 1(3.4- The title compound was obtained from dimethylnonnamoyl)amino-ε-caprolactam and phosphorous pentasulfide (yield 504%). melting point 16
5-166° (recrystallized from ethyl acetate). I R (K B r) cm': 3258, 2
944, 2920, 1544. 14311,35
5. N M R (C, D C +23) δ: 1.
52-1. 96 (4H, m), 2. 26 (6H
, s), 2. 80-2. 92 (2H, m),
3. 03-3. 14 (2H, m), 3. 86
(IHbr), 7. 00 (28, s), 7.
11-7. 25 (3H, m). Elemental analysis value C,
,H,. Calculated value as N and S: C, 71.79.
H, 7.09; N, 9.85S, 11. 2
7. Actual value: C, 71.92; H, 7.03; N
, 9.83;S, 11. 43 Example 61 2-(2-methoxy3-methylstyryl)-5,6,
7.8-Tetrahydro-4H-thiazolo[5,4b]azepine 3-(2-methoxy-3
The title compound was obtained from -methylcinnamoyl)amino-ε-monocablactam and phosphorus pentasulfide (yield 45.3%)
. Melting point 114-115° (recrystallized from Koichitel). r R (K B r) cm-': 3216, 2
920. 152g, 1436. 136g, 135
3. 1005 NMR (d.-DMSO) δ: I. 62-1.
89 (4H, m), 2. 31 (3H, s), 2
.. 90 (2H, t, J = 6Hz), 3.
12 (2H.t, J-5Hz). 3. 75 (3
H, s), 7. 02 (18, t, J= 8H
z), 7. 12 (IHdd J = 2Hz, 8
Hz), 7. 14 (IH, d, J= 16Hz
), 7. 28 (IH, d, J = 16Hz),
7. 39 (IH, dd, J = 2Hz, 8
t(z). Elemental analysis value: C l? H 20N 20S
Calculated values as: C, 67.97; H, 6.71;
N, 9.32; S, 10. 67. Actual value: C, 67.91; H, 6.69; N
, 9J4;S, 10. 85. Example 62 2-(3-methoxyphenyl)-5.6,7.8tetrahydro-4H-thiazolo[5.4-b]azepine 3-(3-methoxybenzoyl) ) The title compound was obtained from amino-ε-monocuboid lactam and phosphorus pentasulfide (yield 40.0%). Melting point 82-8
3° (recrystallized from cyclohexane). I R (K B r)cn+-': 3206,
1597, 1495, 1370, 1272.78
5 NMR (C D CQ3) δ: 1. 61-1.
90 (4H, m), 2, 95 (2H, t, J
= 6Hz), 3. 12 (2H, t, J =
5Hz), 3. 86 (3H, s), 6. 84
-6. 90 (IH, m), 7. 22-7. 3
6 (3H, m) elemental analysis value C,. }I,,N
, OS Calculated value: C, 64.59; H, 6
.. 19; N, 10, 76; S, 12. 32. Actual value: C, 64.52; H, 6, 03; N
, 10, 49;S, 12. 44. Example 63 2-(α-methylstyryl)-5.6.7.8-tetrahydro-4H-thiazolo[5.4-b]azebin 3-(α-methylstyryl)-5.6.7.8-tetrahydro-4H-thiazolo[5.4-b]azebin The title compound was obtained from the (moyl)amino-ε-monolactam and phosphorus pentasulfide (yield 16, 6%). Melting point 122-
123° (recrystallized from isopropyl ether)! R(KBr)cm-': 3226, 2
922, 1552, 1512, 1432, 136
2, H55, 696 NMR (CD CC3) δ: 1. 61-1.
89 (48, m), 2. 32 (3Hs), 2
.. 92 (2H, t, J = 6Hz), 3.
11 (2H, t, J=5Hz), 3. 91(
11 br. s), 7. 13-7. 39 (6H
.. m). Elemental analysis value: C,. H. Calculated value as N, S: C,? 1.07; H, 6.71.
N, 10.36;s, 11. 86. Actual value: C, 71.01; H, 6.55; N
, 10.28;S, 11. 6:{, Example 64 2-(4-}lifluoromethylphenyl)-5.6,7
.. 8-Tetrahydro-4H-thiazolo[5,4b]azepine The title compound was obtained from 3-(4-trifluoromethylbenzoyl)amino-ε-monocablactam and phosphorus pentasulfide in the same manner as in Example 1 ( yield 50.4%). Melting point 158,159° (recrystallized from cyclohexane). T R (K B r) am-': 1518. 1
330, 1159, 1121, 1069,837
.. NMR (CDC(3)δ: 1.65-1.91(4
H. m), 2.942. 99 (2H, m), 3.
14 (2H, t, J=5Hz), 4. 00
(IH. br. s) 7, 61 (2H, d, J-
8Hz), 7. 1116 (2H, d, J=
8Hz) Elemental analysis value: C 14H 13N ts F
Calculated value as 3 C, 56, aa; H, 4J9;
N, 9J9; S 10.75・F, 19.
10. Actual value: C, 56.39; H, 4J3;
N, 9.40; S, 10.78. F, 1g, 9
2. Example 65 2-(3.4-methylenedioxyphenyl)-5.6,
7.8-tetrahydride-4H-thiazolo[5,4b]azepine hydrochloride In the same manner as in Example 1, 3-(3,4-methylenedioxybenzoyl)amino-ε-cabrolactam and phosphorus pentasulfide were reacted, After purification, the raw botanical was neutralized with hydrogen chloride to obtain the title compound (yield 27.2%). Melting point 190192° (recrystallized from methanol-ether) 9 I R (K B r) cm': 3196, 1
619, 1602, 1506, 1348.126
6 NMR (CDC4) 3) δ: 1, 68-1. 90(
4H, m), 3. 173. 28 (4H, m)
.. 6. 04 (2H, s), 6. 85 (IH,
d, J=8Hz, )7. 56 (IH, s)
, 7. 65 (LH, d, J = 8Hz) Elemental analysis value CI4H 15N t0 2S C Calculated value as Q: C, 54.10; H, 4.1116;
N, 9.0L; S, +0.32; (J!, 11.4
1. Actual value: C, 53.72; H, 4.99;
N, 8.85; S, 10. 26; Cff
, 11. 13. Example 66 2-(p-}lyl)-5.6,7.8-tetrahydro4
The title compound was obtained from 3-(p-toluoyl)amino-epsilon monolactam and phosphorus pentasulfide by pouring in the same manner as in Example 1 of H-thiazolo[5.4-b]azepine (yield: 43. 4%). Melting point 128-129° (recrystallized from cyclohexan). I R (K B r) cm-
': 3236, 3018, 2918, 151
6, 1460,! 372,816. NMR (CDCl23) δ: 1. 61-1. 8
9 (4H, m), 2. 35 (3Hs), 2.
91-2. 97 (28, Wl), 3. 11(2
H, t, J=5Hz), 7. 11 (2H.
d, J=8Hz), 7. 65 (2H, d,
J = 8Hz). Elemental analysis value: C,,H,,N
Calculated value as 2S: C, 6181; H, 6.6
0: N, 11.46; S, 13. 12. Actual value: C, 68.57; H, 6.60: N
, 11.62;S, 13. 28. Example 67 2[4(tert-butoxycarponylaminomethyl)phenyl]-5.6,7.8-tetrahydro4
H-thiazolo[5.4-b Coazebin By a method similar to Example 1, the title compound was obtained from 3[4(tertbutquinecarbonylaminomethyl)penzoyl]ami/1epsilon-cabrolactam and phosphorous pentasulfide. (yield 1
9.6%). Melting point 170171° (recrystallized from ethyl acetate), I R (K B r) am ': 3312, 1
673, 1524. 136g, 1269,116
7. N M R (C D C f23) δ: 1. 4
6 (9H, s), 1. 64-1. 90 (4Hm
), 2. 94 (2H, t, J=6Hz),
3. 11 (2H, t, J = 5Hz), 4.
31 (2H, d, J= 6Hz), 7. 27
(2H, d, J = 8Hz), 7. 72 (2
+{, d, J=8Hz') Elemental analysis value・C I9H 25N 30, Calculated value as S: C, 63.48; H, 7.01; N, 1
1.69; S, 8.92. Actual value: C, 63.47; H, 7.07; N
, 11.7g. S, 8.86 Example 68 2-(2,3.4-trimethoxyphenyl)-5,6,
7.8-Tetrahydro-4H-thiazolo[5,4b]azebin The title compound was prepared from 3-(2.3.4trimethoxybenzoyl)amino-ε monolactam and phosphorus pentasulfide by a method similar to Example 1. was obtained (yield 18.9%). Melting point 133-134° (recrystallized from ethanol), I R (K B r) am-': 2934, 1
553. 149g, 1437, 1290,109
2. NMR (CDCff3) δ: 1. 60-1. 9
0 (4H, m), 2. 95 (2H, t, J =
6Hz), 3. 11 (2H, t, J= 5H
z), 3. 89 (6H, s), 3. 96(3)
{, s), 6. 74 (IH, d, J= 9H
z), 7.89 (IH, d, J = 9Hz). Elemental analysis value: Calculated value as C16H toN203S: C, 59.98; H, 6.29; N
, 8.74; 3 10.01 Actual value: C, 59.94; H, 6. :{6;
N. 8, 63; S, 9.95. Example 69 2-(3-trifluoromethylstyryl)-5.6,7
.. 8-Tetrahydro-4H-thiazolo[5,4b]azepine By the same method as in Example 1, the title compound was obtained from 3-(3-trifluoromethylcinnamoyl)amino-ε-monolactam and phosphorus pentasulfide. (yield 51.0%).
融点l51−152°(シクロヘキサンから再結晶).
I R (K B r)cm””’ : 3260,
1546. 1517, 1334, 1160.1+
24.
NMR(CDCQ3)δ: 1. 63−1. 89
(4H, m), 2. 882. 94(2H, m
), 3. 13(2H, t, J = 5Hz).
4. 02(IH, br. s),7. 01(I
H, d, J= 16Hz), 7. 1’5(IH
, d, J = 16Hz), 7. 437. 6
8(4H, m)
元素分析値: C ,6H ,5N.S F 3として
計算値: C,59.25; H,4.66; N
,8.64;S, 9.89; F,17.57.実
測値: C,59.20; H,4.63; N,
8.53;S, 9.67. F,17.39.実施
例70
2 [2 (tert−ブトキシカルボニルアミノ
)エチル]−5.6,7.8−テトラヒドロ−4H−チ
アゾロ[5.4−b]アゼビン
実施例1と同様の方法により、3 − (N − te
rtブトキシカルボニルーβ−アラニル)アミノε一カ
プロラクタムと五硫化燐から表題化合物が得られた(収
率27.2%)。融点151−153°(酢酸エチルか
ら再結晶)9
r R (K B r)cm−’ : 3340, 2
924, 1688, 1547, 1282,126
2, 1161.
NMR(d8−DMSO)δ: 1. 44(9H,
s), 1. 561. 87(4H, m). 2
. 81−2. 87(2H, m). 2. 94(
2H, t, J − 6Hz), 3. 05(2H
, t, J = 5Hz), 3. 41−3. 5
2(2H. m).元素分析値: C I4H tsN
30 tSとして計算値: C,56.54. H
,7、79; N,14.13;S , 10. 7
8
実測値: C,56.51; H,7.91; N
,14.17;S , 10. 79.
実施例71
2−(4−メトキシカルボニルフェニル)−5,6,7
.8−テトラヒド口−4H−チアゾロ[5,4b1アゼ
ビン
実施例1と同様の方法により、3−(4−メトキ/カル
ボニルヘンゾイル)アミノーε一カブ口ラクタムと五硫
化燐から表題化合物が得られた(収率56.6%)。融
点168−170’ (メタノールから再結晶)
I R (K B r)cm−’ : 1730, 1
510, 1441, 1274, 1175.111
4
NMR(CDCI23)δ: 1.45−1.98(
4H,m),2.903. 02(2H, m), 3
. 07−3. 18(2H, m), 3. 92(
3H, s), 7. 78(2H, d, J= 9
Hz), 8. 01(2H, d, J= 9Hz)
.元素分析値: C ,5H ,.N ,O ,Sとし
て計算値: C,62.48; H.5.59;
N,9.71;S,11.12
実測値: C,62.39; H,5.59; N
,9.87;S , 11. 11
実施例72
2−(4−エトキン力ルホニルスチリル)−5.6,7
.8−テトラヒド口−4H−チアゾロ[5,4b]アゼ
ピン
実施例lと同様の方法により、3−(4−エトキシカル
ポニルシンナモイル)アミノーε一カプロラクタムと五
硫化燐から表題化合物が得られた(収率8.7%)。融
点149−150’(酢酸エチルから再結晶)
I R (K B r)am ’ : 1715, 1
522, 1356, 1275, 1252,・11
04.
NMR (C D CQ3)δ: lJ9(3H,t
,J=7Hz).1.601. 86(4H. m),
2. 88−2. 94(2H, m), 3. 1
1−3. 15(2H, m),4. 38(2H,
q, J= 7Hz), 7. Of(IH, d,
J = 16}1z), 7. 18(IH, d,
J= 16Hz), 7. 50(2H, d, J=
8Hz). 8. 01(2H, d, J8Hz)
.
元素分析値: C 18H 20N 20 2Sとして
計算値:’ C , 65、83; H,6.14.
N,8.53.S 9.76、
実厠値: C,65.87. H,6.10. N
,8.62;S, 9.62.
実施例73
2− [1− (tert−ブトキンカルホニルアミ/
)エチル]−5.6,7.8−テトラヒドロー4H−チ
アゾロ[5.4−b]アゼピン
実施例I8と同様の方法で、N − tert−ブト牛
ンカルボニルアラニン、3−アミノーε一カブ口ラクタ
ムおよひ五硫化燐から表題化合物か得られた(収率8
3%)。融点180−182°(酢酸エチルから再結晶
).
T R (K B r)cm ’ : 3244, 1
694, 1513, 1368, 1248,117
1.
NMR(CDCC3)δ: 1.45(9H,s),
1.52(3H,d,J一7Hz). 1. 56−1
. 86(4H, m), 2. 84(2H, t,
J = 6Hz),3. 05(2H, m), 4
. 78−4. 90(IH, m).元素分析値:
C ,.H 23N ,0 2Sとして計算値・C,5
6.54; H,7.79; N,14.13;S
, 10. 78
実測値: C,56.70; H,?.81; N
,14.11:S , 10. 7g.
実施例74
2−(4−ピリンル)−5.6,7.8−テトラヒト口
−4H−チアゾロ[5.4−.b]アセビン実施例18
と同様の方法で、イソニコチン酸、3−アミノーε一カ
ブ口ラクタムおよび五硫化燐から表題化合物が得られた
(収率42.O%)。融点1 6 9 − t 7 0
°(ンクロへキサンから再結晶)I R (K B r
)am”−’ : 1597. 1528, 1491
11, 1439, 1372,1360.
NMR(CDCi23)δ: 1. 60−1. 9
8(4H, m), 2. 90=3.00(2H,m
),3.06−3.18(2H.m),4.1 1(I
H,br.s),7. 60(2H. d, J =
6Hz). 8. 56(2H, d, J= 6Hz
).元素分析値: C ,=H ,3N ,Sとして計
算値:C,62、31; H,5.66; N,1
8.17;S , 13. l!6.
実測値: C,62.45; H,5.64; N
,18.07;S , 13. 82.
実施例75
2−(3−ヒドロキシ−4−メトキシスチリル)5,6
,7.8−テトラヒド口−4H〜チアゾロ15.4−b
]アゼピン・塩酸塩
1−(3−エトキシ力ルポニルオキシ−4−メトキンス
チリル) 一.5,6,7.8−テトラヒドロ4H〜チ
アゾロ[5.4−b]アゼビン(13.2g)を600
dの1規定アンモニアメタノール溶岐に加え、室温で3
時間撹拌した。減圧下溶媒を留去し、残留物をノリカケ
ルカラムク口マトグラフィーで精製すると、2−(3−
ヒドロ牛シ−4一メ1・キシスチリルl−5.6,7.
8−テトラヒドロ4 H−チアゾロ[5.4−b]アゼ
ビンが8.74g(81 9%)得られた。その 1.
50gを塩酸塩としメタノールーエーテルで再結晶する
と0.49g(29.0%)の表題化合物が得られた。Melting point l51-152° (recrystallized from cyclohexane). I R (K B r) cm””’: 3260,
1546. 1517, 1334, 1160.1+
24. NMR (CDCQ3) δ: 1. 63-1. 89
(4H, m), 2. 882. 94 (2H, m
), 3. 13 (2H, t, J = 5Hz).
4. 02 (IH, br. s), 7. 01(I
H, d, J= 16Hz), 7. 1'5 (IH
, d, J = 16Hz), 7. 437. 6
8 (4H, m) Elemental analysis values: C, 6H, 5N. Calculated value as SF 3: C, 59.25; H, 4.66; N
, 8.64; S, 9.89; F, 17.57. Actual value: C, 59.20; H, 4.63; N,
8.53;S, 9.67. F, 17.39. Example 70 2[2(tert-butoxycarbonylamino)ethyl]-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b]azebin 3-(N -te
The title compound was obtained from rt-butoxycarbonyl-[beta]-alanyl)amino[epsilon]-caprolactam and phosphorus pentasulfide (yield 27.2%). Melting point 151-153° (recrystallized from ethyl acetate) 9 r R (K B r) cm-': 3340, 2
924, 1688, 1547, 1282, 126
2, 1161. NMR (d8-DMSO) δ: 1. 44 (9H,
s), 1. 561. 87 (4H, m). 2
.. 81-2. 87 (2H, m). 2. 94(
2H, t, J-6Hz), 3. 05 (2H
, t, J = 5Hz), 3. 41-3. 5
2 (2H.m). Elemental analysis value: CI4H tsN
Calculated value as 30 tS: C, 56.54. H
, 7, 79; N, 14.13; S, 10. 7
8 Actual measurement value: C, 56.51; H, 7.91; N
, 14.17;S, 10. 79. Example 71 2-(4-methoxycarbonylphenyl)-5,6,7
.. 8-Tetrahydro-4H-thiazolo[5,4b1 azebin] The title compound was obtained from 3-(4-methoxy/carbonylhenzoyl)amino-ε-monolactam and phosphorus pentasulfide by a method similar to Example 1. (Yield 56.6%). Melting point 168-170' (recrystallized from methanol) I R (K B r) cm-': 1730, 1
510, 1441, 1274, 1175.111
4 NMR (CDCI23) δ: 1.45-1.98 (
4H, m), 2.903. 02 (2H, m), 3
.. 07-3. 18 (2H, m), 3. 92(
3H, s), 7. 78 (2H, d, J= 9
Hz), 8. 01 (2H, d, J= 9Hz)
.. Elemental analysis values: C, 5H, . Calculated values for N, O, S: C, 62.48; H. 5.59;
N, 9.71; S, 11.12 Actual value: C, 62.39; H, 5.59; N
, 9.87;S, 11. 11 Example 72 2-(4-ethquinylsulfonylstyryl)-5.6,7
.. 8-Tetrahydro-4H-thiazolo[5,4b]azepine The title compound was obtained from 3-(4-ethoxycarponylcinnamoyl)amino-ε-monocaprolactam and phosphorus pentasulfide in the same manner as in Example 1. rate 8.7%). Melting point 149-150' (recrystallized from ethyl acetate) I R (K B r) am': 1715, 1
522, 1356, 1275, 1252, ・11
04. NMR (CD CQ3)δ: lJ9(3H,t
, J=7Hz). 1.601. 86 (4H.m),
2. 88-2. 94 (2H, m), 3. 1
1-3. 15 (2H, m), 4. 38 (2H,
q, J=7Hz), 7. Of(IH, d,
J = 16}1z), 7. 18 (IH, d,
J=16Hz), 7. 50 (2H, d, J=
8Hz). 8. 01 (2H, d, J8Hz)
.. Elemental analysis value: Calculated value as C 18H 20N 20 2S: 'C, 65, 83; H, 6.14.
N, 8.53. S 9.76, actual value: C, 65.87. H, 6.10. N
, 8.62; S, 9.62. Example 73 2-[1-(tert-butquine carbonylamine/
) Ethyl]-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b]azepine In a similar manner to Example I8, N-tert-butoxycarbonylalanine, 3-amino-epsilon The title compound was obtained from lactam and phosphorus pentasulfide (yield 8
3%). Melting point 180-182° (recrystallized from ethyl acetate). T R (K B r) cm': 3244, 1
694, 1513, 1368, 1248, 117
1. NMR (CDCC3) δ: 1.45 (9H, s),
1.52 (3H, d, J-7Hz). 1. 56-1
.. 86 (4H, m), 2. 84 (2H, t,
J = 6Hz), 3. 05 (2H, m), 4
.. 78-4. 90 (IH, m). Elemental analysis value:
C,. Calculated value as H 23N,0 2S・C,5
6.54; H, 7.79; N, 14.13; S
, 10. 78 Actual value: C, 56.70; H,? .. 81; N
, 14.11:S, 10. 7g. Example 74 2-(4-pyrinyl)-5.6,7.8-tetrahuman-4H-thiazolo[5.4-. b] Acevin Example 18
In the same manner as above, the title compound was obtained from isonicotinic acid, 3-amino-[epsilon]-monocuboid lactam, and phosphorus pentasulfide (yield: 42.0%). Melting point 169 - t70
° (recrystallized from ncrohexane) I R (K B r
) am"-': 1597. 1528, 1491
11, 1439, 1372, 1360. NMR (CDCi23) δ: 1. 60-1. 9
8 (4H, m), 2. 90=3.00(2H, m
), 3.06-3.18 (2H.m), 4.1 1 (I
H, br. s), 7. 60 (2H. d, J =
6Hz). 8. 56 (2H, d, J= 6Hz
). Elemental analysis value: Calculated value as C, = H, 3N, S: C, 62, 31; H, 5.66; N, 1
8.17;S, 13. l! 6. Actual value: C, 62.45; H, 5.64; N
, 18.07;S, 13. 82. Example 75 2-(3-hydroxy-4-methoxystyryl)5,6
,7.8-tetrahydro-4H~thiazolo15.4-b
]Azepine hydrochloride 1-(3-ethoxyluponyloxy-4-methkinstyryl) 1. 5,6,7.8-tetrahydro 4H~thiazolo[5.4-b]azevin (13.2 g) at 600
In addition to the 1N ammonia methanol elution in step d, 3
Stir for hours. The solvent was distilled off under reduced pressure, and the residue was purified by Norikakel column chromatography.
Hydrogyf C-4-Me1-Kysistyril-5.6,7.
8.74 g (819%) of 8-tetrahydro4H-thiazolo[5.4-b]azevin was obtained. Part 1.
50 g was converted into a hydrochloride salt and recrystallized from methanol-ether to obtain 0.49 g (29.0%) of the title compound.
融点2]0−211°
I R (K B r)cm”−’ : 3216,
2530, 1601. 1504. 1279947
NMR(d6−DMSO)δ 1. 56−1. 7
9(4H, m)2. 76−2. 87(2H, m
), 3. 02−3. 10(2H, m). 3.
81(3H, s),6. 944. 12(4H,
m), 7. 31(IH, d, J= 16Hz
).元素分析値 C ..H ,.N20,S Cff
として計算値: C,56.71; H,5.65;
N,8.27;S946
実測値: C,56.72; H,5.63; N
,8、30:S. 9.60.
実施例76
2−(4−ヒドロ牛シフェニル)−5.6,7.8テト
ラヒド口−4 8−チアゾロ[5.4−b]アゼピン・
塩酸塩
実施例75と同様の方注により、2−(4−エトキシカ
ルボニルオキシフェニル)−5.6,7.8テトラヒド
口−4H−チアゾロ[5.4−b]アゼビンから表題化
合物を得た(収率32 5%)。融点215−216°
(エタノールーエーテルから再結晶).
I R (K B r)cm ’ : 3378. 2
926, 1607, 1560, 1519,127
9. 12311!.
NMR(d.−DMSO)δ: 1.56−1.82
(48,m),2. 83−2y93(2H, m),
3. 00−3. 1 1(2H, m), 6.
89(2H, d,J = 8Hz), 7. 73(
2H, d, J = 8Hz).元素分析値: C,
3H,5N,OSCQとして計算値: C,55.21
; H,5.35; N,9.91・S , 11
. 34; C f2, 12. 54.実測値:
C,55.19. H,5.41; N,9.74
;S , 11. 10; C Q.. 12. 5
0実施例77
2−(2−アミノエチル)−5.6.7.8−テトラヒ
ド口−4H−チアゾロ[5.4−b]アゼピン・二塩酸
塩
2 [2 (tert−ブトキシカルポニルアミノ
)エチル]−5.6,7.8−テトラヒドロ−4H−チ
アゾロ[5.4−b]アゼピン(1.oog)のメタノ
ール溶液10dに、4.75規定の塩酸メタノール濱液
3dを加え室温で5時間撹拌した。減圧下溶媒を留去し
、残留物をエーテルで洗浄後メタノールーエーテルから
再結晶すると、表題化合物が0.6 4 g(7 0.
5%)得占れた。融点206208°
I R (K B r)cm”” 二 3254
, 293B, 2844, 2796, 1616,
1531, 1500.
NMR (de−DM S O)δ: 1.52−1
.85(4H,m),2.79−2. 84(2H,
m), 2. 99−3. 05(2H, m), 3
. 19−3. 28(411,m)
元素分析値 C.H ,7N.S C4!2として計算
値: C,40.00. H,6.34; N,1
5.55;S,11、87.
実測値: C,39.89; H,6.29; N
,15.24;S , 11. 87.
実施例78
2−(4−アミノメチルフエニル)−5.6.78−テ
トラヒドロー4H−チアゾロ[5.4−b]アゼピン・
二塩酸塩
実施例77と同様の方法により、2−[4−(tert
−ブトキシカルホニルアミノメチル)フエニル]−5.
6,7.8−テトラヒド口−4H−チアゾロ[5.4−
b]アゼピンから表題化合物か得られた(収率65.4
%)。融点261−265°(メタノールから再結晶)
I R (K B r)am−’ : 3224, 2
930, 1606, 1531, 1467,137
2. 1125
NMR(d.−DMSO)δ: 1. 56−1.
86(4H, m)2. 87−2. 93(2H,
m), 3. 02−3. 08(2H, m), 4
. 01−4. 07(2H, m), 7. 57(
2}1, d, J = 8Hz), 7. 85(2
H, d, J= 81{z).元素分析値: C ,
.H ,.N35 C&,として計算値: C,50.
60; H,5.76; N,12.65;S,
9、65; C Q. 21. 34.実測値:
C,50.77; H,5.73; N,12.6
3.S, 9.56; Cl2,21.26.実施
例79
2−(4−メトキシー3−ペンチルオキシスチリル)−
5.6.7.8−テトラヒドロ−4H−チアゾロ[5.
4−bコアゼピン
2−(3−ヒドロキシー4−メトキシスチリル)−5.
6,7.8−テトラヒド口−4H−チアゾロ[5. 4
−b ]アゼピン(1.00g)のジメチルホルムアミ
ド溶液21に、臭化アミル(0.49ml2)および炭
酸カリウム(0.46g)を加え、100°で1時間撹
拌した。冷却後、反応液を炉過し、炉岐をエーテルに溶
解した。この溶岐を水洗乾燥後、減圧下濃縮した。残留
物をシリカゲルカラムクロマトグラフイーで精製し、続
いてイソブロビルエーテルから再結晶すると、表題化合
物が0,19g(15.4%)得られた。融点124−
125°I R (K B r)cm−’ : 324
0, 2930, 1515, 1451. 1263
?236.1022.
NMR (C D Cff3)δ: 0. 94(3
H, t, J= 7Hz), 1. 36−1. 9
3(10B, m), 2. 89(.2H, t,
J = 5Hz), 3. 12(2H, t),3.
88(3H, s), 4、03(2H, q, J
==7Hz), 6. 84(LH, d, J 一8
Hz), 6. 96−7. 04(4H, i).元
素分析値:C■H,.N,O,Sとして計算値: C,
67,71, H,1.58: N,7.52実測
値: C,67.49; H,7.43; N,7
J9.実施例80
4−メチル−2−フェニル−5.6,7.8−テトラヒ
ド口−4H−チアゾロ[5.4−b]アセビン・塩酸塩
2−フエニル−5.6,7.8−テトラヒド口−4H−
チアゾロ[5.4−b]アゼビン(0.83g)のジメ
チルホルムアミド溶液30dに、沃化メチル(0.45
m)および炭酸カリウム(0.75g)を加え、90’
で4.5時間撹拌した。冷却後、反応l夜をC戸過し、
;戸岐をエーテルに濱解した。この溶岐を水洗乾燥後、
減圧下濃縮した。残留物をシリカゲルカラムクロマトグ
ラフィーで精製した後、塩化水素で中和し、エタノール
ーエーテルから再結晶すると表題化合物が0.53g(
52.4%)得られた。融点139−140’
I R (K B r)cn+−’ : 321g,
292g, 2564, 1591, 1524,14
25, 1319. 767
NMR(d.−DMSO)δ: 1. 43−2.
00(41, m).2. 76−3. 16(7H,
m), 7. 30−7.52(3H. m), 7
. 70−7. 93(2H, II1).
元素分析値: C ..H ,,N.S CQとして計
算値・C,59.88; H,6.10; N,9
.98:S , 11. 43.
実測値: C,59.70; H,a.oo; N
,9.86;S , 11. 51.
実施例8l
4−アリルー2−(4−メトキシー3−メチルスチリル
l−5.6.7.8−テトラヒドロ−4Hチアゾロ[5
.4−b]アゼビン・塩酸塩実施例80と同様の方法に
より、2−(4−メトキシー3−メチルスチリル)−5
.6,7.8〜テトラヒド口−4H−チアゾロ[5.4
−b]アゼビン、臭化アリルおよび炭酸カリウムを反応
、精製後生成物を塩化水素で中和し、表題化合物を得た
(収率56.4%)。融点162−163°(エタノー
ルーエーテルから再結晶)
r R (K B r)cm−’ : 2934, 2
346, 1589, 1501, 1439,125
4, 1132.
NMR(d.−DMSO)δ: 1.54−1.68
(2H,m),1. 73−1. 88(2H, m)
. 2. 17(3H, s), 2. 81−2.
90(2H, m),3. 09−3. 18(2H,
m), 3. 74−3. 89(5H, m),
5. 26−5. 40(2H, m). 5. 83
−6. (r2(fH, m), 6. 97(IH.
d, J = 9Hz). 7. 14(IH. d
, J= 16Hz), 7. 30(IH, d,
J= 16}1z), 7. 41−7.45(2H,
m).
元素分析値:C,。H,,N,OsCQとして計算値:
C,63.73; H,6.68; N,7.4
3:S,8、51; CQ.9.41.
実測値: C,63.79; H,6.60; N
,7.41;S, 8.51: Cf2,9.49.
実施例82
2−(2.6−ジフルオロフェニル)−4−メチル−5
.6,7.8−テトラヒドロー4H−チアゾロ[5.4
−b]アゼピン・塩酸塩
実施例80と同様の方法により、l−(2,6/フルオ
ロフェニル)−5.6,7.8−テトラヒド口−4H−
チアゾロ[5.1−b]アゼピン、沃化メチルおよび炭
酸カリウムを反応、精製後生成物を塩化水素で中和し、
表題化合物を得た(収率44 3%)。融点132−1
33°(メタノールエーテルから再結晶).
I R (K B r)cm−’ : 2396, 1
622, 1585, 1530, 1470.101
1. 806
N M R (C D C C3)δ: 1. 70
−1. 82(2H, m), 1, 912. 04
(2H, m), 3. 09(3H, s), 3、
20(2H, t, J= 5Hz),3. 37(2
H, t, J = 6Hz). 7. 12(2H,
t, J = 8Hz), 7. 457. 60(
IH, m)
元素分析値・C ,,H ,,N,S F ,Cffと
して計算値・C,53.0g. H 4.77;
N,8.84.S,10.12. F,11.99;
Cff,11.19.実測値: C,53.16.
H,4.71. N,8.86:S,10.26
; F,12.10; (1!,11.15.実施
例83
2−(2.6−ジフルオ口フェニル)−4−エチル−5
.6,7.8−テトラヒドロー4H−チアゾロ[5.4
−b]アゼビン
実施例80と同様の方法により、2−(2.6ジフルオ
口フエニル)−5.6,7.8−テトラヒド口−4H−
チアゾロ[5.4−b]アゼビン、臭化エチルおよび炭
酸カリウムを反応させ、表題化合物を得た(収率4.2
%)。融点51−52°(エタノールー水から再結晶)
.
I R (K B r)cm−’ : 1524, 1
498, 1461, 1432, 1371,992
,796.
NMR(CDC(!3)δ 1. 25(3H, t
, J = 8Hz), l. 501. 98(4H
, m), 2. 92−3. 09(4H, m),
3. 24(2H, q, J = 8Hz),6、
95−7. 40(3H, m).元素分析値: C
IsH 8aN ts F tとして計算値: C,6
1.20; H,5.48; N,9.52;S,
10.89; F,12.91.実測値: C,61
.04; H,5.40; N,9.58;s,t
o.63; F,13.06.実施例84
4−アリルー2−(2.6−ジフルオ口フエニル)5,
6,7.8−テトラヒドロー4H−チアゾロ[5.4−
b]アゼピン
実施例80と同様の方法により、2−(2.6ジフルオ
口フエニル)−5.6,7.8−テトラヒド口−4H−
チアゾロ[5.4−b]アゼピン、臭化アリルおよび炭
酸カリウムを反応させ、表題化合物を得た(収率44.
3%)。融点68°(石油エーテルから再結晶).
I R (K B r)cm−’ : 1531, 1
467, 1412. 1352, 1243,100
8
NMR(CDCI2−)δ: 1.62−1.90(
4H.m),2.993. 09(4H, m), 3
. 78−L 82(2H, m). 5. 25(I
H, dd, J = 2Hz, 10}1z), 5
. 32(IH, dd, J= 2Hz, 10Hz
), 5. 84−6. 04(IH, m), 6.
93−7. 02(2H, m), 7. 19−7
. 28(IH, m).元素分析値:CIllHI.
N2SF,として計算値: C,62.72: H,
5、26; N,9.14;S,10、47; F
,12.40
実測値: C,62.87; H,5.24. N
,9.14.S,+0.48; F,12.30.実
施例85
4−(エトキシカルボニルメチル)− 2−(4メトキ
シフヱニル)−5.6,7.8−テトラヒドロ4H−チ
アゾロ[5.4−b]アゼピン・塩酸塩実施例80と同
様の方法により、2−(4−メトキシフェニル)−5.
6,7.8−テトラヒドロ4H−チアゾロ[5.4−b
]アゼピン・塩酸塩、ブロモ酢酸エチルおよび炭酸カリ
ウムを反応、精製後生成物を塩化水素で中和し、表題化
合物を得た(収率20.1%)。融点1 1C)−.1
1 1’ (メタノールーエーテルから再結晶).
I R (K B r)am−’ : 1733, 1
596, 1531. 1271, 1260.118
g.
NMR(d.−DMSO)δ: 1. 34(3tl
, t, J= 7Hz),1. 69−1. 96(
4H, m), 3. 25−3. 30(2H, m
), 3. 35−3. 40(2H, m), 3.
87(:{H, s), 4. 01(2}1, s
), 4. 30(2H, q, J= 7Hz),
7. 02(2H, d, J = 9Hz), 8.
22(2t{, d, J = 9Hz).元素分析
値: C,.H,.N,O.SCQとして計算値: C
,56.46. H.6.05; N,7J2;S
. 8J7: CI2,9.26.実測値 C,56
.61; H.5.83: N,7.38;S,
8.40: CC,9.19実施例86
4−アセチルー2−(35−ジーtert−ブチルー4
−ヒドロキ7フエニル)−5.6,7.8−テトラヒト
ロ−4H−チアゾロ[5,4−b]アセピン実施例40
と同様の方法により、2−(3.5−7ーt−ブチルー
4−ヒドロ牛シフエニル)−5.6.7.8−テトラヒ
ドロ−4H−チアゾロ[5.4b]アセピン、トリエチ
ルアミン及び無水酢酸か:)表題化合物か得られた(収
率56 0%)。融点1 9 8−1 9 9°
I R (K B r)Cm−’ : 3542, 2
954, 2924, +666. 1406.138
5 1107
NMR(CDCQ3)δ l. 4g(188, s
), 1. 58−2. 02(4IL m) 2.
13(3H, s), 2. 93(2H, t),
3. 68(2H, t), 5. 45(IH. s
), 7. 88(2H, s).元素分析値: C
,3H 32N ,S○2として計算値 C,6g.9
6. H,8.05. N,6.99:S,8.0
0
?測値: C,6g.78; H,7■99; N
,6.70S 8.00.
実施例87
2−(3−メトキシー4−メチルチオメトキシスチリル
)−5.6,7.8−テトラヒド口−4Hチアゾロ[5
.1−b]アセピン
実施例l8と同様の方法により、3−メトキシ4−メチ
ルチオメトキシケイ皮酸、3−アミノε一カプロラクタ
ム及び五硫化燐から表題化合物が得られた(収率10.
7%)。融点117119°
I R (K B r)cm ’ : 1533, 1
509, 1445, 1370, 1256.N M
R (C D C I23)δ: 1. 67(2
H, m), 1. 82(2H, m),2. 27
(3H, s), 2. 89(2H, t), a.
12(2H, t), 3. 90(3H, s),
5. 26(2H, s), 6. 99(5H,
m).元素分析値: C 1aH 22N 2S !0
2として計算値・C,59、64; H,6.12
; N,7.73S 17.69.
実測値: C,59.57; H,6.22; N
,7.55;S , 17. 62
実施例88
2−(4−ヒドロキシ−3−メト牛シスチリル)一5.
6,7.8−テトラヒド口−4H−チアゾロ[54−b
]アゼピン
実施例87て得られた2−(3−メトキシー4メチルチ
オメトキ/スチリル)−5.6,7.8テトラヒド口−
4H−チアゾロ[5.4−b]アゼビンI.88gをジ
メチルホルムアミド,アセトニトリル,水混液に溶解し
、これに塩化第二水銀2 11gを加えて15時間還流
した。反応後重1専水を加えで、クロロホルムーメタ/
−ルで抽出した。無水硫酸マグネシウムで乾燥した後、
溶媒を減圧下留去した。残渣をンリカケルカラムクロマ
トグラフィー[クロロホルムーメタノール(98: 2
, v/v)で溶出]に付して表題化合物318mgを
得た。Melting point 2] 0-211° I R (K B r) cm"-': 3216,
2530, 1601. 1504. 1279947 NMR (d6-DMSO) δ 1. 56-1. 7
9 (4H, m)2. 76-2. 87 (2H, m
), 3. 02-3. 10 (2H, m). 3.
81 (3H, s), 6. 944. 12 (4H,
m), 7. 31 (IH, d, J= 16Hz
). Elemental analysis value C. .. H. N20, S Cff
Calculated values: C, 56.71; H, 5.65;
N, 8.27; S946 Actual value: C, 56.72; H, 5.63; N
, 8, 30:S. 9.60. Example 76 2-(4-hydrocyphenyl)-5.6,7.8tetrahydride-4 8-thiazolo[5.4-b]azepine.
The title compound was obtained from 2-(4-ethoxycarbonyloxyphenyl)-5.6,7.8tetrahydride-4H-thiazolo[5.4-b]azevin by pouring in the same manner as in Hydrochloride Example 75. (Yield 325%). Melting point 215-216°
(Recrystallized from ethanol-ether). I R (K B r) cm': 3378. 2
926, 1607, 1560, 1519, 127
9. 12311! .. NMR (d.-DMSO) δ: 1.56-1.82
(48, m), 2. 83-2y93(2H, m),
3. 00-3. 1 1 (2H, m), 6.
89 (2H, d, J = 8Hz), 7. 73(
2H, d, J = 8Hz). Elemental analysis value: C,
Calculated value as 3H, 5N, OSCQ: C, 55.21
; H, 5.35; N, 9.91・S, 11
.. 34; C f2, 12. 54. Actual value:
C, 55.19. H, 5.41; N, 9.74
;S, 11. 10; C Q. .. 12. 5
0 Example 77 2-(2-aminoethyl)-5.6.7.8-tetrahydro-4H-thiazolo[5.4-b]azepine dihydrochloride 2[2(tert-butoxycarponylamino)ethyl ]-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b]Azepine (1.oog) in methanol solution (10d) was added with 3d of 4.75N hydrochloric acid methanol residue solution at room temperature for 5 hours. Stirred. The solvent was distilled off under reduced pressure, and the residue was washed with ether and recrystallized from methanol-ether to yield 0.64 g (70.0 g) of the title compound.
5%) I got a good fortune. Melting point 206208° I R (K B r) cm"" 2 3254
, 293B, 2844, 2796, 1616,
1531, 1500. NMR (de-DMSO)δ: 1.52-1
.. 85 (4H, m), 2.79-2. 84 (2H,
m), 2. 99-3. 05 (2H, m), 3
.. 19-3. 28 (411, m) Elemental analysis value C. H, 7N. Calculated value as S C4!2: C, 40.00. H, 6.34; N, 1
5.55; S, 11, 87. Actual value: C, 39.89; H, 6.29; N
, 15.24;S, 11. 87. Example 78 2-(4-aminomethylphenyl)-5.6.78-tetrahydro 4H-thiazolo[5.4-b]azepine.
2-[4-(tert
-butoxycarbonylaminomethyl)phenyl]-5.
6,7.8-Tetrahydro-4H-thiazolo[5.4-
b] The title compound was obtained from azepine (yield 65.4
%). Melting point 261-265° (recrystallized from methanol) I R (K B r) am-': 3224, 2
930, 1606, 1531, 1467, 137
2. 1125 NMR (d.-DMSO) δ: 1. 56-1.
86 (4H, m)2. 87-2. 93 (2H,
m), 3. 02-3. 08 (2H, m), 4
.. 01-4. 07 (2H, m), 7. 57(
2}1, d, J = 8Hz), 7. 85 (2
H, d, J= 81{z). Elemental analysis value: C,
.. H. Calculated value as N35 C&,: C,50.
60; H, 5.76; N, 12.65; S,
9, 65; C Q. 21. 34. Actual value:
C, 50.77; H, 5.73; N, 12.6
3. S, 9.56; Cl2, 21.26. Example 79 2-(4-methoxy3-pentyloxystyryl)-
5.6.7.8-Tetrahydro-4H-thiazolo [5.
4-b coazepine 2-(3-hydroxy-4-methoxystyryl)-5.
6,7.8-Tetrahydro-4H-thiazolo [5. 4
-b ] To a dimethylformamide solution 21 of azepine (1.00 g) were added amyl bromide (0.49 ml2) and potassium carbonate (0.46 g), and the mixture was stirred at 100° for 1 hour. After cooling, the reaction solution was filtered and the filter solution was dissolved in ether. This eluate was washed with water, dried, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography followed by recrystallization from isobrobyl ether to yield 0.19 g (15.4%) of the title compound. Melting point 124-
125°I R (K B r) cm-': 324
0, 2930, 1515, 1451. 1263
? 236.1022. NMR (CD Cff3)δ: 0. 94(3
H, t, J=7Hz), 1. 36-1. 9
3 (10B, m), 2. 89(.2H, t,
J = 5Hz), 3. 12 (2H, t), 3.
88 (3H, s), 4, 03 (2H, q, J
==7Hz), 6. 84 (LH, d, J-8
Hz), 6. 96-7. 04 (4H, i). Elemental analysis value: C■H,. Calculated value as N, O, S: C,
67,71, H, 1.58: N, 7.52 Actual value: C, 67.49; H, 7.43; N, 7
J9. Example 80 4-Methyl-2-phenyl-5.6,7.8-tetrahydride-4H-thiazolo[5.4-b]acevin hydrochloride 2-phenyl-5.6,7.8-tetrahydride -4H-
To 30 d of a dimethylformamide solution of thiazolo[5.4-b]azevin (0.83 g) was added methyl iodide (0.45
m) and potassium carbonate (0.75 g), and stirred for 90'
The mixture was stirred for 4.5 hours. After cooling, the reaction was heated overnight,
; Dissolved Toki into ether. After washing this toki with water and drying it,
It was concentrated under reduced pressure. The residue was purified by silica gel column chromatography, neutralized with hydrogen chloride, and recrystallized from ethanol-ether to yield 0.53 g of the title compound (
52.4%) was obtained. Melting point 139-140' I R (K B r)cn+-': 321 g,
292g, 2564, 1591, 1524, 14
25, 1319. 767 NMR (d.-DMSO) δ: 1. 43-2.
00 (41, m). 2. 76-3. 16 (7H,
m), 7. 30-7.52 (3H.m), 7
.. 70-7. 93 (2H, II1). Elemental analysis value: C. .. H,,N. Calculated value as S CQ: C, 59.88; H, 6.10; N, 9
.. 98:S, 11. 43. Actual value: C, 59.70; H, a. oo;N
, 9.86;S, 11. 51. Example 8l 4-Allyl-2-(4-methoxy3-methylstyryl-5.6.7.8-tetrahydro-4Hthiazolo[5
.. 4-b] Azevin hydrochloride 2-(4-methoxy-3-methylstyryl)-5 was prepared in the same manner as in Example 80.
.. 6,7.8~Tetrahydro-4H-thiazolo[5.4
-b] Azevin, allyl bromide and potassium carbonate were reacted, and the purified product was neutralized with hydrogen chloride to obtain the title compound (yield 56.4%). Melting point 162-163° (recrystallized from ethanol-ether) r R (K B r) cm-': 2934, 2
346, 1589, 1501, 1439, 125
4, 1132. NMR (d.-DMSO) δ: 1.54-1.68
(2H, m), 1. 73-1. 88 (2H, m)
.. 2. 17 (3H, s), 2. 81-2.
90 (2H, m), 3. 09-3. 18 (2H,
m), 3. 74-3. 89 (5H, m),
5. 26-5. 40 (2H, m). 5. 83
-6. (r2(fH, m), 6.97(IH.
d, J = 9Hz). 7. 14 (IH. d
, J=16Hz), 7. 30 (IH, d,
J= 16}1z), 7. 41-7.45 (2H,
m). Elemental analysis value: C. Calculated value as H,,N,OsCQ:
C, 63.73; H, 6.68; N, 7.4
3:S, 8, 51; CQ. 9.41. Actual value: C, 63.79; H, 6.60; N
, 7.41; S, 8.51: Cf2, 9.49.
Example 82 2-(2,6-difluorophenyl)-4-methyl-5
.. 6,7.8-Tetrahydro 4H-thiazolo[5.4
-b]Azepine hydrochloride By the same method as in Example 80, l-(2,6/fluorophenyl)-5.6,7.8-tetrahydride-4H-
React thiazolo[5.1-b]azepine, methyl iodide and potassium carbonate, neutralize the purified product with hydrogen chloride,
The title compound was obtained (yield 44.3%). Melting point 132-1
33° (recrystallized from methanol ether). I R (K B r) cm-': 2396, 1
622, 1585, 1530, 1470.101
1. 806 N M R (C D C C3) δ: 1. 70
-1. 82 (2H, m), 1, 912. 04
(2H, m), 3. 09 (3H, s), 3,
20 (2H, t, J=5Hz), 3. 37 (2
H, t, J = 6Hz). 7. 12 (2H,
t, J = 8Hz), 7. 457. 60(
IH, m) Elemental analysis value・Calculated value as C,,H,,N,S F,Cff・C, 53.0g. H 4.77;
N, 8.84. S, 10.12. F, 11.99;
Cff, 11.19. Actual value: C, 53.16.
H, 4.71. N, 8.86: S, 10.26
; F, 12.10; (1!, 11.15. Example 83 2-(2.6-difluorophenyl)-4-ethyl-5
.. 6,7.8-Tetrahydro 4H-thiazolo[5.4
-b] Azebin By the same method as Example 80, 2-(2.6difluorophenyl)-5.6,7.8-tetrahydride-4H-
Thiazolo[5.4-b]azevin, ethyl bromide and potassium carbonate were reacted to obtain the title compound (yield 4.2
%). Melting point 51-52° (recrystallized from ethanol-water)
.. I R (K B r) cm-': 1524, 1
498, 1461, 1432, 1371,992
, 796. NMR(CDC(!3)δ 1.25(3H, t
, J = 8Hz), l. 501. 98 (4H
, m), 2. 92-3. 09 (4H, m),
3. 24 (2H, q, J = 8Hz), 6,
95-7. 40 (3H, m). Elemental analysis value: C
Calculated value as IsH 8aN ts F t: C, 6
1.20; H, 5.48; N, 9.52; S,
10.89; F, 12.91. Actual value: C, 61
.. 04; H, 5.40; N, 9.58; s, t
o. 63; F, 13.06. Example 84 4-aryl-2-(2,6-difluorophenyl)5,
6,7.8-Tetrahydro 4H-thiazolo[5.4-
b] Azepine By the same method as Example 80, 2-(2.6difluorophenyl)-5.6,7.8-tetrahydride-4H-
Thiazolo[5.4-b]azepine, allyl bromide and potassium carbonate were reacted to obtain the title compound (yield 44.
3%). Melting point 68° (recrystallized from petroleum ether). I R (K B r) cm-': 1531, 1
467, 1412. 1352, 1243,100
8 NMR (CDCI2-) δ: 1.62-1.90 (
4H. m), 2.993. 09 (4H, m), 3
.. 78-L 82 (2H, m). 5. 25(I
H, dd, J = 2Hz, 10}1z), 5
.. 32 (IH, dd, J= 2Hz, 10Hz
), 5. 84-6. 04 (IH, m), 6.
93-7. 02 (2H, m), 7. 19-7
.. 28 (IH, m). Elemental analysis value: CIllHI.
Calculated value as N2SF: C, 62.72: H,
5, 26; N, 9.14; S, 10, 47; F
, 12.40 Actual value: C, 62.87; H, 5.24. N
,9.14. S, +0.48; F, 12.30. Example 85 4-(ethoxycarbonylmethyl)-2-(4methoxyphenyl)-5.6,7.8-tetrahydro 4H-thiazolo[5.4-b]azepine hydrochloride By the same method as in Example 80, 2-(4-methoxyphenyl)-5.
6,7.8-Tetrahydro 4H-thiazolo[5.4-b
]Azepine hydrochloride, ethyl bromoacetate and potassium carbonate were reacted and purified, and the product was neutralized with hydrogen chloride to obtain the title compound (yield 20.1%). Melting point 1 1C) -. 1
1 1' (recrystallized from methanol-ether). I R (K B r) am-': 1733, 1
596, 1531. 1271, 1260.118
g. NMR (d.-DMSO) δ: 1. 34 (3tl
, t, J=7Hz), 1. 69-1. 96(
4H, m), 3. 25-3. 30 (2H, m
), 3. 35-3. 40 (2H, m), 3.
87(:{H, s), 4. 01(2}1, s
), 4. 30 (2H, q, J=7Hz),
7. 02 (2H, d, J = 9Hz), 8.
22 (2t{, d, J = 9Hz). Elemental analysis value: C,. H,. N.O. Calculated value as SCQ: C
,56.46. H. 6.05; N, 7J2; S
.. 8J7: CI2, 9.26. Actual value C, 56
.. 61;H. 5.83: N, 7.38; S,
8.40: CC, 9.19 Example 86 4-acetyl-2-(35-di-tert-butyl-4
-hydroxy7phenyl)-5.6,7.8-tetrahydro-4H-thiazolo[5,4-b]acepine Example 40
2-(3.5-7-t-butyl-4-hydrocyphenyl)-5.6.7.8-tetrahydro-4H-thiazolo[5.4b]acepine, triethylamine and acetic anhydride :) The title compound was obtained (yield 560%). Melting point 198-199°I R (KBr)Cm-': 3542, 2
954, 2924, +666. 1406.138
5 1107 NMR (CDCQ3) δ l. 4g (188, s
), 1. 58-2. 02 (4IL m) 2.
13 (3H, s), 2. 93 (2H, t),
3. 68 (2H, t), 5. 45 (IH.s
), 7. 88 (2H, s). Elemental analysis value: C
, 3H 32N , Calculated value as S○2 C, 6g. 9
6. H, 8.05. N, 6.99: S, 8.0
0? Measured value: C, 6g. 78; H, 7■99; N
, 6.70S 8.00. Example 87 2-(3-methoxy4-methylthiomethoxystyryl)-5.6,7.8-tetrahydro-4Hthiazolo[5
.. 1-b] Acepine The title compound was obtained from 3-methoxy-4-methylthiomethoxycinnamic acid, 3-amino epsilon-caprolactam and phosphorus pentasulfide in the same manner as in Example 18 (yield: 10.
7%). Melting point 117119° I R (K B r) cm': 1533, 1
509, 1445, 1370, 1256. N M
R (C D C I23) δ: 1. 67 (2
H, m), 1. 82 (2H, m), 2. 27
(3H, s), 2. 89 (2H, t), a.
12 (2H, t), 3. 90 (3H, s),
5. 26 (2H, s), 6. 99 (5H,
m). Elemental analysis value: C 1aH 22N 2S! 0
Calculated value as 2・C, 59, 64; H, 6.12
; N, 7.73S 17.69. Actual value: C, 59.57; H, 6.22; N
, 7.55; S, 17. 62 Example 88 2-(4-hydroxy-3-methobovcystyryl)-5.
6,7.8-Tetrahydro-4H-thiazolo[54-b
]Azepine Example 87 2-(3-Methoxy4methylthiomethoxy/styryl)-5.6,7.8 tetrahydride-
4H-thiazolo[5.4-b]azevin I. 88 g was dissolved in a mixed solution of dimethylformamide, acetonitrile, and water, and 11 g of mercuric chloride 2 was added thereto, followed by refluxing for 15 hours. After the reaction, add heavy water to chloroform-meth/
- Extracted with After drying with anhydrous magnesium sulfate,
The solvent was distilled off under reduced pressure. The residue was purified by column chromatography [chloroform-methanol (98:2
, v/v) to obtain 318 mg of the title compound.
融点 175−178°
I R (K B r)cm−’ : 3394, 1
549, 1515, 1462. 13691263
1036
N:vlR(CDC(!+)δ: 1. 67(2H
m), 1、83(2H, Il1),2. 90(
2H, t), 3. 12(2H, t), 3.
90(IH, s), 3. 91(3B, s),
6. 85−7. 05(51 m)元素分析値: C
+eH +eN 2SO 2・0. 5H ,Oとし
て計算値: C,61.71; H,6.15;
N,9.00.S , 10. 30.
実測値: C,62.12; H,5.90; N
,8.91S , 10. 45.
実施例89
2−(2−ビラジニル)−5.6,7.8−テトラヒド
ロー4H−チアゾロ[5.4−b]アゼビン実施例18
と同様の方広により、2−ビラジンカルボン酸、3−ア
ミノーε一カプロラクタム及び五硫化燐から表題化合物
が得られた(収率349%)。融点196198°(酢
酸エチルから再結晶).
I R (K B r)ci+−’ : 3298,
1485, 1353, 1291. 1146753
.
N M R (C D C I23)δ: 1. 7
3(2H, m), 1. 86(2H, m)2.9
8(2L t), 3. 17(2H, t), 4.
29(I}l, brs), 8. 43(211,
s), 9. 26(IH. s).
元素分析値: C .H l2N *Sとして計算値:
C,56.87; H,5.21; N,24、
12;S , 13. 80,
実測値: C,56.97. H,5.23; N
,24.03;S , 13. 86,
実施例90
2−(2−インドリル)−5.6,7.8−テトラヒド
ロー4H−チアゾロ[5.4−b]アゼピン実施例18
と同様の方広により、インドール2−カルホン酸、3−
アミノーε一カブ口ラクタム及ひ五硫化燐から表題化合
物が得られた(収率35 3%)。融点198−200
°
I R (K B r)cm−’ : 3226, 1
551, 1503, 1456, 1366,135
3. 129g, 1257. 1142NMR(d.
−DMso)δ: 1. 63(2H, m), 1
. 74(28,m), 2. 84(2H, t),
3. Of(2H, t), 6. 63(IH,
s), 6. 917. 14(2H. m), 7.
38(IH, d, J = 7. 65Hz),
7. 47(IH, d)II. 46(IH, br
s)
元素分折値 C15H,,N3Sとして計算値: C,
66.88; H,5.61; N,15.60;
S , I1. 90.
実測値:C,66、91; H,5.53; N
15.4OS 11.92
実施例91
2−(4−ジメチルアミノフエニル)−5.6.78−
テトラヒドロ−4H−チアゾロ[5.4−b]アゼピン
実施例18と同様の方法により、4−ジメチルアミノ安
息香酸、3−アミノーε一カブ口ラクタム及び五硫化燐
から表題化合物が得られた(収率II.5%)。融点1
52−154°(酢酸エチルから再結晶)
I R (K B r)cm’−’ : 3252,
1609, 1557, 1524. 14g3,14
67, 1444, 1358, 1269. 1+7
0.N M R (C D C f!+)δ: 1.
68(2H, m), 1. 81(2H, m)2
. 92(2tL t), 3. 08(2H. t)
, 2. 98(6H. s), 6. 68(2H.
d,J= 9, OHz), 7. 64(2tL
d).元素分析値: C ,5H ..N3Sとして計
算値: C,65.90; H,7.00; N,
15.37;3 11.73
実測値: C,65.90; H,6.89; N
,15.25.S , 12. 03、
実施例92
2−(4−メチルチオスチリル)−5.6,7.8=テ
トラヒド口−4H−チアゾロ[5.4−b]アゼ“ビン
実施例18と同様の方法により、4−メチルチオケイ皮
酸、3−アミノーε一カブロラクタム及び五硫化燐から
表題化合物が得られた(収率575%)。融点1571
59°.
I R (K B r)cm ’ : 3260, 1
621, 1545, 1430, 1353,109
1 949.
N M R (C D C C3)δ: 1. 67
(2H, m), 1. 82(28, m),2.
49(3H, s), 2. 89(2H, t),
3. 11(2H, t), 7. 01(2H, q
), 7. 2](2H, d, J = 8. 5H
z), 7. 38(2H, d).元素分折値: C
,6H 1−N−S tとして計算値:C,63.5
4; H a.oo; N,9.26.3 21
.20
実測値: C,63J1; H,5.92: N,
9.27:S , 21. 36
実施例93
2−[1−(2−フリル)エテニル]−5.6,7.8
−テトラヒド口−4H−チアゾロ[5.4−b]アゼビ
ン
実施例18と同様の方法により、β一(2−フノル)ア
クリル酸、3−アミノーε一カブ口ラクタム及び五硫化
燐から表題化合物が得られた(収率14.0%)。融点
125−128°,I R (K B r)cm−’:
3260, 1547, 1422, 1351 9
44 736.NMR (C D Cf2.)δ:
1.68(2H,m),1.81(2H,m)2. 8
9(2H, t), 3. 11(2H, t), 6
. 40(2H, m). &. 91(2H, q)
, 7. 40(IH, d)
元素分析値: C ,,H ,,N ,S Oとして計
算値・C,63.39; H,5.73; N,1
1.37S 13.02,
実測値: C,62.87; H,5.58+ N
,11.17S L3.46.
実施例94
2−[2−(4−メトキンフエニル)エチル1−56.
7.8−テトラヒド口−4H−チアゾロ[5.4b]ア
ゼピン
実施例l8と同様の方法により、4−メトキシフェニル
ブロピオン酸、3−アミノーε一カブ口ラクタム及び五
硫化燐から表題化合物が得られた(収率26.O%)。Melting point 175-178° I R (K B r) cm-': 3394, 1
549, 1515, 1462. 13691263
1036 N:vlR(CDC(!+)δ: 1.67(2H
m), 1, 83 (2H, Il1), 2. 90(
2H, t), 3. 12 (2H, t), 3.
90 (IH, s), 3. 91 (3B, s),
6. 85-7. 05 (51 m) Elemental analysis value: C
+eH +eN 2SO 2・0. Calculated value as 5H,O: C, 61.71; H, 6.15;
N, 9.00. S, 10. 30. Actual value: C, 62.12; H, 5.90; N
, 8.91S, 10. 45. Example 89 2-(2-bilazinyl)-5.6,7.8-tetrahydro 4H-thiazolo[5.4-b]azevin Example 18
The title compound was obtained from 2-virazinecarboxylic acid, 3-amino-epsilon-caprolactam and phosphorus pentasulfide (yield 349%). Melting point 196198° (recrystallized from ethyl acetate). I R (K B r)ci+-': 3298,
1485, 1353, 1291. 1146753
.. N M R (C D C I23) δ: 1. 7
3 (2H, m), 1. 86 (2H, m) 2.9
8 (2Lt), 3. 17 (2H, t), 4.
29(I}l, brs), 8. 43 (211,
s), 9. 26 (IH.s). Elemental analysis value: C. Calculated value as H l2N *S:
C, 56.87; H, 5.21; N, 24,
12;S, 13. 80, Actual value: C, 56.97. H, 5.23; N
, 24.03;S, 13. 86, Example 90 2-(2-indolyl)-5.6,7.8-tetrahydro 4H-thiazolo[5.4-b]azepine Example 18
Indole 2-carphonic acid, 3-
The title compound was obtained from the amino-epsilon lactam and phosphorus pentasulfide (yield 353%). Melting point 198-200
° I R (K B r) cm-': 3226, 1
551, 1503, 1456, 1366, 135
3. 129g, 1257. 1142NMR (d.
-DMso)δ: 1. 63 (2H, m), 1
.. 74 (28, m), 2. 84 (2H, t),
3. Of(2H, t), 6. 63 (IH,
s), 6. 917. 14 (2H.m), 7.
38 (IH, d, J = 7.65Hz),
7. 47 (IH, d) II. 46 (IH, br
s) Elemental analysis value Calculated value as C15H,,N3S: C,
66.88; H, 5.61; N, 15.60;
S, I1. 90. Actual value: C, 66, 91; H, 5.53; N
15.4OS 11.92 Example 91 2-(4-dimethylaminophenyl)-5.6.78-
Tetrahydro-4H-thiazolo[5.4-b]azepine By the same method as in Example 18, the title compound was obtained from 4-dimethylaminobenzoic acid, 3-amino-epsilon monocab lactam and phosphorus pentasulfide (harvested rate II.5%). Melting point 1
52-154° (recrystallized from ethyl acetate) I R (K B r) cm'-': 3252,
1609, 1557, 1524. 14g3,14
67, 1444, 1358, 1269. 1+7
0. N M R (C D C f!+) δ: 1.
68 (2H, m), 1. 81 (2H, m)2
.. 92 (2tLt), 3. 08 (2H.t)
, 2. 98 (6H.s), 6. 68 (2H.
d, J=9, OHz), 7. 64 (2tL
d). Elemental analysis value: C, 5H. .. Calculated value as N3S: C, 65.90; H, 7.00; N,
15.37; 3 11.73 Actual value: C, 65.90; H, 6.89; N
, 15.25. S, 12. 03, Example 92 2-(4-Methylthiostyryl)-5.6,7.8=tetrahydride-4H-thiazolo[5.4-b]azebin By the same method as in Example 18, 4-methylthiostyryl The title compound was obtained from cinnamic acid, 3-amino-ε-cabrolactam and phosphorous pentasulfide (yield 575%). Melting point 1571
59°. I R (K B r) cm': 3260, 1
621, 1545, 1430, 1353, 109
1 949. N M R (C D C C3) δ: 1. 67
(2H, m), 1. 82 (28, m), 2.
49 (3H, s), 2. 89 (2H, t),
3. 11 (2H, t), 7. 01(2H, q
), 7. 2] (2H, d, J = 8.5H
z), 7. 38 (2H, d). Elemental analysis value: C
, 6H 1-N-S Calculated value as t: C, 63.5
4; H a. oo; N, 9.26.3 21
.. 20 Actual measurement: C, 63J1; H, 5.92: N,
9.27:S, 21. 36 Example 93 2-[1-(2-furyl)ethenyl]-5.6,7.8
-tetrahydride-4H-thiazolo[5.4-b]azebin The title compound was prepared from β-(2-phenol)acrylic acid, 3-amino-ε-cabulactam, and phosphorus pentasulfide in the same manner as in Example 18. (yield 14.0%). Melting point 125-128°, I R (K B r) cm-':
3260, 1547, 1422, 1351 9
44 736. NMR (CD Cf2.) δ:
1.68 (2H, m), 1.81 (2H, m)2. 8
9 (2H, t), 3. 11(2H, t), 6
.. 40 (2H, m). &. 91 (2H, q)
, 7. 40 (IH, d) Elemental analysis value: Calculated value as C,, H,, N, SO ・C, 63.39; H, 5.73; N, 1
1.37S 13.02, Actual value: C, 62.87; H, 5.58+N
, 11.17S L3.46. Example 94 2-[2-(4-methquinphenyl)ethyl 1-56.
7.8-Tetrahydro-4H-thiazolo[5.4b]azepine The title compound was obtained from 4-methoxyphenylpropionic acid, 3-amino-epsilon-lactam and phosphorus pentasulfide in a manner similar to Example 18. (yield 26.0%).
融点 80−83°
I R (K B r)cm−’ : 1612, 1
584, 1513, 1486, 1437,124
7. 1178, 1037.
NMR(CDCf23)δ: 1,64(2H,m)
,1.79(2H,m),2. 83−3.10(12
[1, m), 3. 79(3Fl, s), 6.
84(2H, d, J=8.6Hz), 7. 1
4(28, d).元素分折値: C ,8H 20N
2S O ” O、5H ,Oとして計算値 C,6
4.61; H,7.12; N,9.42;S
, 10. 78
実測値: C,64.86. H,6.87. N
,9.48S , 11. 02
実施例95
2−(4−ビフエニルイル)−5.6.7.8−テトラ
ヒド口−4H−チアゾロ[5.4−b]アゼビン
実施例18と同様の方法により、4−フエニル安息香酸
、3−アミノーε一カブロラクタム及び五硫化燐から表
題化合物が得られた(収率60.O%)。融点l80−
183°.
I R (K B r)cm−’ : 3232, 1
520, 1490, 1445, 1371,765
,692.
NMR (C D Cff3)δ: 1. 71(2
H, m), 1. 84(2H, m),2. 97
(2B, t), 3. 13(2H. t), ’y
. 30−7. 50(3H, m), 7. 61(
4H, m), 7. 84(2B, d).元素分析
値: C .@H ,.N .Sとして計算値: C,
74.47; H,5.92; N,9.14S
, 10. 46
実測値: C,74.04; H,5.78; N
,8.86;S , 10. 66.
実施例96
2−(4−ジメチルアミノスチリル)−5.6.78−
テトラヒドロ−4H−チアゾロ[5.4−b]アゼビン
実施例18と同様の方法により、4−ジメチルアミノケ
イ皮酸、3−アミノーε一カフロラクタム及び五硫化燐
から表題化合物が得られた(収率l6.3%)。融点2
07−210’(酢酸エチルから再結晶).
I R (K B r)cm−’ : 3274, 1
604, 1548, 1525, 1443,136
5, 1165.
N M R (C D C Qs)δ: 1. 67
(2H, m). 1. 81(2H, m),2.
88(2H, t), 3. 09(2H, t),
2. 98(6H, s). 6. 68(2H, d
,J = 8. 91Hz). 6. 93(2H,
d), 7. 36(2H, d).元素分析値: C
,7H,,N3S−0.4H.Oとして計算値: C,
66.59; H.7.17; N,13.70;
S , 10. 46.
実厠値: C,66.77:H,6.93; N,1
3.62;S , 10. 85.
実施例97
2−(3−シメチルアミノフエニル)−5.6,7.8
−テトラヒドロ−4H−チアゾロ[5.4−b]アゼピ
ン
実施例l8と同様の方法により、2−ジメチルアミノ安
息香酸、3−アミノーε一カブロラクタム及び五硫化燐
から表題化合物が得られた(収率34.9%)。融点1
64−166°(酢酸エチルから再結晶).
I R (K B r)cn+ ’ : 3228,
1599, 1557, 1502, 1436,13
71. 1a56, 1267.
NMR(CDCl23)δ: 1. 69(2}1,
m), 1. 83(2H, m),2. 95(2
H, t), 3. 10(2H, t), 2. 9
9(6H, s), 6. 71(LH, d), 7
. 04−7. 29(3H, m).元素分析値:
C ,5H ,.N 3Sとして計算値: C,65.
90; H,7.00: N,15.37;S ,
11. 73.
実測値: C,66.06; H,6.99; N
,15J2;S , 11. 86.
実施例98
2−[3−(2−メチルチオ)ピリジル]−5.67,
8−テトラヒドロー4H−チアゾロ[5.4b]アゼビ
ン・二塩酸.塩
実施例18と同様の方法により、2−(メチルチオ)ニ
コチン酸、3−アミノーε一カブロラクタム及び五硫化
燐を反応、精製後生戊物を塩化水素で中和して表題化合
物か得られた(収率61 3%)。融点142−145
°,
I R (K B r)cm−’ : 3424, 1
601, 1519, 1466, 1434,137
1.124g.
NMR(d.−DMSO)δ: l. 70(2H,
m), 1. 91(2H,m), 2. 58(3
H, s), 2. 98(2H, t), 3. 1
8(2H, t), 7. 28(IH, dd),
8. 16(IH, d, J= 7. 73Hz),
8. 55(IH, d, J一4. 76Hz)
元素分析値: C ,.H ,,N.S 2CQ2とし
て計算値:C,44、57; H,4.89; N
,11.99.S,1g.31; CC,20.24
.実測値: C,44.25; H,5.03;
N,11.55;S,17.96:C&,19.60
実施例99
2−(4−ジエチルアミノスチリル)−5.6.78−
テトラヒド口−4H−チアゾロ[5.4−b]アゼピン
実施例18と同様の方法により、4−ジエチルアミノケ
イ皮酸、3−アミノーε一カブ口ラクタム及び五硫化燐
から表題化合物が得られた(収率23 0%)。融点1
71175°(エタノールから再結晶)
I R (K B r)cm−’ + 3280. 1
601, 1547, 1524. 13541272
, 1254. 11g1, 1158. 962NM
R(CDCl23)δ: 1. 17(6H, t)
, 1. 65(28, m),1. 81(2H,
i), 2、87(2H. t), 3. 09(2H
, t), 3. 37(41{, q)6. 64(
2H, d, J = 8. 61Hz), 6. 9
1(2H, d), 7. 33(2Hd).
元素分析値: C,.H,5N3Sとして計算値: C
,69,68; H,7.69; N,12.83
;S, 9.79.
実測値:C,69、75; H,7.76; N,
12.69S,9.72
実施例100
2−(4−メチルアミノフエニル)−5.6,7.8−
テトラヒド口−4H−チアゾロ[5.4 −b3アゼピ
ン・二塩酸塩
実施例l8と同様の方法により、4−メチルアミノ安息
香酸、3−アミノーε一カブ口ラクタム及び五硫化燐を
反応、精製後生成物を塩化水素で中和して表題化合物が
得られた(収率35.5%)。Melting point 80-83° I R (K B r) cm-': 1612, 1
584, 1513, 1486, 1437, 124
7. 1178, 1037. NMR (CDCf23) δ: 1,64 (2H, m)
, 1.79 (2H, m), 2. 83-3.10 (12
[1, m), 3. 79 (3Fl, s), 6.
84 (2H, d, J=8.6Hz), 7. 1
4 (28, d). Elemental analysis value: C, 8H 20N
Calculated value as 2S O ” O, 5H , O C, 6
4.61; H, 7.12; N, 9.42; S
, 10. 78 Actual value: C, 64.86. H, 6.87. N
, 9.48S, 11. 02 Example 95 2-(4-biphenylyl)-5.6.7.8-tetrahydro-4H-thiazolo[5.4-b]azebin 4-phenylbenzoic acid, 3 The title compound was obtained from -amino-ε-cabrolactam and phosphorus pentasulfide (yield 60.0%). Melting point l80-
183°. I R (K B r) cm-': 3232, 1
520, 1490, 1445, 1371,765
, 692. NMR (CD Cff3)δ: 1. 71(2
H, m), 1. 84 (2H, m), 2. 97
(2B, t), 3. 13(2H.t),'y
.. 30-7. 50 (3H, m), 7. 61(
4H, m), 7. 84 (2B, d). Elemental analysis value: C. @H,. N. Calculated value as S: C,
74.47; H, 5.92; N, 9.14S
, 10. 46 Actual value: C, 74.04; H, 5.78; N
, 8.86;S, 10. 66. Example 96 2-(4-dimethylaminostyryl)-5.6.78-
Tetrahydro-4H-thiazolo[5.4-b]azebin The title compound was obtained from 4-dimethylaminocinnamic acid, 3-amino-epsilon-cafrolactam, and phosphorus pentasulfide in the same manner as in Example 18 (yield: l6.3%). Melting point 2
07-210' (recrystallized from ethyl acetate). I R (K B r) cm-': 3274, 1
604, 1548, 1525, 1443, 136
5, 1165. N M R (C D C Qs) δ: 1. 67
(2H, m). 1. 81 (2H, m), 2.
88 (2H, t), 3. 09 (2H, t),
2. 98 (6H, s). 6. 68 (2H, d
, J = 8. 91Hz). 6. 93 (2H,
d), 7. 36 (2H, d). Elemental analysis value: C
,7H,,N3S-0.4H. Calculated value as O: C,
66.59;H. 7.17; N, 13.70;
S, 10. 46. Actual value: C, 66.77: H, 6.93; N, 1
3.62;S, 10. 85. Example 97 2-(3-dimethylaminophenyl)-5.6,7.8
-Tetrahydro-4H-thiazolo[5.4-b]azepine The title compound was obtained from 2-dimethylaminobenzoic acid, 3-amino-epsilon-cabrolactam and phosphorus pentasulfide by a method similar to Example 18 (yield 34.9%). Melting point 1
64-166° (recrystallized from ethyl acetate). I R (K B r)cn+': 3228,
1599, 1557, 1502, 1436, 13
71. 1a56, 1267. NMR (CDCl23) δ: 1. 69(2}1,
m), 1. 83 (2H, m), 2. 95 (2
H, t), 3. 10 (2H, t), 2. 9
9 (6H, s), 6. 71 (LH, d), 7
.. 04-7. 29 (3H, m). Elemental analysis value:
C,5H,. Calculated value as N3S: C, 65.
90; H, 7.00: N, 15.37; S,
11. 73. Actual value: C, 66.06; H, 6.99; N
, 15J2;S, 11. 86. Example 98 2-[3-(2-methylthio)pyridyl]-5.67,
8-Tetrahydro 4H-thiazolo[5.4b]azevin dihydrochloride. In the same manner as in Salt Example 18, 2-(methylthio)nicotinic acid, 3-amino-epsilon-cabrolactam and phosphorus pentasulfide were reacted, and after purification the raw material was neutralized with hydrogen chloride to obtain the title compound ( yield 61.3%). Melting point 142-145
°, I R (K B r) cm-': 3424, 1
601, 1519, 1466, 1434, 137
1.124g. NMR (d.-DMSO) δ: l. 70 (2H,
m), 1. 91 (2H, m), 2. 58 (3
H, s), 2. 98 (2H, t), 3. 1
8 (2H, t), 7. 28 (IH, dd),
8. 16 (IH, d, J = 7.73Hz),
8. 55 (IH, d, J-4.76Hz) Elemental analysis value: C,. H,,N. Calculated value as S2CQ2: C, 44, 57; H, 4.89; N
, 11.99. S, 1g. 31; CC, 20.24
.. Actual value: C, 44.25; H, 5.03;
N, 11.55; S, 17.96: C&, 19.60 Example 99 2-(4-diethylaminostyryl)-5.6.78-
Tetrahydro-4H-thiazolo[5.4-b]azepine By a method similar to Example 18, the title compound was obtained from 4-diethylaminocinnamic acid, 3-amino-epsilon-cabulactam and phosphorus pentasulfide ( yield 230%). Melting point 1
71175° (recrystallized from ethanol) I R (K B r) cm-' + 3280. 1
601, 1547, 1524. 13541272
, 1254. 11g1, 1158. 962NM
R(CDCl23)δ: 1. 17 (6H, t)
, 1. 65 (28, m), 1. 81 (2H,
i), 2, 87 (2H.t), 3. 09 (2H
, t), 3. 37(41{, q)6. 64(
2H, d, J = 8. 61Hz), 6. 9
1 (2H, d), 7. 33 (2Hd). Elemental analysis value: C,. Calculated value as H,5N3S: C
,69,68; H,7.69; N,12.83
;S, 9.79. Actual value: C, 69, 75; H, 7.76; N,
12.69S, 9.72 Example 100 2-(4-methylaminophenyl)-5.6,7.8-
Tetrahydride-4H-thiazolo[5.4-b3 azepine dihydrochloride By the same method as Example 18, 4-methylaminobenzoic acid, 3-amino-epsilon lactam and phosphorus pentasulfide were reacted and purified. The product was neutralized with hydrogen chloride to give the title compound (35.5% yield).
融点 222−225°.
I R (K B r)cm−’ : 3198,
1600, 1527. 1499NMR(CDCQ3
)δ: 1. 64(2H, m), 1. 75(
2H, m),2. 78(3H, s). 2. 9
5(2H, t), 3. 06(2t{, t),
a. 78(2H, d,J = 7. 25Hz),
7. 86(2H, d).元素分析値: C ,.
H ,.N.S CI22として計算値: C,50.
60; H,5.76; N,12.65.実測値
: C,50.80. H,5.78; N,12
.54.実施例101
1−(2−メトキシートランスースチリル)−5.6,
7.8−テトラヒドロー4H−チアゾロ[5,4−b]
アゼビン
実施例18と同様の方法により、シスー2−メトキシケ
イ皮酸、3−アミノーε一カブ口ラクタム及び五硫化燐
から表題化合物が得られた(収率32.1%)。融点1
67i70’ (酢酸エチルから再結晶).
I R (K B r)cII1−’ : 3278,
1616, 1596, 1539. 1492,1
464, 14:{1, 1366. 1246, 1
105, 1024、NMR(CDCI23)δ:
1. 68(28, s+), 1. 80(2H,
m),2. 89(2H, t), 3. 11(2H
, t), a. 8g(3H, s), 6、86(
6H, m).
元素分析値: C ,.H ,.N 2S Oとして計
算値: C,67.10. H,6.33; N,
9.78.7
53
s . ii. 20、
実測値: C,66.91; H,6.30; N
,9.64;S,11、38、
実施例102
2−(2−アミノー5−メチルフエニル)−5.6,7
.8−テトラヒドロー4H−チアゾロ[5,4b]アゼ
ビン
実施例18と同様の方法により、2−アミノ5−メチル
安息香酸、3−アミノーε一カブロラクタム及び五硫化
燐から表題化合物が得られたく収率l2.6%)。Melting point 222-225°. I R (K B r) cm-': 3198,
1600, 1527. 1499NMR (CDCQ3
) δ: 1. 64 (2H, m), 1. 75 (
2H, m), 2. 78 (3H, s). 2. 9
5 (2H, t), 3. 06(2t{, t),
a. 78 (2H, d, J = 7.25Hz),
7. 86 (2H, d). Elemental analysis value: C,.
H. N. S Calculated value as CI22: C, 50.
60; H, 5.76; N, 12.65. Actual value: C, 50.80. H, 5.78; N, 12
.. 54. Example 101 1-(2-methoxytrans-styryl)-5.6,
7.8-Tetrahydro 4H-thiazolo[5,4-b]
The title compound was obtained from cis-2-methoxycinnamic acid, 3-amino-ε-monolactam, and phosphorus pentasulfide in the same manner as in Azevin Example 18 (yield: 32.1%). Melting point 1
67i70' (recrystallized from ethyl acetate). IR(KBr)cII1-': 3278,
1616, 1596, 1539. 1492,1
464, 14:{1, 1366. 1246, 1
105, 1024, NMR (CDCI23) δ:
1. 68 (28, s+), 1. 80 (2H,
m), 2. 89 (2H, t), 3. 11 (2H
, t), a. 8g (3H, s), 6, 86 (
6H, m). Elemental analysis value: C,. H. Calculated as N 2 SO: C, 67.10. H, 6.33; N,
9.78.7 53 s. ii. 20. Actual value: C, 66.91; H, 6.30; N
,9.64;S,11,38, Example 102 2-(2-amino-5-methylphenyl)-5.6,7
.. 8-Tetrahydro-4H-thiazolo[5,4b]azebin By the same method as in Example 18, the title compound was obtained from 2-amino-5-methylbenzoic acid, 3-amino-epsilon-cabrolactam and phosphorus pentasulfide, yield 12 .6%).
融点 113−115°(酢酸エチルより再結晶).r
R (K B r)cII1−’ : 3404,
3350, 3296, 1623. 1558150
6, 1466, 1365, 1258. 1161
.NMR(CDC(!s)δ: 1. 68(2H,
m), 1. 82(2H, m),2. 24(3
H. s), 2. 90(2H, t), 3. 1
0(2H, t), a. 63(IH. d,J =
8.111z>.6.89(l}l,dd),7.1
8(IH,d,J= 1.49Hz)元素分析値:
C,4H,7NffSとして計算値・C,64,83;
H,6.61; N,16、20;S1236、
実測値: C,64.86; H,8.59; N
,16.43;S , i2. 36
実施例+03
2〜(3−アミノー4−メチルフエニル)−5,6.7
.8−テトラヒド口−4H−チアゾロ[5,4b]アセ
ピン
実旋例18と同様の方法により、3−アミノ4−メチル
安息香酸、3−アミノーε一カブロラクタム及び五硫化
燐から表題化合物が得られた(収率32 8%)。Melting point 113-115° (recrystallized from ethyl acetate). r
R(KBr)cII1-': 3404,
3350, 3296, 1623. 1558150
6, 1466, 1365, 1258. 1161
.. NMR(CDC(!s)δ: 1.68(2H,
m), 1. 82 (2H, m), 2. 24 (3
H. s), 2. 90 (2H, t), 3. 1
0(2H, t), a. 63 (IH. d, J =
8.111z>. 6.89 (l}l, dd), 7.1
8 (IH, d, J = 1.49Hz) Elemental analysis value:
Calculated value as C, 4H, 7NffS・C, 64, 83;
H, 6.61; N, 16, 20; S1236, Actual value: C, 64.86; H, 8.59; N
, 16.43; S, i2. 36 Example +03 2-(3-amino-4-methylphenyl)-5,6.7
.. 8-Tetrahydro-4H-thiazolo[5,4b]acepine The title compound was obtained from 3-amino-4-methylbenzoic acid, 3-amino-epsilon-cabrolactam and phosphorus pentasulfide in the same manner as in Example 18. (Yield 328%).
融点 135−137°
l R (K B r)cm−’ : 3436, 3
332, 3226, 1634, 1561,150
0, 1460, 1441. 13681258,N
M R (C D C Q3>δ: 1. 6g(
2H, m), 1. 82(2H, m),2. 1
7(3H, s), 2. 93(2H, t), 3
. 10(2H, t), 3. 60(21+,br
s), 7. 04(1.H, s), 7. 10(
2H, d)元素分析値: C ,.H ,,N3Sと
して計算値: C,64.83; H,6.61;
N,16、20;S , 12. 3B.
実測値:C,64、58; H,6.60; N,
16.04;S , 12. 12.
実施例104
2−(2−アミノー4−夕ロロフェニル)一56.7.
8−テトラヒドo−4i{−チアゾO [5 . 4b
]アゼビン
実施例l8と同様の方法により、2−アミ/4−クロロ
安息香酸、3−アミノーε一カブ口ラクタム及び五硫化
燐から表題化合物が得られた(収率6.7%)。Melting point 135-137° l R (K B r) cm-': 3436, 3
332, 3226, 1634, 1561, 150
0, 1460, 1441. 13681258,N
M R (C D C Q3>δ: 1.6g(
2H, m), 1. 82 (2H, m), 2. 1
7 (3H, s), 2. 93(2H, t), 3
.. 10 (2H, t), 3. 60(21+,br
s), 7. 04 (1.H, s), 7. 10(
2H, d) Elemental analysis value: C,. Calculated value as H,,N3S: C, 64.83; H, 6.61;
N, 16, 20; S, 12. 3B. Actual value: C, 64, 58; H, 6.60; N,
16.04;S, 12. 12. Example 104 2-(2-amino-4-ylolophenyl)-56.7.
8-tetrahydro-4i{-thiazo O [5. 4b
] The title compound was obtained from 2-amino/4-chlorobenzoic acid, 3-amino-epsilon monocab lactam and phosphorus pentasulfide in the same manner as in Azebin Example 18 (yield 6.7%).
融点 154−157°
I R (K B r)am”−’ : 3450,
3384, 1610, 1557. 1491146
5, 1371, 1264, 1148, 1064
.NMR(CDCf!.)δ: 1. 6g(2H,
m), 1. 82(2H, m)2. 89(21
{, t), 3. 10(2H, t), 3. 9
5(1H, brs), 6. 12(2t(brs)
, 6. 60(18, dd), 6. 69(IH
, d, J = 1. 91Hz), 7. 26(
IH, d, J= 8. 43Hz).元素分析値:
C ,3H ,.N3S CCとして計算値: C,
55.81; H,5.04; N,15.02;
S,11.46; Cff,+2.67,実測値:
C,55.70; H,5.02; N,14.8
7;S,11.49. CI2,12.65実施例1
05
2−(4−チオアセトアミ/フエニル)−5.6,7,
8−テトラヒドロ−4H−チアゾロ[5.4−bコアセ
ピン
実施例l8と同様の方広により、4−アセトアミ7安息
香酸、3−アミノーε一カブロラクタム文ひ五硫化燐か
ら表題化合物が得られた(収率10 3%)。Melting point 154-157° I R (K B r) am"-': 3450,
3384, 1610, 1557. 1491146
5, 1371, 1264, 1148, 1064
.. NMR (CDCf!.) δ: 1. 6g (2H,
m), 1. 82 (2H, m)2. 89 (21
{, t), 3. 10 (2H, t), 3. 9
5 (1H, brs), 6. 12(2t(brs)
, 6. 60 (18, dd), 6. 69 (IH
, d, J = 1. 91Hz), 7. 26(
IH, d, J=8. 43Hz). Elemental analysis value:
C,3H,. Calculated value as N3S CC: C,
55.81; H, 5.04; N, 15.02;
S, 11.46; Cff, +2.67, actual value:
C, 55.70; H, 5.02; N, 14.8
7;S, 11.49. CI2, 12.65 Example 1
05 2-(4-thioacetami/phenyl)-5.6,7,
8-Tetrahydro-4H-thiazolo[5.4-b Coasepin By the same method as in Example 18, the title compound was obtained from 4-acetamy7benzoic acid, 3-amino-ε-cabrolactam and phosphorus pentasulfide ( yield 103%).
融点 239−242°
I R (K B r)cm−’: 3434, 15
51, 1515 1496, 1454,+370.
NMR(d8−DMSO)δ: 1.59(2H,m
),1.72(2HII+). 2. 62(311,
s), 2. 80(2H, brs), 2. 9
8(211, brs)6. 25( I}]. br
s), 7. 70(2H, d, J = 8. 6
5Hz). 7. 89(2H,d), 11. 65
(1}1. brs)元素分析値: C I58 I7
N 33 2として計算値: C,59.37; H
,5.65; N,13.85;S , 21. 1
3.
実測値: C,58.92; H,5.66; N
,13.55;S , 21. 23
実施例106
2−(3〜アミノー4−メチルフェニル)−5.6,7
.8−テトラヒド口−4H−チアゾロ[5,4−b]ア
ゼピン・二塩酸塩
実施例18と同様の方法により、3−アミノー4−メチ
ル安息香酸、3−アミノーε〜カブロラクタム及び五硫
化燐を反応、精製後生成物を塩化水素で中和して表題化
合物が得られた(収率364%)。Melting point 239-242° I R (K B r) cm-': 3434, 15
51, 1515 1496, 1454, +370. NMR (d8-DMSO) δ: 1.59 (2H, m
), 1.72 (2HII+). 2. 62 (311,
s), 2. 80 (2H, brs), 2. 9
8 (211, brs)6. 25(I}].br
s), 7. 70 (2H, d, J = 8.6
5Hz). 7. 89 (2H, d), 11. 65
(1}1.brs) Elemental analysis value: C I58 I7
Calculated value as N 33 2: C, 59.37; H
, 5.65; N, 13.85; S, 21. 1
3. Actual value: C, 58.92; H, 5.66; N
, 13.55; S, 21. 23 Example 106 2-(3-amino-4-methylphenyl)-5.6,7
.. 8-tetrahydride-4H-thiazolo[5,4-b]azepine dihydrochloride 3-amino-4-methylbenzoic acid, 3-amino-ε~cabrolactam and phosphorus pentasulfide were reacted in the same manner as in Example 18. After purification, the product was neutralized with hydrogen chloride to obtain the title compound (yield 364%).
融点 170i73°
I R (K B r)cm−’ : 1604, 1
561, 1528. 1453, 1371.NMR
(d.−DMSO)δ: 1,66(2H,m),1
.83(2H,m), 2. 41(3H, s),
2. 92(2H, t), 3. 10(2H, t
), a. 35(2H, brs), 7. 37(
IH, s, J= 8. 05Hz), 7. 72
(2H, d), 7. 90(l}l, s).
元素分析値: C ,4H ,.N3S Cl22・0
. 5H ,Oとして
計算値, C,49.27: H,5.91. N
,12.31;S, 9.40; Cff 20
.77.実測値: C,49.20; H,5.57
; N,12.36;S, 9、53; C c
, 20. 86実施例107
2−(2−ピロリル)−5.6,7.8−テトラヒドロ
ー.4 H−チアゾロ[5.4−b]アゼビン・二塩酸
塩
実施例18と同様の方法により、ビロールー2カルボン
酸、3−アミノーε一カブ口ラクタム及び五硫化燐を反
応、精製後生成物を塩化水素で中和して表題化合物が得
られた(収率l8.6%)。Melting point 170i73° I R (K B r) cm-': 1604, 1
561, 1528. 1453, 1371. NMR
(d.-DMSO) δ: 1,66(2H,m),1
.. 83 (2H, m), 2. 41 (3H, s),
2. 92 (2H, t), 3. 10(2H, t
), a. 35 (2H, brs), 7. 37(
IH, s, J=8. 05Hz), 7. 72
(2H, d), 7. 90(l}l, s). Elemental analysis values: C,4H,. N3S Cl22.0
.. Calculated value as 5H, O, C, 49.27: H, 5.91. N
, 12.31; S, 9.40; Cff 20
.. 77. Actual value: C, 49.20; H, 5.57
; N, 12.36; S, 9, 53; C c
, 20. 86 Example 107 2-(2-pyrrolyl)-5.6,7.8-tetrahydro. 4 H-thiazolo[5.4-b]azevin dihydrochloride By the same method as in Example 18, virol-2 carboxylic acid, 3-amino-ε-monocuboid lactam and phosphorus pentasulfide were reacted, and the purified product was purified. Neutralization with hydrogen chloride gave the title compound (yield 18.6%).
融点 ] 10−113°(メタノールから再結晶),
I R (K B r)am−’ : 3430, 1
631, 1611, 1454, 1372,105
5.
N M R (C D C Q3’)δ: ]. 6
7(2H, m). 1. 74(2H, m),2.
84(2H, t), 3. 08(2+1, t)
, 6. 33(IH. dd), 7. 10(IH
dd), 7. 20(IH, brs).元素分析値
: C IIH 15N3S CLとして計算値: C
,45.21; H,5.17; N,14.38
;S , 10. 97.
実測値: C,45.46; H,5.13; N
,14.47;S , 10. 94
実施例108
2−(3−アミノー4−メトキシフェニル)−5,6,
7.8−テトラヒド口−4H−チアゾロ[5,4b]ア
セピン・二塩酸塩
実施例18と同様の方法により、3−アミノ4−メトキ
シ安息香酸、3−アミノーε一カブ口ラクタム及び五硫
化燐を反応、精製後生成物を塩化水素で中和して表題化
合物が得られた(収率13,0%)。Melting point] 10-113° (recrystallized from methanol),
I R (K B r) am-': 3430, 1
631, 1611, 1454, 1372, 105
5. N M R (C D C Q3') δ: ]. 6
7 (2H, m). 1. 74 (2H, m), 2.
84 (2H, t), 3. 08 (2+1, t)
, 6. 33 (IH. dd), 7. 10 (IH
dd), 7. 20 (IH, brs). Elemental analysis value: C IIH 15N3S Calculated value as CL: C
, 45.21; H, 5.17; N, 14.38
;S, 10. 97. Actual value: C, 45.46; H, 5.13; N
, 14.47;S, 10. 94 Example 108 2-(3-amino-4-methoxyphenyl)-5,6,
7.8-Tetrahydro-4H-thiazolo[5,4b]acepine dihydrochloride 3-amino-4-methoxybenzoic acid, 3-amino-epsilon lactam and phosphorus pentasulfide were prepared in the same manner as in Example 18. After reaction and purification, the product was neutralized with hydrogen chloride to obtain the title compound (yield 13.0%).
融点 194197°(メタノールから再結晶)I R
(K B r)cm−’ : 3318, 1603
, 1591, 1536. 1485,137+,
1352. 12g9, 1245, 1165. 1
035NMR(d.−DMSO)δ: 1.63(2
H,m),1.81(28m), 2. 90(2H,
t), 3. 08(2tl, t), 3. 94
(3H, s), 6. 05(2H, brs),
7. 27(LH, d, J= 8. 67}1z)
, 7. 81(IH, dd)7. 88(I}l,
d, J= 2. 12Hz)、元素分析値: C
,,H ,.N33 Cl2,0として計算値: C,
48.28; H,’5.50; N,12.06
;S, 9、21. Cff,20.36.実創値:
C,47.80; H,5.57; H,11.
82;S, 9.23; Cff,20.17.実施
例109
2−(4−アミノー3−メチルフェニル)−5+6.7
.8−テトラヒド口−4H−チアゾロ[5,4b]アゼ
ビン・二塩酸塩
実施例18と同様の方法により、4−アミノ3−メチル
安息香酸、3−アミノーε一カブ口ラクタム及び五硫化
燐を反応、精製後生成物を塩化水素で中和しで、表題化
合物が得られた(収率1l.3%)。Melting point 194197° (recrystallized from methanol) I R
(KBr)cm-': 3318, 1603
, 1591, 1536. 1485,137+,
1352. 12g9, 1245, 1165. 1
035NMR (d.-DMSO) δ: 1.63 (2
H, m), 1.81 (28m), 2. 90 (2H,
t), 3. 08 (2tl, t), 3. 94
(3H, s), 6. 05 (2H, brs),
7. 27 (LH, d, J= 8.67}1z)
, 7. 81 (IH, dd)7. 88(I}l,
d, J=2. 12Hz), elemental analysis value: C
,,H,. Calculated value as N33 Cl2,0: C,
48.28; H, '5.50; N, 12.06
;S, 9, 21. Cff, 20.36. Actual value:
C, 47.80; H, 5.57; H, 11.
82; S, 9.23; Cff, 20.17. Example 109 2-(4-amino-3-methylphenyl)-5+6.7
.. 8-Tetrahydro-4H-thiazolo[5,4b]azevin dihydrochloride 4-amino-3-methylbenzoic acid, 3-amino-epsilon-lactam and phosphorus pentasulfide were reacted in the same manner as in Example 18. After purification, the product was neutralized with hydrogen chloride to obtain the title compound (yield: 11.3%).
融点 240−243°(メタノールから再結晶).I
R (K B r)am”−’ : 3246. 2
582, 1607. 1521. 14951452
. 1374. 1359. 818NMR(d..−
DMSO)δ: l. 63(2H, m), 1.
76(2H,m), 2. 29(3H, s),
2. 92(2B, brs). 3. 06(2H.
brs),6. 20(2H, brs), 7.
18(IH, d, J = 8. 05Hz), 7
. 71(IHdd, J= 1. 87Hz), 7
. 73(IH, brs).元素分析値: C ,.
H ,.N3S CN2として計算値: C,50.6
0; H,5.76; N,12.65S, 9.
65; CI2,21.34.実測値: C,50.
64; H,5.85; N,12.61.S,
9.81; Cff,21.12.実施例110
2−(2−アミノー6−メチルフェニル)−56.7.
8−テトラヒド口−4H−チアゾロ[5.4一b]アゼ
ビン・二塩酸塩
実施例l8と同様の方法により、2−アミ/6−メチル
安息香酸、3−アミノーε一カブロラクタム及び五硫化
燐を反応、精製後生成物を塩化水素で中和しで、表題化
合物が得られた(収率16.0%)。Melting point 240-243° (recrystallized from methanol). I
R (K B r)am"-': 3246.2
582, 1607. 1521. 14951452
.. 1374. 1359. 818NMR(d..-
DMSO) δ: l. 63 (2H, m), 1.
76 (2H, m), 2. 29 (3H, s),
2. 92 (2B, brs). 3. 06 (2H.
brs), 6. 20 (2H, brs), 7.
18 (IH, d, J = 8.05Hz), 7
.. 71 (IHdd, J= 1.87Hz), 7
.. 73 (IH, brs). Elemental analysis value: C,.
H. Calculated value as N3S CN2: C, 50.6
0; H, 5.76; N, 12.65S, 9.
65; CI2, 21.34. Actual value: C, 50.
64; H, 5.85; N, 12.61. S,
9.81; Cff, 21.12. Example 110 2-(2-amino-6-methylphenyl)-56.7.
8-tetrahydride-4H-thiazolo[5.41b]azevin dihydrochloride 2-amino/6-methylbenzoic acid, 3-amino-epsilon-cabrolactam and phosphorus pentasulfide were prepared in the same manner as in Example 18. After reaction and purification, the product was neutralized with hydrogen chloride to obtain the title compound (yield: 16.0%).
融点 189−192°(メタノールか占再結晶)、I
R (K B r)cm−’ : 3256. 28
04, 1482, 1603, 156L1531,
14H, 1446. 13’70, 1355.
1282. 1250NMR(d.−DMS○)δ:
1. 68(2H, brs), ]. 7g(2H
, brs), 2. 22(3H, s), 2.
89(2H, t), 3. 11(2H, t),5
. 40(2H, brs), 6. 96(IH,
d), 7. 05(IH, d), 7. 30(I
Ht).
元素分析値: C 14H 18N35 C(22とし
て計算値: C,50.60; H,5.76.
N,!2、65;S, 9.65; Cl!,21J
4.実測値: C,5G.42; H,5.93;
N,12.43;S, 9.66; C(,21.
22.実施例III
2−メトキンカルボニル−5.6,7.8−テトラヒト
ロ−4H−チアゾロ[5.4 −b]アゼビン実施例2
3と同様の方法により、塩化メチルオキサリル、3−ア
ミノーε一カブ口ラクタム及び五硫化燐から表題化合物
が得られた(収率19,9%)。Melting point 189-192° (methanol or recrystallization), I
R(KBr)cm-': 3256. 28
04, 1482, 1603, 156L1531,
14H, 1446. 13'70, 1355.
1282. 1250NMR(d.-DMS○)δ:
1. 68 (2H, brs), ]. 7g (2H
, brs), 2. 22 (3H, s), 2.
89 (2H, t), 3. 11 (2H, t), 5
.. 40 (2H, brs), 6. 96 (IH,
d), 7. 05 (IH, d), 7. 30 (I
Ht). Elemental analysis value: C 14H 18N35 C (calculated value as 22: C, 50.60; H, 5.76.
N,! 2, 65; S, 9.65; Cl! ,21J
4. Actual value: C, 5G. 42; H, 5.93;
N, 12.43; S, 9.66; C (, 21.
22. Example III 2-methquinecarbonyl-5.6,7.8-tetrahytro-4H-thiazolo[5.4-b]azevin Example 2
The title compound was obtained from methyloxalyl chloride, 3-amino-ε-monolactam, and phosphorus pentasulfide in the same manner as in Example 3 (yield: 19.9%).
融点 166−168°(酢酸エチルから再結晶).l
R (K B r)c+n−’ : 3412, 3
314, 3264. 1716, 1441.138
1 1241
NMR(d.−DMso)δ: 1.69(2H,m
),1.84(28,m), 2. 98(21{,
t), 3. 17(2H, t), 3. 93(3
H, s), 4. 46(1H, brs).
元素分析値: C ,H ,N ,O ,Sとして計算
値: C,50.92. H,5.70. N.1
3.20;S , 15. 11.
実測値: C,50.98; H,5.71; N
,13.22;S , 15. 25
実施例112
2−(2−アミノー3−メチルフェニル)−5,6,7
.8−テトラヒドロー4H−チアゾロ[5,4−b]ア
ゼピン・二塩酸塩
実施例l8と同様の方法により、2−アミ7〜3−メチ
ル安息香酸、3−アミノーε一カブロラクタム及び五硫
化燐を反応、精製後生戊物を塩化水素で中和して表題化
合物が得られた(収率38.2%)。Melting point 166-168° (recrystallized from ethyl acetate). l
R(KBr)c+n-': 3412, 3
314, 3264. 1716, 1441.138
1 1241 NMR (d.-DMso) δ: 1.69 (2H, m
), 1.84 (28, m), 2. 98(21{,
t), 3. 17 (2H, t), 3. 93(3
H, s), 4. 46 (1H, brs). Elemental analysis value: Calculated value as C, H, N, O, S: C, 50.92. H, 5.70. N. 1
3.20;S, 15. 11. Actual value: C, 50.98; H, 5.71; N
, 13.22;S, 15. 25 Example 112 2-(2-amino-3-methylphenyl)-5,6,7
.. 8-Tetrahydro 4H-thiazolo[5,4-b]azepine dihydrochloride 2-Amino-7-3-methylbenzoic acid, 3-amino-epsilon-cabrolactam and phosphorus pentasulfide were reacted in the same manner as in Example 18. The title compound was obtained by neutralizing the purified raw extract with hydrogen chloride (yield: 38.2%).
融点 208−211°(メタノールから再結晶)T
R (K B r)am−’ : 342g, 157
g, 1542, 1513. 14681308,
1273.
NMR(do−DMSO)δ: 1. 66(2H,
m), 1. 81(2H,m). 2. 35(3
H, sl2. 90(2H, t). 3. 08(
2H, t), a. 29(2H, brs), 7
. 07(IH, t), ’y. 22(1B, d
). 7. 42(IH, d).元素分析値: C
,.H ,.N.S Bff,として計算値・C,50
.60; H,5.76; N,’12.65;S
, 9.65; C&,21、34.実測値: C,
50.69; H,5.73; N,12、58;
S, 9.64; CQ,21.41.実施例113
2−(2−アミノー4.5−ジメトキシフェニル)−5
.6.7.8−テトラヒドロ−4H−チアゾロ[5.4
−b]アゼビン・二塩酸塩
実施例18と同様の方注により、2−アミノー4,5−
ジメトキシ安息香酸、3−アミノーε,カブ口ラクタム
及び五硫化燐を反応、精製後生成物を塩化水素で中和し
て表題化合物が得られた(収率3,9%)。Melting point 208-211° (recrystallized from methanol) T
R(KBr)am-': 342g, 157
g, 1542, 1513. 14681308,
1273. NMR (do-DMSO) δ: 1. 66 (2H,
m), 1. 81 (2H, m). 2. 35 (3
H, sl2. 90 (2H, t). 3. 08(
2H, t), a. 29 (2H, brs), 7
.. 07 (IH, t), 'y. 22 (1B, d
). 7. 42 (IH, d). Elemental analysis value: C
、. H. N. Calculated value as S Bff, C, 50
.. 60; H, 5.76; N, '12.65; S
, 9.65; C&, 21, 34. Actual value: C,
50.69; H, 5.73; N, 12, 58;
S, 9.64; CQ, 21.41. Example 113 2-(2-amino-4,5-dimethoxyphenyl)-5
.. 6.7.8-Tetrahydro-4H-thiazolo[5.4
-b] Azevin dihydrochloride 2-amino-4,5-
Dimethoxybenzoic acid, 3-amino-[epsilon], Kabuguchi lactam, and phosphorus pentasulfide were reacted, and the purified product was neutralized with hydrogen chloride to obtain the title compound (yield 3.9%).
融点 194−197゜(メタノールから再結晶).I
R (K B r)cm−’ : 3444, 16
04, 1531, 1462, 1447,1396
. 1362, 1300. 127g, 1262.
1212, 1140, 1079.NMR(d.−
DMSO)δ: 1.63(2H,n+),1.82
(2B,m). 2. 92(2H, brs), 3
. 07(2tl, brs), 3. 81(3H,
s),3. 85(:3H, s), 7. 06(
IH, s), 7. 10(IH, s), 7.
10(2H,brs).
元素分析値: C .,H ,.N.S O ,CQ,
として計算値・C,47.62; H,5.59;
N,11.11;S, 8.48: (1!,11
74実測値: C,47.54; H,5.74;
N.10.98.S, 8,19; CI2,18
.54.実施例114
2−(3−アミノー4−メチルスチリル)−5,6,
7. 8−テトラヒドロー4H−チアゾロ[5,4−b
コアゼピン・二塩酸塩
実施例l8と同様の方法により、3−アミノー4−メチ
ルケイ皮酸、3−アミノーε一カブロラクタム及び五硫
化燐を反応、精製後生成物を塩化水素で中和しで、表題
化合物が得られた(収率11.8%)。Melting point: 194-197° (recrystallized from methanol). I
R(KBr)cm-': 3444, 16
04, 1531, 1462, 1447, 1396
.. 1362, 1300. 127g, 1262.
1212, 1140, 1079. NMR (d.-
DMSO) δ: 1.63 (2H, n+), 1.82
(2B, m). 2. 92 (2H, brs), 3
.. 07 (2tl, brs), 3. 81 (3H,
s), 3. 85(:3H, s), 7. 06(
IH, s), 7. 10 (IH, s), 7.
10 (2H, brs). Elemental analysis value: C. ,H,. N. SO,CQ,
Calculated value as C, 47.62; H, 5.59;
N, 11.11; S, 8.48: (1!, 11
74 actual value: C, 47.54; H, 5.74;
N. 10.98. S, 8,19; CI2,18
.. 54. Example 114 2-(3-amino-4-methylstyryl)-5,6,
7. 8-tetrahydro 4H-thiazolo[5,4-b
Coazepine dihydrochloride By the same method as in Example 18, 3-amino-4-methylcinnamic acid, 3-amino-ε-cabrolactam and phosphorous pentasulfide were reacted, and after purification, the product was neutralized with hydrogen chloride to obtain the title A compound was obtained (yield 11.8%).
融点 244−247°(メタノールから再結晶).I
R (K B r)am”−’ : 3446, 3
248, 1604. 1518. 1502,144
5, 1372, 1356, 1309, 956,
883, 818.NMR(d.−DMSO−D,O
)δ: 1.69(4Lm),2. 37(3H,
s), 2. 82(2H, brs), 3. 08
(2H. brs), 7. 32(2H, d),
7. 39(IH, d, J= 8. 06Hz),
7. 60(IH, d), 7. 63(IH,s
).
元素分析値: C,.H2,N3SCl2.として計算
値: C,53.63; H,5.91; N,1
1.73;S, 8.95; Cl2,19.79.
実測値:C,53、47; H,5.79; N,
11.73.S, 8.95− CR,19.54.
実施例115
2−[2−(6−メチル)ピリジル]−5.6.7.8
−テトラヒドロー4 8−チアゾロ[5.4 −b]ア
セビン・塩酸塩
実施例18と同様の方法により、6−メチルビコリン酸
、3−アミノーε一カブロラクタム及び五硫化燐を反応
、精製後生成物を塩化水素で中和して表題化合物か得ら
れた(収率40.8%)。Melting point 244-247° (recrystallized from methanol). I
R(KBr)am"-': 3446, 3
248, 1604. 1518. 1502, 144
5, 1372, 1356, 1309, 956,
883, 818. NMR (d.-DMSO-D,O
) δ: 1.69 (4Lm), 2. 37 (3H,
s), 2. 82 (2H, brs), 3. 08
(2H. brs), 7. 32 (2H, d),
7. 39 (IH, d, J = 8.06Hz),
7. 60 (IH, d), 7. 63(IH,s
). Elemental analysis value: C,. H2,N3SCl2. Calculated values as: C, 53.63; H, 5.91; N, 1
1.73; S, 8.95; Cl2, 19.79.
Actual value: C, 53, 47; H, 5.79; N,
11.73. S, 8.95-CR, 19.54.
Example 115 2-[2-(6-methyl)pyridyl]-5.6.7.8
-Tetrahydro4 8-thiazolo[5.4 -b]acevin hydrochloride 6-methylbicolinate, 3-amino-ε-cabrolactam and phosphorus pentasulfide were reacted in the same manner as in Example 18, and the purified product was chlorinated. Neutralization with hydrogen gave the title compound (yield 40.8%).
融点 185−188°(メタノールから再結晶).I
R (K B r)cm ’ : 3444, 32
12, 1582, 1567, 1533.1456
+370.1350.
NMR(d.−DMSO−D20)δ: 1.68(
2H,m),1. 80(2H, m), 2. 61
(3H, s), 2、93(2H, t), 3.
12(2H, t), 7. 39(18, d, J
= 7. 36Hz), 7. 87(IH, d,
J = 7. 77Hz),8. 00(In, t)
.
元素分析値: C .,H .,N.S CI2として
計算値: C,55.41; H,5.72. N
,14.91;S , 11. 38: C f2,
12. 58.実測値: C,55JO; H,5
.64; N,14.82;S , 11. 46;
C Q, 12. 18.実施例116
2−(3−シアノフエニル)−5.6,7.8−テトラ
ヒド口−4H−チアゾロ[5.4−b]アゼビン実施例
lと同様の方法により、3−(3−シアノベンゾイル)
アミノーε一カプロラクタムと五硫化燐から表題化合物
が得られた(収率41.5%)。融点174°(酢酸エ
チルから再結晶).I R (K B r)cm””
: 2914, 222g, 1523, 1483,
1461.1370,802.
NMR(CDCl23)δ: 1. 67−1. 9
1(4H, m), 2. 922. 98(2H,
m), 3. 14(2H. t, J = 5Hz)
, 7. 45(IH, t, J7Hz), 7.
55(IH. m). 7. 96(IH, m),
8. 04−8. 06(IH, m)元素分析値:
C ..8 .3N3Sとして計算値: C,65.8
5. H,5.13. N,16、46S , 1
2. 56
実測値: C,65.91: H,5.05: N
,16.65.S , 12. 53
実施例117
2−(4−ンアノフエニル)−5.6,7.8−テトラ
ヒド口−4H−チアゾロ[5.4−b]アゼピン実施例
lと同様の方法により、3−(4−シアノベンゾイル)
アミノーε一カブロラクタムと五硫化燐から表題化合物
が得られた(収率57,3%)。融点163−164°
(酢酸エチルから再結晶).I R (K B r)a
m ’ : 2222, 1507, 1439,11
73, 1356,834.
NMR(CDCI2s)δ: 1.60−1.91(
4H,+n),2.96(2H,t, J= 6Hz)
, 3. 15(2H, t, J = 5Hz),
4. 10(IFI, br. s),7. 63(2
H, d, J = 8t{z), 7. 84(2H
, d. J= 8Hz).元素分析値: C ,.H
,,N3Sとして計算値: C.65.85; H
,5.13; N,16.46;3 12.56
実測値: C,66.15; H,4.93; N
,16.52;S , 12. 4B.
実施例118
2−[2−(4−イミダゾリル)エテニル]−5,6,
7.8−テトラヒド口−4H−チアゾロ[5,4−b]
アゼピン・二塩酸塩
実施例18と同様の方法により、イミダゾール=4−ア
クリル酸 3−アミノーε一カブロラクタム及び五硫化
燐から表題化合物が得られた(収率12.2%)。融点
170−173°(メタノールから再結晶).
I R (K B r)cm−’ : 3326, 2
746. 1597, 1513, 1450,137
5. 1348.
NMR(d.−DMS O−D,O)δ : 1
.57−1.92(4H, i), 2. 86(2H
, I1), 3. 11(2H, n+), 7.
25(IH, d. J =16. 7Hz), 7.
49(IH, d. J= 16. 7Hz). 7
、88(IH, s),9. 17(IH, s).
元素分析値: C ,,H ..N.S CQ.・0.
5H .0として
計算値: C,43.91; H,5.22; N
,17.07;S, 9.77; CQ,21.6
0実測値: C,44.08. H,5.54.
N,17。24;S, 9,66; Cl2,21
.23実施例119
2−(4−エトキシホルムイミドイルフェニル)5,6
,7.8−テトラヒド口−4H−チアゾロ[E,4−b
コアゼピン・二塩酸塩
2−(4−ンア/フェニノレン−5.6,7.8−テト
ラヒド口−4H−チアゾロ[5.4−b]アゼピン(8
.OOg)のエタノール溶液(700d)に塩化水素を
飽和させ、1晩放置した。これを減圧下濃縮し、残留物
をエーテル洗浄後乾燥すると、融点146°(分解)の
粉末とし表題化合物か得られた(115!量10.9g
,収率93%)。Melting point 185-188° (recrystallized from methanol). I
R (K B r) cm': 3444, 32
12, 1582, 1567, 1533.1456
+370.1350. NMR (d.-DMSO-D20) δ: 1.68 (
2H, m), 1. 80 (2H, m), 2. 61
(3H, s), 2, 93 (2H, t), 3.
12 (2H, t), 7. 39 (18, d, J
= 7. 36Hz), 7. 87 (IH, d,
J = 7. 77Hz), 8. 00(In, t)
.. Elemental analysis value: C. ,H. ,N. S Calculated as CI2: C, 55.41; H, 5.72. N
, 14.91;S, 11. 38: C f2,
12. 58. Actual value: C, 55JO; H, 5
.. 64; N, 14.82; S, 11. 46;
CQ, 12. 18. Example 116 2-(3-cyanophenyl)-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b]azebin 3-(3-cyanobenzoyl)
The title compound was obtained from amino-ε-caprolactam and phosphorus pentasulfide (yield 41.5%). Melting point 174° (recrystallized from ethyl acetate). I R (K B r)cm""
: 2914, 222g, 1523, 1483,
1461.1370,802. NMR (CDCl23) δ: 1. 67-1. 9
1 (4H, m), 2. 922. 98 (2H,
m), 3. 14 (2H.t, J = 5Hz)
, 7. 45 (IH, t, J7Hz), 7.
55 (IH. m). 7. 96 (IH, m),
8. 04-8. 06 (IH, m) Elemental analysis value:
C. .. 8. Calculated value as 3N3S: C, 65.8
5. H, 5.13. N, 16, 46S, 1
2. 56 Actual value: C, 65.91: H, 5.05: N
, 16.65. S, 12. 53 Example 117 2-(4-anophenyl)-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b]azepine 3-(4-cyanobenzoyl) )
The title compound was obtained from amino-ε-cabrolactam and phosphorus pentasulfide (yield 57.3%). Melting point 163-164°
(Recrystallized from ethyl acetate). I R (K B r)a
m': 2222, 1507, 1439, 11
73, 1356, 834. NMR (CDCI2s) δ: 1.60-1.91 (
4H, +n), 2.96 (2H, t, J= 6Hz)
, 3. 15 (2H, t, J = 5Hz),
4. 10 (IFI, br. s), 7. 63(2
H, d, J = 8t{z), 7. 84 (2H
, d. J=8Hz). Elemental analysis value: C,. H
,, Calculated value as N3S: C. 65.85; H
, 5.13; N, 16.46; 3 12.56 Actual value: C, 66.15; H, 4.93; N
, 16.52;S, 12. 4B. Example 118 2-[2-(4-imidazolyl)ethenyl]-5,6,
7.8-Tetrahydro-4H-thiazolo[5,4-b]
Azepine dihydrochloride The title compound was obtained from imidazole 4-acrylic acid 3-amino-epsilon-cabrolactam and phosphorus pentasulfide in the same manner as in Example 18 (yield 12.2%). Melting point 170-173° (recrystallized from methanol). I R (K B r) cm-': 3326, 2
746. 1597, 1513, 1450, 137
5. 1348. NMR (d.-DMS O-D,O) δ: 1
.. 57-1.92 (4H, i), 2. 86 (2H
, I1), 3. 11 (2H, n+), 7.
25 (IH, d. J = 16.7Hz), 7.
49 (IH, d. J= 16.7Hz). 7
, 88 (IH, s), 9. 17 (IH, s). Elemental analysis values: C,,H. .. N. S CQ.・0.
5H. Calculated value as 0: C, 43.91; H, 5.22; N
, 17.07; S, 9.77; CQ, 21.6
0 actual value: C, 44.08. H, 5.54.
N, 17.24; S, 9,66; Cl2,21
.. 23 Example 119 2-(4-ethoxyformimidoylphenyl)5,6
,7.8-tetrahydro-4H-thiazolo[E,4-b
Coazepine dihydrochloride 2-(4-na/phenynolene-5.6,7.8-tetrahydride-4H-thiazolo[5.4-b]azepine (8
.. An ethanol solution (700d) of OOg) was saturated with hydrogen chloride and left overnight. This was concentrated under reduced pressure, and the residue was washed with ether and dried to obtain the title compound as a powder with a melting point of 146° (decomposition) (115! amount: 10.9 g).
, yield 93%).
I R (KBr)cm ’ : 1592. 152
9, 1495, 1443, 1352. 1071
NMR(d.−DMSO)δ: l. 40(3H,
t, J = 7Hz),1. 50−1. 90(4
}1, m), 2. 82−2. 94(2H, m
), 3、01−3. 12(2H, m>. 4.
66(2H, q, J= 7Hz), 7. 92(
28, d, J = 9}1z)8. 18(2H,
d, J= 9Hz).実施例120
2−(4−エトキシホルムイミドイルフェニル)−5.
6,7.8−テトラヒドロー4H−チア′ノロ[5.4
−b]アゼビン
2−(4−エトキシホルムイミドイルフェニル)5.6
,7.8−テトラヒド口−4H−チアゾロ[54−b]
アゼピン・二塩酸塩(1.5g)を重曹水で中和後、ク
ロロホルムで抽出した。抽出層は水洗、乾燥後、減圧下
溶媒を留去した。残留物をシリカゲルのカラムクロマト
グラフィーで精製し、融点14l−143°の粉末とし
て表題化合物が得られた(収量1.1g,収率87%)
。I R (KBr)cm': 1592. 152
9, 1495, 1443, 1352. 1071
NMR (d.-DMSO) δ: l. 40 (3H,
t, J = 7Hz), 1. 50-1. 90 (4
}1, m), 2. 82-2. 94 (2H, m
), 3, 01-3. 12 (2H, m>. 4.
66 (2H, q, J=7Hz), 7. 92(
28, d, J = 9}1z)8. 18 (2H,
d, J=9Hz). Example 120 2-(4-ethoxyformimidoylphenyl)-5.
6,7.8-tetrahydro4H-thia'noro[5.4
-b] azevin 2-(4-ethoxyformimidoylphenyl) 5.6
,7.8-tetrahydro-4H-thiazolo[54-b]
Azepine dihydrochloride (1.5 g) was neutralized with aqueous sodium bicarbonate and extracted with chloroform. The extracted layer was washed with water, dried, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography to obtain the title compound as a powder with a melting point of 14l-143° (yield: 1.1 g, yield: 87%).
.
I R (KBr)cm ’ : 1625, 151
3, 1411, 1370, 1328, 1090
.NMR(CDCf23)δ: l. 41(aH,
t, J−7Hzl 1. 571. 97(4}1,
m), 2. 89−3. 01(2H, m),
3. 06−3. 17(2H, m),4. 32(
2H, q, J= 7Hz), 7. 76(4H,
s).実施例121
2−(4−アミジノフェニル)−5.6,7.8テトラ
ヒド口−4H−チアゾロ[5.4−b]アセビン・二塩
酸塩
2−(4−エトキ/ホルムイミドイルフェニル)5,6
,7.8−テトラヒド口−4H−チアゾロ[5.4−b
]アゼビン・二塩酸塩(1.3g)のエタノールI液(
150m)にアンモニアを飽和させ、l晩放置した。析
出物を屏去後、2戸液を濃縮し、残留物を塩化水素で中
和する事により表題化合物を得たく収量0 5g,収率
42%)。I R (KBr)cm': 1625, 151
3, 1411, 1370, 1328, 1090
.. NMR (CDCf23) δ: l. 41(aH,
t, J-7Hzl 1. 571. 97(4}1,
m), 2. 89-3. 01 (2H, m),
3. 06-3. 17 (2H, m), 4. 32(
2H, q, J= 7Hz), 7. 76 (4H,
s). Example 121 2-(4-amidinophenyl)-5.6,7.8tetrahydro-4H-thiazolo[5.4-b]acevin dihydrochloride 2-(4-ethoxy/formimidoylphenyl)5 ,6
,7.8-tetrahydro-4H-thiazolo[5.4-b
]Azevin dihydrochloride (1.3g) in ethanol I solution (
150 m) was saturated with ammonia and left overnight. After filtering off the precipitate, the two-head solution was concentrated, and the residue was neutralized with hydrogen chloride to obtain the title compound (yield: 0.5 g, yield: 42%).
融点2l8−2200(メタノール・エーテルから再結
晶)5
r R (KBr)cm−’ : 3188. 167
1. 1596, 1502. 1369, 1450
.1438
NMR(d.−DMso)δ: 1. 56−1. 8
3(4H, m). 2. 81−2. 90(2H,
m), 3. 01−3. 11 (28, m),
7. 87(2H, d, J = 9Hz), 7
. 93(2H. d, J = 9Hz)元素分析値
: C .4H ,,N4S・2HCl!として計算値
: C,48.70; H,5.25: N,16.2
3S 9.29; Cl!,20.53.実測値:
C,4g.34; H.5.31; N,16.09;
S, 9.05; CI2,20.31.実施例122
’)−(A−IIJ.’J−ジメ千ルアミジノフエニル
)5,6,7.8−テトラヒド口−4H−チアゾロ[5
4−b]アゼビン・三塩酸塩
2−(4−エトキシホルムイミドイルフェニル)v +
6 .7 ,8−テトラヒド口−4H−チアゾロ[5
.4−b]アゼピン(1.6g)のエタノール溶液(7
0蚊)に3.8Mジメチルアミン・トルエン溶7夜(1
.6m)を加え、室温で1日撹拌した。反応液を濃縮し
、残留物をエーテルで洗浄した後塩化水素で中和する事
により表題化合物を得た(収量1.4g,収率63%)
。Melting point 2l8-2200 (recrystallized from methanol-ether) 5 r R (KBr) cm-': 3188. 167
1. 1596, 1502. 1369, 1450
.. 1438 NMR (d.-DMso) δ: 1. 56-1. 8
3 (4H, m). 2. 81-2. 90 (2H,
m), 3. 01-3. 11 (28, m),
7. 87 (2H, d, J = 9Hz), 7
.. 93 (2H. d, J = 9Hz) Elemental analysis value: C. 4H,,N4S・2HCl! Calculated value: C, 48.70; H, 5.25: N, 16.2
3S 9.29; Cl! , 20.53. Actual value:
C, 4g. 34;H. 5.31; N, 16.09;
S, 9.05; CI2, 20.31. Example 122')-(A-IIJ.'J-dimethylamidinophenyl)5,6,7.8-tetrahydro-4H-thiazolo[5
4-b]Azevin trihydrochloride 2-(4-ethoxyformimidoylphenyl)v +
6. 7,8-Tetrahydro-4H-thiazolo[5
.. 4-b] Ethanol solution of azepine (1.6 g) (7
0 mosquitoes) in 3.8M dimethylamine in toluene for 7 nights (1 mosquito).
.. 6m) was added and stirred at room temperature for 1 day. The reaction solution was concentrated, the residue was washed with ether, and then neutralized with hydrogen chloride to obtain the title compound (yield: 1.4 g, yield: 63%).
.
融点193−196°(メタノール・エーテルから再結
晶).
I R (KBr)cm−’ : 3100, 246
4, 2238, 1664, 1625, 1533
,1437.
NMR(d.−DMSO)δ: 1. 49−1. 9
6(4H, m), 2. 88−2、97(2H,
m), 3. 01−3. 26(8R, m), 7
. 69(2H. d, J = 8Hz), 8.
00(2H, d, J− 8Hz)元素分析値: C
.H −oN 4S ・3 H C Qとして計算値
: C,46.89: H,5.66: N,13.6
7;8.711H:Cθ. 25. 95
実測値: C,46.71; H,5.77; N,1
3.36;S, 8.02; CC,25.16実
施例123
2−(4−N−ペンジルアミジノフエニル)−5.6,
7.8−テトラヒド口−4H−チアゾロ[5,4b]ア
ゼピン・二塩酸塩
実施例122と同様の方広により、2−(4エトキノホ
ルムイミドイルフェニル)−5.6,7.8−テトラヒ
ド口−4H−チアゾロ[5,ib]アセピンとペンジル
アミンを反応させ、生成物を塩化水素で中和し表題化合
物を得た(収率38%)。Melting point 193-196° (recrystallized from methanol-ether). I R (KBr) cm-': 3100, 246
4, 2238, 1664, 1625, 1533
, 1437. NMR (d.-DMSO) δ: 1. 49-1. 9
6 (4H, m), 2. 88-2, 97 (2H,
m), 3. 01-3. 26 (8R, m), 7
.. 69 (2H. d, J = 8Hz), 8.
00 (2H, d, J- 8Hz) Elemental analysis value: C
.. H -oN 4S ・3 H C Calculated value as Q: C, 46.89: H, 5.66: N, 13.6
7;8.711H:Cθ. 25. 95 Actual value: C, 46.71; H, 5.77; N, 1
3.36; S, 8.02; CC, 25.16 Example 123 2-(4-N-penzylamidinophenyl)-5.6,
7.8-tetrahydride-4H-thiazolo[5,4b]azepine dihydrochloride 2-(4ethoquinoformimidoylphenyl)-5.6,7.8-tetrahydride was prepared by the same method as in Example 122. -4H-thiazolo[5,ib]acepine was reacted with penzylamine, and the product was neutralized with hydrogen chloride to obtain the title compound (yield 38%).
融点241−25i’(メタノール・エーテルから再結
晶)
I R (KBr)c+n ’゜2998, 1667
, 1599, 1520, 1497, 1369,
747.
N M R (do D M S O )δ: l.
55−1. 90(4}1, m), 2, 812
. 92(2H. m), 3. 01−3. 26(
2H. m), 4. 73(2H, d, J =
6Hz), 7. 38−7. 46(5H, m),
7. 88(4H, s).元素分析値: C ,,
H ,,N .S・2HCCとして計算値 C,57.
93; H,5.56; N,12.87;S, ?
.36; CQ,16、28.実測値: C,57.
48; H,5.55; N,12.76;S, 7
.48: CI2,16.41.実施例124
2−(4−N−メチルアミジノフエニル)−5,6,7
.8−テトラヒド口−4H−チアゾロ[5,4b]アゼ
ビン・二塩酸塩
実施例122と同様の方法により、2−(4エトキシホ
ルムイミドイルフエニル)−5.6,7.8−テトラヒ
ドロー4H−チアゾロ[5.1−b]アゼビンとメチル
アミン(メタノール溶演)を反応させ、生成物を塩化水
素で中和し表題化合物を得た(収率17%)。Melting point 241-25i' (recrystallized from methanol/ether) I R (KBr)c+n '゜2998, 1667
, 1599, 1520, 1497, 1369,
747. N M R (do D M SO ) δ: l.
55-1. 90(4}1, m), 2, 812
.. 92 (2H.m), 3. 01-3. 26(
2H. m), 4. 73 (2H, d, J =
6Hz), 7. 38-7. 46 (5H, m),
7. 88 (4H, s). Elemental analysis value: C,,
H,,N. Calculated value as S・2HCC C, 57.
93; H, 5.56; N, 12.87; S, ?
.. 36; CQ, 16, 28. Actual value: C, 57.
48; H, 5.55; N, 12.76; S, 7
.. 48: CI2, 16.41. Example 124 2-(4-N-methylamidinophenyl)-5,6,7
.. 8-tetrahydro-4H-thiazolo[5,4b]azevin dihydrochloride 2-(4ethoxyformimidoylphenyl)-5.6,7.8-tetrahydro-4H-thiazolo [5.1-b] Azevin and methylamine (in methanol) were reacted, and the product was neutralized with hydrogen chloride to obtain the title compound (yield 17%).
融点+81−186°(メタノール・エーテルから再結
晶),
I R (KBr)cm ’ : 30g6, 167
3, 1631, 1597. 151g, 1372
,1355 1125.
N M R (d6D M S O )δ:1.50−
1、91(4Fl. ml 2. 862. 97(2
H, m), 3. 00−3. 13(5H, m)
, 7. 88(4H, s).元素分析値 C,,H
,.N.S・2HCN−0.5H,○として
計算値: C,4g.91; H,5.75; N,1
5.21;S, 8.71; Cl!,19.25.実
測値: C,48.83; H,5.58; N,15
.29;S 8.96; CC,19.09.実施例
125
2−(3−エトキンホルムイミドイルフエニル)5.6
,7.8−テトラヒドロー4H−チアゾロ[5.4−b
]アゼピン
実施例119,120と同様の方法により、2(3−ン
アノフェニル)−5.6,7.8−テトラヒド口−4H
−チアゾロ[5.4−b]アゼピンから表題化合物を得
た(収率83 1%)。Melting point +81-186° (recrystallized from methanol/ether), I R (KBr) cm': 30g6, 167
3, 1631, 1597. 151g, 1372
, 1355 1125. N M R (d6D M SO ) δ: 1.50-
1,91(4Fl.ml 2.862.97(2
H, m), 3. 00-3. 13 (5H, m)
, 7. 88 (4H, s). Elemental analysis value C,,H
、. N. S・2HCN-0.5H, Calculated value as ○: C, 4g. 91; H, 5.75; N, 1
5.21; S, 8.71; Cl! , 19.25. Actual value: C, 48.83; H, 5.58; N, 15
.. 29; S 8.96; CC, 19.09. Example 125 2-(3-ethquinformimidoyl phenyl) 5.6
, 7.8-tetrahydro 4H-thiazolo[5.4-b
] 2(3-anophenyl)-5.6,7.8-tetrahydride-4H was prepared in the same manner as azepine Examples 119 and 120.
The title compound was obtained from -thiazolo[5.4-b]azepine (yield 83 1%).
融点 141−143°
I R (KBr)am−’ : 3218. 292
8, 1634, 1524, 1370. 1323
+071.
NMR(CDCC3)δ: 1. 43(3H, t,
J= 7Hz), t. 511. 97(4H,
m), 2. 86−3. 19(4H, m), 3
. 97(IH, br. s)4. 34(2H,
q, J= 711z). 7. 39(IH, t,
J = 8Hz), 7. 68(1tl. di,
J= lHz, 8tlz), 7. 82(IH,
dt, J = IHz. 8Hz),8. 10−
Ill. 14(1B. m).実施例126
2−(3−N,N−ジメチルアミジノフエニル)5,6
,7.8−テトラヒド口−4H−チアゾロ[5.4−b
]アゼピン・二塩酸塩
実施例122と同様の方広により、2−(3エトキシホ
ルムイミドイルフェニル)−5.6,7.8−テトラヒ
ド口−4H−チアゾロ[5.4−b]アゼピンとジメチ
ルアミン(トルエン溶液)を反応させ、生成物を塩化水
素で中和しで、表題化合物を得た(収率70%)。Melting point 141-143° I R (KBr)am-': 3218. 292
8, 1634, 1524, 1370. 1323
+071. NMR (CDCC3) δ: 1. 43 (3H, t,
J=7Hz), t. 511. 97 (4H,
m), 2. 86-3. 19 (4H, m), 3
.. 97 (IH, br. s) 4. 34 (2H,
q, J= 711z). 7. 39 (IH, t,
J = 8Hz), 7. 68 (1tl. di,
J=lHz, 8tlz), 7. 82 (IH,
dt, J = IHz. 8Hz), 8. 10-
Ill. 14 (1B.m). Example 126 2-(3-N,N-dimethylamidinophenyl)5,6
,7.8-tetrahydro-4H-thiazolo[5.4-b
]Azepine dihydrochloride By the same method as in Example 122, 2-(3ethoxyformimidoylphenyl)-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b]azepine and Dimethylamine (toluene solution) was reacted and the product was neutralized with hydrogen chloride to obtain the title compound (70% yield).
融点203−205°(メタノール・エーテルから再結
晶).
I R (KBr)cm−’ : 3022, 166
3, 1631, 1601, 1517, 1373
.NMR(d.−DMs○)δ: 1. 56−1.
85(4H, m), 2. 832.91(2H,
m), 2. 96−3. 08(2H, m), 2
. 99(3H, s), 3. 25(3H, s)
, 7. 52−7. 69(2H, m), 7.
95−7. 99(2H, m).元素分析値: CI
llH20N4S ’ 2HCQ”0.5HvOとして
計算値・C,50.25; H,6.06; N,14
.65;S, 8.39. Cl2,1g.54.
実測値: C,50,59; H,6.36; N,1
4.60;S, 8.46; (J7,1g.43
.実施例127
?(3−N−メチルアミジノフェニル)−5,6,7.
8−テトラヒド口−4H−チアゾロ[5,4−b]アゼ
ピン・二塩酸塩
実施例122と同様の方法により、2−(3エトキノホ
ルムイミドイルフェニル)−5.6,7.8−テトラヒ
ド口−4H−チアゾロ[5.4−b]アゼピンとメチル
アミン(メタノール溶液)を反応させ、生成物を塩化水
素で中和しで、表題化合物を得た(収率54%)。Melting point 203-205° (recrystallized from methanol-ether). I R (KBr) cm-': 3022, 166
3, 1631, 1601, 1517, 1373
.. NMR (d.-DMs○) δ: 1. 56-1.
85 (4H, m), 2. 832.91 (2H,
m), 2. 96-3. 08 (2H, m), 2
.. 99 (3H, s), 3. 25 (3H, s)
, 7. 52-7. 69 (2H, m), 7.
95-7. 99 (2H, m). Elemental analysis value: CI
Calculated value as llH20N4S '2HCQ''0.5HvO・C, 50.25; H, 6.06; N, 14
.. 65;S, 8.39. Cl2, 1g. 54.
Actual value: C, 50,59; H, 6.36; N, 1
4.60;S, 8.46; (J7,1g.43
.. Example 127? (3-N-methylamidinophenyl)-5,6,7.
8-tetrahydride-4H-thiazolo[5,4-b]azepine dihydrochloride 2-(3ethoquinoformimidoylphenyl)-5.6,7.8-tetrahydride was prepared in the same manner as in Example 122. -4H-thiazolo[5.4-b]azepine and methylamine (methanol solution) were reacted, and the product was neutralized with hydrogen chloride to obtain the title compound (yield 54%).
融点205−207°(メタ/−ル・エーテルから再結
晶),
I R (KBr)am−’ : 3192, 305
4, 1678, 1602, 1515, 1371
.NMR (d.− DMS O)δ月. 5g−1.
85(4H, m), 2, 842. 95(2H
, m), 3. 00−3. 10(5H, m),
?、64(IH, t, J= 8Hz), 7.
73−7. 76(II{, m), 8. 03−8
. 11(2H, m).元素分析値: C ,,H
..N.S・2HC(・o.5H,oとして
計算値: C,4g.91; H,5.75; N,1
5.21;S, +!.71; CC,19.25.実
測値:C,4g、55; H,5.66; N,15.
11;S, 8.65. CI2,19.15.実施例
128
2−(5−ペンズイミダゾリル)−5.6,7.8テト
ラヒドロー4H−チアゾロ[5.4−b]アゼビン・二
塩酸塩
実施例1と同様の方法により、3−(5−ペンズイミダ
ゾールカルポニル)アミノーε一カブ口ラクタムと五硫
化燐を反応させ、精製後塩化水素で中和しで、表題化合
物を得た(収率l4%)。Melting point 205-207° (recrystallized from methanol ether), I R (KBr) am-': 3192, 305
4, 1678, 1602, 1515, 1371
.. NMR (d.-DMSO) δ month. 5g-1.
85 (4H, m), 2, 842. 95 (2H
, m), 3. 00-3. 10 (5H, m),
? , 64 (IH, t, J= 8Hz), 7.
73-7. 76(II{, m), 8. 03-8
.. 11 (2H, m). Elemental analysis value: C,,H
.. .. N. Calculated value as S・2HC(・o.5H,o: C, 4g.91; H, 5.75; N, 1
5.21;S, +! .. 71; CC, 19.25. Actual value: C, 4g, 55; H, 5.66; N, 15.
11;S, 8.65. CI2, 19.15. Example 128 2-(5-penzimidazolyl)-5.6,7.8tetrahydro 4H-thiazolo[5.4-b]azevin dihydrochloride 3-(5-penzimidazolyl) The title compound was obtained by reacting the imidazolecarponyl)amino-ε monocab lactam with phosphorus pentasulfide, and neutralizing it with hydrogen chloride after purification (yield 14%).
融点208−210°(メタノール・エーテルから再結
晶)
I R (KBr)cm−’ : 292g, 272
6, 1605, 1514, 1375. 81g.
NMR (dll− DMS O)δ: l. 56−
1. 86C4H. m), 2. 862. 93(
2H, ITl), 3. 02−3. 07(28,
m), 7. 89(IH, d, J = 9Hz
), 7. 97(18, dd, J= 2Hz,
9Hz), 8. 18(IH, br. s),9.
66(LH, s).
元素分析値: C ,.H ,.N .S・2HCf2
−HtOとして
計算値: C,46.54; H,4.74; N,1
5.51;S, 8.88; Cff,19.63
実測値: C,46.72; H,4.92; N,1
5.20;S, 8.95; CQ,19.93.
実施例129
2−(3−ビリジル)−5.6,7.8−テトラヒドロ
ー4H−チアゾロ[5.4−b]アゼピン・二塩酸塩
実施例1と同様の方法により、3−ニコチノイルアミノ
ーε一カブ口ラクタムと五硫化燐を反応させ、精製後塩
化水素で中和しで、表題化合物を得た(収率66.0%
)。Melting point: 208-210° (recrystallized from methanol/ether) I R (KBr) cm-': 292g, 272
6, 1605, 1514, 1375. 81g.
NMR (dll-DMSO)δ: l. 56-
1. 86C4H. m), 2. 862. 93(
2H, ITl), 3. 02-3. 07(28,
m), 7. 89 (IH, d, J = 9Hz
), 7. 97 (18, dd, J= 2Hz,
9Hz), 8. 18 (IH, br. s), 9.
66 (LH, s). Elemental analysis value: C,. H. N. S・2HCf2
Calculated value as -HtO: C, 46.54; H, 4.74; N, 1
5.51; S, 8.88; Cff, 19.63
Actual value: C, 46.72; H, 4.92; N, 1
5.20; S, 8.95; CQ, 19.93.
Example 129 2-(3-biridyl)-5.6,7.8-tetrahydro 4H-thiazolo[5.4-b]azepine dihydrochloride 3-nicotinoylamino The title compound was obtained by reacting ε-1-cubic lactam with phosphorus pentasulfide, and neutralizing it with hydrogen chloride after purification (yield: 66.0%).
).
融点199−200°(メタノール・エーテルから再結
晶).
I R (KBr)am−’ : 3202, 273
0, 2478, 1552, 1499, 1370
.NMR(d. − DMS O)(5 : 1.56
−1.84(4B,m),2.842. 91(2H,
m), 3. 03−3. 08(2H, m),
7. 99(IH, dd, J=5Hz, 8Hz)
. 8. 70(IH, dt, J = 2Hz.
8Hz), 8. 76(II. dd.J= 2Hz
, 5Hz), 9. 09(IH, d, J =
2Hz).元素分析値: C ,2H ..N3S・2
HCQとして計算値: C,47.37. H.4.9
7. N,13.81;S,10.54; CN,23
.31.実測値: C,47.43; H.4.99:
N,13.95S,10.24; Cff,22,9
1.実施例130
2−(3−アミノメチル−4−メチルフエニル)−5.
6,7.8−テトラヒドロー4H−チアゾロ[5,l−
b]アゼピン・二塩酸塩
実施例18と同様の方法により、3−シアノ4−メチル
安息香酸、3−アミノーε一カブ口ラクタム及び五硫化
燐から2−(3−シアノー4ーメチルフェニル)−5.
6,7.8−テトラヒドロ4H−チアゾロ[5.4−b
]アゼビンを得た(収率74.7%)。Melting point 199-200° (recrystallized from methanol-ether). I R (KBr)am-': 3202, 273
0, 2478, 1552, 1499, 1370
.. NMR (d.-DMSO) (5: 1.56
-1.84 (4B, m), 2.842. 91 (2H,
m), 3. 03-3. 08 (2H, m),
7. 99 (IH, dd, J=5Hz, 8Hz)
.. 8. 70 (IH, dt, J = 2Hz.
8Hz), 8. 76 (II. dd. J = 2Hz
, 5Hz), 9. 09(IH, d, J =
2Hz). Elemental analysis values: C, 2H. .. N3S・2
Calculated value as HCQ: C, 47.37. H. 4.9
7. N, 13.81; S, 10.54; CN, 23
.. 31. Actual value: C, 47.43; H. 4.99:
N, 13.95S, 10.24; Cff, 22,9
1. Example 130 2-(3-aminomethyl-4-methylphenyl)-5.
6,7.8-tetrahydro 4H-thiazolo[5,l-
b] Azepine dihydrochloride 2-(3-cyano-4-methylphenyl)-5.
6,7.8-Tetrahydro 4H-thiazolo[5.4-b
] Azevin was obtained (yield 74.7%).
N M R (C D C 123)δ: 1. 71
(2H, m), 1. 84(2H, m),2.
55(3H,,s), 2. 94(2H, t),
3. 13(2H, t), 7. 31(IH, d
J= 8. 42Hz), 7. 84(1B, dd
, J = 1. 93, 8. 42Hz). 7.
98(IH, d. J = 1. 93Hz).次
に2−(3−ンアノー4−メチルフエニル)−5.6,
7.8−テトラヒド口−4H−チアゾロ[5,4−b]
アゼピン(6.12g)及び塩化コバルト6水和物(1
0.8g)のメタノール/テトラヒドロフランd合溶液
(30d/20d)を水冷し、これに水素化ほう素ナト
リウム粉末(8.6g)を少量ずつ加え室温で1時間撹
拌した。反応液に4N塩酸水溶?夜を加えて酸性とした
後、ジエチルエーテルで抽出し、水層をアンモニア水で
アルカリ性としで、クロロホルムで抽出した。抽出層は
硫酸マグ不ンウムで乾燥後、減圧下で溶媒を留去した。N M R (C D C 123) δ: 1. 71
(2H, m), 1. 84 (2H, m), 2.
55 (3H,,s), 2. 94 (2H, t),
3. 13 (2H, t), 7. 31 (IH, d
J=8. 42Hz), 7. 84 (1B, dd
, J = 1. 93, 8. 42Hz). 7.
98 (IH, d. J = 1.93Hz). Then 2-(3-anor-4-methylphenyl)-5.6,
7.8-Tetrahydro-4H-thiazolo[5,4-b]
Azepine (6.12 g) and cobalt chloride hexahydrate (1
A mixed solution of methanol/tetrahydrofuran d (30d/20d) containing 0.8 g) was cooled with water, and sodium borohydride powder (8.6 g) was added little by little thereto, followed by stirring at room temperature for 1 hour. 4N hydrochloric acid solution in the reaction solution? After making the mixture acidic by adding water, it was extracted with diethyl ether, and the aqueous layer was made alkaline with aqueous ammonia and extracted with chloroform. The extracted layer was dried over magnesium sulfate, and then the solvent was distilled off under reduced pressure.
残留物を/リカゲルのカラムで精製後、塩化水素で中和
し、表題化合物を得た(収率22.7%〉。The residue was purified with a Silica gel column and neutralized with hydrogen chloride to obtain the title compound (yield 22.7%).
融点245−248°(メタノールから再結晶).I
R (KBr)cm ’ : 3232, 2932,
+608. 1530, 1499, 1447,l
372
N M R ( D M S O )δ: l. 66
(2H, m), 1. 82(2H, m)+2.
40(3H, s), 2. 92(2H, br.
s). 3. 09(2B. br. s),4. 0
8(2H, br. s), 5、59(2H, br
. s), 7. 34(IH, d, J=8. 0
6Hz), 7. 80(IH, d, J= 8.
06Hz). 7. 89(IH, s).8. 56
(IH, br. s).
元素分析値: C,5H,.N3SCQt− 0.5H
.Oとして
計算値: C,50.70. H,6.24; N,1
1.83.S, 9,02; Cff,19.95.
実測値: C,50.33. H,6.02; N,1
1.74;S, 9.04; CQ,19.62.実
施例131
2−(4−シアノー3−メチルフエニル)−5,6,7
.8−テトラヒド口−4H−チアゾロ[5,4b]アゼ
ピン・塩酸塩
実施例l8と同様の方法により、4−シアノ3−メチル
安息香酸 3−アミノーε一カブ口ラクタム及び五硫化
燐を反応精製後、生成物を塩化水素で中和して表題化合
物が得られた(収率57.4%)。Melting point 245-248° (recrystallized from methanol). I
R (KBr)cm': 3232, 2932,
+608. 1530, 1499, 1447,l
372 NMR(DMSO)δ: l. 66
(2H, m), 1. 82 (2H, m)+2.
40 (3H, s), 2. 92 (2H, br.
s). 3. 09 (2B. br. s), 4. 0
8 (2H, br. s), 5, 59 (2H, br.
.. s), 7. 34 (IH, d, J=8.0
6Hz), 7. 80 (IH, d, J= 8.
06Hz). 7. 89 (IH, s). 8. 56
(IH, br.s). Elemental analysis values: C, 5H,. N3SCQt- 0.5H
.. Calculated value as O: C, 50.70. H, 6.24; N, 1
1.83. S, 9,02; Cff, 19.95.
Actual value: C, 50.33. H, 6.02; N, 1
1.74; S, 9.04; CQ, 19.62. Example 131 2-(4-cyano-3-methylphenyl)-5,6,7
.. 8-Tetrahydro-4H-thiazolo[5,4b]azepine hydrochloride After reaction and purification of 4-cyano-3-methylbenzoic acid, 3-amino-epsilon-lactam and phosphorus pentasulfide in the same manner as in Example 18. The product was neutralized with hydrogen chloride to give the title compound (yield 57.4%).
融点184−186°(メタノールから再結晶)I R
(KBr)cm−’ : 320g, 2514,
2224, 1593. 15+4 14861459
.1371.
NMR(d..−DMS○)δ: 1. 63(2H,
m), 1. 75(28, m), 2. 51(
3H, s), 3. 05(2H, t), 5.
82(IH, br. s), 7. 68(IH,
dd, J= 1. 44, 8、16Hz), 7.
76(LH, d, J= 8. 16Hz),7.
78(LH, S).
元素分析値: C 1sH r#N ss Cβとして
計算値: C,5g.91; H,5.27; N,1
3.74;S , 10. 4g; C 12, 11
. 59.実測値: C.58.58; H,5.22
; N,13.59;S , 10. 20: C f
f, 11. 42.実施例132
2−(4−アミノメチル−3−メチルフェニル)5,6
,7.8−テトラヒドロー4H−チアゾロ[5.4−b
]アゼビン・二塩酸塩
2−(4−シアノー3−メチルフェニル)−5.6,7
.8−テトラヒド口−4H−チアゾロ[5,4−b]ア
ゼピン(20g)及び塩化コバルト6水和物(35.3
g)のメタノール/テトラヒドロフラン混合溶液(9
0F!12/6 0d)を水冷し、これに水素化ほう素
ナトリウム粉末(3 3. 1 g)を少量ずつ加え室
温で20時間撹拌した。反応液に4N塩酸水溶岐を加え
て酸性とした後、ジエチルエーテルで抽出し、水層をア
ンモニア水でアルカリ性としてクロロホルムで抽出した
。抽出層は硫酸マグネシウムで乾燥後、減圧下で溶媒を
留去した。残留物をシリカゲルのカラムで精製後、塩化
水素で中和し、表題化合物を得た(収率20.1%)。Melting point 184-186° (recrystallized from methanol) I R
(KBr)cm-': 320g, 2514,
2224, 1593. 15+4 14861459
.. 1371. NMR (d..-DMS○) δ: 1. 63 (2H,
m), 1. 75 (28, m), 2. 51 (
3H, s), 3. 05 (2H, t), 5.
82 (IH, br. s), 7. 68 (IH,
dd, J=1. 44, 8, 16Hz), 7.
76 (LH, d, J = 8.16Hz), 7.
78 (LH, S). Elemental analysis value: C 1sH r#N ss Calculated value as Cβ: C, 5g. 91; H, 5.27; N, 1
3.74;S, 10. 4g; C 12, 11
.. 59. Actual value: C. 58.58; H, 5.22
; N, 13.59; S, 10. 20: C f
f, 11. 42. Example 132 2-(4-aminomethyl-3-methylphenyl)5,6
, 7.8-tetrahydro 4H-thiazolo[5.4-b
]Azevin dihydrochloride 2-(4-cyano-3-methylphenyl)-5.6,7
.. 8-Tetrahydro-4H-thiazolo[5,4-b]azepine (20 g) and cobalt chloride hexahydrate (35.3
g) methanol/tetrahydrofuran mixed solution (9
0F! 12/6 0d) was cooled with water, and sodium borohydride powder (33.1 g) was added little by little thereto, followed by stirring at room temperature for 20 hours. The reaction solution was made acidic by adding 4N aqueous hydrochloric acid, extracted with diethyl ether, and the aqueous layer was made alkaline with aqueous ammonia and extracted with chloroform. The extracted layer was dried over magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was purified with a silica gel column and then neutralized with hydrogen chloride to obtain the title compound (yield 20.1%).
融点246−250°(メタノールから再結晶)I R
(KBr)cm−’ : 3438, 3210,
2936, 1598, 1523. 1493,14
45, 1372.
NMR(d.−DMSO)δ: 1. 63(2H,
m), 1. 80(2H, m), 2. 41 (
3H, S), 2. 92(2H, br. s),
3. 08(2H, br. s),4. 03(2
H, br. s), 5. 6(1(2H, br.
s), 7. 51(IH. d, J=8、63H
z), 7. 72(2}1, m), 8. 56(
IH, brs).元素分析値:CI,H.N3SCQ
tとして計算値: C,52.02; H,6.11;
N,12.13.S, 9.26; CQ.20.4
1.実測値: C,51.93: H,6.34. N
,11,74.S, 8.98; Cff,20.25
.実施例133
2−(2−ピリジル)−5.6,7.8−テトラヒドロ
ー4H−チアゾロ[5.4−b]アゼビン・二塩酸塩
実施例1と同様の方法により、3−ピコリノイルアミ7
ーε一カブ口ラクタムと五硫化燐を反応させ、精製後生
成物を塩化水素で中和して表題化合物を得た(収率57
.4%)。Melting point 246-250° (recrystallized from methanol) I R
(KBr) cm-': 3438, 3210,
2936, 1598, 1523. 1493,14
45, 1372. NMR (d.-DMSO) δ: 1. 63 (2H,
m), 1. 80 (2H, m), 2. 41 (
3H, S), 2. 92 (2H, br.s),
3. 08 (2H, br.s), 4. 03(2
H, br. s), 5. 6(1(2H, br.
s), 7. 51 (IH. d, J=8, 63H
z), 7. 72(2}1, m), 8. 56(
IH, brs). Elemental analysis values: CI, H. N3SCQ
Calculated value as t: C, 52.02; H, 6.11;
N, 12.13. S, 9.26; CQ. 20.4
1. Actual value: C, 51.93: H, 6.34. N
, 11, 74. S, 8.98; Cff, 20.25
.. Example 133 2-(2-pyridyl)-5.6,7.8-tetrahydro 4H-thiazolo[5.4-b]azevin dihydrochloride 3-picolinoylamide 7
The title compound was obtained by reacting ε-1-cubic lactam with phosphorus pentasulfide and neutralizing the purified product with hydrogen chloride (yield: 57
.. 4%).
融点 181−183°(メタ/−ル・エチルエーテル
から再結晶),
I R (KBr)am ’ : 2508, 235
6, 1624, 1532, 1464, 777.
NMR(d8−DMSO)δ: 1. 60−1. 8
9(48, m), 2. 94(2tL t, J
= 6Hz), 3. 09−3. 14(2H, m
), 7. 45−7. 52(IH,m). 8.
03(IH, t, J = 8Hz), 8. 14
(IH, d, J= gHz),8. 56(IH,
d, J= 5Hz).元素分析値: C 12H
I3N3S・2HCCとして計算値: C,47.37
. H,4.97. N,13.81;S , 10.
54.
実剣値: C,47.28; H,4.93; N,1
3.95;S , 10. 32
実施例134
:2−[4−(4−メチルビペランニル)フエニル]5
,6,7.8−テトラヒト口−4H−チアゾロ[5,4
−b]アゼビン・三塩酸塩
実施例lと同様の方法により、i[4−(4メチルピペ
ランニル)ベンゾイル]アミノーε一力プロラクタムと
五硫化燐を反応させ、精製後生戊物を塩化水素で中和し
て表題化合物を得た(収率l7.5%)。Melting point 181-183° (recrystallized from methanol ethyl ether), I R (KBr)am': 2508, 235
6, 1624, 1532, 1464, 777.
NMR (d8-DMSO) δ: 1. 60-1. 8
9 (48, m), 2. 94 (2tL t, J
= 6Hz), 3. 09-3. 14 (2H, m
), 7. 45-7. 52 (IH, m). 8.
03 (IH, t, J = 8Hz), 8. 14
(IH, d, J= gHz), 8. 56 (IH,
d, J=5Hz). Elemental analysis value: C 12H
Calculated value as I3N3S・2HCC: C, 47.37
.. H, 4.97. N, 13.81; S, 10.
54. Actual sword value: C, 47.28; H, 4.93; N, 1
3.95;S, 10. 32 Example 134: 2-[4-(4-methylbiperanyl)phenyl]5
,6,7.8-tetrahydrogen-4H-thiazolo[5,4
-b] Azevin trihydrochloride By the same method as in Example 1, i[4-(4methylpiperanyl)benzoyl]amino-epsilon prolactam and phosphorus pentasulfide were reacted, and after purification, the raw botanical was chlorinated. Neutralization with hydrogen gave the title compound (yield 17.5%).
融点 176−177°(メタノール・エチルエーテル
から再結晶).
I R (KBr)am−’ : 3410, 269
8, 1601, 1537. 139g, 1251
.NMR(d.−DMSO)δ: 1. 57−1.
94(4H, m), 2. 79(3H, d, J
= 4Hz), 2. 93−2. 99(2H, m
), 3. 03−4. 11(10H, m), 7
. 1D2H, d, J= 9Hz), 7. 89
(2H, d, J = 9Hz).元素分析値: C
,8H ..N 4S・3HCf2・1.5H20と
して
計算値: C,46.51; H,6.50; N,1
2.05;S, 6.90.
実測値: C,46.76; H,6.48; N,1
2.25;S,6.72.
実施例135
2−(l−メチル−1.8−1.2.3−トリアン一ル
ー4−イル)−5.6,7.8−テトラヒドロ4H−チ
アゾロ[5.4−b]アゼビン・塩酸塩実施例1と同様
の方法により、3−(1−メチル−IH− 1.2.3
− トリアゾールー4−カルボニル)アミノーε一カブ
口ラクタムと五硫化燐を反応させ、精製後生成物を塩化
水素で中和して表題化合物を得た(収率45.5%)。Melting point 176-177° (recrystallized from methanol/ethyl ether). I R (KBr)am-': 3410, 269
8, 1601, 1537. 139g, 1251
.. NMR (d.-DMSO) δ: 1. 57-1.
94 (4H, m), 2. 79 (3H, d, J
= 4Hz), 2. 93-2. 99 (2H, m
), 3. 03-4. 11 (10H, m), 7
.. 1D2H, d, J= 9Hz), 7. 89
(2H, d, J = 9Hz). Elemental analysis value: C
, 8H. .. Calculated value as N 4S・3HCf2・1.5H20: C, 46.51; H, 6.50; N, 1
2.05;S, 6.90. Actual value: C, 46.76; H, 6.48; N, 1
2.25; S, 6.72. Example 135 2-(l-methyl-1.8-1.2.3-triane-1-4-yl)-5.6,7.8-tetrahydro 4H-thiazolo[5.4-b]azevin hydrochloric acid 3-(1-methyl-IH- 1.2.3
- Triazole-4-carbonyl)amino-ε-monolactam was reacted with phosphorus pentasulfide, and the purified product was neutralized with hydrogen chloride to obtain the title compound (yield 45.5%).
融点 199−201°(メタノールから再結晶)[
R (KBr)am ’ : 3216, 1610,
1567, 1521. 1495, 1353,1
232.
NMR(d.−DMSO)δ: 1. 55−1. 8
5(4H, m), 2. 812. 87(28,
m), 3. 04−3. 11(2}1, m),
4. 12(3H, s),9. 61(IH, s)
元素分析値: C,.H,3N,S − HC(とじて
計算値: C,44.19; H,5.19; N,2
5.77;S,11.80; Cf2,13.05.実
測値゜C,44.20. H,5.12; N,25.
61;S L1.56; C(!,12.82実施例
136
2−(インドール−3−イル)−5.6,7.8テトラ
ヒド口−4H−チアゾロ[5.4−b]アゼピン・塩酸
塩
実施例lと同様の方広により、3−(インドール−3−
カルポニル)アミノーε一カブロラクタムと五硫化燐を
反応させ、精製後生戊物を塩化水素で中和して表題化合
物を得た(収率9、8%)。Melting point 199-201° (recrystallized from methanol) [
R(KBr)am': 3216, 1610,
1567, 1521. 1495, 1353, 1
232. NMR (d.-DMSO) δ: 1. 55-1. 8
5 (4H, m), 2. 812. 87 (28,
m), 3. 04-3. 11(2}1, m),
4. 12 (3H, s), 9. 61 (IH, s) Elemental analysis value: C,. H, 3N, S - HC (calculated value: C, 44.19; H, 5.19; N, 2
5.77; S, 11.80; Cf2, 13.05. Actual value °C, 44.20. H, 5.12; N, 25.
61;S L1.56;C(!,12.82Example 136 2-(indol-3-yl)-5.6,7.8tetrahydro-4H-thiazolo[5.4-b]azepine/hydrochloric acid 3-(indole-3-
Carponyl)amino-ε-cabrolactam and phosphorus pentasulfide were reacted, and the purified product was neutralized with hydrogen chloride to obtain the title compound (yield 9, 8%).
融点 227−229°(メタノール・エチルエーテル
から再結晶).
r R (KBr)cm−’ : 3134, 160
9, 1495, 1435, 1346, 1241
.740
NMR(d−−DMSO)δ: 1. 60−1. 8
0(4H, m). 2. 912. 97(2H,
m), 3. 00−3. 10(2H, m), 7
. 27−7. 32(2H, m), 7. 56−
7. 61(IH. m), 7. 79−7. 84
(IH, m), 8. 67(IH, dJ=3Hz
).
元素分析値: C IsH 15N 3S ’ H C
(lとして計算値: C,58.90; H,5.27
; N,13.74S , 10. 48; C (1
. I1. 59.実測値: C,5g.79; H,
5.14; N,13.63;S,10.19; C(
!,11.32.実施例137
2−(4−クロo−3−ニトロフェニル)−5,6,7
.8−テトラヒド口−4H−チアゾロ[5,4b]アセ
ビン
実施例18と同様の方法により、4−クロロー3−ニト
ロ安息香酸、3−アミノーε一カブロラクタム及び五硫
化燐から表題化合物が得られた(収率30.7%)。Melting point 227-229° (recrystallized from methanol/ethyl ether). r R (KBr) cm-': 3134, 160
9, 1495, 1435, 1346, 1241
.. 740 NMR (d-DMSO) δ: 1. 60-1. 8
0 (4H, m). 2. 912. 97 (2H,
m), 3. 00-3. 10 (2H, m), 7
.. 27-7. 32 (2H, m), 7. 56-
7. 61 (IH. m), 7. 79-7. 84
(IH, m), 8. 67 (IH, dJ=3Hz
). Elemental analysis value: C IsH 15N 3S 'HC
(Calculated value as l: C, 58.90; H, 5.27
; N, 13.74S, 10. 48; C (1
.. I1. 59. Actual value: C, 5g. 79;H,
5.14; N, 13.63; S, 10.19; C(
! , 11.32. Example 137 2-(4-chloroo-3-nitrophenyl)-5,6,7
.. 8-Tetrahydro-4H-thiazolo[5,4b]acevin The title compound was obtained from 4-chloro-3-nitrobenzoic acid, 3-amino-epsilon-cabrolactam, and phosphorus pentasulfide in the same manner as in Example 18 ( yield 30.7%).
融点 116−118°(メタノールから再結晶)I
R (KBr)cm−’ : 3372, 1562.
1528. 14g4, 1440, H69,13
52, 1339, 1296. 1260NMR(C
DC(3)δ: 1. 71(28, m). l.
85(2H, m),2. 94(2H, t), 3
. 15(2H, t), 4. 09(If{, b
rs), ?. 5i(It{,d,J二8. 47H
z), 7. 86(IH, dd, J = 2.
17Hz, 8. 47Hz)8. 23(IH. d
, J二2.17Hz)元素分析値: C,3H,2N
,SC(20−0.5H20として
計算値・C,48.98; H,4.11; N,13
.18;C c, 11. 12.
実測値: C,49.35; H,3.84; N,1
3.09;C x, +0. 97.
実施例138
2−(l−メチル−2−ピロリル)−5.6,7.8−
テトラヒド口−4H−チアゾロ[5,4−b]アゼビン
・塩酸塩
実施例l8と同様の方法により、■−メチル2−ビロー
ルカルボン酸、3−アミノーε一カブ口ラクタム及び五
硫化燐を反応精製後、塩化水素で中和して表題化合物が
得られた(収率23.l%)。Melting point 116-118° (recrystallized from methanol) I
R(KBr)cm-': 3372, 1562.
1528. 14g4, 1440, H69,13
52, 1339, 1296. 1260NMR(C
DC(3)δ: 1. 71 (28, m). l.
85 (2H, m), 2. 94 (2H, t), 3
.. 15 (2H, t), 4. 09(If{, b
rs), ? .. 5i(It{,d,J28.47H
z), 7. 86 (IH, dd, J = 2.
17Hz, 8. 47Hz)8. 23 (IH. d
, J22.17Hz) Elemental analysis values: C, 3H, 2N
, SC (calculated value as 20-0.5H20 C, 48.98; H, 4.11; N, 13
.. 18; C c, 11. 12. Actual value: C, 49.35; H, 3.84; N, 1
3.09; C x, +0. 97. Example 138 2-(l-methyl-2-pyrrolyl)-5.6,7.8-
Tetrahydro-4H-thiazolo[5,4-b]azevin hydrochloride In the same manner as in Example 18, -methyl-2-pyrrolecarboxylic acid, 3-amino-epsilon lactam and phosphorus pentasulfide were reacted. After purification, the title compound was obtained by neutralization with hydrogen chloride (yield: 23.1%).
融点 193−196°(メタノールから再結晶).I
R (KBr)cm−’ : 343g, 3204
, 1610, 1528, 14134, 1472
1422, 1363, 1351. 1073NMR
(d8− DMS O − D .0)δ: l.
70(2}1, m)1.. 82(28. m),
2. 88(2H. t), 3. 11(2H, t
), 3. 88(3H, s)6. 20(IH,
m), 6.85(IH, m), 7. 05(IH
, m).元素分析値: C ,2H ,6N3S C
l!とじて計算値: C,53.42; H,5.98
; N,15.57S,11.89; CQ,13.1
4.実測値: C,53.55; H,6.06; N
,+5.72;S,12.00; C(1.12.8B
.実施例139
2−(1.2−ジメチル−5−ペンズイミダゾリル)−
5.6,7.8−テトラヒドロ−4H−チアゾロ[5.
4−blアゼピン・二塩酸塩
実施例18と同様の方法により、■,2−ジメチルベン
ズイミダゾール−5−カルボン酸、3アミノーε一力プ
口ラクタム及び五硫化燐を反応精製後、塩化水素で中和
して表題化合物が得られたく収率13.8%)。Melting point 193-196° (recrystallized from methanol). I
R (KBr)cm-': 343g, 3204
, 1610, 1528, 14134, 1472
1422, 1363, 1351. 1073NMR
(d8-DMSO-D.0)δ: l.
70(2}1, m)1. .. 82 (28. m),
2. 88 (2H.t), 3. 11(2H, t
), 3. 88 (3H, s)6. 20 (IH,
m), 6.85 (IH, m), 7. 05 (IH
, m). Elemental analysis values: C, 2H, 6N3S C
l! Calculated value: C, 53.42; H, 5.98
; N, 15.57S, 11.89; CQ, 13.1
4. Actual value: C, 53.55; H, 6.06; N
,+5.72;S,12.00;C(1.12.8B
.. Example 139 2-(1,2-dimethyl-5-penzimidazolyl)-
5.6,7.8-Tetrahydro-4H-thiazolo [5.
4-bl azepine dihydrochloride By the same method as in Example 18, ■,2-dimethylbenzimidazole-5-carboxylic acid, 3-amino-ε monolactam and phosphorus pentasulfide were reacted and purified, and then purified with hydrogen chloride. After neutralization, the title compound was obtained (yield: 13.8%).
融点 172−175°(メタノールから再結晶).J
R (KBr)cm−’ : 3428, 1601
, 1523. 1462, 1439, 1373,
1343,1251.
NMR(dll−DMSO−CDCI2s)δ: 1.
73(2H, m),1. 88(2H, m),
2. 93(3H, s), 3. 02(2H. m
), 3. 16(2H, m), 4. 01(3H
, s), 5. 07(LH, brs), 7.
98(2B, t, J= 9. 7111z), 8
. 32(IH, s)元素分析値: C ,.H ,
llN,S・2HCf2・2H.0として
計算値: C,47.18; H,5.94; N,1
3、75;S, 7.87; CR,17.41.実測
値: C,47.40; H,5.75; N,H.7
9;S, 8.12; C&,17.31.実施例
140
2−(1−メチルイミダゾール−5−イル)−5,6,
7.8−テトラヒドロ−4H−チアゾロ[5,4bコア
ゼピン・二塩酸塩
実施例1と同様の方法により、3−(1−メチルイミダ
ゾール−5−イルカルボニル)アミノーε一カブ口ラク
タムと五硫化燐を反応させ、精製後生成物を塩化水素で
中和して表題化合物を得た(収率21.9%)。Melting point 172-175° (recrystallized from methanol). J
R (KBr) cm-': 3428, 1601
, 1523. 1462, 1439, 1373,
1343, 1251. NMR (dll-DMSO-CDCI2s) δ: 1.
73 (2H, m), 1. 88 (2H, m),
2. 93 (3H, s), 3. 02 (2H. m
), 3. 16 (2H, m), 4. 01(3H
, s), 5. 07 (LH, brs), 7.
98 (2B, t, J= 9.7111z), 8
.. 32 (IH, s) Elemental analysis value: C,. H,
llN, S・2HCf2・2H. Calculated value as 0: C, 47.18; H, 5.94; N, 1
3, 75; S, 7.87; CR, 17.41. Actual measurements: C, 47.40; H, 5.75; N, H. 7
9; S, 8.12; C&, 17.31. Example 140 2-(1-methylimidazol-5-yl)-5,6,
7.8-Tetrahydro-4H-thiazolo[5,4b coazepine dihydrochloride By the same method as in Example 1, 3-(1-methylimidazol-5-ylcarbonyl)amino-ε-monolactam and phosphorus pentasulfide were prepared. After purification, the product was neutralized with hydrogen chloride to obtain the title compound (yield 21.9%).
融点 240−243°(メタ/−ルーエチルエーテル
から再結晶)
I R (KBr)am−’ : 3080, 256
(1, 1358. 142g, 1233, [09
、NMR(d.−DMSO)δ: 1. 52−1.
83(4H. m), 2. 84(2H, t, J
= 6Hz), 3. 00−3. 06(2H,
m), 4. 04(3H, s)8. 08(LH,
d, J= 2Hz), 9. 27(IH, br
. s),元素分析値: C ,,H ,4N4S・2
Hc(とじて計算値: C,43.00; H,5.2
5. N,18.24:S , 10. 44.
実測値: C,42.73; H,5.40; N,1
8.08;S , 10. 09,
実施例141
2−(1−メチルイミダゾール−4−イル)−5,6.
7.8−テトラヒド口−4H−チアゾロ[5,4bコア
ゼピン・二塩酸塩
実施例1と同様の方法により、3−(1−メチルイミダ
ゾールー4−イルカルボニル)アミノーε一カプロラク
タムと五硫化燐を反応させ、精製後生成物を塩化水素で
中和して表題化合物を得た(収率12.4%)。Melting point 240-243° (recrystallized from meta/-ruethyl ether) I R (KBr) am-': 3080, 256
(1, 1358. 142g, 1233, [09
, NMR (d.-DMSO) δ: 1. 52-1.
83 (4H.m), 2. 84 (2H, t, J
= 6Hz), 3. 00-3. 06 (2H,
m), 4. 04 (3H, s)8. 08(LH,
d, J=2Hz), 9. 27 (IH, br
.. s), elemental analysis value: C,,H,4N4S・2
Hc (calculated value: C, 43.00; H, 5.2
5. N, 18.24:S, 10. 44. Actual value: C, 42.73; H, 5.40; N, 1
8.08;S, 10. 09, Example 141 2-(1-methylimidazol-4-yl)-5,6.
7.8-tetrahydride-4H-thiazolo[5,4b coazepine dihydrochloride 3-(1-methylimidazol-4-ylcarbonyl)amino-ε-caprolactam and phosphorus pentasulfide were prepared in the same manner as in Example 1. After reaction and purification, the product was neutralized with hydrogen chloride to obtain the title compound (yield 12.4%).
融点 179−180’(メタノールーエチルエーテル
から再結晶).
I R (KBr)cm−’ : 3446, 302
6, 2596, 2370, 1475, 1438
,l298
NMR(d=−DMSO)δ: l. 55−1. 8
2(4}1, m), 2. 85(2H, t, J
= 6Hz). 3. 04(2H, t, J =
5Hz), 3. 84(3H, s),8. 15
(IH, s), 8. 86(IH, s).元素分
析値: C .,H ,.N4S − 2 H CNと
して計算値: C,43.00; H,5.25; N
,1g.24;S 10.44.
実測値: C,42.67; H,5.44; N,1
8.04;S . 10. 42.
実施例142
2−(3−アミノー4−クロロフェニル)−5,6,7
.8−テトラヒド口−4H−チアゾロ[5,4b]アゼ
ビン・二塩酸塩
2−(4−クロロ−3−ニトロフエニル)−5+6.7
.8−テトラヒドロ−4H−チアゾロ[5.4b]アゼ
ピン(4.3g,13.9mM)を酢酸(40d),水
(10d)の混合溶媒に溶かし、鉄(4.3g)を加え
て90゜Cで30分間加熱撹拌した。鉄を除去後、反応
液を濃縮して得られた残渣をシリカゲルのカラムで精製
した。これを塩化水素で中和して表題化合物が得られた
(収率28.8%)。Melting point 179-180' (recrystallized from methanol-ethyl ether). I R (KBr) cm-': 3446, 302
6, 2596, 2370, 1475, 1438
, l298 NMR (d=-DMSO) δ: l. 55-1. 8
2(4}1, m), 2. 85 (2H, t, J
= 6Hz). 3. 04(2H, t, J =
5Hz), 3. 84 (3H, s), 8. 15
(IH, s), 8. 86 (IH, s). Elemental analysis value: C. ,H,. Calculated value as N4S-2H CN: C, 43.00; H, 5.25; N
, 1g. 24;S 10.44. Actual value: C, 42.67; H, 5.44; N, 1
8.04;S. 10. 42. Example 142 2-(3-amino-4-chlorophenyl)-5,6,7
.. 8-Tetrahydro-4H-thiazolo[5,4b]azevin dihydrochloride 2-(4-chloro-3-nitrophenyl)-5+6.7
.. 8-Tetrahydro-4H-thiazolo[5.4b]azepine (4.3g, 13.9mM) was dissolved in a mixed solvent of acetic acid (40d) and water (10d), iron (4.3g) was added, and the mixture was heated at 90°C. The mixture was heated and stirred for 30 minutes. After removing iron, the reaction solution was concentrated and the resulting residue was purified using a silica gel column. This was neutralized with hydrogen chloride to obtain the title compound (yield 28.8%).
融点 195−197°(メタノールから再結晶),T
R (KBr)cm−’ : 3430, 321g
, 1603, 1521, 1489, 1437,
1373, 1329, 1251, 1053.NM
R(d.−DMS○)δ: l. 69(2H, m)
, 1. 82(2H, m), 2. 92(2H,
t, J = 5. 3Hz). 3. 11(2H
, t, J−5. 0Hz),5. 01(2H,
br. s), 7. 13(IH. dd, J =
2. 1Hz, 8. 4Hz),7. 29(IH
, d, J= 8. 4Hz), 7. 34(IH
, d, J= 2. 1Hz).元素分析値: C
..H .@N .S C Q3・0. 5H ,○と
して
計算値: C,47.86; H,5.25; N,1
2.8g.実測値: C,48.00. H,4.74
; N,12.81実施例143
2−(4−シアノー3−エチルフェニル)−5+6.7
.8−テトラヒド口−4H−チアゾロ[5,4b]アゼ
ビン
実施例l8と同様の方法により、4−シアノー3−エチ
ル安息香酸、3−アミノーε一カブ口ラクタム及び五硫
化燐から表題化合物が得られた(収率69.7%)。Melting point 195-197° (recrystallized from methanol), T
R (KBr)cm-': 3430, 321g
, 1603, 1521, 1489, 1437,
1373, 1329, 1251, 1053. N.M.
R(d.-DMS○)δ: l. 69 (2H, m)
, 1. 82 (2H, m), 2. 92 (2H,
t, J = 5. 3Hz). 3. 11 (2H
, t, J-5. 0Hz), 5. 01(2H,
br. s), 7. 13 (IH. dd, J =
2. 1Hz, 8. 4Hz), 7. 29 (IH
, d, J=8. 4Hz), 7. 34 (IH
, d, J=2. 1Hz). Elemental analysis value: C
.. .. H. @N. S C Q3・0. Calculated value as 5H, ○: C, 47.86; H, 5.25; N, 1
2.8g. Actual value: C, 48.00. H, 4.74
; N, 12.81 Example 143 2-(4-cyano-3-ethylphenyl)-5+6.7
.. 8-Tetrahydro-4H-thiazolo[5,4b]azebin The title compound was obtained from 4-cyano-3-ethylbenzoic acid, 3-amino-epsilon-lactam and phosphorus pentasulfide in a manner similar to Example 18. (yield 69.7%).
融点 103−105°(酢酸エチル,ヘキサンから再
結晶).
I R (KBr)Cm−’ : 3248. 221
6, 1603, 1536, 1497, 1449
,1372, 1359, 1306.
NMR (c D C(!3)δ: 1. 33(3H
, t, J= 7. 6Hz), 1. 70(2H
,m),1.84(2H,m),2.89(2}1,q
,J= 7.6Hz),2.96(2H, t, J
= 5. 8Hz), 3. 15(28. t, J
= 5. 1Hz), 4. 10(1H, br.
s), 7. 59(2H, m), 7. 75(
IH, S).元素分析値: C .,H ,,N 3
Sとして計算値:C,67、81; H,6.05;
N,14.83;S , 11. 31.
実測値: C,67.78; H,6.15; N,1
4.80;S , 11. 22
実施例144
2−(4−アミノメチル−3−エチルフェニル)5.6
,7.8−テトラヒドロ−4H−チアゾロ[5.4−b
]アゼピン・二塩酸塩
実施例132と同様の方法により、2−(4シアノー3
−エチルフエニル)−5.6.7.8−テトラヒド口−
4H−チアゾロ[5.4−b]アゼビン,塩化コバルト
6水和物及び水素化ほう素ナトリウムから表題化合物が
得られた(収率12.5%)。Melting point 103-105° (recrystallized from ethyl acetate, hexane). I R (KBr)Cm-': 3248. 221
6, 1603, 1536, 1497, 1449
, 1372, 1359, 1306. NMR (c D C(!3)δ: 1.33(3H
, t, J=7. 6Hz), 1. 70 (2H
, m), 1.84 (2H, m), 2.89 (2}1, q
, J= 7.6Hz), 2.96(2H, t, J
= 5. 8Hz), 3. 15 (28. t, J
= 5. 1Hz), 4. 10 (1H, br.
s), 7. 59 (2H, m), 7. 75(
IH, S). Elemental analysis value: C. ,H ,,N 3
Calculated value as S: C, 67, 81; H, 6.05;
N, 14.83; S, 11. 31. Actual value: C, 67.78; H, 6.15; N, 1
4.80;S, 11. 22 Example 144 2-(4-aminomethyl-3-ethylphenyl) 5.6
,7.8-tetrahydro-4H-thiazolo[5.4-b
]Azepine dihydrochloride 2-(4cyano 3
-ethylphenyl)-5.6.7.8-tetrahydride-
The title compound was obtained from 4H-thiazolo[5.4-b]azevin, cobalt chloride hexahydrate and sodium borohydride (yield 12.5%).
融点 235−238°(メタノールから再結晶).I
R (KBr)cm−’ : 2848, 1596
. 1520, 1451, 1439, 1374.
1348
N M R (da D M S O )δ; 1.
21(3H, t, J・7. 5Hz),1、64
(2H. m), 1. 78(2H, m), 2.
73(2H, q, J= 7. 5Hz),2.
9 1(2H, m), 3. 06(21 m),
4. 05(2H, d, J= 5. 4Hz),4
. 67(2H, br. s), 7. 52(IH
, d, J = 8. 1Hz), 7. 68(I
H,dd, J= 1. 8Hz, 8. 1Hz).
7. 72(IH, d, J= 1. 8Hz)8
. 53(IH, br. s)
元素分析値: C,8H,,N3S・28C(とじて計
算値 C,53.33; H,6.43・N,11.6
6実測値: C,53.Ht; H,6.46; N,
11.51.実施例145
2−(5−メチル−2−チェニル)−5.6.7.8−
テトラヒド口−4H−チアゾロ[5.4−b]アゼビン
・塩酸塩
実施例l8と同様の方法により、5−メチル2−チオフ
エンカルボン酸、3−アミノーε〜カブロラクタム及び
五硫化燐を反応精製後、塩化水素で中和して表題化合物
か得られた(収率33 4%)。Melting point 235-238° (recrystallized from methanol). I
R (KBr) cm-': 2848, 1596
.. 1520, 1451, 1439, 1374.
1348 N M R (da D M SO ) δ; 1.
21 (3H, t, J・7.5Hz), 1, 64
(2H.m), 1. 78 (2H, m), 2.
73 (2H, q, J= 7.5Hz), 2.
9 1 (2H, m), 3. 06 (21 m),
4. 05 (2H, d, J= 5.4Hz), 4
.. 67 (2H, br.s), 7. 52 (IH
, d, J = 8. 1Hz), 7. 68 (I
H, dd, J= 1. 8Hz, 8. 1Hz).
7. 72 (IH, d, J= 1.8Hz)8
.. 53 (IH, br. s) Elemental analysis value: C, 8H,, N3S・28C (calculated value C, 53.33; H, 6.43・N, 11.6
6 Actual measurement value: C, 53. Ht; H, 6.46; N,
11.51. Example 145 2-(5-methyl-2-chenyl)-5.6.7.8-
Tetrahydride-4H-thiazolo[5.4-b]azevin hydrochloride After reaction and purification of 5-methyl 2-thiophenecarboxylic acid, 3-amino-ε~cabrolactam and phosphorus pentasulfide in the same manner as in Example 18. After neutralization with hydrogen chloride, the title compound was obtained (yield: 334%).
融点 148−150’(メタノールから再結晶),I
R (KBr)am−’ : 3448. 3216
, 1602, 1544, 1520. 1447+
376. 1354, 1279.
N M R (d e D M S O )δ川,
60(2H, m), 1. 79(2H, m),
2. 46<3H, s), 2. 81(2H, t
, J = 5. 27Hz), 3. 05(2f{
, t,J= 5. 42Hz), 5. 13(IH
, br. s), 6. 82(IH, dd, J
=1. 14Hz, 3. 66Hz), 7. 31
(LH, d, J= 3. 66Hz).元素分析値
: C ItH I4N ts t ” H C Qと
して計算値: C,50.25; H,5.27; N
,9.77実測値: C,50.20; H,5.27
・N , 9. 79.実施例146
2−(1.3−ジメチルビラゾール−4−イル)−5.
6,7.8−テトラヒド口−4H〜チアゾロ[5.4−
b]アゼピン・塩酸塩
実施例1と同様の方法により、3−(1.3−ジメチル
ピラゾール−4−イルカルポニル)アミノε一カブ口ラ
クタムと五硫化燐を反応させ、精製後生成物を塩化水素
で中和して表題化合物を得た(収率l7.1%)。Melting point 148-150' (recrystallized from methanol), I
R(KBr)am-': 3448. 3216
, 1602, 1544, 1520. 1447+
376. 1354, 1279. N M R (d e D M SO ) δ River,
60 (2H, m), 1. 79 (2H, m),
2. 46<3H, s), 2. 81 (2H, t
, J = 5. 27Hz), 3. 05(2f{
, t, J=5. 42Hz), 5. 13 (IH
, br. s), 6. 82 (IH, dd, J
=1. 14Hz, 3. 66Hz), 7. 31
(LH, d, J= 3.66Hz). Elemental analysis value: C ItH I4N ts t ” H C Calculated value as Q: C, 50.25; H, 5.27; N
, 9.77 Actual value: C, 50.20; H, 5.27
・N, 9. 79. Example 146 2-(1,3-dimethylvirazol-4-yl)-5.
6,7.8-tetrahydride-4H~thiazolo[5.4-
b] Azepine hydrochloride By the same method as in Example 1, 3-(1,3-dimethylpyrazol-4-ylcarponyl)amino epsilon monocab lactam and phosphorus pentasulfide were reacted, and the purified product was chlorinated. Neutralization with hydrogen gave the title compound (yield 17.1%).
融点 2 15.0−2 17.0°(メタノールーエ
チルエーテルから再結晶).
I R (KBr)am”−’ : 320g, 27
54, 1612, 1519, 1438, 131
1NMR(d. 一DMS○)δ: 1. 55−1.
82(4H, m). 2. a5(3H, s),
2.88(2}1, t, J = 5[1z),
3. 05(2H, t, J−5Hz)3. 83(
3H, s), 8. 51(IH, s).元素分析
値:CI2HI6N4S−HCl2として計算値: C
,50.61; H,6.02; N,19.67;S
,11、26・C &, 12. 45.実測値:C,
50、47; H,6.14; N,19.71:S
, 11. 14; C c, 12. 76.実施例
1 4. 7
2−(1,3−ジメチルピラゾール−5−イル)−5.
6,7.8−テトラヒド口−4H−チアゾロ[54−b
]アゼピン・塩酸塩
実施例1と同様の方法により、3−(1.3−ジメチル
ビラゾール−5−イルカルボニル)アミノε一カブロラ
クタムと五硫化燐を反応させ、精製後生戊物を塩化水素
で中和して表題化合物を得た(収率40.1%)。Melting point 2 15.0-2 17.0° (recrystallized from methanol-ethyl ether). I R (KBr)am"-': 320g, 27
54, 1612, 1519, 1438, 131
1NMR (d. 1DMS○) δ: 1. 55-1.
82 (4H, m). 2. a5 (3H, s),
2.88(2}1, t, J = 5[1z),
3. 05 (2H, t, J-5Hz)3. 83(
3H, s), 8. 51 (IH, s). Elemental analysis value: Calculated value as CI2HI6N4S-HCl2: C
, 50.61; H, 6.02; N, 19.67; S
, 11, 26・C &, 12. 45. Actual value: C,
50, 47; H, 6.14; N, 19.71:S
, 11. 14; C c, 12. 76. Example 1 4. 7 2-(1,3-dimethylpyrazol-5-yl)-5.
6,7.8-Tetrahydro-4H-thiazolo[54-b
]Azepine hydrochloride By the same method as in Example 1, 3-(1,3-dimethylvirazol-5-ylcarbonyl)amino e-cabrolactam and phosphorus pentasulfide were reacted, and after purification, the raw product was treated with hydrogen chloride. Neutralization gave the title compound (yield 40.1%).
融点 273.0−275.00(メタノールー工−テ
ルから再結晶).
I R (KBr)c+n ’ : 3200, 16
06, 1467, 1441, 1355, 126
9.NMR(d.−DMSO)δ: l. 54−1.
83(4H, m), 2. 15(3H, s),
2. 83(2B, t, .+ =6Hz), 3
. 02(2H, t, J= 5Hz)4. 01(
3H, s). 6. 34(IH, s).元素分析
値: C ,,H ,.N.S − H CI2として
計算値: C,50.61; H,6.02; N,1
9.67;S , 11. 26.
実測値: C,50.39. H,6.03: N,1
9.65;S , 11. 66
実施例148
2−[2−(3−インドリル)エテニル]−5.6,7
,8−テトラヒド口−4H−チアゾロ[5.4−b]ア
ゼピン・二塩酸塩
実施例lと同様の方法により、3−(3−インドリルア
クリロイル)アミノ〜ε一カブロラクタムと五硫化燐を
反応させ、精製後生成物を塩化水素で中和して表題化合
物を得た(収率49.5%)。Melting point 273.0-275.00 (recrystallized from methanol-ether). I R (KBr)c+n': 3200, 16
06, 1467, 1441, 1355, 126
9. NMR (d.-DMSO) δ: l. 54-1.
83 (4H, m), 2. 15 (3H, s),
2. 83 (2B, t, .+ = 6Hz), 3
.. 02 (2H, t, J=5Hz)4. 01(
3H, s). 6. 34 (IH, s). Elemental analysis values: C,,H,. N. Calculated value as S-H CI2: C, 50.61; H, 6.02; N, 1
9.67;S, 11. 26. Actual value: C, 50.39. H, 6.03: N, 1
9.65;S, 11. 66 Example 148 2-[2-(3-indolyl)ethenyl]-5.6,7
, 8-Tetrahydro-4H-thiazolo[5.4-b]azepine dihydrochloride 3-(3-indolylacryloyl)amino~ε-cabrolactam and phosphorus pentasulfide were reacted in the same manner as in Example 1. After purification, the product was neutralized with hydrogen chloride to obtain the title compound (yield: 49.5%).
融点 235.0−237.0’ (メタノールーエチ
ルエーテルから再結晶).
I R (KBr)am−’ : 1614, 157
5, 1501, 1434, 1239. 938N
MR(d.−DMSO)δ: 1. 69(4H, b
r. s), 2、80−2. 86(2B, n+)
, 3. 05−3. 12(2H, n+), 7.
16−7. 28(2}1, m)7.38(IH,
d, J = 16Hz), 7. 44−7. 5
3(IH, m), 7. 83(1[1,d, J
= 1611z), 7. 91(IH, d, J
= 3Hz), 7. 94−7. 99(IH,m)
元素分析値 C ,7H .,N3S − 2 H C
Cとして計算値: C,55.44; H,5.20:
N,11.41;S,8.71
実測値: C,55.40; H,5.40. N,1
1.22;3 8.55
実施例1 4. 9
2−(1.5−シメチルピラゾール−3−イル)5.6
,7.8−テトラヒド口−4H−チアゾロ[54−b]
アセピノ・塩酸塩
実施例1と同様の方法により、3(1.5−7メチルピ
ラゾール−3−イルカルボニル)アミノε一カブロラク
タムと五硫化燐を反応させ、精製後生成物を塩化水素で
中和して表題化合物を得た(収率25.3%)。Melting point 235.0-237.0' (recrystallized from methanol-ethyl ether). I R (KBr)am-': 1614, 157
5, 1501, 1434, 1239. 938N
MR (d.-DMSO) δ: 1. 69 (4H, b
r. s), 2, 80-2. 86 (2B, n+)
, 3. 05-3. 12 (2H, n+), 7.
16-7. 28(2}1, m)7.38(IH,
d, J = 16Hz), 7. 44-7. 5
3 (IH, m), 7. 83(1[1,d, J
= 1611z), 7. 91 (IH, d, J
= 3Hz), 7. 94-7. 99 (IH, m) Elemental analysis value C, 7H. ,N3S-2HC
Calculated value as C: C, 55.44; H, 5.20:
N, 11.41; S, 8.71 Actual value: C, 55.40; H, 5.40. N,1
1.22; 3 8.55 Example 1 4. 9 2-(1.5-dimethylpyrazol-3-yl)5.6
,7.8-tetrahydro-4H-thiazolo[54-b]
Asepino hydrochloride By the same method as in Example 1, 3(1.5-7methylpyrazol-3-ylcarbonyl)amino epsilon-cabrolactam and phosphorus pentasulfide were reacted, and after purification, the product was neutralized with hydrogen chloride. The title compound was obtained (yield 25.3%).
融点 207.0−208.0’ (メタノールーエチ
ルエーテルかS再結晶)
+ R (KBr)cm ’ : 31g8, 293
4, 1604, 1556, 1354. 1241
11NMR(d.−DMS○)δ: 1. 55−1.
82(4H, m). 2. 30(3H, s),
2. 83−2. 90(2H, m), 3. 0
5(2H, t, J = 5Hz),3. 78(3
H. s), 6. 78(IH. s).元素分析値
: C 1tH +−N−S ’ H CQ・0.3H
tOとして
計算値: C,49.66; H,6.11; N,1
9.31S L1.05; Cf2,12.22実測
値: C,49.68; H,6.20; N,19.
28S , 10. 97. C Q. 11. 92
.実施例150
1−(5.7−ジメチルピラゾロ[1.5−aコビリミ
ジン−3−イル)−5.6,7.8−テトラヒドロ4H
−チアゾロ[5.4−b]アゼピン・二塩酸塩実施例1
と同様の方法により、3−(5.7一ンメチルビラゾロ
[1.5−a]ピリミシン−3−イルカルホニル)アミ
ノーε一カブ口ラクタムと五硫化燐を反応させ、精製後
生成物を塩化水素で中和して表題化合物を得た(収率2
8.3%)。Melting point 207.0-208.0' (methanol-ethyl ether or S recrystallization) + R (KBr) cm': 31g8, 293
4, 1604, 1556, 1354. 1241
11NMR (d.-DMS○) δ: 1. 55-1.
82 (4H, m). 2. 30 (3H, s),
2. 83-2. 90 (2H, m), 3. 0
5 (2H, t, J = 5Hz), 3. 78(3
H. s), 6. 78 (IH.s). Elemental analysis value: C 1tH +-N-S'H CQ・0.3H
Calculated value as tO: C, 49.66; H, 6.11; N, 1
9.31S L1.05; Cf2, 12.22 actual value: C, 49.68; H, 6.20; N, 19.
28S, 10. 97. C Q. 11. 92
.. Example 150 1-(5.7-dimethylpyrazolo[1.5-a cobyrimidin-3-yl)-5.6,7.8-tetrahydro 4H
-thiazolo[5.4-b]azepine dihydrochloride Example 1
By the same method as above, 3-(5.71-methylvirazolo[1.5-a]pyrimicin-3-ylcarbonyl)amino-epsilon-lactam and phosphorus pentasulfide were reacted, and after purification, the product was neutralized with hydrogen chloride. The title compound was obtained (yield: 2
8.3%).
融点 249.0−252.0°(メタノールーエチル
エーテルから再結晶).
I R (KBr)cm ’ : 2622, 162
1, 1572. 1543, 1442. 1237
NMR(d,−DMS○)δ : l. 73(4H,
br. s), 2. 64(3H, s), 2.
76(3H, s), 2. 87−2. 92(2
H, m), a, 05−3. 11(2H, m)
, 7. 20(IH, s), 9. 03(LH,
s).元素分析値・C ,5H ,7N.S・2HC
Qとして計算値: C,4839. H,5.14;
N,1g.81;S, 8.61.
実測値: C,48.06; H,5.05; N,1
8.58:S874
実施例151
2−(2−ビフエニリル)−5.6,7.8−テトラヒ
ドロー4H−チアゾロ[5,4−b]アセピン実施例1
と同様の方広により、3−(2−ビフエニリルカルボニ
ル)アミノーε一カブロラクタムと五硫化燐を反応させ
、表題化合物を得た(収率10.3%)。Melting point: 249.0-252.0° (recrystallized from methanol-ethyl ether). I R (KBr) cm': 2622, 162
1, 1572. 1543, 1442. 1237
NMR(d,-DMS○)δ: l. 73 (4H,
br. s), 2. 64 (3H, s), 2.
76 (3H, s), 2. 87-2. 92(2)
H, m), a, 05-3. 11 (2H, m)
, 7. 20 (IH, s), 9. 03(LH,
s). Elemental analysis values: C, 5H, 7N. S・2HC
Calculated value as Q: C, 4839. H, 5.14;
N, 1g. 81;S, 8.61. Actual value: C, 48.06; H, 5.05; N, 1
8.58:S874 Example 151 2-(2-biphenylyl)-5.6,7.8-tetrahydro 4H-thiazolo[5,4-b]acepine Example 1
3-(2-biphenylylcarbonyl)amino-ε-cabrolactam and phosphorus pentasulfide were reacted in the same manner as above to obtain the title compound (yield 10.3%).
融点 14 1.0−142.0’ (シクロヘキサン
から再結晶)
I R (KBr)cm ’ : 3222, 293
4, 1533. 14g4, 1372. 7496
98.
NMR(CDCC3)δ: I. 58−1. 82(
4H, m), 2. 87−2. 93(2H, m
), 2. 96−3. 02(21+, m), 7
. 23−7. 44(8H. m), 7.98−8
. 04(18, m)
元素分析値: C ,.H ,.N2Sとして計算値・
C,74.47; H,5.92. N,9.14.S
, 10. 46.
実測値: C,74.75; H,6.01; N,8
.92;3 10.15
実施例152
1−[2−(1−メチルイミタゾールー5−イル)エテ
ニル]−5.6,7.8−テトラヒド口−4Hチアゾロ
[5.4−b]アセピン・二塩酸塩実施例1と同様の方
広により、3−(1−メチルイミダゾール−5−イルア
クリロイル)アミノε一カブロラクタムと五硫化燐を反
応させ、精製後生戊物を塩化水素で中和した表題化合物
を得た(収率6.3%)。Melting point 14 1.0-142.0' (recrystallized from cyclohexane) I R (KBr) cm': 3222, 293
4, 1533. 14g4, 1372. 7496
98. NMR (CDCC3) δ: I. 58-1. 82(
4H, m), 2. 87-2. 93 (2H, m
), 2. 96-3. 02 (21+, m), 7
.. 23-7. 44 (8H.m), 7.98-8
.. 04 (18, m) Elemental analysis value: C,. H. Calculated value as N2S
C, 74.47; H, 5.92. N, 9.14. S
, 10. 46. Actual value: C, 74.75; H, 6.01; N, 8
.. 92;3 10.15 Example 152 1-[2-(1-methylimitazol-5-yl)ethenyl]-5.6,7.8-tetrahydro-4Hthiazolo[5.4-b]acepine・Dihydrochloride 3-(1-methylimidazol-5-ylacryloyl)aminoε-cabrolactam and phosphorus pentasulfide were reacted in the same manner as in Example 1, and after purification, the raw product was neutralized with hydrogen chloride. The title compound was obtained (yield 6.3%).
融点 249.0−250.0’ (メタノールから再
結晶).
I R (KBr)am−’ : 2726, 159
6, 1501, 1372, 1349. 1251
NMR(d.−DMS○)δ: ]. 53−1. 7
7(4H. m), 2. 782.86(2H,m)
.2.98−3.f)5(2L m’).3.89(3
}1,s).7.10(IH, d, J= 16.
2Hz), 7. 32(IH. d, J = 16
. 2Hz), 8. 06(IH, s), 9.
08(IH, s).元素分析値: C ,.H .a
N.S ・2 H Cl2として計算値: C,46.
85. H,5.44. N,16.81.S 9.
62; CC,21.27
実副値: C,46.61; H,5.50; N,1
6.52;8 9.33; CQ..21.2B.実
施例153
2−[2−(ヘンズイミダゾール−5−イル)エテニル
]−5.6.7.8−テトラヒド口−4H−チアゾロ[
5,4−b]アゼピン・二塩酸塩実施例l8と同様の方
注により、5−ペンズイミタゾリルアクリル酸、3〜ア
ミノーε一カブ口ラクタム及び五硫化燐を反応させ、精
製後生戊物を塩化水素で中和した表題化合物を得た(収
率33.5%)。Melting point 249.0-250.0' (recrystallized from methanol). I R (KBr)am-': 2726, 159
6, 1501, 1372, 1349. 1251
NMR (d.-DMS○)δ: ]. 53-1. 7
7 (4H.m), 2. 782.86 (2H, m)
.. 2.98-3. f) 5 (2L m'). 3.89 (3
}1, s). 7.10 (IH, d, J= 16.
2Hz), 7. 32 (IH. d, J = 16
.. 2Hz), 8. 06 (IH, s), 9.
08 (IH, s). Elemental analysis value: C,. H. a
N. Calculated as S 2 H Cl2: C, 46.
85. H, 5.44. N, 16.81. S9.
62; CC, 21.27 Actual subvalue: C, 46.61; H, 5.50; N, 1
6.52; 8 9.33; CQ. .. 21.2B. Example 153 2-[2-(henzimidazol-5-yl)ethenyl]-5.6.7.8-tetrahydro-4H-thiazolo[
5,4-b]Azepine dihydrochloride In the same manner as in Example 18, 5-penzimitazolyl acrylic acid, 3-amino-epsilon lactam, and phosphorus pentasulfide were reacted, and after purification, the raw botanical was neutralized with hydrogen chloride to obtain the title compound (yield 33.5%).
融点 250.0−25 1.0’ (メタノーノ
レーエチルエーテルから再結晶).
J R (KBr)cm ’ : 2994, 293
2, 1606, 1527, 1354. 955.
NMR(d.−DMSO)δ: I. 53−1. 7
7(4H, m), 2,782. 84(2H, m
), 2. 98−3. 05(2H, m), 7.
45(IH, d, J 一16. OHz). 7
. 60(IH, d, J = 16. 0Hz),
7. 86(2H, s), 803(IH, s)
, 9. 64(LH, s)元素分析値: C ,.
H ,8N.S・2HCC・1.5H,Oとして
計算値: C,48.49. H,5.43; N,1
4.14;S,109; C(,17.89.
実測値: C,48.9+.; H,5.3g. N,
14.18.S, 7.93; Cf2,17.6
1.実施例154
2−+3−(2,7−ジメチルイミダゾN.2 −a]
ピリジル)1−5.6,7.8−テトラドロー4 Hチ
アゾロ[5.4−b]アセピン・二塩酸塩2,7−ジメ
チルイミダゾ[1.2一a]ピリジン−3−カルポン酸
(7.8g,41ミリモル)のシメチルホルムアミド溶
7夜(30d)に1,1′一カルホニルシイミダゾール
(7.3g,45ミリモル)を加え、30分間加熱還流
した。この反応肢に3−アミノーε一カブ口ラクタム(
5.8g,45ミリモル)を加えて2時間加熱還流した
。室温まで冷却後重曹水を加えてクc70ホルム、メタ
ノール混合濱媒で抽出し、硫酸マグネシウムで乾燥後、
減圧下溶媒を留去した。残留物をシリカゲルのカラムク
ロマト上で精製し、得られた粉末を五硫化燐(10g,
45ミリモル)と共にピリジン(80d)に懸濁させで
、i o o ’cで44時間加熱撹拌した。室温まで
冷却後、重曹水を加えてクロロホルム、メタノール混合
溶媒で抽出し、硫酸マグネシウムで乾燥後減圧下溶媒を
留去した。残留物をシリカゲルのカラムクロマト上で精
製し、塩化水素で中和後メタノールから再結晶すること
により表題化合物が3.73g(24.5%)得られた
。Melting point 250.0-25 1.0' (recrystallized from methanol ethyl ether). J R (KBr) cm': 2994, 293
2, 1606, 1527, 1354. 955.
NMR (d.-DMSO) δ: I. 53-1. 7
7 (4H, m), 2,782. 84 (2H, m
), 2. 98-3. 05 (2H, m), 7.
45 (IH, d, J-16. OHz). 7
.. 60 (IH, d, J = 16.0Hz),
7. 86 (2H, s), 803 (IH, s)
, 9. 64 (LH, s) Elemental analysis value: C,.
H, 8N. Calculated value as S・2HCC・1.5H,O: C, 48.49. H, 5.43; N, 1
4.14; S, 109; C (, 17.89. Actual value: C, 48.9+.; H, 5.3 g. N,
14.18. S, 7.93; Cf2, 17.6
1. Example 154 2-+3-(2,7-dimethylimidazoN.2-a]
pyridyl) 1-5.6,7.8-tetradraw 4 Hthiazolo[5.4-b]acepine dihydrochloride 2,7-dimethylimidazo[1.21a]pyridine-3-carboxylic acid (7 1,1'-carbonylsiimidazole (7.3 g, 45 mmol) was added to a dimethylformamide solution (30 d) of .8 g, 41 mmol) and heated under reflux for 30 minutes. In this reaction limb, 3-amino-epsilon lactam (
5.8 g, 45 mmol) was added thereto and heated under reflux for 2 hours. After cooling to room temperature, add sodium bicarbonate solution and extract with a mixture of C70 form and methanol. After drying with magnesium sulfate,
The solvent was distilled off under reduced pressure. The residue was purified on silica gel column chromatography, and the resulting powder was treated with phosphorus pentasulfide (10 g,
45 mmol) in pyridine (80d), and the mixture was heated and stirred at IO O'C for 44 hours. After cooling to room temperature, aqueous sodium bicarbonate was added and extraction was performed with a mixed solvent of chloroform and methanol. After drying over magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was purified on silica gel column chromatography, neutralized with hydrogen chloride, and then recrystallized from methanol to obtain 3.73 g (24.5%) of the title compound.
融点 154〜157゜(メタノールから再結晶).I
R (KBr)cm ’ : 3452, 1659
, +604. 1571, 1527, 1456,
1390, +362. 1305, +258.N〜
ffR(d.−DMso)δ: I. 86(21 m
), 1. 78(2H, m)2. 57(3H,
s), 2. 66(3H, s), 2. 93(2
H, m), 3. 17(2H,m), 4. 07
(18, br. s), 7. 44(IH. dd
, J = 1. 65Hz, 6. 96Hz).
7. 79(IH. d, J= l. 65Hz),
9. 65(II{, d, J= 6. 96Hz
)
元素分析値: C ,sH ,sN 4S・2HCff
・0,8H,Oとして
計算値: C,49.82; H,5.64; N,1
4.52;S, 8.31; CQ.,18.3g
.実測値: C,50.01; H,5.80. N,
14.32.S, 8.38; C(!,18.2
0実施例155
2−{4−(4−メチルイミダゾール−1−イル)スチ
リルl−5.6,7.8−テトラヒド口−4H−チアゾ
ロ[5.4−b]アゼビン・二塩酸塩実施例154と同
様の方広により、4−(4−メチルイミダゾール−1−
イル)けい皮酸、3アミノーε一カブ口ラクタム及び五
硫化燐を反応精製後塩化水素で中和して表題化合物か得
与れたく収率34.1%)。Melting point: 154-157° (recrystallized from methanol). I
R (KBr) cm': 3452, 1659
, +604. 1571, 1527, 1456,
1390, +362. 1305, +258. N~
ffR(d.-DMso)δ: I. 86 (21 m
), 1. 78 (2H, m)2. 57 (3H,
s), 2. 66 (3H, s), 2. 93(2)
H, m), 3. 17 (2H, m), 4. 07
(18, br. s), 7. 44 (IH. dd
, J = 1. 65Hz, 6. 96Hz).
7. 79 (IH. d, J= l. 65Hz),
9. 65(II{, d, J= 6.96Hz
) Elemental analysis values: C, sH, sN 4S・2HCff
・Calculated value as 0,8H,O: C, 49.82; H, 5.64; N, 1
4.52;S, 8.31;CQ. , 18.3g
.. Actual value: C, 50.01; H, 5.80. N,
14.32. S, 8.38; C(!, 18.2
0 Example 155 2-{4-(4-methylimidazol-1-yl)styryl-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b]azevin dihydrochloride Example 4-(4-methylimidazole-1-
The title compound was obtained by reaction and purification of cinnamic acid, 3-amino-ε-1-cab lactam, and phosphorus pentasulfide, and then neutralized with hydrogen chloride (yield: 34.1%).
融点 239〜241°(メタノールから再結晶).I
R (KBr)cm−’ : 3440, 1626
, 1595, 1547, 1505, 14421
371, 1352, 1302, 964.NMR(
d.−DMs○)δ: 1. 58〜1. 83(41
{, m), 2. 38(38, s), 2. 8
3(2H, m). 3. 07(2H, m), 7
. 40(2H, s), 780(2tl, d.
J = 8. 83Hz), 7. 88(2H, d
, J = 8. 83Hz), 8.02(IH.
s), 9. 63(IH, s).元素分析値:C,
.H,。N4S・2HCQ・0.5820として
計算値: C,54.54; H,5.54; N,1
3.39;S, 7.66; Cf2,16.95
.実測値: C,54.62; H,5.55; N,
13.62S, 7.65; Cf2,17.08
実施例156
2i3−(6−クロロ−2−メチルイミダゾ[12−a
]ピリジル)l−5.6,7.8−4H−チアゾロ[5
.4−b]アゼピン・二塩酸塩
実施例154と同様の方広により、6−クロロ2−メチ
ルイミタゾ[1.2−a]ピリジン−3カルホン酸、3
−アミノーε一カプ口ラクタム及び五硫化燐を反応精製
後塩化水素で中和して表題化合物が得られた(収率l6
.7%)。Melting point: 239-241° (recrystallized from methanol). I
R (KBr) cm-': 3440, 1626
, 1595, 1547, 1505, 14421
371, 1352, 1302, 964. NMR (
d. -DMs○)δ: 1. 58-1. 83 (41
{, m), 2. 38 (38, s), 2. 8
3 (2H, m). 3. 07 (2H, m), 7
.. 40 (2H, s), 780 (2tl, d.
J=8. 83Hz), 7. 88 (2H, d
, J = 8. 83Hz), 8.02(IH.
s), 9. 63 (IH, s). Elemental analysis value: C,
.. H. Calculated value as N4S・2HCQ・0.5820: C, 54.54; H, 5.54; N, 1
3.39; S, 7.66; Cf2, 16.95
.. Actual value: C, 54.62; H, 5.55; N,
13.62S, 7.65; Cf2, 17.08
Example 156 2i3-(6-chloro-2-methylimidazo[12-a
]pyridyl)l-5.6,7.8-4H-thiazolo[5
.. 4-b]Azepine dihydrochloride By the same method as in Example 154, 6-chloro2-methylimitazo[1.2-a]pyridine-3carphonic acid, 3
-Amino-ε monocapsulactam and phosphorus pentasulfide were reacted and purified, and then neutralized with hydrogen chloride to obtain the title compound (yield 16
.. 7%).
融点 233〜236°(メタノールから再結晶).I
R (KBr)cm ’ : 3424, 1549
, 1514. 1488, 1436, +395,
1348,1255.
NMR(d.−DMSO)δ: 1. 67(2H,
m), 1. 77(21{, m), 2. 94(
2H, m), 3. 06(2H, m), 5.
94(IH, br. s), 8. 03(2H,
s), 9. 9:{(IH. s)元素分析値:C1
5H1,N4SCQ・2HCQ・0.5H20として
計算値: C,44.96; H,4.53; N,1
3.98;s, g.oo.
実測値: C,44.58; H,4.75; N,1
3.63;S, 7.80.
実施例157
2−(2−イミタゾ[1.2−a]ピリジル)−56.
7.8−テトラヒド口−4H−チアゾロ[5,4b]ア
ゼピン・二塩酸塩
実施例154と同様の方法により、イミダゾ[1.2−
alピリジン−2−カルポン酸、3−アミノε一カブロ
ラクタム及び五硫化燐を反応精製後塩化水素で中和して
表題化合物か得られた(収率17.2%)。Melting point: 233-236° (recrystallized from methanol). I
R (KBr)cm': 3424, 1549
, 1514. 1488, 1436, +395,
1348, 1255. NMR (d.-DMSO) δ: 1. 67 (2H,
m), 1. 77(21{, m), 2. 94(
2H, m), 3. 06 (2H, m), 5.
94 (IH, br. s), 8. 03(2H,
s), 9. 9: {(IH.s) Elemental analysis value: C1
Calculated value as 5H1,N4SCQ・2HCQ・0.5H20: C, 44.96; H, 4.53; N, 1
3.98;s, g. oo. Actual value: C, 44.58; H, 4.75; N, 1
3.63;S, 7.80. Example 157 2-(2-imitazo[1.2-a]pyridyl)-56.
7.8-Tetrahydro-4H-thiazolo[5,4b]azepine dihydrochloride Imidazo[1,2-
After reaction and purification of alpyridine-2-carboxylic acid, 3-amino epsilon-cabrolactam and phosphorus pentasulfide, the title compound was obtained (yield: 17.2%) by neutralizing with hydrogen chloride.
融点 l76〜179°(メタノールから再結晶)I
R (KBr)am ’ : 3488, 3030.
1572, 1529, 1450. 1432.1
367 1204
NMR(d.−DMSO)δ: 1. 68(2H,
m), 1. 78(2H, m), 2. 91(2
H, t, J= 5. 13Hz), 3. 09(
21, t, J = 4. 72Hz),7. 46
(IH, m), 7. 86(2H, m), 8.
77(IH, s), 8. 89(IH, d,J
= 6. 72Hz)
元素分析値: C .,H ,.N,S − 2 H
Ci2として計算値: C,48.98; H,4.7
0; N,16.32;S, 9.34.
実厠値: C,48.55; H,4、84; N,1
6.07;S, 9.30.
実施例158
2−(6−クロロイミタゾ[1.2−a]ピリジン3−
イル)−5.6.7.8−テトラヒド口−4Hチアゾロ
C5,4−bEアゼピン・塩酸塩実施例154と同様の
方広により、6−クロロイミタゾCI,2一a3ピリジ
ン−3−カルボン酸、3−アミノーε一カブ口ラクタム
及び五硫化燐を反応精製後塩化水素で中和して表題化合
物が得与れたく収率16,O%)。Melting point 176-179° (recrystallized from methanol) I
R(KBr)am': 3488, 3030.
1572, 1529, 1450. 1432.1
367 1204 NMR (d.-DMSO) δ: 1. 68 (2H,
m), 1. 78 (2H, m), 2. 91(2)
H, t, J=5. 13Hz), 3. 09(
21, t, J = 4. 72Hz), 7. 46
(IH, m), 7. 86 (2H, m), 8.
77 (IH, s), 8. 89 (IH, d, J
= 6. 72Hz) Elemental analysis value: C. ,H,. N,S-2H
Calculated value as Ci2: C, 48.98; H, 4.7
0; N, 16.32; S, 9.34. Actual value: C, 48.55; H, 4, 84; N, 1
6.07;S, 9.30. Example 158 2-(6-chloroimitazo[1.2-a]pyridine 3-
yl)-5.6.7.8-tetrahydride-4HthiazoloC5,4-bE azepine hydrochloride By the same method as in Example 154, 6-chloroimitazoCI,2-a3pyridine-3-carboxylic acid, The title compound was obtained by reaction and purification of 3-amino-ε-monolactam and phosphorus pentasulfide and neutralization with hydrogen chloride (yield: 16.0%).
融点 245〜248°(メタノールから再結晶).I
R (KBr)am ’ : 3420, 1553
, 1510, 1475, 1430. 1386,
1342.
NMR(d.−DMSO)δ: 1. 65(2H,
m), 1. 76(2H, m)2. 91(2H,
t, J= 5. 13Hz), 3. 04(2H
. m), 4. 31(IH,br. s). 7.
92(LH, dd, J= 1. 93Hz, 8
. lll7Hz), 8. 03(18,d, J
= 8. 87Hz), 8. 59(IH, s),
9。84(IH, d. J= 1. 93Hz).
元素分析値:C14H13N4SCQ−HC(2として
計算値: C,49.27: H,4.13. N,1
6.42.S, 9.39; Cff.20.7g.実
測値: C,49.23; H.4.11; N,16
.38;S, 9.25; (12.20.49.実施
例159
2−(8−イミダゾ[1.2−a]ピリジル)−5,6
.7.8−テトラド口−4H−チアゾロ[5.4b]ア
ゼピン・二塩酸塩
イミダゾ[1.2−a]ピリジン−6−カルボン酸・臭
化水素塩(9.34g,38.6ミリモル)のテトラヒ
ドロフランil(30d!)にトリエチルアミン(7.
8 1g,7 7.2ミリモル)及び1,1′一カルボ
ニルジイミタゾール(6.88g,42.4ミリモル)
を加え、30分間加熱還流した。この反応液に3アミノ
ーε一カプロラクタム(5. 4 4g, 4 2.4
ミリモル)を加えて30分間加熱還流し、さらに室温で
2日間撹拌した。反応液に重曹水を加えてクロロホルム
、メタノール混合冶媒で抽出し、硫酸マグネ/ウムで乾
燥後、減圧下溶媒を留去した。残留物をシリカゲルのカ
ラムクロマト上で精製し、得られた粉末を五硫化燐(5
.44g,424ミリモル)と共にピリンン(50d)
に懸濁させて120〜130゜Cて5時間加熱撹拌した
。室温まで冷却後、重菩水を加えてクロロホルム、メタ
ノールd合溶媒で抽出し、硫酸マグネシウムで乾燥後減
圧下溶媒を留去した。残留物をシリカゲルのカラム上で
精製し、塩化水素で中和後メタノールから再結晶するこ
とにより表題化合物が76,1 mg(0 . 6%)
得られた。Melting point 245-248° (recrystallized from methanol). I
R(KBr)am': 3420, 1553
, 1510, 1475, 1430. 1386,
1342. NMR (d.-DMSO) δ: 1. 65 (2H,
m), 1. 76 (2H, m)2. 91 (2H,
t, J=5. 13Hz), 3. 04 (2H
.. m), 4. 31 (IH, br. s). 7.
92 (LH, dd, J= 1.93Hz, 8
.. 1ll7Hz), 8. 03 (18, d, J
= 8. 87Hz), 8. 59 (IH, s),
9.84 (IH, d. J= 1.93Hz). Elemental analysis value: C14H13N4SCQ-HC (calculated value as 2: C, 49.27: H, 4.13. N, 1
6.42. S, 9.39; Cff. 20.7g. Actual value: C, 49.23; H. 4.11; N, 16
.. 38; S, 9.25; (12.20.49. Example 159 2-(8-imidazo[1.2-a]pyridyl)-5,6
.. 7.8-tetrado-4H-thiazolo[5.4b]azepine dihydrochloride imidazo[1.2-a]pyridine-6-carboxylic acid hydrobromide salt (9.34 g, 38.6 mmol) Tetrahydrofuran (30d!) and triethylamine (7.
8 1 g, 7 7.2 mmol) and 1,1'-carbonyldiimitazole (6.88 g, 42.4 mmol)
was added and heated under reflux for 30 minutes. Add 3-amino-ε-caprolactam (5.4 4 g, 4 2.4
mmol) was added, heated under reflux for 30 minutes, and further stirred at room temperature for 2 days. Aqueous sodium bicarbonate was added to the reaction mixture, and the mixture was extracted with a mixed solvent of chloroform and methanol. After drying over magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was purified on silica gel column chromatography, and the resulting powder was purified with phosphorus pentasulfide (5
.. 44 g, 424 mmol) with pirin (50 d)
The suspension was heated and stirred at 120-130°C for 5 hours. After cooling to room temperature, diluted bodice water was added and extracted with a mixed solvent of chloroform and methanol. After drying over magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was purified on a silica gel column, neutralized with hydrogen chloride, and recrystallized from methanol to yield 76.1 mg (0.6%) of the title compound.
Obtained.
融点 189〜192°(メタノールから再結晶).I
R (KBr)Cm−’ : 3450, 1642
, +572. 1520. 1506, 1461,
13g5,1373,1330.
NMR(d.−DMS○)δ: 1. 66(2H,
m), 1. 77(2H,m), 3. 06(4H
, m), 4. 64(IH. br. s), 7
. 52(IH, t+ J−= 711Hz), 8
. 08(LH, d, J= 7. 41Hz),
8. 15(LH, d, J= 2.02Hz),
8. 52(IH, d, J= 2. 02Hz),
8. 89(LH, d, J= 663HZ)
元素分析値: c 1−H 14N−S・2HCf2・
H.0として
計算値: C,46.54; H,5.02: N,1
5−51;S , 19. 63.
実測値: C,46.80:H,4.73; N,15
.78;S , 19. 49.
実施例160
2i3−(2−メチルイミダゾ[1 . 2−aコビリ
ジル)l−5.6,7.8−テトラド口−4H−チアゾ
ロ[5.4−b]アゼピン・二塩酸塩実施例18と同様
の方法により、2−メチルイミダゾ[1.,2−a]ピ
リジン−3−カルボン酸、3アミノーε一カブロラクタ
ム及び五硫化燐を反応精製後、塩化水素で中和して表題
化合物か得られた(収率5.7%)。Melting point: 189-192° (recrystallized from methanol). I
R(KBr)Cm-': 3450, 1642
, +572. 1520. 1506, 1461,
13g5,1373,1330. NMR (d.-DMS○) δ: 1. 66 (2H,
m), 1. 77 (2H, m), 3. 06 (4H
, m), 4. 64 (IH.br.s), 7
.. 52 (IH, t+J-=711Hz), 8
.. 08 (LH, d, J = 7.41Hz),
8. 15 (LH, d, J = 2.02Hz),
8. 52 (IH, d, J = 2.02Hz),
8. 89 (LH, d, J = 663HZ) Elemental analysis value: c 1-H 14N-S・2HCf2・
H. Calculated value as 0: C, 46.54; H, 5.02: N, 1
5-51;S, 19. 63. Actual value: C, 46.80: H, 4.73; N, 15
.. 78;S, 19. 49. Example 160 2i3-(2-methylimidazo[1.2-a cobiridyl)l-5.6,7.8-tetrado-4H-thiazolo[5.4-b]azepine dihydrochloride Example 18 By a similar method, 2-methylimidazo [1. , 2-a] pyridine-3-carboxylic acid, 3-amino-ε-cabrolactam, and phosphorous pentasulfide were reacted and purified, and then neutralized with hydrogen chloride to obtain the title compound (yield 5.7%).
融点 219〜221°(メタノールから再結晶),r
R (KBr)cm−’ : 33g0, 1605
, 1523, 1483, 1449. 140g,
1352, 1322, 1264.
NMR(d.−DMSO)δ: 1, 66(2H,
m), 1. 71(2H, m)2. 72(3H,
s), 2. 94(2H. m), 3. 07(
2H, m), 5. 00(IHbr. s), 7
. 58(IL m), 8. 01(2H, m),
9. 83(IH, m).元素分析値: C ,s
H ,aN4S・2HCl2として計算値: C,50
.42; H,5.08; N,15.68;S, 8
.91: CI2,19.84.実測値:C,49.9
8; H,5.20; N,15、59;S, 8.9
4: C(1.19.64.実施例161
2−(4−シアノー3−イソブロビルフェニル)5,6
.7.8−テトラヒドロー4H−チアゾロ[54−b]
アゼピン
実施例18と同様の方法により、4−シアノー3−イソ
ブロビル安息香酸、3−アミノーε一カブ口ラクタム及
び五硫化燐から表題化合物が得られた(収率62.O%
)。Melting point 219-221° (recrystallized from methanol), r
R (KBr) cm-': 33g0, 1605
, 1523, 1483, 1449. 140g,
1352, 1322, 1264. NMR (d.-DMSO) δ: 1, 66 (2H,
m), 1. 71 (2H, m)2. 72 (3H,
s), 2. 94 (2H.m), 3. 07(
2H, m), 5. 00(IHbr.s), 7
.. 58 (IL m), 8. 01 (2H, m),
9. 83 (IH, m). Elemental analysis value: C, s
Calculated value as H,aN4S・2HCl2: C,50
.. 42; H, 5.08; N, 15.68; S, 8
.. 91: CI2, 19.84. Actual value: C, 49.9
8; H, 5.20; N, 15, 59; S, 8.9
4: C (1.19.64. Example 161 2-(4-cyano 3-isobrobylphenyl) 5,6
.. 7.8-Tetrahydro 4H-thiazolo[54-b]
The title compound was obtained from 4-cyano-3-isobrobylbenzoic acid, 3-amino-epsilon-cab-lactam, and phosphorus pentasulfide in the same manner as in Azepine Example 18 (yield: 62.0%).
).
融点 l25〜127°(酢酸エチル、ヘキサンから再
結晶).
I R (KBr)am−’ : 3220, 221
6, 1603, 1553, 1520, 1497
,1437, 1369, 1354, 1266.N
M R (C D Cl!3)δ: 1. 36(6
H, d, J= 6. 92Hz),1. 70(2
H, i), 1、85(2H, m), 2. 96
(2H, t, J= s. 74Hz),3. 14
(2H, t, J= 5. 17Hz). 3. 3
8(IH, m). 4. 09(IH. br.s)
, 7.58(2H, s), 7. 80(IH,
s).元素分析値: C .7H ,IIN3Sとして
計算値: C,68.65. H,6.44; N,1
4.13;S , 10. 7g.
実測値: C,68.50: H,6.72. N,1
4.25;S , 10. 61.
実施例162
2−(4−アミノメチル−3−イソプロビルフエニル)
−5.6,7.8−テトラヒドロー4H−チアゾロ[5
.4−b]アゼピン・二塩酸塩実施例132と同様の方
法により、2−(4−シアノー3−インブロビルフェニ
ル)−5.6,7.8−テトラヒド口−4H−チアゾロ
[5.4−b]アセピン、塩化コバルト6水和物及ひ水
素化ほう素ナトリウムから表題化合物か得られた(収率
351%)。Melting point l25-127° (recrystallized from ethyl acetate, hexane). I R (KBr)am-': 3220, 221
6, 1603, 1553, 1520, 1497
, 1437, 1369, 1354, 1266. N
M R (C D Cl!3) δ: 1. 36 (6
H, d, J=6. 92Hz), 1. 70 (2
H, i), 1, 85 (2H, m), 2. 96
(2H, t, J=s. 74Hz), 3. 14
(2H, t, J= 5.17Hz). 3. 3
8 (IH, m). 4. 09 (IH.br.s)
, 7.58 (2H, s), 7. 80 (IH,
s). Elemental analysis value: C. Calculated value as 7H, IIN3S: C, 68.65. H, 6.44; N, 1
4.13;S, 10. 7g. Actual value: C, 68.50: H, 6.72. N,1
4.25;S, 10. 61. Example 162 2-(4-aminomethyl-3-isoprobylphenyl)
-5.6,7.8-tetrahydro-4H-thiazolo[5
.. 4-b]Azepine dihydrochloride 2-(4-cyano-3-imbrobylphenyl)-5.6,7.8-tetrahydro-4H-thiazolo[5.4 -b] The title compound was obtained from acepine, cobalt chloride hexahydrate and sodium borohydride (yield 351%).
融点 260〜263°(メタノールから再結晶)I
R (KBr)am−’ : 3450, 2932,
1599, 1520, 1463, 1371.1
353
NMR(de−DMSO)δ: 1. 25(68,
d, J= 6. 80Hz),1. 63(2H,
m), 1. 77(2H, m). 2. 92(2
H. t, J = 5. 27Hz),3. 06(
2H, t, J= 4.85Hz), 3. 19(
LH, m), 4. 14(3H, br.s).
7. 52(IH. d, J= 8. lOHz),
7. 64(IH, dd, J= 1. 83Hz
. 8. 10Hz), 7. 86(1]{. d,
J = 1. 83Hz), 8. 54(2H,
br.s).
元素分析値: C ,7H ,3N3S・2HCR・0
.DH20として
計算値: C,53.26; H,6.84. N,1
0.96;S, 8.36; Cff,18.49実測
値: C,53.54; H.6.38; N,10.
92S, 8.20. CI2.18.48.実施例1
63
2−{4−(イミタゾール−1−イル)フエニル}一5
.6,7.8−テトラヒドロー4H−チアゾロ[5,l
−b]アセビン・二塩酸塩
実施例18と同様の方法により、4−(イミタゾールー
l−イル)安息香酸、3−アミノーεカブ口ラクタム及
び五硫化燐を反応精製後、塩化水素で中和して表題化合
物が得られた(収率619%)。Melting point 260-263° (recrystallized from methanol) I
R(KBr)am-': 3450, 2932,
1599, 1520, 1463, 1371.1
353 NMR (de-DMSO) δ: 1. 25 (68,
d, J=6. 80Hz), 1. 63 (2H,
m), 1. 77 (2H, m). 2. 92(2)
H. t, J = 5. 27Hz), 3. 06(
2H, t, J= 4.85Hz), 3. 19(
LH, m), 4. 14 (3H, br.s).
7. 52 (IH. d, J = 8. lOHz),
7. 64 (IH, dd, J= 1.83Hz
.. 8. 10Hz), 7. 86(1) {. d,
J = 1. 83Hz), 8. 54 (2H,
br. s). Elemental analysis value: C, 7H, 3N3S・2HCR・0
.. Calculated value as DH20: C, 53.26; H, 6.84. N,1
0.96; S, 8.36; Cff, 18.49 Actual value: C, 53.54; H. 6.38; N, 10.
92S, 8.20. CI2.18.48. Example 1
63 2-{4-(imitazol-1-yl)phenyl}-5
.. 6,7.8-tetrahydro 4H-thiazolo[5,l
-b] Acevin dihydrochloride 4-(imitazol-l-yl)benzoic acid, 3-amino-epsilon lactam and phosphorus pentasulfide were reacted and purified in the same manner as in Example 18, and then neutralized with hydrogen chloride. The title compound was obtained (yield 619%).
融点 229〜231’(メタノールから再結晶)I
R (KBr)am−’ : 2636. 1616.
1597, 1540, 1475, 1453,1
374, 1352, 1336.
NMR(d,−DMS○)δ: I. 66(2H,
m), 1. 81(2H, m), 2. 92(2
H. m), 3. 06(2H, m), 5. 0
0(IH, br. s), 7. 97(5H, m
), 8. 39(IH, s), 9. 89(1}
1, s)元素分析値・C,.H.6N,S・2HC&
として計算値: C,52.04; H.4.91;
N,15.17;S, 8.68; CQ,19.20
.実測値: C,51.63; H,4.89; N,
14.90;S, 8.49; Cf2,18.81.
実施例164
2−(2.2−シフェニルエテニル)−5.6.78−
テトラヒドロー4H−チアゾロ[5.4−b]アゼピン
実施例18と同様の方法により、3,3−ジフェニル−
2−ブロペン酸、3−アミノーε一カフロラクタム及び
五硫化燐から表題化合物が得られた(収率75 6%)
。Melting point 229-231' (recrystallized from methanol) I
R(KBr)am-': 2636. 1616.
1597, 1540, 1475, 1453,1
374, 1352, 1336. NMR (d, -DMS○) δ: I. 66 (2H,
m), 1. 81 (2H, m), 2. 92(2)
H. m), 3. 06 (2H, m), 5. 0
0 (IH, br. s), 7. 97 (5H, m
), 8. 39 (IH, s), 9. 89(1}
1, s) Elemental analysis value・C,. H. 6N, S・2HC&
Calculated value: C, 52.04; H. 4.91;
N, 15.17; S, 8.68; CQ, 19.20
.. Actual value: C, 51.63; H, 4.89; N,
14.90; S, 8.49; Cf2, 18.81.
Example 164 2-(2.2-cyphenylethenyl)-5.6.78-
Tetrahydro 4H-thiazolo[5.4-b]azepine 3,3-diphenyl-
The title compound was obtained from 2-bropenic acid, 3-amino-ε-cafrolactam and phosphorus pentasulfide (yield 75.6%).
.
融点 169〜171°(酢酸エチルから再結晶)I
R (KBr)cm ’ : 3290, 1599,
1549. 14g7, 1441, 1435,1
415, 1369, 1349, 1254.NMR
(CDC(..−D20)δ: 1. 61(2H,
m), 1. 73(2H, m). 2. 83(2
H, t, J= 5. 64Hz), 2. 94(
2H, t, J4. 95Hz), 7. 20 〜
7. 37(8H, m), 7. 43 〜7. 5
4(3H, m).元素分析値: C ,,H ,oN
2Sとして計算値: C,75.1117; l{,
6.06; N,8.43S 9.64.
実測値: C,75.77; H 6.12; N,8
J5;S, 9.51.
実施例165
2−+2−(1−メチルイミタゾールー4−イル)エテ
ニルl−5.6,7.8−テトラヒドロ−4 I−{チ
アゾ口[5.4−b]アセピン・二塩酸塩3−{β−(
1−メチルイミタゾール−4−イル)アクリロイル}ア
ミノーε一カブロラクタム(826g,0.32モル)
、五硫化燐(70g,0.32モル)をピリジン(30
0d)中、1 2 0 ’Cで8時間更に70’Cで1
4時間加熱撹拌した。室温まで冷却後、反応岐に重曹水
を加えてクロロホルム、メタノール混合溶媒で抽出し、
硫酸マグネシウムで乾燥浚減圧下溶媒を留去した。残留
物をシリカゲルのカラムクロマト上で精製し、塩化水素
で中和後メタノールから再結晶することにより表題化合
物が1 8.9g(7 8.2%)得られた。Melting point 169-171° (recrystallized from ethyl acetate) I
R (KBr)cm': 3290, 1599,
1549. 14g7, 1441, 1435,1
415, 1369, 1349, 1254. NMR
(CDC(..-D20)δ: 1.61(2H,
m), 1. 73 (2H, m). 2. 83 (2
H, t, J=5. 64Hz), 2. 94(
2H, t, J4. 95Hz), 7. 20 ~
7. 37 (8H, m), 7. 43 ~7. 5
4 (3H, m). Elemental analysis values: C,,H,oN
Calculated value as 2S: C, 75.1117; l{,
6.06; N, 8.43S 9.64. Actual value: C, 75.77; H 6.12; N, 8
J5;S, 9.51. Example 165 2-+2-(1-methylimitazol-4-yl)ethenyl l-5.6,7.8-tetrahydro-4 I-{thiazo[5.4-b]acepine dihydrochloride 3-{β-(
1-methylimitazol-4-yl)acryloyl}amino-ε-cabrolactam (826 g, 0.32 mol)
, phosphorus pentasulfide (70 g, 0.32 mol) was dissolved in pyridine (30
0d) at 120'C for 8 hours and then at 70'C for 1
The mixture was heated and stirred for 4 hours. After cooling to room temperature, add aqueous sodium bicarbonate to the reaction mixture and extract with a mixed solvent of chloroform and methanol.
The mixture was dried with magnesium sulfate and the solvent was distilled off under reduced pressure. The residue was purified on silica gel column chromatography, neutralized with hydrogen chloride, and then recrystallized from methanol to obtain 18.9 g (78.2%) of the title compound.
融点 193〜196°(メタノールから再結晶)I
R (KBr)cm ’ : 3418, 2992,
1636, 1599. 1513, 144914
37. +374. 1360, 1273, 125
1, 944NMR(d8−DMSo)δ: I. 6
3(2H, m), 1. 74(2tl, m),
2. 83(2H, m), 3. 05(2H, m
), 3. 87(3H, s), 4. 95(IH
,br. s), 7. 16(IH, d, J=
16. 31Hz), 7. 47(IH, d, J
16. 31Hz). 7. 86(LH, s),
9. 19(IH, s).元素分析値: C ,.H
,.N ,S・2 H C Q・0.5820として
計算値: C,45.62; H,5.59; N,1
6.37S, 9.37: Cf!,20.71実
測値: C,45.66; H,5、53; N,16
.50;S, 9.63. CR,20.86実施
例166
2−11(1−エチルイミタゾール−4−イル)エテニ
ルl−5.6,7.8−テトラヒド口−4Hチアゾロ[
5,4.−b]アゼピン・二塩酸塩実施例165と同様
の方法により、3−{β一(lエチルイミダゾール−4
−イル)アクリロイル}アミ/一ε一カブロラクタム及
び五硫化燐を反応精製後塩化水素で中和して表題化合物
か得られたく収率60,9%)。Melting point 193-196° (recrystallized from methanol) I
R (KBr)cm': 3418, 2992,
1636, 1599. 1513, 144914
37. +374. 1360, 1273, 125
1,944 NMR (d8-DMSo) δ: I. 6
3 (2H, m), 1. 74 (2tl, m),
2. 83 (2H, m), 3. 05 (2H, m
), 3. 87 (3H, s), 4. 95 (IH
,br. s), 7. 16(IH, d, J=
16. 31Hz), 7. 47 (IH, d, J
16. 31Hz). 7. 86 (LH, s),
9. 19 (IH, s). Elemental analysis value: C,. H
、. Calculated value as N, S・2 HC Q・0.5820: C, 45.62; H, 5.59; N, 1
6.37S, 9.37: Cf! , 20.71 Actual value: C, 45.66; H, 5, 53; N, 16
.. 50;S, 9.63. CR, 20.86 Example 166 2-11(1-ethylimitazol-4-yl)ethenyl-5.6,7.8-tetrahydro-4Hthiazolo[
5,4. -b]Azepine dihydrochloride By the same method as in Example 165, 3-{β-(lethylimidazole-4
-yl)acryloyl}ami/1epsilon-cabrolactam and phosphorus pentasulfide were reacted and purified, and then neutralized with hydrogen chloride to obtain the title compound (yield: 60.9%).
融点 181〜184°(エタノールから再結晶).l
R (KBr)am ’ : 3430, 1637
, 1600, 1542, 1507, 14511
430, 1374, 1357, 1278. 12
53, 959NMR(d,.−DMS○)δ: I.
44(3H, t, J= 7. 29Hz11.
62(211, m), ]. 74(211, m)
, 2. 82(2H, m). 3. 05(2H,
m)4. 21(2H, q, J = 7. 29
Hz), 6. 10(IH. br. s), 7.
12(IH. d, J = 16. 4Hz),
7. 47(IH, d, J = 16. 4Hz)
, 7. 96(IH, s), 9. 25(IH,
s)元素分析値: C I4H 20N−S CI2
2として計算値: C,48.42:H,5.80;
N,16.13;S, 9.23; C&,20.42
.実測値二G,4g.22. H,5.85:N,15
.91S, 9.31; C(,19.77.実施例1
67
2−(2−キノリル)−5.6,7.8−テトラヒドロ
ー4H−チアゾロ[5.4−b]アゼビン実施例1と同
様の方法により、3−(2−キ/リル)カルポニルアミ
ノーε一カブ口ラクタムと五硫化燐から表題化合物が得
られた(収率72 6%)。Melting point: 181-184° (recrystallized from ethanol). l
R(KBr)am': 3430, 1637
, 1600, 1542, 1507, 14511
430, 1374, 1357, 1278. 12
53, 959 NMR (d,.-DMS○) δ: I.
44 (3H, t, J = 7.29Hz11.
62 (211, m), ]. 74 (211, m)
, 2. 82 (2H, m). 3. 05 (2H,
m)4. 21 (2H, q, J = 7.29
Hz), 6. 10 (IH.br.s), 7.
12 (IH. d, J = 16.4Hz),
7. 47 (IH, d, J = 16.4Hz)
, 7. 96 (IH, s), 9. 25 (IH,
s) Elemental analysis value: CI4H 20N-S CI2
Calculated value as 2: C, 48.42: H, 5.80;
N, 16.13; S, 9.23; C&, 20.42
.. Actual value 2G, 4g. 22. H, 5.85: N, 15
.. 91S, 9.31; C (, 19.77. Example 1
67 2-(2-quinolyl)-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b]azebin 3-(2-ky/lyl)carponylamino The title compound was obtained from the ε-1-cubic lactam and phosphorus pentasulfide (yield 726%).
融点 243〜245°(エタノールから再結晶)I
R (KBr)cm ’ : 3254, 1596,
1526, 1502, 1476, 1456,1
434. 1424, 1372, 1356 129
9.NMR(d.−DMS○)δ: I. 69(4B
, m), 2. 87(2H, m), 3. 05
(2H, m), 6. 61(LH, s), 7.
55(IH, dt, J = 1. 32Hz,
6. 81Hz), 7. 74(Ill, dt,
J= 1. 32Hz, 6. 81Hz), 794
(2H, br. d. J = 8. 14Hz),
8. 09(IH, d, J−8. 731]z)
,8. 34(IH. d, J= 8. 73Hz)
.元素分析値: C ,.H ,5N 3Sとして計算
値: C,68.30; H,5.37; N,14.
93;S , If. 40.
実測値二C,68.31; H,5.39; N,14
.73;S IIJI.
実施例168
2−(インダゾール−3−イル)−5.6.7.8テト
ラヒド口−4 8−チアゾロ[5.4−b]アゼピン
実施例18と同様の方l去により、インダゾール3−カ
ルホン酸、3−アミノーε一カプ口ラクタム及び五硫化
燐から表題化合物か得られた(収率24%)。Melting point 243-245° (recrystallized from ethanol) I
R (KBr)cm': 3254, 1596,
1526, 1502, 1476, 1456,1
434. 1424, 1372, 1356 129
9. NMR (d.-DMS○) δ: I. 69 (4B
, m), 2. 87 (2H, m), 3. 05
(2H, m), 6. 61 (LH, s), 7.
55 (IH, dt, J = 1.32Hz,
6. 81Hz), 7. 74(Ill, dt,
J=1. 32Hz, 6. 81Hz), 794
(2H, br. d. J = 8. 14Hz),
8. 09 (IH, d, J-8.731]z)
,8. 34 (IH. d, J = 8.73Hz)
.. Elemental analysis value: C,. Calculated values as H, 5N 3S: C, 68.30; H, 5.37; N, 14.
93; S, If. 40. Actual value 2C, 68.31; H, 5.39; N, 14
.. 73;S IIJI. Example 168 2-(indazol-3-yl)-5.6.7.8tetrahydride-48-thiazolo[5.4-b]azepine By removal in the same manner as in Example 18, indazole 3-calphone The title compound was obtained from acid, 3-amino-ε-monocaplactam and phosphorus pentasulfide (24% yield).
融点 252〜255°(酢酸エチルから再結晶).I
R (KBr)Cm ’ : 3330, 1640
, 1616, 1525. 1495, 1429.
135g, 1338, 1324, 1296, 1
277.NMR(d.−DMSO−D20)δ: I.
77(4H, m), 300(2tl, br.
s), 3. 28(2H. br. s), 7.
46(IO, t, J− 7. 65Hz), 7.
65(IH, t, J = 7. 51Hz),
7. 94(IH, d, J = 8. 43Hz)
. 8. 98(IH, d, J= 7. 43Hz
)元素分析値: C,.H..N.S − 0.2H.
Oとして計算値: C,61.38; H,5.30;
N,20.45;S , 11. 70.
実測値・C,61.40. H,5.18; N,20
.30;S,11、70.
実施例169
2−+(Z)−4−ジエチルアミノスチリル}−5,6
,7.8−テトラヒド口−4H−チアゾロ[5,4b]
アゼピン
2−{(E)−4−ジエチルアミノスチリル}−5,6
,7.8−テトラヒド口−4H−チアゾロ[5,4b]
アゼピン(1.8g)のエタノール溶l夜(2 0 0
0d)を室内の散乱光の下で静置して異性化反応を進行
させた。反応液を濃縮しで、残留物をシリカゲルのカラ
ムクロマトで精製することにより表題化合物が7 6
0mg(4 1.4%)得られた。Melting point 252-255° (recrystallized from ethyl acetate). I
R(KBr)Cm': 3330, 1640
, 1616, 1525. 1495, 1429.
135g, 1338, 1324, 1296, 1
277. NMR (d.-DMSO-D20) δ: I.
77 (4H, m), 300 (2tl, br.
s), 3. 28 (2H.br.s), 7.
46 (IO, t, J-7.65Hz), 7.
65 (IH, t, J = 7.51Hz),
7. 94 (IH, d, J = 8.43Hz)
.. 8. 98 (IH, d, J= 7.43Hz
) Elemental analysis value: C,. H. .. N. S-0.2H.
Calculated value as O: C, 61.38; H, 5.30;
N, 20.45; S, 11. 70. Actual value C, 61.40. H, 5.18; N, 20
.. 30; S, 11, 70. Example 169 2-+(Z)-4-diethylaminostyryl}-5,6
,7.8-tetrahydro-4H-thiazolo[5,4b]
Azepine 2-{(E)-4-diethylaminostyryl}-5,6
,7.8-tetrahydro-4H-thiazolo[5,4b]
Azepine (1.8g) dissolved in ethanol (200g)
0d) was allowed to stand indoors under scattered light to allow the isomerization reaction to proceed. The title compound was obtained by concentrating the reaction solution and purifying the residue using silica gel column chromatography.
0 mg (41.4%) was obtained.
融点 88〜91’
I R (KBr)am−’ : 32g0, 160
9, 1539, 1520, 1491, 1435
,1399, 1365, 1352, 1266,
1191. 1154NMR(CDCff3)δ: l
. 18(6H, t, J= 7. 1Hz), 1
. 66(2H, m), 1. 81(2H, m)
. 2. 87(2H, m). 3. 02(2H,
a+), 3.38(4H, q, J = 7.
1Hz), 6. 45(IH, d, J= 12.
0Hz), 6. 59(IH, d, J= 12
. 0Hz). 6. 65(2H, d, J= 8
. 7Hz), 7. 35(2H, d, J =
8. 7Hz).元素分析値: C ,.H .5N.
Sとして計算値:C,69、68; H,7.69;
N,12.83;S,9.79
実測値・C,69.10; H,7.75; N,!2
.49;S,9.62
実施例l70
2−f(Z)− 4−クロロスチリルl−5.6,7.
8−テトラヒドロ−4H−チアゾロ[5.4−b]アゼ
ビン
実施例169と同様の方法により、2−+(E)4−ク
ロロスチリルl−5.6,7.8−テトラヒド口−4H
−チアゾロ[5.4−b]アゼピンから表題化合物か得
られた(収率11.2%)。Melting point 88-91' I R (KBr)am-': 32g0, 160
9, 1539, 1520, 1491, 1435
,1399, 1365, 1352, 1266,
1191. 1154NMR (CDCff3) δ: l
.. 18 (6H, t, J= 7.1Hz), 1
.. 66 (2H, m), 1. 81 (2H, m)
.. 2. 87 (2H, m). 3. 02 (2H,
a+), 3.38 (4H, q, J = 7.
1Hz), 6. 45 (IH, d, J= 12.
0Hz), 6. 59 (IH, d, J= 12
.. 0Hz). 6. 65 (2H, d, J= 8
.. 7Hz), 7. 35 (2H, d, J =
8. 7Hz). Elemental analysis value: C,. H. 5N.
Calculated value as S: C, 69, 68; H, 7.69;
N, 12.83; S, 9.79 Actual value C, 69.10; H, 7.75; N,! 2
.. 49;S,9.62 Example l70 2-f(Z)-4-chlorostyryl l-5.6,7.
8-Tetrahydro-4H-thiazolo[5.4-b]azevin By a method similar to Example 169, 2-+(E)4-chlorostyryl-5.6,7.8-tetrahydride-4H
The title compound was obtained from -thiazolo[5.4-b]azepine (yield 11.2%).
融点 128〜130’C
I R (KBr)am−’ : 3236, 162
2, 1549, 1521, 1489, 1436
,1367,1355,1273,1250,961,
802NMR(CD(d!3)δ : 1. 62(2
H, m), 1. 77(2}1, m), 2.8
5(2H, t, J = 5. 8Hz), 3.
01(2H, m), 3. 84(18, br.
s),6. 60(1B. d, J= 12. 2H
z), 6. 67(18, d, J= 12. 2
Hz),7. 35(4H, s).
元素分析値: C +sH +sNzS CQとして計
算値: C,61.95; H,5.20; N,9.
63;S , 11. oa; C Q. 12. 1
9.実測値: C,61.79; H,5.25; N
,9.60;s,H.oo; C(2,12.26
実施例171
2−+(Z)−3.4−ジクロ口スチリルl−5.67
,8−テトラヒド口−4H−チアゾロ[5.4−b]ア
ゼビン
実施例169と同様の方法により、2−1(E)3,4
−ジクロロスチリルl−5.6,7.8−テトラヒドロ
−4H−チアゾロ[5.4−b]アゼビンから表題化合
物が得られた(収率13.0%)。Melting point 128-130'C I R (KBr)am-': 3236, 162
2, 1549, 1521, 1489, 1436
,1367,1355,1273,1250,961,
802NMR(CD(d!3)δ: 1.62(2
H, m), 1. 77(2}1, m), 2.8
5 (2H, t, J = 5.8Hz), 3.
01 (2H, m), 3. 84 (18, br.
s), 6. 60 (1B. d, J= 12. 2H
z), 6. 67 (18, d, J= 12.2
Hz), 7. 35 (4H, s). Elemental analysis value: C +sH +sNzS Calculated value as CQ: C, 61.95; H, 5.20; N, 9.
63;S, 11. oa; C Q. 12. 1
9. Actual value: C, 61.79; H, 5.25; N
, 9.60; s, H. oo; C(2,12.26 Example 171 2-+(Z)-3.4-dichlorostyryl l-5.67
,8-tetrahydro-4H-thiazolo[5.4-b]azebin 2-1(E)3,4
The title compound was obtained from -dichlorostyryl l-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b]azevin (yield 13.0%).
融点 130〜132゜C
I R (KBr)cm−’ : 3444, 320
g 1623 1525 1471, 1436137
5,1357,1274,1250.827N M R
(C D C (ls”)δ: 1. 64(28,
m), 1. 79(2L m), 2.86(2H
, i), 3、05(2H, m), 3. 91(
LH, br. s), 6. 51(IH,d, J
= 12. 2Hz), 6. 65(IH, d,
J= 12. 2Hz). 7. 27(IH,dd
, J = 1. 93Hz, 8. 22Hz),
7. 44(IH, d, J = 8. 22Hz)
,7. 66(IH, d, J = 1. 93Hz
).元素分析値: C +aH 14N−S C Qt
として計算値: C,55.39; H,4J4; N
,8.61;S, 9.86: C(1.21.80.
実測値: C,55.17; H,4.38; N,8
.54;S, 9.77; CQ.21.80.実施例
172
2−f(Z)−4−メトキシスチリル)−5.6,7.
8−テトラヒドロー4H−チアゾロ[5.4−b]アゼ
ピン
実施例169と同様の方法により、2−((E)一4−
メトキンスチリル}−5.6,7.8−テトラヒド口−
4H−チアゾロ[5.4 −b]アゼピンから表題化合
物が得与れたく収率9.6%)。Melting point 130-132°C I R (KBr) cm-': 3444, 320
g 1623 1525 1471, 1436137
5,1357,1274,1250.827N M R
(C D C (ls”) δ: 1.64 (28,
m), 1. 79 (2L m), 2.86 (2H
, i), 3, 05 (2H, m), 3. 91(
LH, br. s), 6. 51 (IH, d, J
= 12. 2Hz), 6. 65 (IH, d,
J=12. 2Hz). 7. 27 (IH, dd
, J = 1. 93Hz, 8. 22Hz),
7. 44 (IH, d, J = 8.22Hz)
,7. 66 (IH, d, J = 1.93Hz
). Elemental analysis value: C +aH 14N-S C Qt
Calculated value as: C, 55.39; H, 4J4; N
, 8.61; S, 9.86: C (1.21.80.
Actual value: C, 55.17; H, 4.38; N, 8
.. 54;S, 9.77;CQ. 21.80. Example 172 2-f(Z)-4-methoxystyryl)-5.6,7.
8-Tetrahydro-4H-thiazolo[5.4-b]azepine 2-((E)-4-
Metkinstyryl}-5.6,7.8-tetrahydride-
The title compound was obtained from 4H-thiazolo[5.4-b]azepine (yield: 9.6%).
融点 101−104°C
I R (KBr)cm−’ : 3438, 327
8. 162g, 1606, 1544, 1509
,1455. 143g, 1364, 1351,
1297, 1248, 1172, 1038.NM
R (C D Cl2,)δ: 1. 65(2H,
m), 1. 77(2}1, m), 2.85(2
H. t, J = 5. 82Hz), 3. 01
(2H, t, J = 5. 15Hz), 3.8
4(3H, s), 6. 59(IH, d. J=
12. 1Hz), 6. 66(IH, d, J
= 12. 1Hz). 6. 91(2H, d,
J = 8. 82Hz), 7. 35(2H, d
, J一8. 82Hz).
元素分析値: C +eH 1sN 2S Oとして計
算値: C,67.10: H,6.33; N,9.
78:S , 11. 20,
実測値: C,66.83; H,6.34; N,9
.69;S , 11. 08
実施例173
2−+1−(2−ピリシル)エテニルl−5.6,7.
8−テトラヒドロー4H−チアゾロ[5.4−b]アゼ
ピン
β−(2−ビリジル)アクリル酸塩酸塩(3g,16.
2ミリモル)のジメチルホルムアミド溶肢(2Cltf
2)、トリエチルアミン(3.27g.32.3ミリモ
ル)、1−ヒドロ牛7ペンゾトリアゾール水和物(2.
7 2g, 1 7.8 ミリモル)を加えて水冷し、
ジシクロへキシルカルボジイミド(3.67g,17.
8ミリモル)のジメチルホルムアミド溶l夜(2M)を
滴下した。室温で2時間撹拌した後、反応液に3−アミ
ノーε一カブロラクタム(2.28g.17.8ミリモ
ル)を加えて室温で一晩撹拌した。重背水を加えてクロ
ロホルム、メタノール混合溶媒で抽出し、硫酸マグネシ
ウムで乾燥後減圧下溶媒を留去した。残留物をシリカゲ
ルのカラムクロマト上で精製し、五硫化燐(3.6g,
1 6.2ミリモル)と共にビリジン(20m)中1
20℃で5時間加熱撹拌した。室温まで冷却後、反応液
に重曹水を加えてクロロホルム、メタノール混1媒で抽
出し、硫酸マグネシウムで乾燥後減圧下溶媒を留去した
。残留物をシリカゲルのカラムクロマト上で精製し酢酸
エチルから再結晶することにより表題化合物が6 3
5mg(1 5.2%)得られた。Melting point 101-104°C I R (KBr) cm-': 3438, 327
8. 162g, 1606, 1544, 1509
, 1455. 143g, 1364, 1351,
1297, 1248, 1172, 1038. N.M.
R (C D Cl2,) δ: 1. 65 (2H,
m), 1. 77(2}1, m), 2.85(2
H. t, J = 5. 82Hz), 3. 01
(2H, t, J = 5.15Hz), 3.8
4 (3H, s), 6. 59 (IH, d. J=
12. 1Hz), 6. 66 (IH, d, J
= 12. 1Hz). 6. 91 (2H, d,
J=8. 82Hz), 7. 35 (2H, d
, J-8. 82Hz). Elemental analysis value: Calculated value as C + eH 1sN 2 SO: C, 67.10: H, 6.33; N, 9.
78:S, 11. 20, Actual value: C, 66.83; H, 6.34; N, 9
.. 69;S, 11. 08 Example 173 2-+1-(2-pyricyl)ethenyl l-5.6,7.
8-Tetrahydro 4H-thiazolo[5.4-b]azepine β-(2-biridyl)acrylic acid hydrochloride (3g, 16.
2 mmol) dimethylformamide solution (2Cltf
2), triethylamine (3.27 g. 32.3 mmol), 1-hydrobor-7penzotriazole hydrate (2.
72g, 17.8 mmol) and cooled with water.
Dicyclohexylcarbodiimide (3.67g, 17.
A solution of 8 mmol) in dimethylformamide (2M) was added dropwise. After stirring at room temperature for 2 hours, 3-amino-ε-cabrolactam (2.28 g, 17.8 mmol) was added to the reaction mixture, and the mixture was stirred at room temperature overnight. Heavy backwater was added and extracted with a mixed solvent of chloroform and methanol. After drying over magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was purified on silica gel column chromatography and purified with phosphorus pentasulfide (3.6 g,
1 in pyridine (20 m) with 6.2 mmol)
The mixture was heated and stirred at 20°C for 5 hours. After cooling to room temperature, aqueous sodium bicarbonate was added to the reaction mixture, extracted with a mixture of chloroform and methanol, dried over magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was purified on silica gel column chromatography and recrystallized from ethyl acetate to give the title compound 63
5 mg (15.2%) was obtained.
融点 158〜160’(酢酸エチルから再結晶),l
R (KBr)cm ’ : 3220, 1629
, 1583, 1555, 1513, 1471,
1445, 1419, 1367, 1355. 1
273, 959.NMR(CDCC.)δ: l.
70(2H, m), 1. 81(2H. m),
292(2H, t, J= 5. 76Hz), 3
. 13(2H, t, J== 5. 19Hz),
4.09(1B, br. s), 7. 13(I
H, d. J = 16. 0Hz), 7. 14
(18, m), 7. 39(IH, d, J =
7. 93Hz), 7. 51(IH, d, J
= 16. 0Hz),7. 65(IH, dt,
J = 1. 83Hz, 7. 70Hz), 8.
57(IH, d, J=4. 76Hz).
元素分析値: C ,.H ,,N,Sとして計算値:
C,65J4; H,5.87; N,16.33.
実測値: C,65.02; H,5.93; N,1
5.98.実施例174
2−+2.2−ビス(4−ジエチルアミノフエニル)エ
テニルl−5.6,7.8−テトラヒド口−4H−チア
ゾロ[5.4−bコアゼビン
実施例173と同様の方法により、β1β′−ビス(4
−ジエチルアミノフェニル)アクリル酸、1ヒドロキシ
ベンゾトリアゾールー水’FD物、/シクロへキシル力
ルポジイミド、3−アミノーεカプロラクタム及び五硫
化燐から表題化合物が得られた(収率12.6%)。Melting point 158-160' (recrystallized from ethyl acetate), l
R (KBr)cm': 3220, 1629
, 1583, 1555, 1513, 1471,
1445, 1419, 1367, 1355. 1
273, 959. NMR (CDC.) δ: l.
70 (2H, m), 1. 81 (2H.m),
292 (2H, t, J= 5.76Hz), 3
.. 13 (2H, t, J== 5.19Hz),
4.09 (1B, br.s), 7. 13(I
H, d. J = 16. 0Hz), 7. 14
(18, m), 7. 39 (IH, d, J =
7. 93Hz), 7. 51 (IH, d, J
= 16. 0Hz), 7. 65 (IH, dt,
J = 1. 83Hz, 7. 70Hz), 8.
57 (IH, d, J=4.76Hz). Elemental analysis value: C,. Calculated values as H,,N,S:
C, 65J4; H, 5.87; N, 16.33.
Actual value: C, 65.02; H, 5.93; N, 1
5.98. Example 174 2-+2.2-bis(4-diethylaminophenyl)ethenyl l-5.6,7.8-tetrahydro-4H-thiazolo[5.4-b coazebin by a method similar to Example 173 β1β′-bis(4
The title compound was obtained from -diethylaminophenyl)acrylic acid, 1-hydroxybenzotriazole-water'FD product, cyclohexyllupodiimide, 3-amino-epsilon caprolactam and phosphorus pentasulfide (yield 12.6%).
融点 173〜175°(酢酸エチルから再結晶).I
R (KBr)am−’ : 2972. 1608
. 15g8, 1549, 1519, 1468,
1401. 1351, 1266. 11!13.
1154, 816.NMR(CDCi2s)δ: 1
. 15(6B, t, J= 7. 05Hz),
1. 23(6H, t, J= 7. 05Hz).
1. 62(2H, m), 1. 74(2H.
m), 283(2H, t, J= 5. 64Hz
), 2. 97(2H, t, J = 4. 90
Hz). 3、34(4H, q, J= 7、05H
z), 3. 42(4H, Q, J= 7. 05
Hz), 3.65(IH, br. s). 6.
58(2H, d, J=8. 98Hz), 6.
76(2H, dJ = 8. 81Hz), 7.
04(2H, d, J = 8. 81Hz), 7
. 15(IH, s),7.23(2H, d, J
= 8. 98Hz).元素分析値: C 1sH s
sN 4Sとして計算値: C,73.37; H,8
.07; N,11.80;S, 6.75.
実測値: C,?3.19; H,8.15; N,1
1,59;S,6.61.
実施例175
21?(4−ジエチルアミノフェニル)エチルl−5.
6,7.8−テトラヒド口−4H−チアゾC’[5.4
−b]アゼピン・二塩酸塩実施例18と同様の方広によ
り、3−(4−ジエチルアミノフエニル)プロビオン酸
、3−アミノーε一カブロラクタム及び五硫化燐を反応
精製後、塩化水素で中和して表題化合物が得られた(収
率l2.2%)。Melting point 173-175° (recrystallized from ethyl acetate). I
R(KBr)am-': 2972. 1608
.. 15g8, 1549, 1519, 1468,
1401. 1351, 1266. 11!13.
1154, 816. NMR (CDCi2s) δ: 1
.. 15 (6B, t, J = 7.05Hz),
1. 23 (6H, t, J = 7.05Hz).
1. 62 (2H, m), 1. 74 (2H.
m), 283 (2H, t, J= 5.64Hz
), 2. 97 (2H, t, J = 4.90
Hz). 3, 34 (4H, q, J= 7, 05H
z), 3. 42 (4H, Q, J= 7.05
Hz), 3.65 (IH, br.s). 6.
58 (2H, d, J=8.98Hz), 6.
76 (2H, dJ = 8.81Hz), 7.
04 (2H, d, J = 8.81Hz), 7
.. 15 (IH, s), 7.23 (2H, d, J
= 8. 98Hz). Elemental analysis value: C 1sH s
Calculated value as sN 4S: C, 73.37; H, 8
.. 07; N, 11.80; S, 6.75. Actual value: C,? 3.19; H, 8.15; N, 1
1,59;S,6.61. Example 175 21? (4-diethylaminophenyl)ethyl l-5.
6,7.8-Tetrahydro-4H-thiazoC'[5.4
-b] Azepine dihydrochloride 3-(4-diethylaminophenyl)probionic acid, 3-amino-ε-cabrolactam and phosphorus pentasulfide were purified by reaction in the same manner as in Example 18, and then neutralized with hydrogen chloride. The title compound was obtained (yield 12.2%).
Claims (1)
ていてもよい脂肪族基、カルボン酸アシル基若しくはス
ルホン酸アシル基を、R^2は水素原子又は、それぞれ
置換基を有していてもよい芳香環基若しくは脂肪族基を
示す]で表わされる化合物またはその塩を含有すること
を特徴とする降圧剤。 2、R^1が水素原子で、R^2が、それぞれ置換基を
有していてもよいフェニル基又は炭素数2〜4のアルケ
ニル基である請求項1記載の降圧剤。 3、R^2が式 ▲数式、化学式、表等があります▼ [式中、R^5,R^6及びR^7はそれぞれ同一又は
異なって水素原子、低級アルキル基又は置換基を有して
いてもよい芳香環基を示し、R^5とR^7は互に結合
し環を形成していてもよい。ただし、R^8,R^7の
少なくとも一方は置換基を有していてもよい芳香環基で
ある。]で表わされる基である請求項1記載の降圧剤。 4、R^2が式 −CH=CH−R^6′ (式中、R^6′はアミノ基または置換アミノ基で置換
された芳香環基を示し、チアゾロアゼピン環に対し、シ
ス配位である)で表わされる基である請求項1記載の降
圧剤。 5、R^6′が、モノ−又はシ−低級アルキルアミノ基
で置換されたフェニル基である請求項4記載の降圧剤。 6、式 ▲数式、化学式、表等があります▼[ I ″] [式中、R^1は水素原子又は、それぞれ置換基を有し
ていてもよい脂肪族基、カルボン酸アシル基若しくはス
ルホン酸アシル基を、R^2は式 −CH=CH−R^6′ (式中、R^6′はアミノ基または置換アミノ基で置換
された芳香環基を示し、チアゾロアゼピン環に対し、シ
ス配位である)で表わされる基を示す]で表わされる化
合物。 7、R^6′がモノ−又はジ−低級アルキル置換アミノ
基で置換されたフェニル基である請求項6記載の化合物
。[Claims] 1. Formula [I] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [I] [In the formula, R^1 is a hydrogen atom or an aliphatic group which may have a substituent, respectively. , a carboxylic acid acyl group or a sulfonic acid acyl group, and R^2 represents a hydrogen atom, or an aromatic ring group or an aliphatic group each optionally having a substituent, or a salt thereof. An antihypertensive agent characterized by: 2. The antihypertensive agent according to claim 1, wherein R^1 is a hydrogen atom and R^2 is a phenyl group or an alkenyl group having 2 to 4 carbon atoms, each of which may have a substituent. 3. R^2 is a formula ▲ There are mathematical formulas, chemical formulas, tables, etc. R^5 and R^7 may be bonded to each other to form a ring. However, at least one of R^8 and R^7 is an aromatic ring group which may have a substituent. The antihypertensive agent according to claim 1, which is a group represented by the following. 4, R^2 has the formula -CH=CH-R^6' (wherein, R^6' represents an amino group or an aromatic ring group substituted with a substituted amino group, and has a cis-coordination with respect to the thiazoloazepine ring. The antihypertensive agent according to claim 1, which is a group represented by (a). 5. The antihypertensive agent according to claim 4, wherein R^6' is a phenyl group substituted with a mono- or cy-lower alkylamino group. 6. Formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [ I ″] [In the formula, R^1 is a hydrogen atom, or an aliphatic group, a carboxylic acid acyl group, or a sulfonic acid group, each of which may have a substituent. An acyl group, R^2 is of the formula -CH=CH-R^6' (wherein, R^6' represents an amino group or an aromatic ring group substituted with a substituted amino group, and the cis-configuration is 7. The compound according to claim 6, wherein R^6' is a phenyl group substituted with a mono- or di-lower alkyl-substituted amino group.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000833A JPH03206042A (en) | 1990-01-06 | 1990-01-06 | Hypotensor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000833A JPH03206042A (en) | 1990-01-06 | 1990-01-06 | Hypotensor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH03206042A true JPH03206042A (en) | 1991-09-09 |
Family
ID=11484621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000833A Pending JPH03206042A (en) | 1990-01-06 | 1990-01-06 | Hypotensor |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH03206042A (en) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000078761A1 (en) * | 1999-06-23 | 2000-12-28 | Sepracor, Inc. | Indolyl-benzimidazole antibacterials, and methods of use thereof |
| US6984652B2 (en) | 2003-09-05 | 2006-01-10 | Warner-Lambert Company Llc | Gyrase inhibitors |
| WO2009028588A1 (en) * | 2007-08-31 | 2009-03-05 | Eisai R & D Management Co., Ltd. | Polycyclic compound |
| US7618960B2 (en) | 2005-11-24 | 2009-11-17 | Eisai R&D Management Co., Ltd. | Morpholine type cinnamide compound |
| US7667041B2 (en) | 2004-05-26 | 2010-02-23 | Eisai R&D Management Co., Ltd. | Cinnamide compound |
| US7713993B2 (en) | 2006-03-09 | 2010-05-11 | Eisai R&D Management Co., Ltd. | Multi-cycle cinnamide derivatives |
| US7737141B2 (en) | 2006-07-28 | 2010-06-15 | Eisai R&D Management Co., Ltd. | Prodrug of cinnamide compound |
| US7923563B2 (en) | 2004-10-26 | 2011-04-12 | Eisai R&D Management Co., Ltd. | Amorphous object of cinnamide compound |
| US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| US8008293B2 (en) | 2007-02-28 | 2011-08-30 | Eisai R&D Management Co., Ltd. | Bicyclic oxomorpholine derivative |
| US8048878B2 (en) | 2005-11-24 | 2011-11-01 | Eisai R&D Management Co., Ltd. | Two cyclic cinnamide compound |
| WO2011154696A1 (en) | 2010-06-08 | 2011-12-15 | Cambridge Enterprise Limited | Anti-inflammatory agents |
| JP2013531002A (en) * | 2010-07-09 | 2013-08-01 | アブビー・ベー・ブイ | Fused heterocyclic derivatives as S1P modulators |
| US9662337B2 (en) | 2010-07-09 | 2017-05-30 | Abbvie B.V. | Bisaryl (thio)morpholine derivatives as S1P modulators |
| US9951084B2 (en) | 2010-07-09 | 2018-04-24 | Abb Vie B.V. | Spiro-cyclic amine derivatives as S1P modulators |
| US11535632B2 (en) | 2019-10-31 | 2022-12-27 | ESCAPE Bio, Inc. | Solid forms of an S1P-receptor modulator |
-
1990
- 1990-01-06 JP JP2000833A patent/JPH03206042A/en active Pending
Cited By (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000078761A1 (en) * | 1999-06-23 | 2000-12-28 | Sepracor, Inc. | Indolyl-benzimidazole antibacterials, and methods of use thereof |
| US6984652B2 (en) | 2003-09-05 | 2006-01-10 | Warner-Lambert Company Llc | Gyrase inhibitors |
| US7667041B2 (en) | 2004-05-26 | 2010-02-23 | Eisai R&D Management Co., Ltd. | Cinnamide compound |
| US7687640B2 (en) | 2004-05-26 | 2010-03-30 | Eisai R&D Management Co., Ltd. | Cinnamide compound |
| US7880009B2 (en) | 2004-05-26 | 2011-02-01 | Eisai R&D Management Co., Ltd. | Cinnamide compound |
| US7923563B2 (en) | 2004-10-26 | 2011-04-12 | Eisai R&D Management Co., Ltd. | Amorphous object of cinnamide compound |
| US8048878B2 (en) | 2005-11-24 | 2011-11-01 | Eisai R&D Management Co., Ltd. | Two cyclic cinnamide compound |
| US7618960B2 (en) | 2005-11-24 | 2009-11-17 | Eisai R&D Management Co., Ltd. | Morpholine type cinnamide compound |
| US7973033B2 (en) | 2006-03-09 | 2011-07-05 | Eisai R&D Management Co., Ltd. | Multi-cyclic cinnamide derivatives |
| US7713993B2 (en) | 2006-03-09 | 2010-05-11 | Eisai R&D Management Co., Ltd. | Multi-cycle cinnamide derivatives |
| US7897632B2 (en) | 2006-03-09 | 2011-03-01 | Eisai R&D Management Co., Ltd. | Multi-cyclic cinnamide derivatives |
| US7737141B2 (en) | 2006-07-28 | 2010-06-15 | Eisai R&D Management Co., Ltd. | Prodrug of cinnamide compound |
| US8008293B2 (en) | 2007-02-28 | 2011-08-30 | Eisai R&D Management Co., Ltd. | Bicyclic oxomorpholine derivative |
| JP5433418B2 (en) * | 2007-08-31 | 2014-03-05 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Polycyclic compound |
| CN101815713A (en) * | 2007-08-31 | 2010-08-25 | 卫材R&D管理有限公司 | Polycyclic compounds |
| WO2009028588A1 (en) * | 2007-08-31 | 2009-03-05 | Eisai R & D Management Co., Ltd. | Polycyclic compound |
| US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| AU2008292390B2 (en) * | 2007-08-31 | 2013-04-04 | Eisai R & D Management Co., Ltd. | Polycyclic compound |
| US9453000B2 (en) | 2007-08-31 | 2016-09-27 | Eisai R&D Management Co., Ltd. | Polycyclic compound |
| WO2011154696A1 (en) | 2010-06-08 | 2011-12-15 | Cambridge Enterprise Limited | Anti-inflammatory agents |
| JP2013531002A (en) * | 2010-07-09 | 2013-08-01 | アブビー・ベー・ブイ | Fused heterocyclic derivatives as S1P modulators |
| US9662337B2 (en) | 2010-07-09 | 2017-05-30 | Abbvie B.V. | Bisaryl (thio)morpholine derivatives as S1P modulators |
| US9670220B2 (en) | 2010-07-09 | 2017-06-06 | Abbvie B.V. | Fused heterocyclic derivatives as S1P modulators |
| US9951084B2 (en) | 2010-07-09 | 2018-04-24 | Abb Vie B.V. | Spiro-cyclic amine derivatives as S1P modulators |
| US10179791B2 (en) | 2010-07-09 | 2019-01-15 | Abbvie B.V. | Spiro-cyclic amine derivatives as S1P modulators |
| US10807991B2 (en) | 2010-07-09 | 2020-10-20 | Abbvie B.V. | Spiro-cyclic amine derivatives as S1P modulators |
| US11427598B2 (en) | 2010-07-09 | 2022-08-30 | AbbVie Deutschland GmbH & Co. KG | Spiro-cyclic amine derivatives as S1P modulators |
| US11535632B2 (en) | 2019-10-31 | 2022-12-27 | ESCAPE Bio, Inc. | Solid forms of an S1P-receptor modulator |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH03206042A (en) | Hypotensor | |
| CA1067079A (en) | Nitrogen-containing heterobicyclic compounds | |
| DE69221988T2 (en) | Process for the preparation of substituted maleimides | |
| TWI394743B (en) | Bicyclic azabicyclic carboxamide derivatives, preparation and therapeutic use thereof | |
| EP0370381B1 (en) | 2(1H)-quinolinone compounds, processes for the preparation thereof and pharmaceutical composition comprising the same | |
| EP0351856B1 (en) | Thiazolo[5,4-b]azepine compounds | |
| WO2000009506A1 (en) | 1h-imidazopyridine derivatives | |
| JP2011519849A (en) | Piperidine and pyrrolidine compounds | |
| IE55156B1 (en) | Pharmacologically active pyrazolo(4,3-c)pyridines | |
| JP2010508288A (en) | Heterocyclic amide compounds useful as kinase inhibitors | |
| CA2598133A1 (en) | Pgd2 receptor antagonists for the treatment of inflammatory diseases | |
| SU1531855A3 (en) | Method of obtaining aminomethylbenzoyl derivatives of benzothiazine dioxide | |
| KR20050099525A (en) | Process for preparing pyrrolotriazine kinase inhibitors | |
| US5739130A (en) | Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them | |
| JPH08337583A (en) | Heterocyclic compound and its production | |
| WO1986001510A1 (en) | Tricyclic oxindole antiinflammatory agents | |
| FI96315C (en) | Process for the preparation of therapeutically useful pyrroloquinoline, benzothiazine, acridine, phenoxazine and phenothiazine derivatives | |
| EP0306185A1 (en) | Tricyclic fused pyrimidine derivatives their production and use | |
| US4539400A (en) | Pyridin-3-yl substituted ortho-fused pyrrole derivatives | |
| CN115611901B (en) | Azepine compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof | |
| JPH0377881A (en) | Nicotinamide compound | |
| SU1245260A3 (en) | Method of producing 9-formyl-derivatives of pyrido /1,2-a/ pyrimidine or their optically active antipodes | |
| JPS60178879A (en) | Furanone derivative | |
| Nemazany et al. | A new and efficient route to amino derivatives of [1, 6]‐and [2, 7] naphthyridones | |
| JPH04128291A (en) | New heterocyclic compound and its production |